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The longstanding belief that women are born with a finite ovarian reserve has been 
debated for over a decade, ever since the discovery, and subsequent isolation, of 
purported oogonial stem cells (OSCs) from adult mammalian ovaries.  This rare cell 
population has now been reported in the mouse, rat, pig, rhesus macaque monkey and 
humans and, although a physiological role for the cells has not been proven, they do 
appear to generate oocytes when cultured in specific environments, resulting in live 
offspring in rodents.  The primary aim of this thesis was to verify independently the 
existence of OSCs in human ovary and determine whether they could be isolated from 
a large animal model, the cow.  The secondary aim was to investigate the cells’ in vitro 
potential, both to undergo neo-oogenesis and as a model for germ cell development. 
Putative bovine and human OSCs were isolated from disaggregated adult ovarian 
cortex using a previously validated fluorescence-activated cell sorting (FACS)-based 
technique, with cells sorted for externally expressed DDX4 (VASA).  Freshly isolated 
and cultured cells were characterised by analysing their expression of pluripotency and 
germline markers, using RT-PCR, immunocytochemistry and Western blotting.  The 
in vitro neo-oogenesis potential of the cells was explored by injecting fluorescently 
labelled cells into fragments of adult ovarian cortex and by forming aggregated 
artificial “ovaries” with putative OSCs and fetal ovarian somatic cells.  Germ cell 
model experiments comprised treatment of cultured cells with BMP4 and/or retinoic 
acid (RA), with subsequent quantitative RT-PCR and immunocytochemistry analysis 
for downstream BMP4- and RA-response genes, and liposomal-mediated transfection 
of cells with a DAZL overexpression plasmid to assess their meiosis-related gene 
response. 
Scarce populations of putative OSCs were retrieved from 5 human samples (aged 13-
40 years) and 6 bovine samples.  The cells were cultured long-term for up to 7 months 
and demonstrated consistent expression of several pluripotency-associated and 
germline markers at the mRNA and protein level, including LIN28, NANOG, 
POU5F1 (OCT4), IFITM3 (fragilis), STELLA, PRDM1 (BLIMP1), and C-KIT, 
indicating their early germline nature.  Investigation of neo-oogenesis potential 
revealed that putative human OSCs were associated rarely with fetal somatic cells in 
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primordial follicle-like structures, but could not be confirmed to have undergone 
oogenesis.  However, like early germ cells, putative bovine and human OSCs were 
BMP4 and RA responsive, with both species demonstrating significant upregulation 
of expression of ID1 and bovine cells exhibiting a significant increase in MSX1, MSX2 
and the meiotic marker SYCP3 in response to BMP4 and/or RA treatment.  Cells could 
be successfully transfected to overexpress DAZL; however, no significant downstream 
gene expression changes were observed. 
This is the first report of putative bovine OSC isolation and corroborates a previous 
report showing putative human OSC isolation.  Although the expression of both stem 
cell and germline markers indicates the cells have characteristics of OSCs, their 
capacity to enter meiosis and form functional oocytes has yet to be determined.  
Putative bovine OSCs, however, show promise as a novel model for investigating germ 
cell development.  If their potential can be harnessed, then OSCs may have a role in 
clinical applications, for example in fertility preservation, in the future.  Future 
experiments will examine the neo-oogenesis capabilities of the cells further and 






It has long been believed that women are born with all the eggs they will ever have.  
However, since 2004, unique cells have been detected in the ovary that seemingly 
make new eggs when grown in the right conditions.  These cells, called oogonial stem 
cells (OSCs), have been isolated from mice, rats, pigs, monkeys and humans.  When 
mouse and rat OSCs are transplanted back into ovaries, live mice and rats have been 
born from eggs apparently created by the stem cells.  However, there is no proof that 
these cells make new eggs under normal circumstances within the ovary and the idea 
of egg-producing stem cells has been controversial, with many scientists challenging 
the findings.  The aim of this research was to investigate whether these cells exist in 
cow and human ovaries and, if so, to explore whether they could make new eggs when 
grown in a dish. 
By cutting up pieces of ovary and using an antibody to select cells containing a marker 
called DDX4, a rare population of cells was isolated from both bovine and human adult 
ovaries.  These cells exhibited markers of a stem cell with egg-like qualities, implying 
the cells may be able to divide repeatedly over a long period of time and also develop 
into new eggs.  The cells multiplied successfully for up to 7 months in the laboratory 
and continued to show the stem cell and egg markers.  Attempts were made to create 
eggs from the cells by injecting them back into ovaries and also by creating “artificial 
ovaries” by combining them with another type of cell that supports egg growth, but it 
could not be proven that the cells could form new eggs.  However, when the cells were 
treated with two substances (BMP4 and retinoic acid) that encourage the precursors of 
eggs to mature into eggs before females are born, they behaved in the same way as the 
egg precursors.  This suggested that these cells may provide a great opportunity to look 
more closely at how eggs grow and develop as they could be used in experiments to 
simulate what happens to these egg precursors in real life.  This is of great scientific 
value as there is a very limited availability of human eggs to perform experiments on. 
This is the first time in the world that these cells have been discovered in the cow and 
confirms previous research in humans.  If these cells can form new, healthy eggs, then 
they could provide a new treatment option for girls and women at risk of infertility due 
to cancer treatment who, due to age or time constraints, cannot have eggs collected 
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prior to starting treatment.  Future experiments will explore further the ability of the 
cells to form new eggs in a dish and also investigate new ways of delivering the cells 
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1.1 Development of the Female Germ Cell 
 Formation of the Ovarian Reserve 
In mammals, reproduction is only possible through the production of a unique cell 
population, known as germ cells.  The female and male counterparts of this cell type 
must become haploid and be able to undergo fertilisation, in order to create a zygote 
with the correct complement of chromosomes.  This process permits perpetuation of 
the species by giving rise to the next generation.  The female germ cell, the oocyte, is 
the largest cell in the body.  It is contained within the fundamental structure of the 
mammalian ovary, the ovarian follicle, consisting of an oocyte surrounded by 
supportive somatic (granulosa and theca) cells.  The follicle has two essential roles: (i) 
the maturation and release of an oocyte for fertilisation and (ii) production of 
reproductive hormones.  These hormones, which include estrogen and progesterone, 
are important for general systemic wellbeing, and are vital to the correct function of 
several organs in the body including the ovary, uterus, bone and breasts. 
The formation of the oocyte population, known as the ovarian reserve, could be 
considered an extremely wasteful biological process, with millions of female germ 
cells undergoing attrition during its creation.  In mammals, it is a highly regulated 
process (Fig. 1.1) which starts early in the post-implantation embryo, with paracrine 
signalling from adjacent cells inducing the specification of a small number of 
primordial germ cells (PGCs) from a subdivision of epiblast cells within the inner cell 
mass (ICM) of the blastocyst (Irie et al., 2014).  Members of the transforming growth 
factor β1 (TGFβ1) family called bone morphogenetic proteins (BMPs) appear to be 
critical for germ cell specification, with mouse studies demonstrating that homozygous 
null mutants for Bmp4 (Lawson et al., 1999) and Bmp8b (Ying et al., 2000) either 
have a complete lack of PGCs or at least an extreme depletion.  The role of BMP 
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Although PGC development has been most thoroughly studied in mice, this thesis 
focusses on human and bovine ovarian tissue and therefore the timeline of the process 
in these two species will be described.  Humans and cows have very similar gestation 
lengths (40 weeks versus 39 weeks) and their ovarian reserves are also formed at 
comparable timings (Fig. 1.2).   
 
 
Figure 1.2.  Comparison of the time frame for the formation of the follicular pool 
in the human and bovine fetus, showing very similar temporal processes. 
 
PGCs initially reside within a transient structure known as the primitive streak.  From 
there, rapidly proliferating PGCs migrate to the hind gut using pseudopodia to produce 
amoeboid movements and subsequently reach the genital ridges by 6 weeks gestation 
in humans (Fujimoto et al., 1977) and 9 weeks gestation in cattle (Aerts and Bols, 
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2010).  The targeted migration of PGCs appears to be in response to genital ridge-
derived chemotactic signals and is aided by cell-cell interactions.  The role of the 
genital ridge in secreting chemoattractants is well established, with mouse PGCs 
exhibiting migration towards isolated genital ridges in vitro (Godin et al., 1990).  Both 
stem cell factor (SCF; also known as Kit ligand, KL) and stromal cell-derived factor 1 
(SDF1) have been demonstrated to guide mouse PGC movement: in vitro experiments 
demonstrated that PGCs migrate in response to SCF (Farini et al., 2007), whilst knock-
out studies revealed that interaction between genital ridge-derived SDF1 and its 
receptor, C-X-C chemokine receptor type 4 (CXCR4), on PGCs is required for correct 
migration to occur (Molyneaux et al., 2003).  With regards cell-cell interactions, 
integrin β1 enables cell migration, with PGC expression of the protein critical for 
colonisation of the gonads, likely through both cell-cell and cell-ECM interactions 
(Anderson et al., 1999). 
Sexual differentiation occurs at 6-7 weeks gestation in humans (Sarraj and Drummond, 
2012) and by 6 weeks in the cow (Erickson, 1966): the absence of the sex-determining 
region on the Y chromosome (SRY), plus the presence of female sex-determining 
genes such as wingless-type MMTV integration site family member 4 (WNT4; Vainio 
et al., 1999), leads to differentiation of PGCs into oogonia and the creation of ovaries 
(Sarraj and Drummond, 2012).  Oogonia continue to undergo mitosis, with numbers 
in humans increasing from ~26,000 at 6 weeks gestation to ~250,000 at 9 weeks 
gestation (Bendsen et al., 2006).  In cattle, the numbers at equivalent gestations are 
~16,000 and ~325,000 respectively (Erickson, 1966).  During this time oogonia 
associate with somatic cells within the gonad, becoming enclosed in germ cell nests.  
Incomplete cytokinesis during mitotic division of the oogonia results in cytoplasmic 
bridges connecting the cells, thus allowing bi-directional communication (Pepling and 
Spradling, 1998, Hartshorne et al., 2009).  In cattle, the germ cells are contained within 
more defined ovigerous cords (Smith et al., 2007).   
In order to attain haploid status, germ cells have the unique ability to undergo meiosis.  
Oogonia enter meiosis from approximately 9-12 weeks gestation in humans (Motta et 
al., 1997, Bendsen et al., 2006) and 11 weeks in cattle (Erickson, 1966), but entry can 
continue until around 19 weeks gestation (Hartshorne et al., 2009), meaning that germ 
cells at many differing stages of maturation can be present in the ovary simultaneously.  
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
General Introduction 6 
There appears to be a spatial distinction between oogonia that are still undergoing 
mitotic divisions and those entering meiosis, with the former being distributed around 
the periphery of the ovaries and the latter being located centrally (Anderson et al., 
2007).  Upon entering meiosis, oogonia are thereafter termed oocytes.  Oocytes 
progress through the stages of prophase I: leptotene (chromatin condensation), 
zygotene (pairing of homologous chromosomes with formation of synaptonemal 
complex) and pachytene (recombination of chromosomes) until arresting in the 
diplotene stage, where chromosomes start to separate from each other, but remain 
attached at chiasmata (Baillet and Mandon-Pepin, 2012).  Mouse studies have 
demonstrated that the RNA-binding protein Deleted in azoospermia-like (Dazl) is an 
essential requirement for meiotic entry (Lin et al., 2008) and human studies have 
shown that DAZL expression is significantly upregulated around the time of meiotic 
entry, with its expression being centrally located in “nests” (Anderson et al., 2007).  It 
is possible that the synaptonemal complex protein 3 (SYCP3) gene, which is required 
for the pairing of homologous chromosomes in zygotene (Yuan et al., 2002), is a 
DAZL target in the human female gonad as male knock-out mice studies have 
demonstrated that Dazl increases the translation of Sycp3 mRNA (Reynolds et al., 
2007).  Ovarian-derived retinoic acid (RA) is also regarded as critical in inducing 
meiotic entry in mammals, including humans (Le Bouffant et al., 2010, Childs et al., 
2011), acting through Stimulated by retinoic acid gene 8 (STRA8).  STRA8 is a key 
regulator of the initiation of meiosis, with Stra8-deficient mouse PGCs unable to 
undergo premeiotic DNA replication and subsequently failing to demonstrate the 
chromosomal changes required during meiosis (Baltus et al., 2006).  The roles of both 
DAZL and RA in meiosis will be discussed in more depth in Chapter 6.   
After approximately 18 weeks gestation in humans, germ cell nests begin to break 
down and the earliest follicular structures, called primordial follicles, are formed. The 
first primordial follicles in bovine ovaries can be seen by 13 weeks gestation (Yang 
and Fortune, 2008).  In mice, it has been postulated that nest breakdown occurs in a 
stepwise manner due to apoptosis of some of the oogonia within the nests: this creates 
smaller nests which continue to decrease in size due to continuing apoptosis, until a 
small number of oocytes remain which will form primordial follicles (Pepling and 
Spradling, 2001).  In this model, the oogonia that undergo apoptosis are considered 
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“nurse cells”, supplying essential molecules via the cytoplasmic bridges to the 
neighbouring oogonia that will ultimately become oocytes, before undergoing 
programmed cell death (Pepling and Spradling, 2001).  There is no evidence 
supporting the extension of this theory to humans or cattle, however.  Primordial 
follicles consist of an oocyte arrested in prophase I, surrounded by one layer of 
flattened squamous cells and arise when pre-granulosa cells are recruited by oocytes.  
Concurrently, PGCs continue to proliferate, with the number of resultant oogonia 
reaching a peak of ~5 - 7 million by the 5th month of gestation in humans (Hartshorne 
et al., 2009) and ~2.7 million by the 4th month of gestation in cattle (Erickson, 1966).  
Subsequently, however, there is substantial germ cell elimination: in addition to 
apoptosis of oogonia within nests, death occurs in non-enclosed oogonia/oocytes.  The 
exact reason for this germ cell loss is unknown, but may be due to intrinsic factors, 
such as genetic errors generated during prophase I or failure to arrest, and/or extrinsic 
factors, including erroneous paracrine signalling from neighbouring somatic cells with 
the absence of “survival factors” such as activin (Hartshorne et al., 2009).  Moreover, 
research suggests that the B-cell lymphoma/leukaemia 2 (BCL2) family of proteins, 
which comprises both pro- and anti-apoptotic members, play a key role in germ cell 
death (Aitken et al., 2011, Hutt, 2015).  Examples include the pro-apoptotic BCL-2 
associated X protein (BAX) and the anti-apoptotic BCL2 protein.  Bax is upregulated 
in fetal mouse oocytes undergoing apoptosis (DeFelici et al., 1999), with knock-out 
studies demonstrating that Bax-deficient mice have increased numbers of oocytes 
(Greenfeld et al., 2007).  In contrast, Bcl2-deficient mice exhibited significantly 
reduced oocyte numbers (Ratts et al., 1995). 
Oocyte atresia is so extensive that, in the human, only ~600,000 follicles are formed 
from ~5 - 7 million germ cells by the 5th month of gestation, with ~590,000 follicles 
remaining by the time of birth, and there are merely ~360,000 still present by 13 years 
of age (Wallace and Kelsey, 2010).  In cattle, less than 70,000 follicles remain at birth 
(Erickson, 1966).  During reproductive life, oocytes within primordial follicles remain 
quiescent, arrested in the diplotene stage of prophase I, until they are activated to grow.  
Cohorts of immature follicles are continuously recruited, with one follicle selected for 
ovulation per menstrual cycle.  This contributes to the inexorable decline of follicles 
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until the ovarian reserve reaches approximately 1000 follicles, at which point the 
menopause occurs (Fig. 1.3).   
 
Figure 1.3  The change in non-growing follicle (NGF) numbers per ovary from 
conception to menopause in humans.  Follicles peak in numbers at approximately 5 
months gestation before declining throughout life.  The decline is initially rapid, but 
slows in later reproductive years.  Exhaustion of the ovarian reserve results in the 
menopause.  Based on data from Wallace and Kelsey, 2010. 
 
 Does post-natal oocyte formation occur?  
The current well-established and widespread belief within the field of Reproductive 
Biology is that women possess their lifetime’s supply of oocytes by the time they are 
born, known as a fixed ovarian reserve, and that the menopause occurs once this supply 
has been exhausted.  However, the debate surrounding whether or not female mammals 
are furnished with a fixed quantity of germ cells at birth has been ongoing since the 
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Waldeyer, a 19th century embryologist, is widely regarded as being the first advocate 
for the idea that females are born with a finite supply of oocytes (Waldeyer, 1870) and 
his views were supported by several other well-known biologists in the early 1900s 
(Allen, 1923).  However, the prevailing belief began to shift in the 1920s, when 
proponents for the theory that neo-oogenesis occurs in the post-natal ovary emerged, 
with their assertions based on thorough histological analysis of ovarian tissue 
(Robinson, 1918, Allen, 1923, Evans and Swezy, 1932).  Indeed, following 
investigations in rats, guinea pigs, cats, dogs and humans, Evans and Swezy stated 
firmly that: 
“The concept that…the ova are all formed before birth and remain 
quiescent until sexual maturity calls them into activity, has no foundation 
in fact. On the contrary, all the ova of adult life are new formations and are 
being constantly produced and as constantly destroyed.” (Evans and 
Swezy, 1932) 
It wasn’t until the landmark paper of Sir Solomon Zuckerman in 1951 that the question 
appeared to be answered once and for all (Zuckerman, 1951).  Following his extensive 
review of the existing literature involving oocyte counting, he concluded, in direct 
contrast to Evans & Swezy (Evans and Swezy, 1932): 
“None of the experimental and quantitative evidence which we have 
considered thus supports the view that oogenesis occurs in the adult ovary, 
and much of it bears very clearly against the proposition.” (Zuckerman, 
1951)  
The evidence presented by Zuckerman was such that he established the basic doctrine 
that has been steadfastly upheld ever since: female mammals form no new germ cells 
post-natally (Zuckerman, 1951).  This is one of the most significant examples of sexual 
dimorphism in mammals as it is in direct contrast to the male germ cell population, 
which undergoes continuous proliferation throughout post-pubertal life.  The dogma 
was subsequently supported by studies utilising tritiated thymidine labelling of 
proliferating cells, which failed to demonstrate the presence of mitotically active germ 
cells by monitoring the uptake of the radioisotope in the ovaries of adult mice (Rudkin 
and Griech, 1962, Borum, 1967) and rats (Hirshfield, 1984).  Furthermore, treatment 
of rats in utero with busulphan, a chemotherapeutic agent that damages PGCs, was 
shown to cause premature exhaustion of the ovarian reserve (Hirshfield, 1994).  This 
appeared to indicate that the ovarian reserve is determined prior to birth, with no neo-
oogenesis occurring post-natally, although a deleterious effect of busulphan on the 
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ovarian stromal cells could have contributed to the reduction in follicle formation.  
Henderson and Edwards’ “production line hypothesis” is also regarded as supportive 
of the concept of a fixed ovarian reserve: analysis of the frequency of chiasmata within 
mouse oocytes revealed that frequency decreased with increasing age of the mouse 
(Henderson and Edwards, 1968).  It was hypothesised that this indicated oocytes 
recommence meiosis in the order they are formed in the fetal gonad, with oocytes in 
older mice undergoing more proliferation pre-natally than younger oocytes.  If post-
natal neo-oogenesis occurs then, according to this theory, it could be assumed that little 
change in chiasmata frequency would be seen with age as newly formed oocytes in the 
older mice would not exhibit low chiasmata frequencies.  However, the “production 
line hypothesis” remains a theory; indeed, a recent study of chiasmata frequency in 
prophase I-stage oocytes of human fetal ovaries demonstrated no correlation between 
levels of recombination and the gestation at which the oocytes entered meiosis 
(Rowsey et al., 2014). 
This central tenet of the field was not called into question again until 2004, when 
Johnson et al. reported the existence of what have been termed female germline stem 
cells (fGSCs) in the adult mouse ovary which appeared capable of forming new 
oocytes post-natally (Johnson et al., 2004).  Subsequently, the debate has been 
reignited, with proponents for and against the theory of neo-oogenesis (Powell, 2007) 
(discussed in depth in section 1.2).     
 
 Ovarian Insufficiency  
The fixed ovarian reserve dogma may once again be up for debate, however, what is 
unquestionable is that reproductive senescence occurs.  Ovarian insufficiency, where 
the ovary can no longer maintain its reproductive and endocrinological roles, is a 
physiological, age-related process occurring at an average age of 51 years old in 
women (Nelson et al., 2013).  With increasing life expectancies, the length of a 
woman’s post-reproductive lifespan is becoming longer, distinguishing humans from 
other animals, including primates (Hawkes et al., 1998).  In addition to troublesome 
menopausal symptoms such as hot flushes and night sweats that affect quality of life, 
post-menopausal loss of ovarian-derived estradiol has significant effects on women’s 
health, with issues including osteoporosis, heart disease and depression (Sowers and 
La Pietra, 1995).   
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There are also pathological causes of premature ovarian insufficiency (POI) which 
affect younger women and girls.  POI has a heterogeneous aetiology but can be broadly 
categorised as either iatrogenic (i.e. caused by medical treatment) or non-iatrogenic.  
Overall, idiopathic POI accounts for the majority of POI cases (Goswami and Conway, 
2007); however, increasing numbers of girls and young women of reproductive age 
are suffering iatrogenic POI as a result of life-saving treatment for diseases such as 
cancer and autoimmune diseases (Panay and Kalu, 2009).  Improvements in such 
treatments have led to a significant increase in survival rates over the last 15-20 years, 
especially in childhood cancers (Magnani et al., 2006), hence a preponderance of POI 
sufferers who have not yet started, or completed, their family.   
Although it is becoming clear that cancer treatment can have wide-reaching long-term 
adverse effects, it is the irreversibility of POI (due to the assumed inability to make 
new oocytes post-natally) that can be one of the most upsetting consequences, with 
sufferers reporting a lower quality of life than those cancer survivors without POI 
(Kondapalli et al., 2014).  Current fertility preservation strategies are becoming more 
effective; however, an ideal fertility preservation strategy for these women would not 
only prevent a delay in life-saving treatment but also produce a large number of 
oocytes.  The idea that fGSCs may exist and could prove useful in this regard is one 
of the principal reasons for research into their existence and function.  
 
1.2 Germline Stem Cells 
 The Function of Germline Stem Cells  
Stem cells are defined by their ability to self-renew and differentiate into different cell 
types.  Adult stem cells have a more restricted lineage than embryonic stem cells 
(ESCs) but are able to proliferate for protracted periods of time and their differentiated 
progeny are essential for the ongoing maintenance and repair of tissue over an animal’s 
lifespan.  This includes sustaining the circulating blood cell populations and allowing 
turnover of intestinal luminal cells.  Germline stem cells (GSCs) are a unique type of 
unipotent adult stem cell as they differentiate into the gametes that are vital for the 
continuation of a species.   
The concept of a GSC was first hypothesised in 1901 during studies on 
spermatogenesis (Regaud, 1901a, Regaud, 1901b).  The author proposed the theory 
that the post-pubertal testis must contain a population of cells that could both self-
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renew and differentiate into mature sperm.  Decades of subsequent study have 
validated this hypothesis and male GSCs, known as spermatogonial stem cells (SSCs), 
have been recognised to participate in spermatogenesis in all species in which the 
process has been studied (Brinster, 2007).  Research into the equivalent cell type in 
females has produced more conflicting data, with fGSCs having a confirmed role in 
post-natal neo-oogenesis in some species (discussed further in section 1.2.3).     
Equally as important as the GSCs themselves is their surrounding microenvironment, 
known as the germ cell niche.  These specialised somatic areas within the gonad are 
responsible for controlling the self-renewal and differentiation of GSCs, thus 
maintaining the population (Spradling et al., 2011).  Furthermore, it is thought that it 
is the presence of germ cell niches that differentiates those species that undergo post-
natal neo-oogenesis from those that cannot (Spradling et al., 2011).  The exact 
mechanisms by which the niche “holds” GSCs in an undifferentiated state have not 
been elucidated, but bi-directional paracrine and juxtacrine signaling between the 
somatic cells and GSCs likely plays a critical role.  In mammals, communication 
between daughter germ cells is also possible due to the cytoplasmic bridges formed 
between the cells during incomplete mitotic cytokinesis of the founder cell.  These 
bridges are large, measuring 0.5 - 3µm, and can allow both molecules and organelles 
as large as mitochondria to transfer between cells (Greenbaum et al., 2011).  Such 
“cytoplasmic sharing” is hypothesised to regulate the synchronisation of mitosis and 
control entry into meiosis (Greenbaum et al., 2011).  The germ cell niche has been 
investigated in detail in both Drosophila and the nematode, Caenorhabditis elegans 
(C. elegans) and will be discussed in more detail in section 1.2.3. 
 
 Prospective Molecular Markers of Mammalian GSCs 
If a cell is to be denoted a GSC, it would be assumed to express both markers of 
stemness and of the germline, thus indicating its early germline nature.  Detailed in 
this section are some candidate molecular markers of fGSCs based upon their 
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1.2.2.1 POU5F1 
POU Class 5 Homeobox 1 (POU5F1), otherwise known as octamer-binding 
transcription factor 4 (OCT4) is a transcription factor of the Pit-Oct-Unc (POU) family 
whose gene is highly conserved between mouse, cows and humans (Pesce et al., 1998).  
Its expression in both mammalian ESCs and germ cells is well established (Okamoto 
et al., 1990, Rosner et al., 1990, Nichols et al., 1998, Pesce et al., 1998, Richards et 
al., 2004): it appears to prevent differentiation of stem cells, with its expression being 
downregulated as cells proceed along a differentiation pathway.  It can be found in 
murine embryos as early as the 4-cell stage and is subsequently localised to the epiblast 
of the ICM (Pesce et al., 1998).  Its importance in early embryogenesis has been 
demonstrated by the peri-implantation lethality of the homozygous knock-out 
genotype in mouse embryos due to lack of pluripotency of the ICM (Nichols et al., 
1998).  Furthermore, both human (Yu et al., 2007) and bovine (Nong et al., 2015) 
embryonic fibroblasts have been reprogrammed to become induced pluripotent stem 
cells (iPSCs) by introducing pluripotency genes, including POU5F1, into the 
differentiated cells. 
As gastrulation occurs, POU5F1 expression becomes constrained to the germline until 
it is specifically located in PGCs.  Murine studies targeting post-implantation POU5F1 
expression by using a Cre/loxP system specific to PGCs have revealed that lack of 
POU5F1 leads to PGC apoptosis rather than differentiation (Kehler et al., 2004), 
indicating that it is essential for PGC survival, but not for maintaining PGCs in their 
dedifferentiated state.  Furthermore, it has also been demonstrated to be critical for 
PGC specification (Okamura et al., 2008).  In mice, once PGCs have entered meiosis, 
POU5F1 is downregulated (Pesce et al., 1998).  Its expression is switched back on 
again just after birth in meiotically-arrested oocytes and persists until the late stages of 
oocyte maturation (Pesce et al., 1998).  In contrast, human POU5F1 expression 
decreases over time: it is highly expressed in PGCs, but declines during the second 
trimester with expression limited to mitotic cortical germ cells and disappears when 
oocytes are undergoing folliculogenesis (Stoop et al., 2005, Anderson et al., 2007).  
This suggests that once oocytes are in close contact with granulosa cells and are 
undergoing meiosis, they are no longer capable of being pluripotent.  In summary, 
given its presence in both stem cells and PGCs, POU5F1 seems an appropriate marker 
for a fGSC. 
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1.2.2.2 LIN28 
Similarly to POU5F1, LIN28 is a candidate marker of fGSCs as it is found in both 
stem cells and the germline.  It is a gene of ancient origin, with homologues in many 
different species including Drosophila, mice and humans (Moss and Tang, 2003).  It 
encodes for a RNA-binding protein initially discovered to be involved in the timing of 
embryonic development of C. elegans (Ambros, 2000).  It was then discovered to be 
widely expressed in the developing embryos of other animals, but had more limited 
expression in differentiated adult cells (Moss and Tang, 2003).  Subsequent studies in 
human ESCs (hESCs) demonstrated that LIN28 expression was downregulated as 
hESCs differentiated and suggested, therefore, that LIN28 could be used as a marker 
of stemness (Richards et al., 2004).  As with POU5F1, both human (Yu et al., 2007) 
and bovine (Nong et al., 2015) embryonic fibroblasts could be reprogrammed to iPSCs 
by  LIN28. 
The role of LIN28 within the germline has been described with changing temporal and 
spatial expression over the course of the first and second trimesters in fetal human 
ovaries (Childs et al., 2012).  Its expression is restricted to PGCs and is highest in the 
first trimester, with all PGCs expressing the protein.  In the second trimester, only 
immature germ cells around the periphery of the ovary continue to express LIN28, 
with no expression detected in the more centrally located mature germ cells.  
Furthermore, LIN28-positive germ cells co-expressed POU5F1 but never 
demonstrated expression of the meiotic entry marker, SYCP3, indicating it is an early 
PGC marker (Childs et al., 2012).  It has been suggested that LIN28 performs its 
pluripotency role by inhibiting the transcriptional processing of a microRNA (pri-let-
7 miRNA) which is important in cell differentiation (Viswanathan et al., 2008).  The 
similarities in temporal expression of LIN28 and its miRNA target across gestations 
in human fetal ovaries further supports that their functions are connected (Childs et 
al., 2012).  
 
1.2.2.3 NANOG 
NANOG is another transcription factor expressed in both pluripotent stem cells and 
germ cells, thus rendering it a prospective marker of fGSCs.  It is found in both mouse 
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(Chambers et al., 2003, Mitsui et al., 2003) and human (Chambers et al., 2003, 
Richards et al., 2004) ESCs and, in conjunction with POU5F1, is critical to 
maintaining the cells in a pluripotent state of self-renewal with downregulation of 
NANOG coinciding with increased cell differentiation (Chambers et al., 2003, Clark 
et al., 2004).  Its role in generating iPSCs from human (Yu et al., 2007) and bovine 
(Nong et al., 2015) fetal fibroblasts has also been demonstrated. 
In the human embryo, NANOG expression is subsequently restricted to PGCs within 
the fetal ovary (Perrett et al., 2008) and in mice, it is expressed in proliferating and 
migrating PGCs until the time of meiotic entry (Chambers et al., 2003, Yamaguchi et 
al., 2005).  It has been shown to be essential to migrating PGC survival in the mouse 
embryo, with inducible, specific knockdown of Nanog in PGCs of transgenic mice 
resulting in migratory PGC apoptosis and not differentiation (Yamaguchi et al., 2009).  
Yamaguchi et al. postulated that the cell death may be a result of downstream gene 
dysregulation, with Nanog-deficient PGCs demonstrating downregulation of genes 
including the DNA-binding protein inhibitor, Id1 (Yamaguchi et al., 2009).  Therefore, 
NANOG is a marker of both ESCs and early, pre-meiotic PGCs.  
 
1.2.2.4 PRDM1 
PR domain zinc finger protein 1 (PRDM1; also known as BLIMP-1) is a 
transcriptional repressor expressed in all three layers of the blastocyst (ectoderm, 
endoderm and mesoderm), including the primitive streak (Ohinata et al., 2009) and in 
migratory PGCs (Chang et al., 2002).  Its structure includes zinc fingers for DNA 
binding (Saiti and Lacham-Kaplan, 2007).  Lineage tracing using a Prdm1-Cre-GFP 
transgenic mouse strain demonstrated that it is only found in cells destined to be PGCs 
and its expression in PGCs appears to precede both Developmental pluripotency-
associated protein 3 (Dppa3) and Interferon-induced transmembrane protein 3 (Ifitm3) 
expression thereby making it the earliest marker of mouse PGCs (Saiti and Lacham-
Kaplan, 2007, Ohinata et al., 2009).  Furthermore, Prdm1-mutant mice have a reduced 
number of PGCs which neither proliferate nor migrate correctly, indicating the critical 
role of the protein in PGC development (Vincent et al., 2005, Ohinata et al., 2009).  
Bmp4 (which, as mentioned in section 1.1.1, is necessary for germ cell specification) 
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has been shown to be important in the induction of epiblast cells to express Prdm1 and 
thus facilitates germ cell specification (Ohinata et al., 2009).   
In humans, PRDM1 expression has also been demonstrated in fetal ovaries, whilst 
hESCs upregulate its expression during differentiation into germ cells (Lin et al., 
2014).  Chronologically, it appears to be expressed at the same stage of differentiation 
as POU5F1, but prior to DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 (DDX4) and 
SYCP3 (Lin et al., 2014), indicating it may be a premeiotic marker of germ cells.  Data 
on the role of PRDM1 in bovine germ cell development are not available.  Of note, 
although PRDM1 is clearly a marker of PGCs, it has many other roles throughout the 
body, including differentiation of B lymphocytes (Chang et al., 2002), therefore it 
cannot be considered a germ cell-specific marker.    
 
1.2.2.5 DPPA3 
DPPA3 has several aliases, including STELLA, STELLAR and PGC7.  It was initially 
detected in preimplantation embryos, PGCs and oocytes of all stages of development 
in the mouse and deemed to be an excellent marker of cells of early germline lineage 
(Saitou et al., 2002).  More precisely, in the post-implantation embryo it is expressed 
from the time of PGC specification through PGC migration until embryonic day 13.5 
(E13.5) whereupon it is downregulated until birth, when immature oocytes begin to 
express it again (Saitou et al., 2002).  Despite the timing of the onset of its expression, 
a knock-out study demonstrated that it is not required for germ cell specification 
(Bortvin et al., 2004).  As it is not expressed in mature sperm (Saitou et al., 2002), 
Dppa3 is therefore a maternal factor of embryogenesis and it has been shown to be 
essential in protecting the early mouse embryo from premature DNA methylation 
(Nakamura et al., 2007).  As such, it allows correct genomic imprinting and epigenetic 
modifications which are critical for normal development.   
Its human homologue is expressed on chromosome 12 (Bowles et al., 2003) and, 
although it is expressed at low levels in hESCs, its expression is upregulated in hESCs 
undergoing germ cell differentiation (Wongtrakoongate et al., 2013).  Expression is 
restricted to the fetal ovary by the second half of pregnancy (Clark et al., 2004) and it 
appears to be expressed at the same stage of differentiation as POU5F1 and PRDM1 
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(Lin et al., 2014).  Post-natally, both primordial follicles and mature, metaphase II 
(MII) oocytes express DPPA3 in humans (Grondahl et al., 2013).  DPPA3 is also 
abundant in bovine oocytes and preimplantation embryos and its role in preventing 
early DNA demethylation has been recapitulated in bovine embryos, thus it could be 
hypothesised that a similar process occurs in early human embryos (Bakhtari and Ross, 
2014).  In larger animal models, DPPA3 therefore appears to be a marker of germ cells 
at a slightly later stage in development than LIN28 and NANOG.   
 
1.2.2.6 IFITM3 
IFITM3, also known as Fragilis, is a cell surface protein which is evolutionarily 
conserved, with homologues detected in the human and bovine genomes (Saitou et al., 
2002, Lange et al., 2003).  It was first identified in mouse embryos, with strong, 
specific expression seen in the area where PGCs specification occurs (Saitou et al., 
2002).  There are conflicting data regarding its role in migratory PGCs, with some 
research suggesting it is present (Tanaka and Matsui, 2002) and others reporting that 
it is markedly downregulated (Saitou et al., 2002), with knock-out studies 
demonstrating that Ifitm3 is not necessary for normal germ cell development, 
including migration (Lange et al., 2008).  A possible role for Ifitm3 in PGC 
specification has been demonstrated, however, by examining the relationship between 
Bmp4 and Ifitm3 expression, with Bmp4-null mutants exhibiting no Ifitm3 expression 
(Saitou et al., 2002).  With regards the timing of its expression, Ifitm3 appears to 
precede that of Dppa3, with the latter only expressed in early PGCs with high levels 
of Ifitm3 (Saitou et al., 2002).   
Human data are lacking, although bovine studies have demonstrated that IFITM3 
expression is confined to the epiblast of the blastocyst, from which PGCs are specified 
(Smith et al., 2007).  Given its conservation across species, however, it is likely that 
IFITM3 is a reliable marker of germ cells in humans and cows. 
 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
General Introduction 20 
1.2.2.7 C-KIT 
C-KIT is a cell surface tyrosine kinase receptor whose ligand, SCF (also known as Kit 
ligand (KL)), causes dimerisation of C-KIT and downstream phosphorylation of 
intracellular pathways (Saiti and Lacham-Kaplan, 2007).  Its role in murine germ cell 
development is long established, with expression detected from the time of PGC 
specification to the point of meiotic entry, then disappearing until oocytes enter the 
diplotene stage (Manova and Bachvarova, 1991).  Mutations in the c-kit gene do not 
affect PGC specification, but does have a detrimental effect on PGC proliferation, 
indicating its mitogenic role (Besmer et al., 1993).  In the post-natal ovary, oocytes 
express c-kit, whilst surrounding granulosa cells express SCF; mutations affecting 
SCF expression lead to follicular arrest at the primary stage, suggesting that these 
molecules are involved in oocyte growth (Besmer et al., 1993).   
Human C-KIT expression has been demonstrated in oogonia and post-natal oocytes at 
all stages of development (Horie et al., 1993, Robinson et al., 2001, Stoop et al., 2005).  
The interspecies variation in expression seen in POU5F1 between mouse and human 
is again observed, with human C-KIT expression persisting throughout fetal 
development (Stoop et al., 2005).  This difference in both POU5F1 and C-KIT 
expression may be explained by the asynchronous entry of human PGCs into meiosis: 
this may result in mitotic PGCs continuing to express C-KIT whilst those undergoing 
meiosis cease to produce it, thereby there is no hiatus in apparent expression as seen 
in the mouse.  In contrast to POU5F1 expression, however, C-KIT expression is 
maintained in oocytes after POU5F1 expression has declined (Stoop et al., 2005).  C-
KIT also has roles in melanogenesis and haematopoiesis (Besmer et al., 1993), 
therefore, as with PRDM1, cannot be regarded as a germ cell-specific marker. 
 
1.2.2.8 DDX4 
DDX4 (or VASA) is an intracytoplasmic, ATP-dependent RNA helicase which is 
reported to be exclusively expressed by germ cells: expression in pluripotent cells and 
non-gonadal tissue has not been demonstrated (Castrillon et al., 2000, Toyooka et al., 
2000).  In both mice and humans, it is first detected in PGCs colonising the genital 
ridges and continues to be expressed throughout the rest of the germ cell 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
General Introduction 21 
developmental pathway, with expression persisting in post-meiotic oocytes (Castrillon 
et al., 2000, Toyooka et al., 2000, Stoop et al., 2005).  In humans, its expression 
increases as the oocyte matures and, as with C-KIT, its initial co-localisation with 
POU5F1 ceases once folliculogenesis commences (Castrillon et al., 2000, Stoop et al., 
2005).  Bovine studies have not been as detailed, but demonstrate that DDX4 
expression is constrained to germ cells in the fetus (Bartholomew and Parks, 2007) 
and can be detected up to the antral follicle stage in adult ovaries (Pennetier et al., 
2004).  In vitro co-culture studies have suggested that its expression is “switched on” 
by cell-cell interactions with somatic cells within the genital ridge (Toyooka et al., 
2000) and its role in germ cell development appears to be relatively conserved across 
species, including C. elegans, Drosophila and mice, with knock-out studies 
demonstrating various germline deficiencies (Ewen-Campen et al., 2010).  DDX4 is 
thus a well-established germ cell-specific marker across the phylogenetic spectrum 
(Ewen-Campen et al., 2010). 
 
 Female GSCs in Non-Mammalian Species  
The role of fGSCs is well-established in several animals (reviewed in Dunlop et al., 
2014), in particular “lower” invertebrates such as C. elegans and Drosophila (Fig. 1.5).  
In C. elegans, a GSC population is formed in the larvae and, in the adult, these cells 
maintain a stable population of germ cells and are constantly producing gametes 
(Kimble, 2011).  Around 35-70 GSCs reside in a germ cell niche at the distal end of 
the gonad, called the distal tip cell (DTC), which maintains their self-renewal 
properties (Kimble and White, 1981); however, as the GSCs extend outside the niche, 
they begin to mature and enter meiosis, with maturation occurring in the distal-to-
proximal direction (Kimble, 2011).  The Notch signaling pathway is a key regulator in 
this process: it both stimulates GSC mitosis and is essential in repressing meiotic entry, 
thereby maintaining the GSC population (Kimble, 2011). 
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Figure 1.5.  The germ cell niches of (A) C. elegans and (B) Drosophila.  Proximity 
of the DTC maintains C. elegans GSCs in their pluripotent state and thus they mature 
in a distal-to-proximal direction. The germarium of Drosophila contain escort cells 
which prevent GSCs from being in contact with each other.  GSCs divide to become 
cystoblasts which generate 16 germline cysts.  DTC = distal tip cell, GSC = germline 
stem cell.  Adapted from Chen et al., 2013. 
 
In Drosophila, ovaries are made up of 16 to 18 tubes, called ovarioles, and a germ cell 
niche, containing approximately two GSCs, is found at the tip of each ovariole, termed 
the germarium (Xie and Spradling, 2000).  The niche comprises three different somatic 
cell types: terminal filament cells at the anterior end of the ovariole, caps cells which 
are associated with the GSCs and escort cells which prevent the GSCs from touching 
each other (Spradling et al., 2011).  GSCs mitose asymmetrically, forming a GSC and 
a cystoblast cell, with the former maintaining the GSC population by remaining beside 
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the cap cells, and the latter continuing to divide until 16 germline cysts have been 
produced.  Only one of these cells will become an oocyte, while the remainder become 
supportive or ‘nurse’ cells (Spradling et al., 2011).  The regulatory pathways involved 
in maintaining the Drosophila GSC population and promoting differentiation are 
complex but, in brief, the terminal filament cells activate the JAK-STAT signaling 
pathway within the cap cells which, in turn, induces the production of BMP ligands.  
In response, the GSCs repress the expression of an inducer of differentiation, bag-of-
marbles (bam) and maintain high levels of the translational repressor NANOS, thereby 
sustaining GSC function and preventing differentiation.  Once the GSCs have left the 
niche, however, they are no longer exposed to BMP ligands, therefore bam is 
upregulated and daughter cells can differentiate into germ cells (Spradling et al., 
2011). 
Female GSCs have also been described in non-mammalian vertebrates, including some 
species of fish.  Teleost fish such as zebrafish (Danio rerio) (Draper et al., 2007) and 
the medaka (Oryzias latipes) (Nakamura et al., 2010) have been reported to undergo 
post-natal neo-oogenesis.  It has been postulated that the germ cell niche in zebrafish 
is situated in the germinal zone, a discrete area on the ovarian surface (Beer and 
Draper, 2013).  Furthermore, as in Drosophila, the Nanos protein appears to be 
essential for ongoing oogenesis in the adult ovary of the zebrafish, with the nanos1, 
nanos2 and nanos3 genes all implicated in maintaining the fGSC population (Draper 
et al., 2007, Beer and Draper, 2013).  In the medaka, the germ cell niche is termed the 
germinal cradle and is located in the ovarian cords (Nakamura et al., 2010).  Once 
again, Nanos has been found to be important, with mitotically-active medaka fGSCs 
expressing nanos2 (Nakamura et al., 2010).  The existence of specialised niches across 
phyla with some similarities in regulatory pathways is indicative of evolutionary 
conservation within the animal kingdom. 
 
 The Evidence for Female GSCs in Mammals  
In such fertile species as flies and fish, where oocytes have to be produced in large 
quantities over the animal’s lifespan, as with sperm in mammals, it seems logical that 
neo-oogenesis is continuous in adulthood.  However, evidence of fGSCs has also been 
reported in some mammalian species which are much less fecund than fish or flies.  
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Indeed, under certain conditions, oocytes and even offspring have been created from 
such cells (Fig. 1.6).  
 
 
Figure 1.6.  Putative female germline stem cells have been isolated in five species 
thus far, with live mice and rat pups, porcine oocyte-like cells, macaque monkey 
embryos and human immature follicles generated from them under specific 
conditions (Zou et al., 2009, White et al., 2012, Wolff et al., 2013, Bui et al., 2014, 
Zhou et al., 2014, Wolff et al., 2014, Xiong et al., 2015, Lu et al., 2016, Wolff, 2016). 
 
1.2.4.1 Mice 
Jonathan Tilly’s group were investigating follicular atresia in a mouse model when the 
authors reached an unintended, and surprising, conclusion: that their findings could 
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only be explained by neo-oogenesis (Johnson et al., 2004).  The authors performed 
follicle counts over the reproductive lifespan of the C57BL/6 mouse and discovered 
that, given the rate of follicular degeneration, the ovary should be exhausted of oocytes 
much earlier than is observed in vivo.  To ensure that they were not counting 
accumulating atretic follicles, they chemically synchronised the atresia of primordial 
and primary follicles and found that unhealthy oocytes were cleared within 3 days.  
They confirmed their findings using two other mouse strains: CD1 and AKR/J.  By 
comparing their numerical findings to those of a previously reported model (Faddy et 
al., 1987), they surmised that approximately 77 new follicles would be required daily 
in order to sustain the mouse follicular pool until reproductive senescence.  Further 
investigation revealed the existence of ovoid cells in the ovarian surface epithelium 
(OSE) which dual-stained for Ddx4 and 5-bromodeoxyuridine (BrdU), a marker of 
proliferation (Johnson et al., 2004).  These cells were not contained within a follicular 
structure and were found to be in differing stages of mitosis.  Discrete cells expressing 
Sycp3 (a marker of meiotic entry) in the OSE were also reported, implying that a 
population of mitotically active germ cells capable of entering meiosis and thus 
forming new oocytes, was present in the adult mouse ovary.  The authors were further 
convinced of this hypothesis when wild-type ovarian fragments transplanted onto 
ubiquitously green fluorescent protein (GFP)-expressing mouse ovaries contained 
GFP-positive oocytes surrounded by non-fluorescent wild-type granulosa cells in the 
grafted tissue after 3-4 weeks (Johnson et al., 2004).  The ability of these oocytes to 
be fertilised was not assessed, therefore their functional capabilities were unknown.   
Follicular quantification has subsequently endorsed Johnson et al.’s follicular kinetics 
findings (Johnson et al., 2004), thus providing further indirect evidence of post-natal 
neo-oogenesis in mice.  Using stereological methods, it has been demonstrated that in 
adult C57BL/6 mice the average number of primordial follicles remained stable from 
post-natal days 7 to 100, with a decline in numbers only observed following this time 
period (Kerr et al., 2006).  One possible explanation for this apparent follicle stability 
is that new follicles are being formed in the adult, thus, although this study did not 
identify any fGSC population, it does support the concept of neo-oogenesis.   
The concept has also been indirectly supported by analysis using lineage tracing.  A 
study in mice examined how many mitotic divisions an oocyte had undergone since it 
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was formed, also known as oocyte “depth”, by analysing microsatellite mutations 
retrospectively (Reizel et al., 2012).  Microsatellites are nucleotide repeats in non-
coding areas of DNA (therefore mutations within them do not have a phenotypic effect 
on the animal) and mutation information can be used to indicate the oocyte “depth”.  
It was discovered that oocyte “depth” increases with age, i.e. the oocytes of older mice 
had undergone more mitotic divisions than those of younger mice.  Two principal 
hypotheses could help explain this finding: (1) the “production line hypothesis” which 
states that oocytes recommence meiosis in the order in which they were formed in the 
fetal gonad (Henderson and Edwards, 1968), so that oocytes in older mice will have 
undergone more proliferation pre-natally than younger oocytes, or (2) the post-natal 
neo-oogenesis hypothesis, as oocytes with increased “depth” may have been formed 
by continually dividing OSCs in the adult ovary.  Interestingly, the “depth” was further 
increased in mice who had one ovary removed (Reizel et al., 2012), which again could 
be explained by post-natal neo-oogenesis within the remaining ovary. 
 
Further studies by Tilly’s group focussed on the location of the putative fGSCs, as the 
scarcity of the population within the ovary implied that there may be an extra-ovarian 
source (Johnson et al., 2005a).  Given the common embryonic origin of 
haematopoietic stem cells and PGCs in the proximal epiblast, the authors directed their 
studies towards bone marrow (BM) and reported that BM expressed several germ cell 
markers at the mRNA level, including Ddx4, Ifitm3 and Dazl.  In addition, mice that 
had been sterilised with cyclophosphamide and busulfan chemotherapy and 
subsequently received a BM transplant (BMT) from a healthy mouse, had their ovarian 
function restored, with follicles of every developmental stage seen by histological 
analysis (Johnson et al., 2004, Lee et al., 2007).  This was in direct contrast to 
chemotherapy-sterilised mice who did not receive a BMT, whose ovaries contained 
very few follicles (Johnson et al., 2005a).  This phenomenon did not seem to be 
restricted to BM: a peripheral blood stem cell transplant (PBSCT) from transgenic 
mice in which a Pou5f1 promoter drives GFP expression, appeared to also replenish 
chemotherapy-sterilised ovaries, with GFP-positive oocytes seen in primordial 
follicles less than 2 days after PBSCT (Johnson et al., 2005a).  The developmental 
competence of such oocytes was not tested, however. 
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Transgenic mice which expressed GFP under the control of Pou5f1 were also used to 
demonstrate the existence of putative fGSCs in separate research (Zhang et al., 2008).  
By tracking GFP, Zhang et al. detected oval aggregates in the ovarian cortex which 
were not contained in follicular structures.  The aggregates were isolated from 
dissociated ovary by visualisation under a fluorescent microscope and demonstrated 
co-localisation of Pou5f1, Ddx4 and c-kit by immunofluorescence.  Furthermore, the 
aggregates expressed meiotic entry genes (SYCP3 and disrupted meiotic cDNA 1; 
DMC1) at the mRNA level, but not growth differentiation factor-9 (GDF-9), which is 
a marker of mature oocytes.  The authors therefore postulated that these aggregates 
contained putative fGSCs of which a subpopulation was undergoing folliculogenesis, 
with oogonia transitioning to oocytes (Zhang et al., 2008). 
Yet, none of these studies had isolated a pure population of fGSCs and assessed their 
ability to undergo both oogenesis and fertilisation.  It wasn’t until 2009 that there was 
a breakthrough in the field, when Zou et al. reported the isolation of fGSCs from 
neonatal and adult mouse ovaries which produced developmentally competent oocytes 
and, upon fertilisation, live pups (Zou et al., 2009).  The authors confirmed the 
existence of cells which stained for both Ddx4 and BrdU in the OSE and went on to 
use Ddx4 to select putative fGSCs from disaggregated neonatal and adult ovarian 
tissue by immunomagnetic methods.  Characterisation of the isolated cells revealed a 
euploid karyotype, maternal imprinting and a molecular signature expected of a GSC, 
with the expression of both pluripotency (e.g. Pou5f1) and germline (e.g. Ddx4, Ifitm3) 
markers.  The stem cell quality of the cells was confirmed by the presence of high 
telomerase activity and alkaline phosphatase (ALP) staining.  Transfection of both the 
neonatal and adult putative fGSCs with GFP-containing retrovirus and transplantation 
into the ovaries of chemoablated mice revealed GFP-positive oocytes within the host 
ovaries within 2 months.  Furthermore, mating of recipient mice with wild-type males 
resulted in GFP-positive offspring (27% of offspring in neonatal fGSC-transplanted 
mice and 28% in adult fGSC-transplanted mice).  These offspring were themselves 
fertile and produced GFP-positive offspring in the F2 generation.  Importantly, 
injection of the cells subcutaneously into nude mice did not cause teratomas, indicating 
that the cells were restricted to germ cell differentiation (Zou et al., 2009).  
Consequently, it has been postulated that fGSCs are established at a point in the PGC 
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differentiation pathway after migration and before germ cell nest formation (Abban 
and Johnson, 2009), as post-migratory mouse PGCs can become embryonic germ cell 
lines that form teratomas (Shim et al., 2008). 
The same group has subsequently demonstrated that putative fGSCs can also be 
isolated using an antibody against a different germ cell marker, Ifitm3, with greater 
efficiency than that found using Ddx4 (Zou et al., 2011).  Ddx4- and Ifitm3-isolated 
cells had the same characteristics and were considered to be the same cell type.   
The isolation and culture of putative mouse fGSCs has since been reported by a 
handful of other groups (Pacchiarotti et al., 2010, Hu et al., 2012, White et al., 2012, 
Hernandez et al., 2015, Xiong et al., 2015, Lu et al., 2016) using varying 
methodologies.  Pacchiarotti et al. used transgenic mice in which GFP expression was 
driven by a Pou5f1 promoter and isolated putative Pou5f1-expressing fGSCs by 
detecting GFP during fluorescence-activated cell sorting (FACS) (Pacchiarotti et al., 
2010).  These cells expressed other germline markers (Ddx4 and c-kit) at the protein 
level and did not form teratomas.  The cells appeared to spontaneously form larger 
oocyte-like cells (OLCs) during in vitro culture and also aggregated with neonatal 
granulosa cells when cultured in hanging drops of culture medium to form structures 
reminiscent of primordial follicles; however, subsequent development and fertilisation 
capabilities were not tested.  Of note, the authors of this paper did not find that the 
GFP-Pou5F1-positive cells, that they supposed were putative fGSCs, expressed the 
proliferative marker proliferating cell nuclear antigen (PCNA), in situ within the OSE.  
They therefore hypothesised that these cells did not have a physiological role in the 
normal post-natal ovary and, as such, remained quiescent unless activated by specific 
environmental circumstances (Pacchiarotti et al., 2010).   
Hu et al. did not perform any selection process in order to isolate putative fGSCs in 
adult mice ovary: they simply dissociated the ovaries, plated them onto a feeder layer 
of mouse embryonic feeder (MEF) cells and analysed the colonies that established in 
culture (Hu et al., 2012).  The colonies stained for ALP and expressed pluripotency 
markers (Pou5f1, Nanog) at the mRNA level and both pluripotency (Pou5f1, Nanog) 
and germline (Ddx4) markers at the protein level using immunofluorescence, thereby 
convincing the authors that the cells were putative fGSCs.  Additionally, the authors 
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reported that, in contrast to previous assertions, these cells were located around the 
follicles in the ovarian cortex, rather than the OSE.  When the cells were suspended in 
culture, they formed embryoid bodies (EB) and, in the presence of porcine follicular 
fluid (PFF), differentiated into larger OLCs which had upregulated expression of 
oocyte markers (Figla, zona pellucida 1, 2 and 3 (ZP1, 2 and 3).  However, the EBs 
could also be induced to form neurones, cardiomyocytes and pancreatic cells under 
specific in vitro culture conditions, suggesting the cells could be reprogrammed to 
attain pluripotency (Hu et al., 2012).     
Both White et al. and Hernandez et al. used the same isolation process, utilising FACS 
to select for Ddx4-positive cells from dissociated adult mouse ovary (White et al., 
2012, Hernandez et al., 2015).  In their paper, White et al. coined the term oogonial 
stem cells (OSCs), which can be regarded as interchangeable with fGSC (White et al., 
2012).  Given that the data within this thesis was derived using the same isolation 
methodology as White et al. (White et al., 2012), and in the interest of consistency, 
the term OSC will be used for the remainder of this thesis when referencing 
mammalian fGSCs.  White et al. reported the existence of a scarce population of 
putative mouse OSCs, comprising 1.5% ± 0.2% of the mixed cell population used in 
the experiments (White et al., 2012).  As only the cortex was utilised, this translated 
to a prevalence of 0.014% ± 0.002% within the entire ovary.  Freshly isolated cells 
expressed mRNA of germline markers, including Ddx4, Ifitm3, Prdm1 and Dazl, and 
this expression was retained after long-term propagation in in vitro culture.  The cells 
did not produce teratomas.  As seen previously (Pacchiarotti et al., 2010), OLCs which 
expressed oocyte markers (including Zp1-3, Gdf-9 and newborn ovary homeobox 
(Nobox)) at the mRNA level were generated spontaneously during in vitro culture.  
Furthermore, ploidy analysis revealed that some cultured cells attained haploid status 
indicating that they may have undergone meiosis.  The oogeneic potential of the 
putative OSCs was further tested by transducing the cells to express GFP using a GFP-
containing retrovirus and injecting the cells into the ovaries of adult mice.  GFP-
positive oocytes were detected within growing follicles after 5-6 months and, after 
ovulation hyperstimulation, cumulus-oocyte complexes (COC) were collected from 
the oviducts, of which some COCs contained a GFP-positive oocyte associated with 
wild-type granulosa cells.  These GFP-positive oocytes could be fertilised and reached 
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the hatching blastocyst stage, although the ability of these blastocysts to create 
liveborn pups was not verified.  Follow-up studies revealed that, as well as retaining 
germline marker expression, mouse OSCs gain pluripotency marker expression (e.g. 
Pou5f1, Nanog) during in vitro culture, with no pluripotency markers detected in 
freshly isolated cells (Imudia et al., 2013).  This pattern is analogous to SSCs, which 
attain multipotency in culture (Guan et al., 2007).  The molecular similarities of OSCs 
and SSCs has been confirmed by Wu’s group, who demonstrated that the two cell types 
express 853 of the same genes on microarray analysis, equivalent to over half of the 
highly expressed genes detected in the two cell types (Xie et al., 2014). 
Hernandez et al.’s findings supported the rarity of this population, with 1.9 – 3.7% of 
ovarian cells being Ddx4-positive (Hernandez et al., 2015).  Although these cells 
expressed the germline markers Ifitm3 and Prdm1, paradoxically the authors were 
unable to detect Ddx4 expression, including after in vitro expansion, which contradicts 
the previous findings detailed above.  No functional testing of these putative OSCs 
was performed. 
The use of immunomagnetic sorting for Ifitm3 has been reproduced by another group 
recently (Xiong et al., 2015, Lu et al., 2016).  The isolated cells expressed germline 
markers (Ifitm3, Ddx4, Prdm1), had a normal karyotype and injection of GFP-
expressing OSCs into the ovaries of sterilised mice generated GFP-positive F1 
offspring (Lu et al., 2016).  The cells could also be isolated from mice that had 
undergone chemotherapy, and after expansion and GFP-transfection in vitro, injection 
into sterilised mice generated GFP-positive offspring (Xiong et al., 2015). 
Research has shown that the prevalence of putative OSCs decreases with age, with 
Pacchiarotti et al. reporting a decrease in population size from 1-2% of the neonatal 
ovary, to 0.05% of the adult ovary (Pacchiarotti et al., 2010).  However, putative OSCs 
have also been reported in aged mouse ovaries (Niikura et al., 2009).  Immuno-
localisation demonstrated the existence of small clusters of Stra8-producing cells in 
the ovarian surface epithelium (OSE) implying that pre-meiotic germ cells are present, 
but are perhaps not able to progress through meiosis to become functional oocytes.  
However, upon introduction of these cells into a younger ovarian environment, 
primordial follicle structures were produced, which expressed the oocyte marker, 
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Nobox (Niikura et al., 2009).  This infers that the conditions of the niche surrounding 
such stem cells are just as important as the cells themselves in allowing their full 
potential to be achieved.    
Finally, with regards mouse research, very recently published research has provided 
some evidence for a physiological role for OSCs: lineage tracing of transgenic adult 
mice that expressed yellow fluorescent protein (YFP) in response to a Pou5f1 promoter 
revealed non-follicular Pou5f1-expressing “small germ cells” which also co-expressed 
varying levels of Ddx4, Dazl, Sycp3 and Stra8 (Guo et al. 2016).  In addition, some of 
these cells stained for BrdU, indicating that a population of mitotically-active cells are 
indeed present in the adult mouse ovary, which possibly sequentially acquire the 
expression of germline and meiotic entry markers and may thus contribute to the 
follicular pool (Guo et al., 2016).  The re-expression of Pou5f1 in oocytes at later 
stages of development precludes this model from providing more robust evidence as 
to the subsequent developmental potential of these labelled cells. 
 
1.2.4.2 Rats 
Using the same Ifitm3-based immunomagnetic sorting technique as used in mice (Zou 
et al., 2011), putative OSCs have been isolated from adult rat ovaries (Zhou et al., 
2014).  Zhou et al. demonstrated cells in the OSE which dual-stained for Ifitm3 and 
BrdU, suggesting these were putative OSCs (Zhou et al., 2014).  Isolated cells had a 
euploid karyotype, stained for ALP and had high telomerase activity, indicative of 
stem cells.  They demonstrated mRNA expression of pluripotency (Pou5f1) and 
germline markers (Ifitm3, Ddx4, Dazl) and spontaneously differentiated in in vitro 
culture into OLCs which expressed Zp3.  As seen in Zou et al.’s mouse study (Zou et 
al., 2009), GFP-expressing rat OSCs produced GFP-positive oocytes when injected 
into recipient rats and, furthermore, produced live GFP-positive offspring after mating, 
thus proving their developmental competency. 
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1.2.4.3 Bats 
Another mammal where potential OSCs and a germ cell niche have been identified is 
the Phyllostomidae family of bats.  Interestingly, the reproductive system of these bats 
is comparable to primates, with anatomical and menstrual cycle similarities: 
Glossophaga soricina bats are monovular and polyoestrous, with 22-26 day menstrual 
cycles, a luteal phase and menstruation (Rasweiler, 1972). G. soricina bats, along with 
Artibeus jamaicensis and Sturnira lilium bats, have polarised ovaries with follicles and 
corpora lutea located in the medulla and non-growing primordial follicles situated in 
the cortical region (Antonio-Rubio et al., 2013).  Immunohistochemistry revealed a 
population of cells with morphological similarities to PGCs, which the authors termed 
adult cortical germ cells (ACGCs), and further investigation with immunofluorescence 
indicated that these cells simultaneously expressed markers of proliferation 
(phosphorylated-histone 3; H3ph), pluripotency (POU5F1 and DPPA3) and germ cells 
(DDX4, IFITM3 and C-KIT), leading the authors to conclude that ACGCs may 
contribute to neo-oogenesis in the phyllostomid bat (Antonio-Rubio et al., 2013).  
However, although some of these ACGCs appeared to be in primordial follicle-like 
structures, their ability to complete folliculogenesis and definitively replenish the 
ovarian reserve has not been established. 
 
1.2.4.4 Pigs 
Putative OSCs have been reported in the ovaries of both juvenile (Bai et al., 2013) and 
adult (Bui et al., 2014) pigs.  Studies in juvenile (4 – 6 months old) porcine ovaries 
appeared to demonstrate that putative OSCs, as characterised by the expression of 
POU5F1 and DDX4, were present in the theca layers of the ovaries, rather than the 
OSE (Bai et al., 2013).  Cells were isolated by performing cell scrapings between the 
OSE and the medullary region, were cultured in vitro and demonstrated pluripotency 
(e.g. POU5F1) and germ cell (e.g. DDX4, C-KIT) expression by immunofluorescence.  
Their reproductive capacity was not investigated; however, the cells could differentiate 
in in vitro culture into many different cell types and formed teratomas when 
transplanted into mice (Bai et al., 2013).  This indicates their pluripotent nature, which 
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contradicts the findings of apparent unipotency in mice (Zou et al., 2009, Pacchiarotti 
et al., 2010, White et al., 2012). 
Adult porcine putative OSCs were initially isolated by a similar method to Hu et al.’s 
methodology in mice (Hu et al., 2012), whereby ovaries were dissociated and grown 
on a feeder layer (Bui et al., 2014).  Flow cytometry of putative OSCs after 1 week of 
in vitro expansion, perhaps unsurprisingly, revealed a heterogeneous population, 
differing in size (a quarter of cells were 5-7µm and the remainder were 10-12µm) and 
gene expression, with a small minority of cells expressing DDX4, IFITM3 and C-KIT.  
PCR demonstrated that the cells expressed both stem cell markers (including POU5F1, 
NANOG) and germline markers (including DDX4, IFITM3, C-KIT, PRDM1) at the 
mRNA level, both after 1 week and 4 weeks of culture.  The cells could be propagated 
in culture long-term, with no loss of proliferative capacity, stained positively for ALP, 
had a normal karyotype and did not form teratomas in nude mice.  OLCs, as identified 
by morphology, were spontaneously formed in vitro and when cells were cultured in a 
differentiation medium containing PFF, the OLCs that formed expressed oocyte 
markers including ZP, SYCP3 and GDF-9.  The group developed their research further 
and sorted cells immunomagnetically for stage specific embryonic antigen 4 (SSEA4), 
a stem cell marker (Bui et al., 2014, Henderson et al., 2002).  These cells similarly 
appeared to differentiate in vitro into OLCs and when transfected GFP-expressing cells 
were injected into porcine ovarian cortex and xenografted into nude mice, cells co-
expressing GFP and oocyte markers (e.g. GDF-9) could be detected.  Folliculogenesis 
and fertilisation competency was not assessed. 
 
1.2.4.5 Cows 
To date, no direct evidence exists that OSCs exist in post-natal bovine ovaries with no 
isolation of such cells reported.  However, similar to the findings described in the 
mouse (Johnson et al., 2004), a study examining the senescence of bovine ovaries 
reported high levels of follicular atresia during the prime reproductive period of the 
cow, despite both the non-growing (primordial) and growing follicle population 
remaining relatively stable (Erickson, 1966).  Although the underlying reason for this 
was not further elucidated, one such reason could be that the follicular pool is 
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undergoing replenishment during that period, with reproductive senescence occurring 
once ageing of the OSCs and/or the germ cell niche prevents further neo-oogenesis. 
 
1.2.4.6 Prosimian Primates 
Several prosimian primates have been found to have mitotically-active germ cells in 
the adult ovary, including the brown greater galago (Galago crassicaudatus), the 
Demidoff's bushbaby (G. demidoffi) and the potto (Perodicticus potto) (Ioannou, 
1967).  These cells were found in germ cell nests located in the adult ovarian cortex 
and tritiated thymidine studies demonstrated DNA synthesis activity (Ioannou, 1967).  
Similar studies on the Senegal galago (G. senegalensis) concluded that, by examining 
staining intensity and meiotic stage, some labelled oogonia had undergone at least one 
mitotic division and some had entered meiosis in the 10 days between labelling and 
ovariectomy (Butler and Juma, 1970).  In addition, the loris family are prosimian 
primates related to the lemur, of which two members have been described as having 
post-natal proliferating germ cells: one member of each of the loris subcategories, a 
slow loris (Nycticebus coucang) (Duke, 1967) and a slender loris (Loris tardigradus 
lydekkerianus) (Ioannou, 1967, David et al., 1974).  These studies also demonstrated 
uptake of tritiated thymidine by collections of cells within the ovarian cortex; however, 
the ability of these cells to undergo post-natal oogenesis and folliculogenesis has not 
been proven.  
 
1.2.4.7 Non-human primates 
Indirect evidence that monkeys may undergo post-natal neo-oogenesis was provided 
in the middle of the 20th century, when investigations into follicular atresia in the 
rhesus macaque monkey (Macaca mulatta; an Old World monkey) were published 
(Vermande-Van Eck, 1956).  Just as Johnson et al. described in their mouse studies 
(Johnson et al., 2004), Vermande-Van Eck determined that the rate of atresia was such 
that the ovarian reserve should be exhausted within 2 years (Vermande-Van Eck, 
1956).  In reality, rhesus macaque monkeys do not go through the menopause until 
approximately 25 years old (Walker and Herndon, 2008).  From her observations, 
Vermande-Van Eck calculated that the average lifespan of a rhesus macaque oocyte 
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was 6 months, with a maximum lifespan of approximately 2 years, thus she concluded 
that to allow for a reproductive lifespan of more than two decades, oogenesis must 
continue in adulthood (Vermande-Van Eck, 1956).   
This line of evidence has been supported by the reported isolation of OSCs from the 
same species of monkey (Hernandez et al., 2015).  Using the published FACS protocol 
utilising DDX4 for cell selection (White et al., 2012, Woods and Tilly, 2013), a 
DDX4-positive population of cells comprising 2.5 – 50.6% of ovarian cells was 
isolated from 17 different monkeys (Hernandez et al., 2015).  After in vitro expansion, 
these putative OSCs were fluorescently tagged with GFP using lentiviral transduction 
before autologous injection was performed.  Four months later, the monkey underwent 
ovarian hyperstimulation and 5 oocytes were aspirated (including 4 MII oocytes and 1 
immature oocyte), with one MII oocyte expressing GFP as confirmed by fluorescence 
microscopy and polymerase chain reaction (PCR) (Wolff et al., 2013, Wolff et al., 
2014).  This was the first demonstration of an OSC-derived mature oocyte in primates, 
and fertilisation and early embryo development (but not pregnancy) has subsequently 
been reported (Wolff, 2016). 
Recently, the possibility that post-natal neo-oogenesis may also occur in New World 
monkeys has been raised (Fereydouni et al., 2014, Fereydouni et al., 2016).  Research 
in neonatal common marmoset monkeys (Callithrix jacchus) has demonstrated that 
they possess primitive ovaries containing many oogonia which retain a pluripotent 
molecular mRNA signature (POU5F1 and LIN28) despite being post-natal 
(Fereydouni et al., 2014).  Immunohistochemistry demonstrated pre-meiotic, 
POU5F1- and LIN28-positive germ cells as well as more mature, POU5F1- and 
LIN28-negative germ cells and by the time the monkey was 1 year old, no POU5F1 or 
LIN28 expression was detectable. Cells from dissociated neonatal ovaries could be 
cultured long-term on feeder layers, did not produce teratomas and spontaneously 
produced OLCs which expressed germ cell markers (including DDX4 and DPPA3) 
and a marker of meiotic entry (SYCP3) (Fereydouni et al., 2016).  However, in contrast 
to previous studies into OSCs and the findings in whole neonatal ovaries, these 
cultured cells did not express markers of OSCs until later passages (e.g. LIN28, 
DPPA3, PRDM1, DDX4) or, in some cases, did not express them at all (e.g. POU5F1, 
NANOG), suggesting that they are not OSCs, as defined by previous groups.  The 
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authors hypothesised that this incongruity may be due to the fact that the cultured cells 
contained OSE cells with stem cell capabilities and the pluripotency marker-
expressing oogonia did not survive in the culture environment (Fereydouni et al., 
2016).  Investigation into the in vitro oogeneic potential of adult marmoset ovarian 
cells was not performed. 
 
1.2.4.8 Humans  
When the research contained within this thesis was commenced, there had only been 
one report of OSCs being isolated in humans (White et al., 2012).  Since then, one 
other group has reported that they have also been successful using the same protocol 
as White et al., although with differing molecular findings (Hernandez et al., 2015).  
Utilising the same DDX4-selecting FACS protocol as in their mouse studies, White et 
al. demonstrated that a rare population of DDX4-positive cells could be isolated from 
human ovarian cortex, comprising 1.7% ± 0.6% of the ovarian cortex (White et al., 
2012).  Of note, the group have subsequently reported that cells have been found in 
women in their 50s, indicating they are not solely a phenomenon of young women 
(unpublished data cited within Woods and Tilly, 2012).  The cells expressed germ cell 
markers (including DDX4, IFITM3, C-KIT, PRDM1), spontaneously generated larger 
OLCs during in vitro culture which expressed the oocyte markers Y-box binding 
protein 2 (YBX2) and LIM homeobox protein 8 (LHX8) at the protein level and some 
cells exhibited haploid status (White et al., 2012).  The putative OSCs were reported 
to undergo oogenesis both in vitro and in vivo with detection of the differentiated OSCs 
performed by transfecting them with a GFP-containing retrovirus beforehand.  In vitro, 
aggregates of putative OSCs and dissociated ovarian cortex produced large GFP-
positive cells surrounded by GFP-negative cells in follicle-like structures within 3 days 
of culture.  Xenografting of GFP-OSC injected human ovarian cortex into 
immunodeficient mice revealed GFP-positive oocytes surrounded by non-GFP cells in 
primordial or primary follicles within 7 days of transplantation (White et al., 2012).  
More mature follicles were not generated and both ethical and legal reasons currently 
prevent assessment of the fertilisation capabilities of any mature oocytes. 
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Hernandez et al. used an identical isolation protocol, but in contrast to the above study 
the size of the DDX4-positive population was larger and more variable, comprising 
4.5 – 24% of ovarian cells (Hernandez et al., 2015).  Furthermore, and consistent with 
the group’s mouse and rhesus macaque monkey findings in the same paper, although 
the cells expressed germ cell markers (PRDM1, IFITM3, DPPA3), they did not appear 
to express DDX4, either using PCR or mass spectrometry, despite this being the 
protein the cells were selected for.  The cells appeared to generate OLCs spontaneously 
during in vitro culture, but no further oogeneic assessments were performed 
(Hernandez et al., 2015). 
In summary, there is a growing body of evidence for the presence of OSCs and the 
process of post-natal neo-oogenesis in mammals, although in contrast to non-
mammalian species, a germ cell niche has not been described.  However, the concept 
remains controversial, with opponents being sceptical of the findings and producing 
data in support of the fixed ovarian reserve dogma. 
 
 The Arguments against Neo-oogenesis and OSCs 
Critics of the neo-oogenesis hypothesis have three principal issues with the findings 
discussed above:  
1) The data produced by OSC proponents are open to alternative explanations 
(Gosden, 2004, Byskov et al., 2005, Telfer et al., 2005, Notarianni, 2011, 
Oatley and Hunt, 2012). 
2) There are questions regarding the validity of the use of DDX4 in isolation 
methodologies (Telfer and Albertini, 2012, Albertini and Gleicher, 2015, 
Hernandez et al., 2015). 
3) Reproducibility of results has proved problematic (Eggan et al., 2006, Zhang 
et al., 2015). 
This section will expand on these points and discuss rebuttals made by supporters of 
the concept of an adult mammalian OSC. 
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1.2.5.1 Alternative Explanations for the Data 
This was the first matter of contention following the publication of Johnson et al.’s 
2004 and 2005 studies (Johnson et al., 2004, Gosden, 2004, Byskov et al., 2005, 
Johnson et al., 2005a, Telfer et al., 2005).  With regards the follicular atresia 
observations in the 2004 paper, it was highlighted that classification of follicle health 
by morphology alone is subjective and fixing of tissue may result in an overestimate 
of follicular atresia (Gosden, 2004, Greenfeld and Flaws, 2004, Byskov et al., 2005), 
thus data based on counts can be flawed.  In addition, the mathematical model of Faddy 
et al. on which Johnson et al. based their assumption that 77 new follicles would be 
required daily could have led to an overestimate of the shortfall in follicle numbers, as 
(a) there may be differences between the different strains of mice used by the two 
groups, and (b) the rate of decline in follicle numbers changes with age; therefore 
Faddy et al.’s estimate of primordial follicle depletion may not be applicable to all 
stages of reproductive life (Faddy et al., 1987, Johnson et al., 2004, Gosden, 2004, 
Greenfeld and Flaws, 2004).  It should be noted, however, that Faddy et al. performed 
counts over a 100 day period, and therefore their analysis should take account of much 
of the age-related changes in the rate of follicle decline (Faddy et al., 1987).       
In addition, indirect evidence of neo-oogenesis using follicular quantification, 
mathematical modelling and lineage tracing techniques (Johnson et al., 2004, Kerr et 
al., 2006, Reizel et al., 2012) has been contradicted by other groups.  By comparing 
follicle counts in mice from 6 days post-natal to 12 months of age, it has been reported 
that follicle development dynamics indicate that the ovarian reserve is not 
supplemented by post-natal neo-oogenesis (Bristol-Gould et al., 2006).  Indeed, in this 
study, the fixed ovarian reserve mathematical model was able to replicate the rise and 
fall in preantral follicles that is observed over time, whereas the stem cell model did 
not correspond to the same pattern in the mouse (Bristol-Gould et al., 2006).  This was 
despite attempting to integrate Johnson et al.’s assertion that 77 new follicles per day 
are required to be formed to sustain the follicular pool (Johnson et al., 2004).  The 
authors reported that much lower follicular production rates (i.e. less than 10 new 
follicles daily) are compatible with their experimental findings, but that this was 
within the error margin of their counting methodology.  This research has been 
supported in humans by Wallace and Kelsey’s modelling work, which demonstrated 
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that the follicular kinetics of a theoretical germline stem cell model does not fit with 
that seen in vivo (Wallace and Kelsey, 2010).  It has been suggested that for Johnson 
et al.’s (Johnson et al., 2004) and Kerr et al.’s (Kerr et al., 2006) assertions regarding 
follicular counts to be regarded as reliable, much bigger sample sizes would be 
required (Faddy and Gosden, 2007). 
Related to the subject of follicular dynamics, research using a knock-out mouse model 
for Foxo3 has implied that post-natal neo-oogenesis does not occur (John et al., 2007).  
Due to Foxo3’s role in inhibiting primordial follicle activation, this strain of mice 
exhibits universal follicular activation shortly after birth, leading to POI (Castrillon et 
al., 2003).  Interestingly, all other aspects of germ cell development and 
folliculogenesis are unaffected by the knock-out (John et al., 2007), indicating that, 
should neo-oogenesis exist, follicles should continue being formed and ovulated 
throughout life and POI would not occur. 
Although lineage tracing has provided support for post-natal neo-oogenesis (Reizel et 
al., 2012), this technique has provided conflicting data with a separate study presenting 
indirect evidence in support of the fixed ovarian reserve dogma.  Using a tamoxifen-
inducible Cre system in mice, germ cells were labelled with YFP and their behaviour 
over time was observed (Lei and Spradling, 2013).  The investigators found that the 
turnover of primordial follicles was very low, with follicles being extremely stable, 
exhibiting a half-life of 10 months.  Furthermore, the authors never detected any 
evidence of YFP-labelled germ cell clusters, which they believed would be indicative 
of OSC proliferation [although other researchers have reported the existence of such 
clusters in OSE scrapings in adult mice and sheep (Bhartiya et al., 2013)].  Zhang et 
al. also used an inducible Cre system, in which Gdf-9-positive cells (i.e. oocytes) were 
selectively ablated in adult mice (Zhang et al., 2014).  After complete ablation of the 
ovarian reserve, no new oocytes were detected up to 1 year following induction of the 
Cre system. 
 
With respect to the cells that Johnson et al. postulated were OSCs (Johnson et al., 
2004), sceptics suggested that the presence of BrdU in the OSE-located, Ddx4-positive 
cells may be due to mitochondrial DNA (mtDNA) synthesis rather than evidence of 
cellular proliferation (Notarianni, 2011).  Certainly, Zuckerman believed that: 
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“mitotic activity in the adult germinal epithelium is not necessarily 
indicative of oogenesis” (Zuckerman, 1951). 
Alternative explanations also have been proposed for the observed behaviour of OSCs 
in culture.  It has been suggested that the reason OSCs appear to take much longer to 
establish in culture than SSCs may be as a result of in vitro transformation (Oatley and 
Hunt, 2012).  However, given the relative paucity of research into OSCs in comparison 
to SSCs, it is difficult to make such comparisons between the two cell types at this 
time.  Another critique is that spontaneously in vitro generated OLCs may be cells 
undergoing oncosis rather than oogenesis (Notarianni, 2011).   
The finding of GFP-positive oocytes surrounded by wild-type somatic cells (Johnson 
et al., 2004) when GFP-positive grafts are transplanted onto wild-type ovaries has been 
the subject of scepticism, with questions raised over why wild-type oocytes surrounded 
by GFP-positive somatic cells were not also detected (Greenfeld and Flaws, 2004).  It 
has been suggested that these follicles are a result of ovarian plasticity rather than neo-
oogenesis (Gosden, 2004, Byskov et al., 2005), as disaggregated ovaries can 
reassemble into follicles that can ovulate (Gosden, 1990).  This indicates that the 
damage caused during grafting may cause “reshuffling” of cells between the two 
strains of tissue, with GFP-positive oocytes recombining with wild-type somatic cells 
(Gosden, 2004).  Studies have shown that injection of GFP-expressing fetal ovarian 
cells into the ovaries of post-natal wild-type mice do result in the formation of GFP-
expressing follicles, but both the oocyte and the somatic cells fluoresce (Zhang et al., 
2012).  In other words, the adult ovary supported the development of, but did not 
contribute to, neo-folliculogenesis (Zhang et al., 2012).  However, it should be noted 
that the ovarian cells that were injected were not purified in any way and therefore it 
is unclear whether the results would have been different if a solely OSC population 
had been used.  Concerns have also been raised that the GFP expression seen in oocytes 
may be a result of transfer from other cells, perhaps by cell fusion, rather than evidence 
of the cells being de novo oocytes (Byskov et al., 2005, Telfer et al., 2005, Vogel, 
2012).   
Results which suggested that putative OSCs, or their precursors, are blood-borne due 
to germline markers such as Pou5f1, Ddx4 and Ifitm3 being present in the blood and 
bone marrow (Johnson et al., 2005a) have been especially criticised, with the argument 
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made that these markers should not be considered to be germ cell-specific (Telfer et 
al., 2005).  It is possible that the findings merely indicate the permissiveness of blood 
and bone marrow cells rather than bona fide OSCs.  The assertion that patients who 
receive bone marrow transplants do not acquire a restoration of ovarian activity (Telfer 
et al., 2005) was rapidly counteracted by the Tilly group who cited several instances 
where women had conceived following BMT despite previously suffering POI 
(Johnson et al., 2005b).  Furthermore, a post-menopausal patient who underwent 
heterotopic reimplantation of cryopreserved ovarian tissue to her anterior abdominal 
wall has spontaneously conceived on four occasions from her native ovaries (Oktay et 
al., 2011).  The mechanism underlying this remains unclear: she may still have had 
some functional oocytes in her native ovaries despite her clinical and biochemical 
diagnosis of POI, as seen in a separate case where spontaneous conception occurred in 
a woman who had apparently undergone POI secondary to chemo- and radiotherapy 
(Bath et al., 2004).  However, another hypothesis is that neo-oogenesis occurred in the 
previously menopausal ovaries (Oktay, 2006), perhaps triggered by the heterotopic 
transplant.   
Another line of argument is that, if OSCs exist, how have they gone unnoticed for so 
long (Telfer et al., 2005)?  They have, however, been demonstrated to be a remarkably 
rare population, which apparently declines with age (Pacchiarotti et al., 2010, White 
et al., 2012), therefore perhaps it has only become possible to detect them following 
the advent of new technologies.  A related line of questioning is why does reproductive 
senescence occur if OSCs are present (Greenfeld and Flaws, 2004, Oatley and Hunt, 
2012)?  The counterargument is twofold: (1) OSCs are likely to undergo the same 
detrimental ageing process as other cells and thus lose their ability to differentiate into 
oocytes, and (2) an aged stromal environment may be inhibitory to oogenesis.  Many 
other stem cells, including haematopoietic, neural and skeletal muscle stem cells, lose 
function during the mammalian lifespan (Signer and Morrison, 2013) and therefore 
OSCs may not be immune from the ageing process.  Indeed, in Drosophila, where 
lifelong neo-oogenesis is an accepted phenomenon, fGSC proliferation and thus 
oogenesis declines with age (Zhao et al., 2008).  In addition to reduced oocyte 
production, there is also increased oocyte apoptosis, the incidence of which increases 
with age (Zhao et al., 2008).  It has been reported that this observation coincides with 
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a decrease in important signalling pathways (including BMP signalling) in the germ 
cell niche which may have a detrimental effect on fGSC mitosis (Pan et al., 2007, Zhao 
et al., 2008).  Therefore, both the intrinsic nature of the cell itself and its extrinsic 
environment are important in maintaining stem cell function.  As previously discussed, 
mouse OSC prevalence decreases with age (Pacchiarotti et al., 2010) and the function 
of aged OSCs only resumes when transplanted back into a young stromal environment 
(Niikura et al., 2009), indicating that reproductive senescence and post-natal oogenesis 
are not necessarily mutually-exclusive.     
 
1.2.5.2 The Use of DDX4 for Isolation of Putative OSCs 
Perhaps the most controversial area of debate concerns the use of Ddx4/DDX4 to 
select putative OSCs.  DDX4 is considered to be a specific marker of PGCs and 
developing oocytes within the ovary and is generally believed to be intracytoplasmic 
in location (Castrillon et al., 2000).  As sorting methods for intact cells require the use 
of cell surface markers to which antibodies can bind, it does not therefore seem 
possible that DDX4 could be utilised in this manner.  However, it has been postulated 
that the protein has an external epitope in OSCs, which is internalised in more mature 
germ cells (White et al., 2012; Fig. 1.7), as bioinformatics has suggested that the 
protein does in fact have transmembrane-spanning domains, thus justifying its use 
(Abban and Johnson, 2009, Zou et al., 2009).  A study has demonstrated that some 
cells do express DDX4 on the cell surface: a porcine cell line transfected with a DDX4-
containing plasmid expressed DDX4 on its cell surface as confirmed by flow 
cytometry, showing that it is possible for DDX4 to be expressed externally (Kakiuchi 
et al., 2014).  Furthermore, flow cytometry of disaggregated pre-pubertal porcine 
testes detected a population of small cells with the DDX4 antibody used by White et 
al. (White et al., 2012) which expressed PRDM1 and IFITM3, although they did not 
appear to form germ cells and the authors concluded that they were not GSCs 
(Kakiuchi et al., 2014).  Further information on the nature of the external epitope has 
come from White et al.’s study which demonstrated that only an antibody against the 
C-terminus of the protein is capable of selecting a Ddx4-positive cell population, 
whereas Ddx4-positive cells can only be detected by a N-terminus antibody if the cells 
are permeabilised (White et al., 2012).     
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Figure 1.7.  DDX4 cellular localisation.  (A) It is postulated that, in OSCs, DDX4 
has transmembrane domains such that the C-terminus is extracellular (White et al., 
2012), before being internalised in (B) oocytes where it is found to be intracytoplasmic 
(Castrillon, 2000). 
 
Yet, conflicting data has been reported demonstrating that Ddx4/DDX4 is not 
expressed by putative mouse and human OSCs (Zhang et al., 2012, Hernandez et al., 
2015).  Zhang et al. used a fluorescent germline reporter mouse (Rosa26rbw/+;Ddx4-
Cre) in which Ddx4-expressing cells change from fluorescing green to fluorescing 
either red (RFP), orange (OFP) or cyan (CFP) (Zhang et al., 2012).  This allows the 
Ddx4-positive cells to be traced.  No proliferation of isolated, in vitro cultured female 
RFP-expressing cells was found over 72 hours, in contrast to male cells which mitosed 
1-3 times; indeed, these female cells did not establish in culture at all.  However, as 
the cells were selected only on their expression of RFP and no further characterisation 
of these cells was apparently performed, it is possible the cells the authors were 
examining were oocytes, which clearly would not be expected to proliferate (Woods 
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et al., 2013).  In reply, Tilly’s group subsequently used a similar transgenic mouse 
strain (Rosa26tdTm/tdTm;Ddx4-Cre) whereby Ddx4 promoted the expression of tomato 
red (tdTM) to repeat the proliferation analysis experiment and demonstrated that 
oocytes were indeed included in the likely cell population that Zhang et al. examined 
(Zhang et al., 2012, Park and Tilly, 2015).  They also demonstrated that a 
subpopulation of tdTM-positive cells could be isolated during FACS using a DDX4-
antibody and this population behaved like OSCs; e.g. they established in culture and 
expressed germline markers (Prdm1, Dppa3, Ifitm3, Ddx4) (Park and Tilly, 2015). 
However, despite using the same protocol as White et al. (White et al., 2012, Woods 
and Tilly, 2013), and identifying apparently Ddx4/DDX4-positive populations by flow 
cytometry, three groups have been unable to demonstrate Ddx4/DDX4 expression at 
either the mRNA or protein level, nor by mass spectrometry in freshly isolated or 
cultured cells (Hernandez et al., 2015, Zhang et al., 2015, Zarate-Garcia et al., 2016), 
although Zhang et al. only analysed a small number of cells (n = 38) by mRNA 
sequencing (Zhang et al., 2015).  Furthermore, the mouse cells that Zarate-Garcia et 
al. isolated died after 2-3 months (Zarate-Garcia et al., 2016), calling into question 
whether they isolated the correct population.  Hernandez et al. thus investigated the 
specificity of the polyclonal antibody utilised in the protocol by transducing human 
OSCs with a lentivirus containing DDX4 with a “tag” at the C-terminus (Hernandez 
et al., 2015).  When FACS was performed using the DDX4-antibody and an antibody 
against the tag, an apparently DDX4-positive population was identified, but no tag-
positive population was seen.  However, if the cells were permeabilised, both DDX4- 
and tag-positive cells were seen.  Zhang et al. reported that cultured cells did not 
express DDX4 on immunofluorescence, but that the DDX4-antibody used by White et 
al. (White et al., 2012) did detect a population of “DDX4-positive” cells (Zhang et al., 
2015).  Moreover, Zarate-Garcia et al. have disputed the bioinformatics finding that 
DDX4 has a transmembrane location (Abban and Johnson, 2009, Zou et al., 2009), by 
providing in silico evidence that several other computer-based programmes do not 
predict an external epitope for the protein (Zarate-Garcia et al., 2016).  These findings 
have led to the conclusion that the DDX4-antibody is detecting another protein and is 
not specific: as such, sorting based on DDX4 has been deemed inadequate by some in 
the field (Albertini and Gleicher, 2015, Hernandez et al., 2015, Zhang et al., 2015, 
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Zarate-Garcia et al., 2016).  However, Tilly’s group defended the use of DDX4, 
suggesting that technical constraints may be the reason for the evident lack of DDX4 
expression (Woods and Tilly, 2015).  Furthermore, a monoclonal DDX4 antibody has 
also been used to isolate OSCs (Fakih et al., 2015) and the sequence targeted by the 
C-terminus antibody is only homologous with a sequence in ATP-binding cassette 
subfamily C member 12 (ABCC12) that is located intracellularly (Woods and Tilly, 
2013).   
However, although the use of DDX4 is contentious, OSCs have been isolated using 
other putative markers (e.g. Ifitm3 (Zou et al., 2011, Xiong et al., 2015, Lu et al., 
2016)); therefore the DDX4 argument alone is not sufficient to prove that OSCs do not 
exist.   
 
1.2.5.3 Reproducibility of the Data 
Reproducibility of data is a fundamental aspect of science in order that results are 
deemed reliable.  Studies on all types of stem cells are proving particularly challenging 
to replicate, with technical difficulties, or methodological differences, often at the root 
of the problem (Check, 2007).  Research on OSCs has proved no exception: the 
problems with repeating the DDX4-based isolation have already been discussed 
(section 1.2.5.2) and Tilly reported that it took many months for his group to 
recapitulate the isolation of mouse OSCs reported by Zou et al. (Zou et al., 2009, 
Vogel, 2012).  Some other reproducibility issues are now detailed below. 
Firstly, the detection of proliferation within the mouse OSE (Johnson et al., 2004) was 
contradicted by mouse, monkey and human data which found no evidence of mitotic 
markers (Ki-67 and PCNA) within the adult ovary (Liu et al., 2007, Yuan et al., 2013).  
Moreover, the discovery that genes of early meiosis (e.g. Sycp3, Dmc1) were 
detectable in post-natal mouse ovaries (Johnson et al., 2004, Zhang et al., 2008) was 
also challenged by these studies, with no mRNA or protein evidence of such genes 
being identified (Liu et al., 2007, Yuan et al., 2013).   
Two murine experiments have been unable to reproduce Johnson et al.’s (Johnson et 
al., 2004) findings that OSCs are blood-borne (Eggan et al., 2006, Begum et al., 2008).  
In the first experiment, two mice (one wild-type and one transgenic mouse which 
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ubiquitously expressed GFP) were surgically linked (parabiosis) to share a circulatory 
system (Eggan et al., 2006).  It was hypothesised that if OSCs were indeed present in 
the bloodstream, then GFP-positive oocytes would be found in the wild-type mouse’s 
ovaries and vice versa.  Upon superovulation, MII oocytes were collected and 
examined, revealing no oocyte chimaerism: i.e. wild-type mice only ovulated non-
GFP-expressing oocytes, whilst GFP mice ovulated only GFP-expressing oocytes.  
This remained true if the wild-type mouse underwent gonadotoxic treatment, ruling 
out the theory that the ovaries may need to experience an injury to allow circulating 
OSCs to embed and undergo folliculogenesis.  Finally, the investigators performed a 
GFP-positive BMT on wild-type, sterilised mice and reported that no ovulated oocytes 
were GFP-positive (Eggan et al., 2006).  This appeared extremely convincing, 
although only ovulated, mature oocytes were examined, whereas Tilly’s group 
examined solely immature follicles within the ovary (Johnson et al., 2005a, Lee et al., 
2007).  The second experiment involved grafting wild-type ovaries, some of which 
were irradiated, into GFP-expressing mice and subsequently analysing the graft for 
GFP-positive oocytes (Begum et al., 2008).  None were detected, thus once again 
refuting the theory that OSCs are found within the circulation.    
Proof that the cells in question can undergo oogenesis and create healthy offspring is 
clearly essential if it is to be believed that they are OSCs.  With the exception of two 
groups whose work has demonstrated the creation of live mouse and rat offspring from 
OSCs (Zou et al., 2009, Zhou et al., 2014, Lu et al., 2016), evidence that the putative 
OSC populations described by other groups can develop into healthy, competent, 
fertilisable oocytes is lacking.  Using White et al.’s isolation and human xenograft 
protocol (White et al., 2012), Zhang et al. failed to replicate the findings of GFP-
positive oocytes in human ovarian cortex grafted into immunodeficient mice up to 4 
weeks following grafting (Zhang et al., 2015).  Furthermore, the authors demonstrated 
that sorted cells from red-fluorescing (Tomato) mice did not undergo neo-oogenesis 
when injected into the ovaries of chemoablated mice (Zhang et al., 2015). 
  
Clearly, there are very distinct viewpoints on the subject of neo-oogenesis and OSCs 
in female mammals; however, overall, the data available suggests that a population of 
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cells exist that, under the right conditions, may be able to undergo oogenesis.  It 
remains uncertain whether OSCs have a physiological role in the “normal” ovary, 
although very recent research suggests they might, at least in the mouse (Guo et al., 
2016).  Thus, it is undoubtedly an interesting and exciting area of research that is 
worthy of study. 
 
 The Capacity of other Stem Cells to form Oocytes  
A separate population of ovarian stem cells has also been reported to undergo 
oogenesis in specific environments.  Named by some as very small embryonic-like 
(VSEL) stem cells, these cells are collected from scrapings of the OSE and are smaller 
than the putative OSCs discussed previously, being less than 4 µm in diameter (Virant-
Klun et al., 2008).  They were first described in post-menopausal women and women 
suffering POI: collected cells expressed pluripotency markers (including POU5F1, 
NANOG and SSEA-4) and generated large OLCs in vitro, although their developmental 
competency was not tested (Bukovsky et al., 2005, Virant-Klun et al., 2008, Parte et 
al., 2011).  Counterpart cells have been identified in the adult rabbit, sheep and 
marmoset monkey (Parte et al., 2011).  Virunt-Klun et al. went on to purify these cells 
using immunomagnetic and FACS sorting for the presence of SSEA-4 and 
demonstrated that they express similar markers to OSCs, including LIN28, PRDM1 
and DPPA3 (Virant-Klun et al., 2013).  Parte et al. actually detected a second putative 
stem cell population, larger in size and which could be considered analogous to OSCs 
(Parte et al., 2011).  It has therefore been proposed that VSELs are precursors to OSCs 
(Parte et al., 2011), although the reported existence of VSELs has also attracted 
controversy (Notarianni, 2011). 
Other non-ovarian stem cells have also been reported to have the ability to produce 
oocytes.  Both ESCs and iPSCs can be induced to become primordial germ cell-like 
cells (PGCLCs) in mice in a two-step manner, by first exposing the cells to activin A 
and basic fibroblast growth factor (bFGF) and then culturing the cells in the presence 
of other growth factors including BMP4, BMP8a and epidermal growth factor (EGF) 
(Hayashi et al., 2012).  Following aggregation of these PGCLCs with 
developmentally-appropriate fetal gonadal somatic cells and transplantation under the 
ovarian bursa of immunodeficient mice, oocytes at the germinal vesicle stage could be 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
General Introduction 48 
collected, matured in vitro and fertilised to produce live, normally imprinted pups 
(Hayashi et al., 2012).  This research highlights the importance of the stem cell niche 
in permitting normal development of the oocyte.  Human ESC research has resulted in 
the production of follicle-like structures, but the oocytes did not possess a zona 
pellucida (Aflatoonian et al., 2009).   
However, human endometrial mesenchymal cells (EnSCs) found in menstrual blood 
have been found to rescue the fertility of chemoablated rodents (Lai et al., 2015).  GFP-
expressing EnSCs injected into the tail vein of sterilised mice were detected within the 
ovaries 2 months after transplantation.  Although they appeared to differentiate into 
granulosa cells rather than OSCs, with expression of FSH receptor, the authors 
postulated that they support OSC renewal, as transplanted chemo-ablated mice had 
more DDX4-BrdU dual-stained cells (deemed OSCs) than non-transplanted chemo-
ablated mice (Lai et al., 2015).   
Moreover, human amniotic fluid stem cells (hAFSCs) have been induced by the 
presence of PFF to form OLCs, which coincided with upregulation of BMP15 
expression and that of other oocyte markers, including ZP2 and 3 and DDX4 (Cheng 
et al., 2012).  A human hepatic cell line (Ma et al., 2013) and fetal porcine skin cells 
(Linher et al., 2009) have also been reported to undergo differentiation into a distinct 
cell type in vitro which expresses pluripotency (e.g. POU5F1) and germline (e.g. 
DPPA3, PRDM1, DDX4) markers and, during prolonged culture, these cells can form 
OLCs (Linher et al., 2009) or follicle-like structures containing OLCs (Ma et al., 
2013).  None of these types of cells have been fertilised and therefore their 
reproductive potential is as yet unknown.   
 
An advantage that OSCs may have over these other types of cells is that they are 
postulated to be unipotent and thus already further down the differentiation pathway 
than, for example, ESCs.  This means that induction to form oocytes may not take as 
many steps, or factors, and thus may be faster and easier.  Moreover, the use of OSCs 
bypasses the ethical issues surrounding the destruction of embryos for the collection 
of ESCs. 
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1.3 Hypotheses 
Given the importance of reproducibility in science, the controversy surrounding the 
concept of OSCs and the great potential such a cell population could have scientifically 
and clinically, it was important to investigate whether the isolation of putative OSCs 
could be recapitulated.  At the time of commencing the research within this thesis, 
putative OSCs had only been isolated in mice (Zou et al., 2009, Pacchiarotti et al., 
2010, Zou et al., 2011, Hu et al., 2012, White et al., 2012) and, by one group, in 
humans (White et al., 2012) and therefore this research concentrated on repeating the 
isolation of human OSCs and attempting the isolation of putative OSCs in a large 
animal model, namely the cow.  Furthermore, if such a population of cells were to 
exist, it would be imperative to test their functional capabilities. 
Our hypotheses therefore were that a population of mitotically active cells with 
germline potential (i.e. OSCs) could be isolated from human and bovine ovarian cortex 
and cultured long-term in vitro.  Secondly, that these cells could be shown to undergo 
neo-oogenesis and demonstrate potential as a germ cell model. 
 
1.4 Aims 
In order to test the hypotheses, the following specific aims were devised: 
1. To corroborate independently the existence of OSCs by isolating and purifying 
cells from bovine and human ovarian cortical tissue using a previously 
validated approach (White et al., 2012). 
2. To characterise these cells and determine whether they demonstrate stem cell 
and germline-specific gene expression at the mRNA and protein level. 
3. To use in vitro culture systems to attempt to support neo-folliculogenesis and 
produce mature oocytes, characterised using oocyte- and meiosis-specific 
markers to examine their viability. 
4. To investigate the potential of the cells as a model for germ cell development 
by exposing them to key regulators of the germ cell differentiation pathway. 
5. To develop a novel system to deliver cells into adult ovarian cortex. 
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Standard laboratory protocols from Prof. Richard Anderson’s and Prof. Evelyn 
Telfer’s laboratories were used for all methods unless otherwise specified.  Non-sterile 
glassware and plastics were autoclaved prior to use by support staff at the Centre for 
Reproductive Health and Centre for Integrative Physiology, University of Edinburgh.  
Manufacturers’ locations can be found in Appendix 1.  
 
2.1 Tissue Collection 
2.1.1 Bovine Ovarian Tissue 
Post-mortem adult bovine ovaries from freshly killed heifers were collected by Mr. 
John Binnie (technician in Prof. Telfer’s laboratory) from a local abattoir (Bridge of 
Allan, UK) and transported to the laboratory in HEPES-buffered M199 medium (Life 
Technologies) supplemented with amphotericin B (2.5 µg/ml; Life Technologies), 
pyruvic acid (25 µg/ml), penicillin G (75 µg/ml) and streptomycin sulphate (50 µg/ml; 
all chemicals from Sigma-Aldrich).  Thin slices of ovarian cortex were aseptically 
removed using a scalpel under a laminar flow hood, placed in a glass Petri dish and 
immersed in dissecting medium consisting of Leibovitz L-15 supplemented with 
sodium pyruvate (2mM), glutamine (2mM; all Life Technologies), bovine serum 
albumin (BSA; 3mg/ml), penicillin G (75 µg/ml) and streptomycin sulphate (50 µg/ml; 
all from Sigma-Aldrich).  These slices were examined under light microscopy and any 
medullary tissue was removed before the tissue was cut into approximately 1cm x 1cm 
x 1mm pieces.  Approximately two pieces from each abattoir collection were fixed 
immediately for 24 hours in 4% neutral buffered formalin (NBF).  The remaining 
ovarian cortical pieces were immediately vitrified and cryopreserved as described in 
section 2.2. 
Fetal bovine ovaries were collected from the same abattoir.  The reproductive organs 
from two fetuses were retrieved and transported to the laboratory in the transport 
medium detailed above.  Ovaries were dissected from the fallopian tubes and either 
snap frozen or subjected to enzymatic dissociation.  Both ovaries from a 166 day old 
fetus (estimated by measurement of crown-rump length (CRL) = 44cm) were snap 
frozen for subsequent use as positive controls in reverse transcriptase-polymerase 
chain reaction (RT-PCR) and Western blotting.  The ovaries were placed in 1.5ml 
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microfuge tubes (Eppendorf) and immediately placed on dry ice for 10 mins before 
being transferred to a -80ºC freezer.  Both ovaries from a 164 day old fetus (CRL = 
43cm) were enzymatically dissociated as described in Chapter 5. 
 
2.1.2 Human Ovarian Tissue 
Post-pubertal ovarian biopsies were performed on seven adult women (22-40 years 
old) and one post-pubertal teenager (13 years old) (Table 2.1).  Two women and the 
teenager were undergoing laparoscopic ovarian tissue removal for cryopreservation 
for the purposes of fertility preservation.  Both adults had previously received 
chemotherapy, whilst the teenager had her tissue removed prior to cancer therapy.  The 
remaining 5 adults had ovarian tissue removed during elective Caesarean section.  All 
women were recruited by Research Nurses, Joan Creiger and Anne Saunderson, gave 
informed written consent and the study received Lothian Research Ethical Committee 
approval (reference number: REC10/S1101/24).   
The ovarian pieces were placed in dissecting medium (described above) and, using a 
light microscope, medullary tissue was aseptically removed with a scalpel under a 
laminar flow hood.  The cortex was then cut into approximately 0.5cm x 0.5cm x 1mm 
pieces and vitrified as described in section 2.2.  One piece of cortex from each patient 
was fixed for 24 hours in 4% NBF and the remaining pieces were vitrified as described 
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Table 2.1.  Characteristics of patients who consented to use of their ovarian tissue 
for the purposes of research. ABVD = adriamycin, bleomycin, vinblastine and 










Laparoscopic ovarian cortical 
stripping for cryopreservation 
2 22 
Hodgkin’s Lymphoma 
(relapse; previous ABVD 
chemotherapy) 
Laparoscopic ovarian cortical 
biopsies for cryopreservation 
3 32 N/A Elective Caesarean Section 
4 33 
Previous breast cancer 
(BRCA2 mutation; previous 
taxol and FEC chemotherapy) 
Prophylactic bilateral 
oophorectomies 
5 33 N/A Elective Caesarean Section 
6 38 N/A Elective Caesarean Section 
7 39 N/A Elective Caesarean Section 
8 40 N/A Elective Caesarean Section 
 
Fetal human ovarian tissue was collected from morphologically normal second 
trimester fetuses (16-19 weeks gestation) after medical termination of pregnancy.  
Recruitment was performed by Research Nurses, Joan Creiger and Anne Saunderson, 
written informed consent was obtained from the mothers and the study received 
Lothian Research Ethical Committee approval (LREC08/S1101/1).  The gestation of 
the fetuses was calculated from ultrasound findings prior to the termination and 
confirmed by foot length measurement in the lab.  Sex of the fetus was determined by 
visualisation of the external genitalia and dissection of the ovaries was performed by 
Dr. Rosey Bayne (from Prof. Anderson’s group) under sterile conditions.  The ovaries 
were dissected from attached mesonephros tissue using sterile 25G needles and placed 
in Dulbecco’s Phosphate-Buffered Saline (DPBS; Life Technologies).  They were then 
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either snap frozen for subsequent use in RT-PCR and Western blotting or 
enzymatically dissociated as per Chapter 5.   
 
2.2 Tissue Vitrification and Thawing 
2.2.1 Vitrification 
After dissection and cutting, ovarian cortical pieces were immediately vitrified and 
cryopreserved as previously described (Kagawa et al., 2009).  Cortical pieces were 
equilibrated at room temperature for 25 minutes in a holding medium comprising 
Leibovitz L-15, sodium pyruvate (2mM), glutamine, penicillin G (75 µg/ml), 
streptomycin sulphate (50 µg/ml), 20% (weight/volume; w/v) fetal bovine serum 
(FBS; Life Technologies), and supplemented with 7.5% (volume/volume; v/v) 
ethylene glycol (EG) and 7.5% (v/v) dimethyl sulphoxide (DMSO, both Sigma-
Aldrich).   The pieces were then placed in a second equilibration medium  consisting 
of the above holding medium supplemented with 20% (v/v) EG, 20% (v/v) DMSO and 
0.5 mol/L sucrose; Sigma-Aldrich) for 15 minutes at room temperature.  Fine forceps 
were subsequently used to thread the pieces onto sterilised stainless steel acupuncture 
needles (Acumedic®) and these needles were submerged briefly in liquid nitrogen.  
Once the tissue was frozen, the needles were placed in cryovials and stored in the 
vapour phase of liquid nitrogen. 
 
2.2.2 Thawing 
Cryovials containing cryopreserved ovarian cortical pieces were removed from the 
liquid nitrogen container and transported to a laminar flow hood on dry ice.  The 
protocol described by Kagawa et al. (Kagawa et al., 2009) was again used.  The 
acupuncture needles holding the tissue were removed and both needles and tissue were 
placed in a thaw medium for 1 min at 37ºC.  The thaw medium comprised the holding 
medium described in section 2.2.1, supplemented with 1.0 mol/L sucrose.  The needles 
were then transferred to a second thaw medium consisting of the holding medium 
supplemented with 0.5 mol/L sucrose and incubated for 5 mins at room temperature.  
The pieces of tissue were then removed from the needles using fine forceps and washed 
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twice in holding medium for 10 mins per wash.  The tissue was then ready for use in 
experiments. 
   
2.3 Isolation of Putative OSCs 
Ovarian cortex was dissociated, prepared and sorted for DDX4-positive cells as per 
the protocol previously published by Tilly’s group (White et al., 2012, Woods and 
Tilly, 2013) with some modifications. 
 
2.3.1 Ovarian Cortex Dissociation 
Vitrified bovine and human ovarian cortex was thawed as per section 2.2 before being 
mechanically and enzymatically disaggregated.  Approximately 15 pieces of bovine 
tissue and 2 - 4 pieces of human tissue were used for each experiment.  Cortical pieces 
were placed in 1ml of 600u/ml (bovine) or 400u/ml (human) collagenase type IV 
(Worthington Biochemical Company) pre-warmed to 37ºC and supplemented with 
DNase I (stock concentration of 1mg/ml; Roche) at a 1:100 DNase I:collagenase ratio 
in Hank’s Balanced Salt Solution (HBSS) minus calcium (Ca2+) and magnesium 
(Mg2+); Life Technologies).  Varying concentrations of collagenase type IV (400u/ml 
to 800u/ml) and DNase I:collagenase ratios (1:1000 to 1:100) were trialled to 
determine the optimal enzymatic conditions.  The pieces were cut into approximately 
1mm x 1mm x 1mm fragments with scalpels in a glass Petri dish, transferred into a 
gentleMACSTM C tube (Miltenyi Biotec) and a further 4ml of collagenase:DNase 
mixture added.  The tube was then placed in a gentleMACSTM Dissociator (Miltenyi 
Biotec) and mechanically dissociated using the pre-set “h_tumor_01.01 
“h_tumor_02.01” and “h_tumor_03.01” programmes successively.  In between 
programmes, tissue fragments that were trapped in the gentleMACSTM C tube rotor 
were placed back in the enzyme solution using sterile forceps within a laminar flow 
hood and the tube was rotated in a MACSmix™ Tube Rotator (Miltenyi Biotec) on its 
highest setting for 20 min incubations at 37ºC / 5% CO2.  Once the “h_tumor_03.01” 
programme was completed, the sample was removed from the tube by a sterile 10ml 
glass pipette (Fisher Scientific) and filtered into a 15ml centrifuge tube (Fisher 
Scientific) through a 100µm filter (Partec CellTrics®, Partec).  The filter was soaked 
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in Leibovitz L-15 supplemented with 10% (v/v) FBS prior to use to help prevent cell 
adherence to the filter.  The gentleMACSTM C tube was washed with 10ml HBSS 
minus calcium (Ca2+) and magnesium (Mg2+) warmed to 37ºC and this solution was 
also passed through the filter.  The sample was centrifuged at 300 rcf for 5 mins at 
room temperature with the brake off, the supernatant was carefully removed and the 
cell pellet was resuspended in 10ml of warmed HBSS as a wash step.  The sample 
underwent repeat centrifugation at the above specifications and the cell pellet was then 
blocked in 500µl blocking solution (2% (v/v) normal goat serum (Life Technologies) 
and 2% (w/v) BSA in HBSS minus Ca2+ and Mg2+, sterile-filtered through a 0.2µm 
filter (Corning)) for 20 mins at 4ºC. Fifty to one hundred microlitres of the sample was 
placed into two other 15ml tubes to be used as a negative control (both primary and 
secondary antibodies omitted) and a secondary antibody only control (with only the 
primary antibody omitted).  The cell suspensions were kept at 4ºC from this point 
onwards and used in the FACS protocol detailed below in section 2.3.2. 
 
 Alternative ovarian cortex dissocation protocol 
Due to the low cell yields and high cell death rates achieved using this dissociation 
protocol, post-doctoral colleagues in Prof. Telfer’s group (Dr. Marie McLaughlin and 
Dr. Yvonne Clarkson) investigated further adaptations of the disaggregation aspects 
of the protocol aiming to improve the number of live cells used in flow cytometry.  
Their optimised protocol was subsequently utilised by myself to collect higher cell 
yields for the purposes of characterisation of freshly isolated cells.  This protocol 
entailed thawing the tissue as per section 2.2 and cutting the tissue with scalpels as 
above, but in the absence of enzymes.  Tissue was then placed into gentleMACSTM C 
tubes and an enzyme combination of 400 u/ml collagenase I/II (Roche) and 10.9 u/ml 
DNase I in warmed HBSS plus Ca2+ and Mg2+ (to potentiate the enzyme effect; Life 
Technologies).  The gentleMACSTM Dissociator steps were followed as above, but the 
incubation steps inbetween were omitted, thus reducing the exposure time of the tissue 
to the enzymes with the aim of reducing resultant cell death.  The cell pellet was then 
blocked and divided into separate 15ml tubes as per section 2.3.1.  The protocol 
described in section 2.3.2 was then followed. 
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2.3.2 FACS 
The sample was washed in HBSS, centrifuged at 300 rcf for 5 mins at 4ºC with the 
brake off and subsequently resuspended in 100µl of the primary antibody solution 
(rabbit anti-DDX4 antibody (ab13840; Abcam) at 1:10 concentration in blocking 
solution).  After 20 mins incubation at 4ºC, two washing steps were performed with 
HBSS.  The secondary antibody only control was washed once with HBSS and then 
both cell suspensions were resuspended in 250µl secondary antibody (goat anti-rabbit 
IgG antibody conjugated to allophycocyanin (APC) (cat no. 111-136-144; Jackson 
ImmunoResearch) at 1:250 concentration in blocking solution).  Again, after 20 mins 
incubation at 4ºC, the cell suspensions were washed twice in HBSS.  The negative 
control was washed once with HBSS and then all three cell suspensions were 
resuspended in 500µl of buffer solution (1% (v/v) FBS in HBSS) and subjected to 
FACS within 30 mins.       
 
A BD FACSAriaTM II cytometer (BD Biosciences) was used for all experiments.  A 
schematic of the method is depicted in Fig. 2.1.   
 
 
Figure 2.1.  The basic principle underlying FACS.  (A) To select a specific cell 
population a primary antibody against a cell surface protein is used.  An appropriate 
secondary antibody with a fluorescent tag is then utilised to allow detection of the 
desired cell population by flow cytometry.  Our experiments used a rabbit anti-DDX4 
primary antibody and goat anti-rabbit APC-conjugated secondary antibody. (B) A 
schematic of the FACS process.  A heterogenous sample of cells is placed in the cell 
sorter and single cells are subjected to a laser beam.  Using the laser signal, the machine 
detects both the relative size of the cell (forward scatter; FSC) and granularity of the 
cell (side scatter; SSC).  Fluorescence of several wavelengths is also detected and the 
cell sorter can be programmed to separate the cell suspension according to presence or 
absence of the desired fluorescence. (Red star = desired fluorescently tagged cells.) 
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The cytometer located at the Queen’s Medical Research Institute (QMRI) Flow 
Cytometry Facility (University of Edinburgh, UK) was used for initial experiments, 
whilst the cytometer located at the School of Biological Sciences (SBS) Flow 
Cytometry Core Facility (University of Edinburgh, UK) was used for experiments 
utilising the protocol in section 2.3.1.1.  Staff at the Facilities (Shonna Johnston, Fiona 
Rossi and Will Ramsay at QMRI and Dr. Martin Waterfall at SBS) performed the 
analysis and cell sorting in discussion with myself.  The cell sample was compared to 
the negative control sample and secondary antibody only sample and gates were set up 
in order to select APC-positive (fluorescence wavelength: 670nm), and therefore 
DDX4-positive populations (Fig. 2.2).  A DNA stain, 4',6-diamidino-2-phenylindol 
(DAPI; 5µg/ml stock used at 1:200; fluorescence wavelength: 450nm; Life 
Technologies), was added before sorting.  DAPI was used at a concentration (advised 
by FACS staff) at which live cells did not become stained, allowing dead cells (i.e. 
cells with damaged cell membranes) to be identified and thus excluded.  Live DDX4-
positive (i.e. APC-positive and DAPI-negative) cells that were to be cultured were 
collected directly into 1ml of OSC culture medium (detailed below in section 2.4) in 
1 well of a 24 well plate (Corning) and immediately placed in an incubator at 37ºC / 
5% CO2.  DDX4-positive cells collected for molecular characterisation of mRNA were 
collected in 350µl of RLT buffer (Qiagen) and 1% (v/v) β-mercaptoethanol (β-ME; 
Sigma-Aldrich) was subsequently added in a laminar flow hood.  The cells were then 
processed as per section 2.9. 
Figure 2.2.  Simplified schematic of FACS plots to demonstrate how a specific cell 
population is selected.  (A) “Events” (i.e. anything detected by the FACS machine, 
including cells and debris) are plotted according to their size and granularity.  Debris 
(black dots) are excluded by their small size and intact cells (red dots) are then gated 
for (thin black line).  (B) The intact cells are then examined and only single cells (red 
dots) are gated for (thin black line).  Singlets are found in a diagonal line of 
approximately x = y, whilst doublets or aggregates of cells (blue dots) are found 
elsewhere on the plot.  (C)  Using fluorescence wavelengths specific to the secondary 
antibody and DAPI, live, single cells of interest can be detected.  Comparisons with a 
negative control allows gates (thin black lines) to be applied so that secondary-
antibody bound cells in the sample (quadrants (ii) and (iv) can be distinguished from 
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unbound cells (quadrants (i) and (iii).  As DAPI stains dead cells, cells in quadrant (iv) 
will be both live and positive for the protein of interest (in the case of this thesis, 
DDX4) and therefore will be collected. 
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2.4 In vitro Culture of Putative OSCs 
Cells collected from FACS were cultured in vitro in OSC culture medium comprising 
MEMα (containing GlutaMAXTM; Life Technologies) supplemented with 10% (v/v) 
FBS, 1 mM nonessential amino acids (NEAA), 1X-concentrated penicillin-
streptomycin-glutamine (PSG; all Life Technologies), 1 mM sodium pyruvate, 1X-
concentrated N-2 supplement (R&D Systems), 103 units/ml leukaemia inhibitory 
factor (LIF; Merck Millipore), 10 ng/ml recombinant human EGF, 1 ng/ml bFGF (both 
from Life Technologies), and 40 ng/ml glial cell-derived neurotropic factor (GDNF; 
R&D Systems) as per White et al. (White et al., 2012).  The culture medium was filter-
sterilised through a 0.2 µm filtration device prior to use.  Cells were cultured on plastic 
without the need for a feeder layer and fed on alternate days with 50-150µl of fresh 
OSC culture medium, depending on the size of the well the cells were in.  Passaging 
of cells was performed once confluence was reached using 0.25% (v/v) trypsin-
ethylenediaminetetraacetic acid (EDTA; Life Technologies).   
 
2.4.1 Cell cryopreservation and thawing  
DDX4-positive cells were cryopreserved using a method previously described for 
embryonic stem cells (Kent, 2009).  Cells were trypsinised, centrifuged at 800 x g for 
5 mins at room temperature and the cell pellet was gently resuspended in 500µl of 
OSC medium.  Five hundred microlitres of cryopreservation medium (60% (v/v) FBS, 
20% (v/v) OSC culture medium, 20% (v/v) DMSO) was then added drop-wise and 
gently mixed.  The cell suspension was then transferred to a 2ml cryovial (Greiner 
Bio-One) and placed in an isopropanolol freezing container (Mr Frosty Freezing 
Container; Thermo Scientific).  The following day the cryovial was placed in a liquid 
nitrogen storage container.    
Cells were successfully re-established in culture following thawing.  The cryovial was 
removed from liquid nitrogen and placed in a 37ºC water bath.  The thawed contents 
were then transferred to a 15ml tube and 4ml of OSC culture medium was added.  After 
centrifugation at 800 x g for 5 mins, the cell pellet was resuspended in fresh OSC 
culture medium and placed in 1 well of a 24 well plate. 
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2.5 Cell labelling with fluorescent markers 
In order to track cells in neo-oogenesis experiments in Chapter 5, cells were labelled 
with fluorescent markers using two different methods. 
 
2.5.1 Lentivirus Transduction 
Cells were transduced to express green or red fluorescence using GFP- or mCherry-
tagged lentiviruses (Lv-cppt-SFFV-IRES-hrGFP-opre at 1.6 x 107 viral particles/ml 
and Lv-cppt-SFFV-IRES-mCherry-opre at 1.2 x 106 viral particles/ml; designed and 
provided by Dr. Pamela Brown at the Biomedical Core Facility, Shared University 
Research Facilities (SuRF), University of Edinburgh, UK; Fig. 2.3).  Both lentiviruses 
contained a central polypurine tract (cppt) to allow viral RNA integration and an 
optimised post-translational enhancer (opre) and internal ribosome entry site (IRES) 
to increase translation efficiency.  A spleen focus-forming virus (SFFV) promoter, 
which aids stable transduction of stem cells, was used to drive fluorescence expression.  
Both bovine and human cells were counted prior to transfection using a 
haemocytometer.  In order to do this, cells were trypsinised, centrifuged at 800 x g for 
5 mins and resuspended in OSC medium.  Ten microlitres of the cell suspension was 
placed into the haemocytometer.  The total number of cells in each of the four 4x4 
grids were counted, with cells touching the left and bottom sides of each square 
included, but those touching the right and top sides excluded from the count. The total 
number was divided by four to obtain an average and this number represented the 
number of cells multiplied by 104 per ml of sample.  The total number of cells in the 
suspension was then calculated depending on the size of the sample.  Cells were plated 
down to achieve approximately 50% confluence the following day at which point they 
were exposed to OSC culture medium containing varying ratios of viral particles to 
cells (5:1, 10:1 or 20:1 for GFP experiments and 1:1, 5:1, 10:1 for mCherry 
experiments).  Polybrene (hexadimethrine bromide; H9268, Sigma-Aldrich) was 
added to the viral medium at a concentration of 6 µg/ml to improve transduction 
efficiency.  Polybrene is a positively-charged polymer which neutralises the repulsion 
between the viral particles and the negatively-charged sialic acid on the cell 
membrane.  Viral medium was replaced with fresh medium after 24 (GFP) or 72 
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(mCherry) hours as this allowed adequate uptake of the lentivirus as assessed by 
microscopic visualisation.  Fluorescing cells were analysed and imaged using an 
inverted microscope (Axiovert 200; Zeiss) and an attached Hamamatsu camera 
(Hamamatsu Photonics UK Ltd.).  Images were compared to non-transfected cells to 
remove background or auto-fluorescence. 
 
 
Figure 2.3.  Lentiviral transduction of cells.  Lentiviruses contain all the necessary 
components to allow integration of its RNA into the host cell genome, including 
reverse transcriptase and integrase. Lentiviruses transduce cells by cell membrane 
fusion with the target cell.  The viral mRNA is then reverse transcribed to create 
double-stranded DNA, which is then integrated into the host DNA within the nucleus.  
The host cell then transcribes the integrated DNA and produces the desired protein, in 
this case a fluorescent protein (either GFP or mCherry). 
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Cells exposed to lentivirus were purified using FACS for GFP or mCherry 
fluorescence.  Cells were trypsinised, resuspended in OSC medium and transported to 
a BD FACSAriaTM II cytometer (BD Biosciences; QMRI, University of Edinburgh) 
on fresh ice.  Staff at the Facility (Shonna Johnston, Fiona Rossi and Will Ramsay) 
performed the analysis and cell sorting in discussion with myself.  Transduced cell 
samples were compared to cells which had not been exposed to lentivirus and gates 
were set up using fluorescence wavelengths of 525nm and 582nm in order to select 
GFP- or mCherry-expressing cells, respectively.  DAPI was added to exclude dead 
cells (fluorescence wavelength 450nm).  Purified samples of live transduced cells were 
collected into OSC medium and plated down into 24 well plates.  In order to analyse 
the long term stability of transfection, repeat flow cytometry was performed 2 weeks 
and 14 weeks (GFP-expressing bovine cells only) after purification, with gates applied 
using a sample of non-transfected cells as before.   
 
2.5.2 Rhodamine Dextrans Labelling 
Bovine and human cells were labelled with rhodamine-conjugated dextrans 
(Rhodamine B (570/590), D1824; Molecular ProbesTM, Thermo Scientific) to produce 
a red fluorescence (Fig. 2.4).  Cells were exposed to 75µg/ml of rhodamine-conjugated 
dextrans in OSC medium for 24 hours before the medium was replaced with fresh OSC 
medium.  As with the transfected cells, cells that endocytosed rhodamine-conjugated 
dextrans were analysed and imaged using an inverted microscope (Axiovert 200; 
Zeiss) and Zen software (Zeiss).  They were compared to cells that had not been 
exposed to dextrans to remove background or auto-fluorescence (fluorescent 







Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
General Materials and Methods 66 
 
 
Figure 2.4.  Tagging of cells with dextran conjugates.  Dextrans in the surrounding 
culture medium are endocytosed by the cell and subsequently contained within 
vesicles in the cytoplasm.  This confers a punctate fluorescence to the cell. 
 
2.6 Fixing and Processing of Tissue 
2.6.1 Fixation, embedding and sectioning 
For immunohistochemistry (IHC) and immunofluorescence (IF) experiments, tissue 
was fixed in either 4% NBF for 24 hours or Bouin’s solution for 3 hours before being 
transferred to 70% (v/v) ethanol.  The tissue was either mechanically processed into 
paraffin wax using a standard protocol and a Histostar Embedding Workstation (Leica) 
by staff at SuRF (University of Edinburgh) or manually embedded.  Tissue that was 
manually embedded was dehydrated by placing it in increasing concentrations of 
ethanol (70%, 90% and 100%) for 1 hour before being placed in cedarwood oil (VWR 
International) for 24 hours.  The pieces were subsequently placed in toluene (Fisher 
Scientific) for 30 mins to remove the oil and then embedded in paraffin for 4 hours at 
60ºC with hourly wax changes.  A Leica RM2125 microtome (Leica) was used to cut 
paraffin-embedded tissue into 6µm sections and mounted onto electrostatically-
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charged slides (Leica) using a 37ºC water bath.  Slides were dried overnight at 50ºC 
and stored long-term at room temperature.            
 
2.6.2 Dewaxing and rehydration 
Tissue to be analysed by IHC and IF was dewaxed by placing slides in xylene (VWR 
International) for two washes of 5 mins each.  Rehydration was then performed by 
placing the slides in decreasing amounts of ethanol (two washes in 100%, then 95%, 
80% and 70%) for 20 secs each.  Slides were then washed in tap water prior to either 
staining or antigen retrieval. 
 
2.6.3 Haematoxylin and eosin staining 
After dewaxing and rehydration, slides were placed in Harris haematoxylin solution 
(CellPath) for 2 mins to stain nuclei purple.  The slides were then washed in tap water 
before being dipped in acid alcohol to remove non-specific staining.  After a further 
wash in tap water, the slides were placed in Scott’s Tap Water Substitute (STWS; 
CellPath) for 20 secs to increase the intensity of the haematoxylin stain and placed 
back in tap water.  Slides were dipped briefly in 1% eosin (CellPath) to stain cytoplasm 
pink, washed in tap water and inspected under a light microscope to assess the quality 
of staining.  Slides were then dehydrated through increasing concentrations of ethanol 
(70%, 85%, 90% and two washes of 100%) for 20 secs each, before being placed in 
xylene for 2 washes of 5 mins each.  Slides were subsequently mounted with glass 
coverslips in a laminar flow hood using DPX mountant (Sigma-Aldrich) and left to 
dry at room temperature.   
 
2.6.4 Immunohistochemistry 
Immunohistochemistry was performed to identify the location of proteins of interest 
within tissue.  Two different methods were utilised and their use will be specified in 
individual chapters.  Specific primary and secondary antibody details will also be 
detailed in individual chapters. 
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 Avidin/Biotin Peroxidase Detection 
Slides were dewaxed and rehydrated as per section 2.6.2 before undergoing antigen 
retrieval in order to expose proteins that may have been masked during processing.  
Slides were heated in 0.01M citrate buffer (pH 6.0) using a microwave (5 mins at high 
power until boiling, then 15 mins on simmer setting, with regular replenishment of 
buffer).  In order to block endogenous peroxidases and thus prevent non-specific 
binding by the primary and secondary antibodies, slides were subsequently incubated 
for 30 mins in 3% hydrogen peroxide (H2O2; Sigma-Aldrich) in methanol (VWR 
International).  After repeated washing in 1x tris-buffered saline (TBS) containing 
0.1% (v/v) Tween® 20 (TBST; both Sigma-Aldrich), non-specific binding by the 
secondary antibody was additionally ensured by blocking slides in species-appropriate 
normal serum (Vectastain® ABC Kit, Vector Laboratories) diluted in TBST (3 drops 
of serum in 10mls TBST).  Two washes in TBST were again performed and the slides 
were incubated overnight with a suitable primary antibody (diluted in serum blocking 
solution) at 4ºC.  For negative controls, the primary antibody was omitted and the 
slides were incubated in serum alone.  The next day, the slides were washed in TBST 
twice, and incubated in the appropriate biotinylated secondary antibody (1 drop in 
10mls TBST; Vectastain® ABC Kit) for 1 hour at room temperature.  After two more 
washes in TBST, slides were incubated in avidin/biotin ABC complex (made up as per 
the manufacturer’s instructions; Vectastain® ABC Kit) for 30 mins at room 
temperature and washed once more in TBST.  A 3,3'-Diaminobenzidine stain (DAB; 
made up as per the manufacturer’s instructions; Vector Laboratories) was used to 
visualise the bound antibody complexes and the slides were placed in tap water to stop 
the reaction when required.  The sections were then counterstained with haematoxylin, 
treated with acid alcohol and STWS and finally dehydrated and mounted as per section 
2.6.2.        
 
 ImmPRESSTM Peroxidase Detection 
After dewaxing and rehydrating as described in section 2.6.2, antigen retrieval was 
performed in 0.01M sodium citrate (pH 6) in an Instant Pot® slow cooker (Instant Pot 
Company).  The slide container was placed in 1.5 litres of deionised water in the cooker 
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and heated for 5 mins at full power before the cooker was allowed to vent steam for 
20 mins with the slides inside.  Endogenous peroxidases were blocked for 10 mins in 
Dako REALTM peroxidase-blocking solution (Dako) and washed in 1x TBS several 
times.  Slides were then incubated in 2.5% (v/v) normal horse serum (ImmPRESSTM 
kit; Vector Laboratories) for 30 mins at room temperature, washed in TBS twice and 
subsequently incubated in the appropriate primary antibody (diluted in serum blocking 
solution) overnight at 4ºC.  The primary antibody was omitted for negative controls.  
The following day, slides were washed twice in TBS, and incubated with 
ImmPRESSTM reagent (Vector Laboratories) for 30 mins at room temperature.  After 
further washing in TBS, antibody binding was visualised using DAB (Dako) and then 
slides were counterstained with haematoxylin, treated with acid alcohol and STWS 
and dehydrated and mounted as per section 2.6.2. 
 
2.6.5 Immunofluorescence  
IF was performed to identify the location of proteins of interest within tissue.  As IF 
allows for more sensitive detection of proteins, lower antibody concentrations were 
used than for IHC.  Specific primary and secondary antibody details will be detailed 
in individual chapters.   
Slides were dewaxed and dehydrated as described in section 2.6.2 and subsequent 
antigen retrieval was performed using the Instant Pot slow cooker as per section 
2.6.4.2.  Endogenous peroxidases were blocked with Dako REALTM peroxidase block 
(Dako) for 10 mins at room temperature and slides were then thoroughly washed in 1x 
phosphate-buffered saline (PBS; Life Technologies).  Slides were subsequently 
blocked for 30 mins in species-appropriate serum blocking solution containing 20% 
(v/v) normal serum and 5% (w/v) BSA in 1x PBS.  After further washing in PBS, 
slides were incubated in the appropriate primary antibody (diluted in blocking 
solution) overnight at 4ºC.  For negative controls, the primary antibody was omitted.  
On the second day, two washes in PBS were performed and then an appropriate 
secondary antibody (diluted in blocking solution) was used, with an incubation of 30 
mins at room temperature.  After further washing in PBS, a fluorescein tyramide signal 
amplification detection kit (Perkin Elmer) was used at a concentration of fluorescein 
to amplification diluent of 1:50.  Slides were incubated at room temperature for 10 
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mins and slides were exposed to as little light as possible during all subsequent steps.  
Slides were then washed twice in PBS and either DAPI (blue; Sigma-Aldrich), 
propidium iodide (PI, red; Sigma-Aldrich) or Sytox Green (green; InvitrogenTM, 
Themo Scientific) nuclear counterstain was applied for 10 mins at room temperature 
(all at 1:1000, diluted in PBS).  After further washing in PBS, slides were mounted 
with PermaFluorTM (Fisher Scientific) and stored at 4°C in the dark. 
 
2.7 Fixing and Processing of Cells 
2.7.1 Cell culture and Fixation 
Cells to be analysed by immunocytochemistry (ICC) were cultured until confluent in 
4- or 8-well Nunc Lab-TekTM II chamber slides (Fisher Scientific).  For bovine 
experiments, chamber slides had to be pre-coated with 0.01% (w/v) poly-L-lysine 
(Sigma-Aldrich) so that the cells remained adherent to the slide during processing.  
The slide chambers were filled with poly-L-lysine for 5 mins, then washed with 
distilled water (dH2O) and air dried for 2 hours in a laminar flow hood prior to cells 
being plated down.  Once the cells were confluent, the chamber slides were washed 
twice in 1x PBS and fixed in either Bouin’s solution, 4% NBF or 50:50 
methanol:ethanol for 10 mins, depending on the species of cells or primary antibodies 
used (further details in individual chapters).  If methanol:ethanol fix was used, then 
the chamber slides were placed at -20ºC during this time.  After further washing with 
PBS, fresh PBS was applied to each well, the slides were sealed with Parafilm (Bemis) 
and they were stored at 4°C until ICC experiments were performed.   
 
2.7.2 Immunocytochemistry 
ICC was performed to identify the expression and location of proteins of interest 
within cultured cells.  It also allowed for comparisons in intensity of staining in 
experiments involving pharmacological treatments in Chapter 6.   
If Bouin’s or NBF was used as a fixative, then cells had to be permeabilised prior to 
proceeding with immunocytochemistry.  Simultaneous permeabilisation and blocking 
was performed for 20 mins at room temperature using a permeabilisation and blocking 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
General Materials and Methods 71 
buffer: 1x PBS containing 0.2% (v/v) Tween® 20, 1% (w/v) BSA and 10% (v/v) 
species-appropriate normal serum.  This was followed by a 10 min incubation in 
species-appropriate serum blocking solution comprising 5% (w/v) BSA and 20% 
normal serum in 1x PBS.  As the methanol:ethanol solution both fixes and 
permeabilises cells, no further permeabilisation step was required for these cells.  Cells 
fixed by this method were therefore washed in PBS twice and then blocked for 20 mins 
at room temperature in species-appropriate serum blocking solution comprising 5% 
(w/v) BSA and 20% (v/v) normal serum in 1x PBS.  All slides, regardless of fixative, 
were washed in PBS twice more, then incubated with the required primary antibody 
diluted in the blocking solution above and stored at 4°C overnight.  The primary 
antibody was replaced by serum blocking solution for negative controls.  The 
following day, slides were washed in PBS and incubated in the relevant peroxidase-
labelled secondary antibody diluted in blocking solution for 30 mins at room 
temperature.  Following further washing in PBS, the chambers were removed from the 
slide.  Fluorescein tyramide signal amplification was then performed as per section 
2.6.5, with an incubation of 10 mins at room temperature and slides kept in the dark 
as much as possible thereafter.  After further washing with PBS, a DAPI, PI or Sytox 
Green nuclear counterstain (all at 1:1000, diluted in PBS) was applied for 10 mins at 
room temperature.  Slides were once again washed twice in PBS and mounted with 
PermaFluorTM, before being stored at 4°C in the dark until ready for analysis.   
 
2.8 Analysis of Histological Results 
2.8.1 Light Microscopy 
Tissue used in IHC experiments was examined for expression of proteins of interest 
under a Provis AX70 light microscope (Olympus).  Images of slides were taken using 
a camera fitted to this microscope (AxioCam HRc, Zeiss) and scale bars were applied 
using AxioVision or Zen software (both Zeiss).  Microsoft Powerpoint (Microsoft) 
was used to compile images. 
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2.8.2 Fluorescent Microscopy 
IF and ICC experiments were analysed using a confocal laser scanning microscope 
(Zeiss LSM 710 or 780).  Blue (DAPI) fluorescence was visualised using a wavelength 
of 405nm, green fluorescence wavelength was 488nm and red fluorescence 
wavelength was 561nm.  Identical laser settings were used within each experiment.  
Images were acquired using the attached camera, scale bars were applied using the Zen 
software (Zeiss) and images composed in Microsoft Powerpoint (Microsoft).  Negative 
controls were analysed in every experiment to ensure background or auto-fluorescence 
was corrected for and accurate interpretations of the data were made. 
 
2.9 Gene Expression Analysis 
In order to characterise the cells, analysis for the expression of messenger RNA 
(mRNA) of putative OSC and oocyte-specific markers was performed. 
 
2.9.1 RNA extraction 
Cells to be analysed for mRNA expression were lysed in 350µl RLT Buffer (Qiagen) 
containing 1% (v/v) β-ME (Sigma-Aldrich) and homogenised using a Qiashredder 
(Qiagen) as per the manufacturer’s instructions.  Total RNA was subsequently 
extracted using a RNeasy Micro Kit (Qiagen) as per the manufacturer’s instructions, 
with on-column DNase I digestion for 30 mins.  Total RNA was eluted in RNase-free 
water (Qiagen) and total RNA concentrations were measured by spectrophotometry 
using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific).  Samples were 
stored at -80°C.  
For the purposes of positive controls, RNA was also extracted from fetal bovine (166 
days gestation) and human (19+5 weeks gestation) ovaries.  To assess the specificity of 
the primers, adult mouse skeletal muscle RNA was used (tissue retrieved by Kelsey 
Grieve in Prof. Anderson’s group).  The ovary and muscle tissue was homogenised in 
the lysis buffer described above in a 1.5ml microfuge tube (Eppendorf) and then 
centrifuged briefly.  The supernatant was then used for RNA extraction as detailed 
above. 
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2.9.2 cDNA synthesis 
The Maxima First Strand cDNA Synthesis Kit (Thermo Scientific) was used to 
perform reverse transcription of extracted RNA as per the manufacturer’s instructions, 
with the amount of RNA used dependent on the experiment (denoted hereafter as RT+ 
samples).  A PTC-100 Thermal Cycler (Bio-Rad) was used with the cycling conditions 
described in Table 2.2.   
 
Table 2.2.  First strand cDNA synthesis Thermocycler programme for Maxima 
Kit. 











For the purpose of negative controls to allow identification of contamination in 
subsequent experiments, reactions were performed using the same amount of total 
RNA with the Reverse Transcriptase enzyme omitted (RT- samples).  The cDNA was 
stored at -20ºC.  
 
2.9.3 Reverse transcriptase-polymerase chain reaction (RT-PCR) 
To detect the presence of particular transcripts, RT-PCR was performed using 1µl of 
RT+ or RT- cDNA reactions and MyTaqTM HS Red Mix (Bioline) to a total reaction 
volume of 25µl (Table 2.3).  Forward and reverse primers were reconstituted at 25µM 
concentration, and used at a final concentration of 0.5µM.   
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Table 2.3.  RT-PCR reaction mix using MyTaqTM HS Red Mix. 
Reagent Amount (µl) Source 
MyTaqTM HS Red Mix 12.5 Bioline 
25µM Forward Primer 0.5 Integrated DNA Technologies 
25µM Reverse Primer 0.5 Integrated DNA Technologies 
RNase-free H2O 10.5 Qiagen 
cDNA 1  
 
Primer sequences for genes of interest were designed using Primer Blast (National 
Center for Biotechnology Information, NCBI) or obtained from the literature and 
purchased from Integrated DNA Technologies (IDT) (Tables 2.4, 2.5 (bovine 
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Samples were subjected to identical cycling conditions using a PTC-100 Thermal 
Cycler (Table 2.7). 
 
Table 2.7.  RT-PCR Thermocycler Programme for MyTaqTM reaction mix. 
Step Temperature (ºC) Time 
1 
Initial denaturation of DNA 
95 1 min 
2 
Denaturation of DNA 
95 15 secs 
3 
Annealing of Primers 
60 30 secs 
4 
Extension Reaction 
72 30 secs 
Steps 2 - 4 repeated for 35 cycles 
5 
Final Extension 
72 10 mins 
 
Samples were resolved through 2.5% (w/v) agarose gels (Bioline; in 1x Tris-acetate-
EDTA (TAE)) with GelRedTM (Cambridge Bioscience) staining at 0.01% (v/v) used 
to visualise DNA bands.  Gels were run at 100 - 150 volts and 1x TAE was used as a 
running buffer.  DNA ladders (100 bp; Bioline) were used to identify approximate 
product sizes.  Gels were analysed under UV light using either a Gene Flash UV 
transilluminator (Syngene) or U:Genius3 UV transilluminator (Syngene) and images 
were captured using the attached cameras.  In freshly isolated putative bovine OSC 
experiments, gene fragment template DNA (designed by Dr. Yvonne Clarkson using 
MacVector7.2 and purchased from IDT) was used as a positive control (Tables 2.4 and 
2.5).  Bovine or human fetal ovary cDNA was used as a positive control for cultured 
cells from each species to validate the use of the primers.  Mouse skeletal muscle was 
used as a negative control.  Two other types of negative controls were used to detect 
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contamination and subjected to the same procedures: RT- samples and samples with 
cDNA substituted for RNase-free water.  Two reference genes, whose use had been 
previously established in Prof. Anderson’s laboratory, were used to verify the 
effectiveness of the RT-PCR reactions: β-actin (ACTB) in bovine experiments and 
Ribosomal Protein L32 (RPL32) in human experiments.  ACTB was also used as a 
reference gene for mouse skeletal muscle (Table 2.8). 
 




Forward Primer (5’-3’) Reverse Primer (5’-3’) 
Product size 
(base pairs) 




2.9.4 Quantitative RT-PCR 
For quantitative analysis of specific gene expression, quantitative RT-PCR (qRT-
PCR) was performed using 1/10 dilutions of cDNA, Brilliant III Ultra-Fast SYBR 
Green Master Mix (Agilent Technologies), and forward and reverse primers at a final 
concentration of 500 nM (Table 2.9), with a final reaction volume of 10µl.  Samples 
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Table 2.9.  qRT-PCR reaction mix.  
Reagent Amount (µl) Source 
SYBR Green 5 Agilent Technologies 
1/50 dilution of 
Reference dye 
(in RNase-free H2O) 
0.15 Agilent Technologies 
25µM Forward Primer 0.2 Integrated DNA Technologies 
25µM Reverse Primer 0.2 Integrated DNA Technologies 
RNase-free H2O 2.45 Qiagen 
cDNA 2  
 
The ABI7900HTFast system (Applied Biosystems, Thermo Scientific) with SDS2.4 
software was utilised to analyse the quantification cycle (Cq) value of genes of interest 
for each sample.  This is a measure of the number of cycles required for the machine 
to detect a signal: the lower the Cq value, the more highly expressed the gene is.  
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Table 2.10.  qRT-PCR ABI7900HTFast cycling conditions. 
Step Temperature (ºC) Time 
1 
(Hot start to activate DNA Taq 
Polymerase in SYBR Green Master Mix) 
95 3 min 
2 
(Denaturation and annealing) 
95 5 secs 
3 
(Extension) 
60 15 secs 
Steps 2 - 3 repeated for 40 cycles 
4 








Duplicate RT+ reactions were performed for each sample per gene of interest to 
increase reliability and one RT- reaction for each sample per gene of interest was 
performed to detect contamination.  Bovine or human fetal ovary cDNA was used as 
a positive control for each species to validate the use of the primers.   
Primer sequences were designed using Primer Blast (NCBI) and purchased from 
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 Statistical Analysis of qRT-PCR data 
The expression of each analysed gene was calculated relative to the expression of the 
reference genes β-actin (bovine samples) and RPL32 (human samples).  Normalised 
gene expression was calculated using the ΔΔCq method (Livak and Schmittgen, 2001): 
for each sample, the average Cq value of the reference gene was calculated and 
subtracted from the average Cq value of the gene of interest to determine the ΔCq value.  
A “control” value from the experiment (e.g. a vehicle sample in Chapter 6) was then 
selected and subtracted from each ΔCq value to calculate the ΔΔCq value.  As Cq values 
are on a logarithmic base 2 scale, the fold change in gene expression was determined 
by calculating 2^-ΔΔCq.  Microsoft Excel (Microsoft) was used for these calculations.  
Subsequent statistical analyses was then performed using GraphPad Prism (GraphPad 
Software, Inc.).  Calculated 2^-ΔΔCq values were logarithmically transformed and 
checked for normalcy using the Shapiro-Wilks normality test (or Kolmorogov-
Smirnov test if the n ≤ 3).  If data were normal, then they were analysed with the 
parametric one-way analysis of variance (ANOVA) with a post-hoc Tukey test.  If the 
data were not normal, then they were analysed with the non-parametric Kruskal-Wallis 
test with post-hoc Dunn’s test.  A p level of < 0.05 was considered significant. 
 
2.10 Western Blotting 
2.10.1 Protein extraction and measurement 
Protein expression was analysed in cultured cells.  Cells were cultured in 100mm 
culture dishes (Corning) until confluent and then washed with DPBS.  Cell lysis was 
performed using radioimmunoprecipitation assay (RIPA) buffer supplemented with 1 
tablet of cOmpleteTM Mini protease inhibitor (Roche) and 1 tablet of PhosSTOP 
phosphatase inhibitor (Roche) for 10 mins on ice.  Cells were removed from culture 
plates using a cell scraper and placed in a 1.5ml microfuge tube.  Cell lysates were 
centrifuged at 14000 x g for 10 mins at 4°C and the supernatants were carefully 
removed and stored at -20°C.  Protein extraction from fetal bovine and human ovary 
was also performed for the purposes of positive controls.  Snapfrozen bovine ovary 
(166 days gestation) and freshly dissected human ovary (19+6 weeks gestation) were 
homogenised in RIPA lysis buffer plus supplements as detailed above and centrifuged 
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at 14000 x g for 10 mins at 4°C.  The supernatant was then removed and stored at -
20°C. 
Protein concentrations were measured in a 96-well plate (Corning) using Bio-Rad 
Protein Assay Reagents (Bio-Rad) as per the manufacturer’s instructions.  Triplicates 
of each sample were analysed as quality control.  After 15 mins incubation at room 
temperature, absorbance measurements were made using a Multiskan Ex Microplate 
Reader (Thermo Scientific) and samples were compared with BSA concentration 
standards (ranging from 0 µg/ml to 1000 µg/ml) that had been run on the same plate 
in order to calculate protein concentrations.     
 
2.10.2 Separation and Transfer  
Lysates were added to 4xSDS Sample Buffer (625mM Tris, 5% (v/v) glycerol, 2% 
(v/v) SDS, 0.0025% (v/v) bromophenol blue in dH2O; all Sigma-Aldrich)) containing 
15% (v/v) β-ME and denatured at 99ºC for 6 mins.  Lysates were separated by SDS 
polyacrylamide gel electrophoresis (SDS-PAGE) on Bio-Rad mini-protean Tris-
glycine TGX gels, with between 10-30µg of lysates added per lane depending on the 
experiment.  Tris/glycine/SDS x1 (25mM Tris, 192mM glycine, 0.1% (v/v) SDS at pH 
8.3; Bio-Rad) was used as a running buffer and gels were run at 125v until the loading 
dye had reached the bottom of the gel.  A pre-stained protein ladder was used to 
identify approximate product molecular weights (PageRulerTM Plus; Thermo 
Scientific).  Gels were washed in dH2O twice for 5 mins before being washed in Fast 
Semi-dry Transfer Buffer (Thermo Scientific) for 10 mins.  Meanwhile, Immobilon 
FL membrane (Merck Millipore) was cut to size and soaked in methanol for 30 secs, 
dH2O for 1 min and Transfer Buffer for 15 mins.  Two pieces of filter paper per gel 
were also simultaneously soaked in Transfer Buffer for 15 mins.  Semi-dry transfer 
was then performed by sandwiching the gel and membrane between the two pieces of 
filter paper in a semi-dry blotter at 25V for 9 mins.   
 
2.10.3 Serum blocking, antibody probing and detection 
After transfer, the membranes were blocked in a 1:1 ratio of Rockland blocking buffer 
(Rockland) to 1x PBS containing 0.05% Tween® 20 (PBST) for 1 hour at room 
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temperature.  The membranes were then incubated in the required dilutions of primary 
antibodies (in blocking buffer) overnight at 4ºC.  The following day, the membranes 
were washed four times in PBST for 5 mins each and incubated with the appropriate 
Alexa Fluor 680 conjugated secondary antibody for 1 hour at room temperature.  After 
two 5 min washes in PBST and two 5 min washes in 1x PBS, a Li-cor Classic infrared 
imaging system (Li-cor Biotechnology) was used to detect the fluorescent signals of 
protein bands.  The membranes were re-probed for the reference gene ACTB with a 
mouse anti-β-actin primary antibody (used at 1:5000; A5441, Sigma-Aldrich) and a 
donkey anti-mouse IRDye 800 conjugated secondary antibody (used at 1:10000; 
Rockland), before being re-imaged on the Li-Cor imaging system. 
 
2.11 Commonly Used Solutions 
2.11.1 Citrate Buffer 
820ml of 0.1M sodium citrate was combined with 90ml of 0.2M citric acid 
monohydrate in 900ml of dH2O and altered to a pH of 6.0 with sodium hydroxide (all 
Sigma-Aldrich), before being made up to 1000ml with dH2O. 
 
2.11.2 PBS 
To make 1x PBS, 1 PBS tablet (Sigma-Aldrich) was added to 200ml of dH2O. 
 
2.11.3 RIPA buffer 
RIPA buffer was made by combining 25mM Tris.HCl (12.11g Tris base added to 80ml 
dH2O and adjusted to pH 7.5 with hydrochloric acid), 150mM sodium chloride, 1% 
(v/v) Triton X-100, 0.1% (v/v) SDS and 0.05% (w/v) sodium deoxycholate (all Sigma-
Aldrich) in dH2O. 
 
2.11.4 TAE 
A stock of 50x TAE was made by adding 484g Tris base, 114.2g glacial acetic acid 
and 100ml 0.5M EDTA (all Sigma-Aldrich) to 2000ml of dH2O and adjusting the 
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solution to a pH of 8.0 with hydrochloric acid (Sigma-Aldrich).  TAE (x1) was used 
in experiments by diluting the stock in dH2O. 
 
2.11.5 TBS 
A stock of 10x TBS was made by adding 121.1g Tris base and 170g NaCl (both Sigma-
Aldrich) to 2000ml of dH2O and adjusting the solution to a pH of 7.4 with hydrochloric 
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3.1 Introduction 
3.1.1 Isolation of putative OSCs 
As discussed in section 1.2.4, a few groups have reported the isolation of OSCs in 
adult mice (Zhang et al., 2008, Zou et al., 2009, Pacchiarotti et al., 2010, Zou et al., 
2011, Hu et al., 2012, White et al., 2012, Hernandez et al., 2015, Xiong et al., 2015, 
Lu et al., 2016), rats (Zhou et al., 2014), pigs (Bui et al., 2014), rhesus macaque 
monkeys (Hernandez et al., 2015) and humans (White et al., 2012, Hernandez et al., 
2015).  Three different methodologies have been used, ranging in complexity and each 
with their own benefits and disadvantages: from simple dissociation of ovarian cortex 
with analysis of cells that established in culture, to immunomagnetic cell selection and 
fluorescence-activated cell isolation (Table 3.1).  Selection for both Ddx4 and Ifitm3 
has been used successfully (Zou et al., 2009, Zou et al., 2011, White et al., 2012, 
Hernandez et al., 2015, Xiong et al., 2015, Lu et al., 2016), although it has been 
suggested that Ifitm3-based selection is more effective that Ddx4-based methods, with 
significantly more (almost twice as many) putative OSC cells isolated using Ifitm3 
(Zou et al., 2011).  The authors postulated that this may be because Ifitm3 offers more 
binding sites to its antibody than the hypothesised transmembrane domain of Ddx4 
(Zou et al., 2011). Ifitm3 is a cell surface protein (Saitou et al., 2002), thus its use also 
avoids some of the controversy around the use of Ddx4 (see section 1.2.5.2.). 
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Table 3.1.  Some of the advantages and disadvantages to the three methods used 
for isolating putative OSCs to date. 
Technique Pros Cons 
Culture of 
dissociated cortex 
with no selection 
for protein 
expression 
 Technically more 
straightforward 
 Rapid and cheap 
 Possibly less damaging to 
cells as subjected to fewer 
processing steps 
 Results in impure cell 
populations (although 
can select out cells 
containing protein of 
interest if it is linked to 
a fluorescent marker) 
 Relies on population of 
interest outgrowing 






 Selects for cells expressing 
a desired protein of interest 
on the cell surface 
 Quicker than FACS 
 Cheaper than FACS 
 No exclusion of dead 
cells 
 No selection on the 
basis of cell size (i.e. 
OSCs and damaged 
oocytes both collected) 
 Inadequate 
disaggregation is 
detrimental to sorting 
efficiency (Zou et al., 
2011) 
FACS 
 Selects for cells expressing 
a desired protein of interest 
(can be internally 
expressed if the protein is 
linked to a fluorescent 
marker) 
 Can select cells on basis of 
size, so can isolate a purer 
population than MACS 
 Can exclude dead cells 
 Requires expensive 
equipment 




detrimental to sorting 
efficiency 
 Can cause more cell 
damage than MACS 
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3.1.2 In vitro culture of putative OSCs 
Once isolated, the medium in which the stem cells are cultured is critical for healthy 
growth and for maintenance of an undifferentiated state in order for the cell line to 
propagate.  With this in mind, all groups who have reported the in vitro culture of 
putative OSCs have used a serum-containing medium to provide growth factors, and 
all but one (Pacchiarotti et al., 2010) supplemented the medium with a combination of 
specific growth factors, such as EGF, bFGF and LIF in order to both encourage 
proliferation and prevent differentiation (Zou et al., 2009, Hu et al., 2012, White et al., 
2012, Bui et al., 2014, Zhou et al., 2014, Hernandez et al., 2015, Xiong et al., 2015, 
Lu et al., 2016).  The inclusion of LIF in particular has proved beneficial, with Hu et 
al. reporting that cells in LIF-containing medium formed more colonies (Hu et al., 
2012).  Despite the inclusion of factors in the culture medium that prevent 
differentiation of stem cells, nearly all groups have reported the spontaneous 
differentiation of some of the cells into OLCs during in vitro culture, which have been 
characterised on the basis of morphology and/or molecular analysis (Zou et al., 2009, 
Pacchiarotti et al., 2010, Hu et al., 2012, White et al., 2012, Bui et al., 2014, Zhou et 
al., 2014, Hernandez et al., 2015).  Moreover, to date, all groups have used a feeder 
layer to help the putative OSCs establish in culture, although White et al. have reported 
that cells will establish without such a layer, but at lower efficiency (Zou et al., 2009, 
Pacchiarotti et al., 2010, Hu et al., 2012, White et al., 2012, Bui et al., 2014, Zhou et 
al., 2014, Hernandez et al., 2015, Xiong et al., 2015, Lu et al., 2016).   
 
3.1.3 Fluorescent labelling of putative OSCs 
The definitive test of a putative OSC is whether the OSC can form functional oocytes.  
The conditions used to demonstrate this differentiation thus far have required that the 
cells are traceable in order to ascertain whether observed oocytes are pre-existing or 
have been derived from OSCs.  As such, cells have been successfully induced to 
express GFP by both viral transduction and liposome-mediated transfection and such 
cells have continued to propagate in culture (Zou et al., 2009, Zhang et al., 2011, White 
et al., 2012, Wolff et al., 2013, Wolff et al., 2014, Zhou et al., 2014, Xiong et al., 
2015, Lu et al., 2016).   
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3.1.4 Aims of this chapter 
The overall aim of the experiments detailed in this chapter was to attempt the 
recapitulation of putative OSC isolation and in vitro culture.  The principal aim was to 
isolate putative OSCs from human ovarian cortex, in order that the resulting data were 
as clinically applicable as possible.  However, we chose to undertake the experiments 
using bovine ovarian cortex initially, allowing the protocol to be optimised in our 
laboratory before testing it on human tissue.  The reason for this was threefold: (1) 
bovine tissue is more easily accessible in large quantities than human tissue, which is 
much more precious, (2) the cow is a good large animal model for human reproductive 
physiology and therefore data from bovine tissue may be more translatable to humans 
than rodent data and (3) attempting the isolation of bovine OSCs was a novel 
experiment not previously reported in the literature.  With regards the second point, 
both cows and humans are mono-ovular species, with similar follicular development 
(see Fig. 1.2) and as such cows are considered to be a valuable and relevant model for 
human ovarian development (Campbell et al., 2003). 
Due to a previous collaboration between Prof. Telfer and Jonathan Tilly and given that 
the method had already successfully isolated putative OSCs from human tissue, for the 
purposes of this research isolation was attempted using the FACS-based protocol his 
group had published (White et al., 2012, Woods and Tilly, 2013).  The fact that FACS 
potentially yields a purer isolated population than MACS and that our group had access 
to the required FACS equipment further supported the decision.  The protocol utilises 
DDX4 for cell selection, which is the subject of great debate (see section 1.2.5.2); 
however, given that its use had been previously validated in mice (Zou et al., 2009) 
and humans (White et al., 2012), White et al.’s protocol was adhered to (White et al., 
2012, Woods and Tilly, 2013).  The culture medium detailed by the Tilly group (White 
et al., 2012, Woods and Tilly, 2013) would also be used if cells were isolated.  Given 
that the function of any isolated cells was to be tested, a secondary aim of the research 
in this chapter was to fluorescently label isolated cells.  Due to local expertise in 
lentiviral vectors, this was the proposed method to be used, in place of a retrovirus.  At 
the time of the experiments within this chapter, this was a novel technique, which has 
subsequently been validated by other groups in this cell population (Wolff et al., 2013, 
Wolff et al., 2014, Xiong et al., 2015, Lu et al., 2016). 
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3.2 Materials and Methods 
3.2.1 Immunohistochemistry of DDX4-positive cells in ovarian 
cortex  
Immunohistochemistry was performed to identify DDX4-positive cells within adult 
ovarian cortex.  For bovine experiments, a small piece of fresh cortex was dissected 
and fixed in 4% NBF for 24 hours as per section 2.1.1, then processed into paraffin 
and sectioned onto slides as per section 2.6.1.  IHC was performed using 
ImmPRESSTM peroxidase detection as detailed in section 2.6.4.2, with a polyclonal 
rabbit anti-DDX4 primary antibody (used at 1:500; ab13840, Abcam, Cambridge, 
UK).  The primary antibody was omitted for negative controls.  
For human experiments, a biopsy of ovarian cortical tissue was taken with written and 
informed consent from a 22 year old woman undergoing an elective Caesarean section.  
A small piece was fixed in 4% NBF for 24 hours, processed into paraffin and sectioned 
onto slides as per section 2.6.1.  IHC was performed by a colleague (Dr. Marie 
McLaughlin) using avidin/biotin detection as per section 2.6.4.1, using normal goat 
serum (Vectastain® ABC Kit, Vector Laboratories) as a blocking agent, the same 
polyclonal rabbit anti-DDX4 primary antibody (used at 1:500; ab13840, Abcam) and 
a biotinylated goat anti-rabbit IgG secondary antibody (Vectastain® ABC Kit, Vector 
Laboratories).  The primary antibody was omitted for negative controls. 
 
3.2.2 Isolation of putative OSCs 
Putative OSCs were isolated from vitrified adult bovine and human ovarian cortex 
using the methods detailed in section 2.3.  Due to low cell yields, cells were either 
collected for culture or for characterisation.  Moreover, when cells were collected for 
culture, only one population could be collected at a time as they were collected directly 
into a well of a 24-well plate and the machine did not have the capabilities to sort two 
different populations simultaneously into a plate.  
To estimate the size of the bovine cells, beads of known diameter (3.2µm, SPHEROTM 
Rainbow 6-peak Calibration Particles; Spherotech), 6µm (BD CalibriteTM Beads; BD 
Biosciences) and 10µm (Flow-CheckTM Fluorospheres; Beckman Coulter) were 
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placed in the BD FACSAriaTM II cytometer and their average FSC values compared 
with those of the isolated cell populations.   
To attempt to investigate the ploidy of the bovine DDX4-positive cells, a FACS 
experiment was performed.  Bovine cortex was thawed, dissociated and subjected to 
FACS as per section 2.3.  The collected isolated DDX4-positive cells were then placed 
back in the BD FACSAriaTM II cytometer and an attempt to measure the intensity of 
DAPI staining as an indication of ploidy was made. 
One experiment was performed to examine whether IFITM3 could be used to select 
for putative OSCs.  The methods detailed in section 2.3 were utilised, with the 
exception of the antibodies.  An anti-IFITM3 primary antibody (ab74699; Abcam, 
used at 1:10) and a goat anti-rabbit secondary antibody conjugated to Alexa Fluor® 
488 (ab150077; Abcam, used at 1:250) were used instead. 
Cells isolated by the alternative dissociation protocol (section 2.3.1.1.) were collected 
for molecular analysis (section 2.3.2).   
 
3.2.3 In vitro culture and cryopreservation of putative OSCs 
Putative OSCs which established in in vitro culture were cultured, passaged and 
cryopreserved as per section 2.4. 
In initial experiments, cells were plated onto mouse embryonic feeder cells (MEFs; 
VHBio Ltd.) as a feeder layer.  Twenty-four well culture plates (Corning) were coated 
in 0.1% (w/v) gelatin for 3 hours at 37ºC before the gelatin was removed and the MEFs 
were added to the wells.  MEFs, stored in liquid nitrogen, were thawed in a 37ºC water 
bath for 2 mins and resuspended in MEF culture medium as per the manufacturer’s 
instructions.  In brief, thawed MEF suspension was added at a 1:10 ratio to Dulbecco’s 
Modified Eagle Medium (DMEM; Life Technologies) containing 10% (v/v) FBS and 
1X-concentrated PSG, centrifuged at 270 x g for 5 mins and the supernatant discarded.  
The pellet was resuspended to a concentration of 1 x 105 MEFs/ml and 0.5ml of cell 
suspension was added to each well (i.e. 50,000 cells/well).  The plates were incubated 
at 37ºC / 5% CO2.  The MEF-coated plates were made up at least 24 hours prior to 
putative OSCs being placed in the wells. 
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Cells from Patient 2 at passage 10 (P10) were used for live cell imaging purposes, with 
cells recorded by an inverted microscope (Axiovert 200; Zeiss) for 16 hours, with 
images taken every 30 mins. 
 
3.2.4 Cell labelling with fluorescent markers 
Cells were labelled with fluorescent markers by lentivirus transduction or rhodamine 
dextrans endocytosis as per section 2.5. 
 
3.2.5 Statistical analyses 
The estimated cell sizes of the bovine populations were calculated by comparing the 
average FSC value of the isolated populations to the average FSC of beads of known 
size.  The FSC values of the beads were plotted on a scatterplot of cell size by mean 
FSC and a linear trend line was calculated using Microsoft Excel 2013. Using the 
equation, y = mx + c, from this trend line, the cell sizes of the isolated populations 
could be approximated by inputting their FSC values.       
Growth rates of bovine and human cells were monitored by recording the required 
frequency and magnitude of passaging.  Growth curves were then calculated using 
GraphPad Prism 5.0 (GraphPad Software, Inc.; California, USA).  Data was 
logarithmically transformed by log base 2 to graphically represent the data as y = mx 
+ c.  GraphPad Prism 5.0 was then used to statistically analyse the resultant slopes 
(gradients) to assess if significant differences in growth rates existed.  To compare the 
growth rates of the bovine cells and human cells, the mean slope (“m”) and intercept 
(“c”) values were calculated for the cell lines of each species and plotted graphically.  
To assess the statistical significance between the growth rates of the two species, the 
slope values (“m”) for each species were compared by an unpaired, two-tailed t test, 
after testing for normalcy using the Kolmogorov-Smirnov test. 
A dose response curve for GFP lentiviral transduction of bovine cells was calculated 
using GraphPad Prism 5.0 by logarithmically transforming the lentiviral particle: OSC 
ratio and plotting the values against transduction rate (%).  A non-linear regression 
curve fit was performed using an exponential growth equation. 
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3.3 Results 
3.3.1 DDX4-positive cell populations in adult ovarian cortex 
Immunohistochemistry was performed on adult bovine and human ovary to determine 
the location of DDX4-expressing cells in adult ovarian cortex that are detected by the 
anti-DDX4 antibody used for putative OSC isolation.  Two separate populations of 
DDX4-positive cells were identified in both species: (a) oocytes in follicles of varying 
stages of development and (b) a much smaller population, distributed sparsely and 
apparently randomly throughout the cortex, measuring 6 - 10 µm in diameter (Fig. 
3.1).  This latter population was rarely detected and had an expanded cytoplasm 
compared with surrounding stromal cells.  Moreover, the cells did not appear to be 
associated with any particular structures, such as follicles, blood vessels, or the surface 
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Figure 3.1.  Immunohistochemical detection of DDX4-positive cells in adult 
bovine (A-C) and human (D-F) ovarian cortex indicated by brown staining.  Two 
separate populations were identified: oocytes within follicles (A (scale bar = 50µm) 
and D (scale bar = 40µm)) and a smaller population not associated with follicles or 
other structures and measuring 6 - 10 µm in diameter ((B) and (E); red arrows; scale 
bar = 20µm).  The primary antibody was omitted for negative controls (C (scale bar = 
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3.3.2 Isolation and culture of bovine DDX4-positive cells 
3.3.2.1 Cell isolation 
The FACS-based protocol previously published (White et al., 2012, Woods and Tilly, 
2013) was optimised for use in bovine tissue initially over the course of 4 months, with 
adaptations to the enzymatic dissociation steps.  A range of collagenase type IV 
concentrations was tested, with 600u/ml deemed optimal as this allowed adequate 
disaggregation compared with a lower concentration (400u/ml) and more acceptable 
levels of cell death as detected by DAPI during flow cytometry compared with a higher 
concentration (800u/ml).  This was an increase in concentration from that previously 
published (400u/ml; White et al., 2012, Woods and Tilly, 2013).  The DNase I: 
collagenase ratio was also increased tenfold from that used by White et al. (White et 
al., 2012, Woods and Tilly, 2013) from 1:1000 to 1:100 as this improved the cell yield 
during FACS.  An additional alteration to the White et al. protocol (White et al., 2012, 
Woods and Tilly, 2013) was the soaking of the filter in a serum-containing medium 
prior to use, which also enhanced cell yield as ascertained subjectively by the size of 
the cell pellet retrieved following filtration.      
Varying methods of mechanical disaggregation were also trialled, including using a 
pestle and mortar, a cell dissociation sieve and a homogeniser, all of which were too 
harsh on the tissue and did not produce intact cells as observed under a light 
microscope.  A gentleMACSTM Dissociator was subsequently used and the protocol 
described by White et al. (White et al., 2012, Woods and Tilly, 2013) for mechanical 
dissociation was followed for all experiments that yielded DDX4-positive cells.   
Once the cell isolation protocol was adjusted, DDX4-positive cells were consistently 
isolated from bovine ovarian cortex (n = 9; Fig. 3.2).  Two discrete populations were 
identified, with Population A containing cells smaller in cell size but higher in 
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Figure 3.2.  Representative FACS plots for dissociated bovine ovarian cortex.  (A) 
All events detected by the machine were gated so that only intact cells were analysed.  
Gate 1 contained smaller cells than Gate 2.  (B)  Single cells were subsequently gated 
for and used for fluorescent analyses.  (C) Population A cells were derived from Gate 
1.  No APC-positive cells (and therefore DDX4-positive cells) were detected if the cell 
suspension had no antibodies (negative) or the secondary antibody only.  DAPI 
staining allowed for exclusion of dead cells such that live, DDX4-positive cells were 
found in the bottom right quadrant.  The area of increased density of cells within that 
quadrant was gated as the DDX4-positive cells.  (D) Population B cells were derived 
from Gate 2.  Again, no APC-positive cells were detected in the two negative controls 
and live, DDX4-positive cells were located in the bottom right hand quadrant. 
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These cell populations were scarce, making up a very small proportion of the 
dissociated ovarian cortex, with an average yield of 3.8% ± 1.2% (± S.E.M.) for 
Population A and 1.0% ± 0.2% (± S.E.M.) for Population B.  This equated to raw cell 
numbers per isolation ranging from 171 - 1526 for Population A and 199 - 1033 for 
Population B (Table 3.2).  By comparison with beads of known size, the sizes of the 
cells could be estimated, with the average size of Population A being 14 µm in 
diameter and the average size of Population B being 16 µm.  To attempt to investigate 
the differences between the two populations, an experiment was performed on freshly 
isolated cells to analyse their ploidy using DAPI.  Unfortunately, there were too few 
cells (Population A: 351 cells, Population B: 81 cells) to perform the experiment. 
 
Table 3.2.  Raw numbers of DDX4-positive cells isolated during each bovine 
experiment and the purpose of each experiment.  Population A was smaller in cell 
size but more abundant than Population B.  * Population B was not identified until 
Experiment 2, therefore none were collected in Experiment 1.  ** No Population B 
cells were collected in Experiments 6 or 9 due to technical difficulties resulting in not 
enough sample remaining after Population A collection was performed. 
Expt. Pop. A (no. of cells) Pop. B (no. of cells) Utilisation of cells 
1 718 * Characterisation 
2 277 1033 Culture (Cell Line 1) 
3 1526 199 Characterisation 
4 171 430 Culture (Cell Line 2) 
5 454 261 Culture (Cell Line 3) 
6 646 ** Characterisation 
7 1338 667 Culture (Cell Line 4) 
8 1000 318 Culture (Cell Line 5) 
9 274 ** Culture (Cell Line 6) 
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An experiment was performed with an anti-IFITM3 antibody to assess whether a 
similar population could be detected using this method.  No convincing IFITM3-
positive population(s) could be identified, however, and due to time constraints this 
technique was not pursued further. 
When the dissociation protocol was changed to the one devised by colleagues in Prof. 
Telfer’s group, the cell yields increased.  Initially only one population could be 
detected, with a yield of 14.4% ± 4.8% (S.E.M.) (raw numbers of 784 - 64872, n = 5; 
experiments performed by Dr. Marie McLaughlin and Dr. Yvonne Clarkson from Prof. 
Telfer’s group).  Once gating strategies were altered, the two populations were again 
found with yields of 19.4% ± 5.4% (S.E.M.) of total cell population for Population A 
and 5.6% ± 1.2% (S.E.M.) for Population B (n = 4; experiments performed by myself).  
This equated to raw cell numbers of 115355 - 200000 for Population A and 13030 - 
140000 for Population B.  These cells were all used for characterisation of freshly 
isolated cells (see Chapter 4) and were not cultured.  
 
3.3.2.2 In vitro culture of isolated cells 
In initial experiments, mouse embryonic feeder cells (MEFs) were used to encourage 
and support the growth of isolated cells subsequently added to the wells.  This was 
performed in adherence to the White et al. methodology (White et al., 2012, Woods 
and Tilly, 2013); however, no proliferating putative OSC colonies were observed and 
the MEFs did not adhere well to the plates, thus ascertaining discrete cell populations 
was not possible.  The use of MEFs was therefore abandoned and isolated cells were 
clearly seen establishing in culture consequently. Population B cells established in 
culture following 6 individual experiments (Table 3.2).  This was in contrast to 
Population A which only established once in culture (Expt. 9), although the growth 
and morphology of these cells once established were indistinguishable from 
Population B.  Proliferating cells were first visible within 1 week of culture in colony-
like clusters with ill-defined edges and were ready for passage 3 - 7 days later.  After 
the first passage, cells proliferated evenly over the plate.  The cells exhibited an 
elongated shape with protruding cytoplasmic branches (Fig. 3.3(a)).  In accordance 
with other groups who have reported the isolation of OSCs, the cultured bovine cells 
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spontaneously produced floating spherical cells of 30-40 µm in diameter (Fig. 3.3(b)).  
This occurrence was very infrequent: as an estimate, at least one OLC and no more 
than ten OLCs were observed during the entire in vitro culture period of each cell line 
and only in the later passages (i.e. after passage 10). 
 
 
Figure 3.3.  Bovine cells cultured in vitro.  (A)  Cultured bovine cells were elongated 
in shape.  Their morphology was maintained during long-term culture (Cell Line 4, 
passage 17; scale bar = 100µm).  (B)  An example of a rarely observed oocyte-like cell 
(OLC) spontaneously formed during in vitro culture.  Scale bar = 50µm. 
 
Isolated bovine cells were propagated continuously for up to 6 months, with Cell Line 
4 undergoing more than 30 passages.  The different cell lines showed statistically 
significant differences in growth rates (p = 0.005658; Fig. 3.4).   
Cultured cells could be cryopreserved for future use; however, successful thawing and 
reestablishment in culture of cryopreserved cells was only possible if 10% (v/v) 
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Figure 3.4.  Bovine cell lines exhibited significantly different rates of growth 
during in vitro culture.  (A) Non-transformed data demonstrating that Cell Line 4 
grew most readily in culture, whilst Cell Line 1 proliferated least quickly. (B) Log 
transformed data, the analysis of which showed significant differences between the 
slopes (p = 0.005658).  The sixth cell line was not cultured past 20 days for 
experimental reasons, therefore is not included.    
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3.3.2.3 Fluorescent labelling 
Cultured bovine cells were transduced readily with both GFP and mCherry lentiviruses 
(Fig. 3.5).  Transduction rates with GFP lentivirus improved with increasing ratios of 
GFP lentiviral particles to cells, with a transduction rate of 82% achieved when a ratio 
of 20 lentivirus particles to 1 bovine cell was used (Fig. 3.6).  Following purification 
by FACS, GFP-expressing cells re-established in culture and after 2 weeks of 
expansion almost all cells continued to express GFP (Fig. 3.7).  The long-term stability 
of the transduction was tested after 14 weeks of expansion and 58% of cells were noted 
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Figure 3.5.  Lentiviral transduction of cultured bovine cells.  (A) GFP-transduced 
bovine cells.  Scale bar = 50µm.  (B) FACS was used to collect a purified population 
of GFP-positive cells. (i) A non-transduced cell sample was used to gate for GFP-
positive cells.  (ii) The most highly fluorescent GFP-positive cells (blue dots) are in 
the small box.  A ratio of 20:1 lentiviral particles to cells yielded a transduction rate of 
82%. (C)  Bovine cells expressing mCherry.  Scale bar = 100µm.  (D)  FACS was also 
used to collect a purified population of mCherry-positive cells.  No DAPI was used in 
this experiment. (i) Again, a non-transduced cell sample was used to gate for mCherry-
positive cells.  (ii) Cells positive for mCherry (orange dots) are in the top portion of 
the chart.  A ratio of 5:1 lentiviral particles to cells yielded a transduction rate of 88.8%. 
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Figure 3.6.  GFP-lentiviral transduction rates of cultured bovine cells.  
Transduction efficiency improved with increasing ratios of lentiviral particles to cells. 
 
 
Figure 3.7.  Lentiviral transduction demonstrated long-term stability in cultured 
bovine cells as shown by flow cytometry.  (A) Non-transduced cells were analysed 
to gate for GFP-positive cells.  (B) The vast majority of cells remained GFP-positive 
(blue dots) 2 weeks after transduction.  (C)  58% of cells remained GFP-positive (blue 
dots) 14 weeks after transduction. 
Transduction with mCherry lentivirus was more efficient, with a peak transduction 
rate of 88.8% utilising a 5:1 ratio of lentivirus particles to cells.  Increasing the ratio 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
Isolation and Culture of Putative OSCs 109 
further did not improve transduction rates.  Qualitative examination of expanded 
purified GFP- or mCherry-expressing cells revealed that lentiviral transduction 
appeared to negatively affect the mitotic activity and health of the cells, although this 
was not confirmed quantitatively when growth rates were statistically analysed (Fig. 
3.8).  Furthermore, the FACS process for purification appeared detrimental to the 




Figure 3.8.  GFP lentiviral transduction did not significantly negatively affect the 
growth rate of cultured bovine cells compared to non-transduced cells.  (A) Non-
logarithmically transformed data illustrated that non-transduced cells appeared to grow 
faster than transduced cells; although statistical analysis of transformed data (B) 
demonstrated no significant difference between the slopes (p = 0.1532). 
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As a result, labelling with rhodamine-conjugated dextrans was attempted as an 
alternative method of fluorescent labelling (Fig. 3.9).  This approach was successful, 
with no effect on cell growth rates when compared with non-dextrans exposed cells.  
Cells were not purified for further use due to the deleterious effect of FACS on cell 
health observed previously. 
 
 
Figure 3.9.  Cultured bovine cells could be fluorescently labelled with rhodamine-
conjugated dextrans.  An enlarged image of a dextrans-labelled cell is shown in the 
white boxes, demonstrating a perinuclear punctate expression.  Scale bar = 100 µm. 
 
 
3.3.3 Isolation and culture of human DDX4-positive cells 
3.3.3.1 Cell isolation 
After optimisation of the cell sorting protocol using bovine tissue, experiments were 
commenced on human ovarian cortex.  Two to four pieces of human tissue were used 
per patient, per experiment.  All tissue was cryopreserved at the time of biopsy and 
subsequently thawed when required.  As detailed in Chapter 2, the patients comprised 
one teenager undergoing ovarian cortex cryopreservation prior to chemotherapy, five 
women undergoing elective Caesarean section and two women undergoing ovarian 
cortex cryopreservation having previously had non POI-inducing chemotherapy.  The 
use of 600 u/ml of collagenase caused over-dissociation of human tissue, with 
substantial cell death as detected by the use of DAPI during flow cytometry; therefore 
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we reverted to using 400 u/ml.  The DNase I: collagenase ratio of 1:100 was 
maintained.  As with the bovine experiments, once the protocol was modified, DDX4-
positive cells were consistently isolated from adult human ovarian cortex (n = 8; Fig. 
3.10).  Two discrete populations, Populations A and B, were detected as in the bovine 
experiments, and constituted only a small number of the mixed cell population, with 
an average yield of 1.9 ± 0.6% (± S.E.M.) and 1.4 ± 0.7% (± S.E.M.) for Populations 
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Figure 3.10.  Representative FACS plots for dissociated human ovarian cortex.  
(A) Intact cells were gated from all events.  Gate 1 contained smaller cells than Gate 
2.  (B)  Single cells were subsequently gated for and used for fluorescent analyses.  (C) 
Population A cells were derived from Gate 1.  No APC-positive cells (and therefore 
DDX4-positive cells) were detected if the cell suspension has no antibodies (negative) 
or the secondary antibody only.  DAPI staining allowed for exclusion of dead cells 
such that live, DDX4-positive cells were found in the bottom right hand box.  (D) 
Population B cells are derived from Gate 2.  Again, no APC-positive cells were 
detected in the two negative controls and live, DDX4-positive cells were located in the 
bottom right hand box. 
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In terms of raw numbers of cells, this equated to a range of 21 - 2296 for Population 
A and 0 - 2024 for Population B (Table 3.3).   
 
Table 3.3.  Raw numbers of DDX4-positive cells isolated during each human 









(no. of cells) 
Established 
in culture 
1 13 78 N 102 Y 
2 22 165 N 274 Y 
3 32 365 N 67 Y 
4 33 276 Y 91 Y 
5 33 21 N 2 N 
6 38 10 N 14 N 
7 39 162 N 0 N 
8 40 2296 Y 2024 Y 
 
There was no apparent correlation between the number of cells isolated and the age of 
the patient, although it is a small sample size (Fig. 3.11).  There did appear to be an 
association between the source of the tissue and cell yield, however, with samples from 
women undergoing ovarian cortex cryopreservation yielding more cells than from the 
pregnant patients, with the notable exception of Patient 8.  Indeed, the highest cell 
yields were obtained from Patient 8 who was noted to have more friable tissue on 
thawing and thus the cortex was more easily dissociated.  
Due to tissue availability, the new dissociation protocol was not performed on human 
tissue and, due to low cell yields, all freshly isolated cells were collected for in vitro 
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3.3.3.2 In vitro culture of isolated cells 
Population B cells from 5 of the patients became established in culture after 3 - 14 
days in vitro (Table 3.3).  They reached confluence and were ready for passage 11 - 
28 days later.  The tissue of the other 3 patients appeared to be over-dissociated, with 
high levels of cell death seen during FACS.  This resulted in lower absolute numbers 
of cells being collected, thus possibly explaining why these cells did not establish in 
culture.  Population A cells established on two occasions, from Patients 4 and 8.  The 
time they took to establish and the time to first passage was comparable to Population 
B.  No feeder layer was required for the establishment and growth of either population.  
As seen in the bovine cells, the human cells initially grew in colony-like structures, 
but grew more evenly following the first passage.  The human cells also had the same 
elongated morphology as the bovine cells (Fig. 3.12(a)) and, as seen in the bovine 
cultures, the two different human populations looked identical microscopically.  
Isolated cells from Patient 4 have been cultured continuously in vitro for 7 months, 
undergoing more than 20 passages.  Live cell imaging of Patient 2-derived cells 
demonstrated amoeboid-like movement of the cells across the base of the culture well 
(see video submitted with thesis).  Floating spherical cells of 30-40 µm in diameter 
were also seen to be spontaneously generated from human cells (Fig. 3.12(b)).  Again, 
this observation was rare, with the incidence estimated to be similar to that of the 
bovine OLCs (i.e. at least one OLC and no more than ten OLCs during the entire in 
vitro culture period of each cell line and only in the later passages). 
 
Figure 3.12.  Human cells cultured in vitro.  (A)  Cultured human cells were 
elongated in shape and maintained their morphology during long-term culture (Patient 
2, passage 10).  (B)  An example of an infrequently observed OLC spontaneously 
formed during in vitro culture.  Scale bars = 50µm. 
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Statistically significant variable rates of growth have been observed between patients 
(p = 0.001738; Fig. 3.13).  This is not accounted for by age or pathology.  Of note, 
although Population A cells derived from Patient 8 had identical growth to Population 
B cells, Patient 4-derived Population A cells grew more slowly than their Population 
B counterparts and ceased to proliferate after passage 14.  Furthermore, human-derived 
cells appeared to have a slower rate of proliferation than bovine-derived cells (p = 
0.0043; Fig. 3.14).     
Human cells could also be cryopreserved, with successful thawing possible when 
DMSO was used as a cryoprotectant.     
 
Figure 3.13.  Growth rates of cultured human cells.  (A) Human cell lines exhibited 
variable rates of growth during in vitro culture.  (B)  This was confirmed statistically 
by analysis of transformed data, with the slopes being significantly different from each 
other (p = 0.001738).  
B 
A 
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Figure 3.14.  Comparison of the mean growth rates of bovine and human cells 
revealed that bovine cells had a significantly higher growth rate than human cells 
(p = 0.0043). 
 
3.3.3.3 Fluorescent labelling 
Cultured human cells were less readily transducible with fluorescently-labelled 
lentiviruses than bovine cells, with FACS determining a transduction rate of 36% using 
a 20:1 GFP lentivirus particles to cultured cell ratio (compared with 82% in bovine 
cells) and 60.8% using a 5:1 mCherry lentivirus particles to cell ratio (compared with 
88.8% in bovine cells).  An increased mCherry ratio of 10:1 resulted in high cell death 
rates as determined by DAPI staining during FACS.  Both GFP and mCherry 
expression were clearly visible in transduced cells under an inverted microscope (Fig. 
3.15).  As with the transduced bovine cells, purified transduced human cells 
propagated much more slowly than non-transduced cells (p = 0.04245; Fig. 3.16).  
Rhodamine-conjugated dextrans labelling was an effective substitute with no apparent 
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Figure 3.15.  Lentiviral transduction of cultured human cells.  Cells could be 
transduced to express GFP (A) and mCherry (C).  (B) and (D) Corresponding phase 
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Figure 3.16.  Lentiviral transduction with either GFP or mCherry was 
detrimental to the growth rate of cultured human cells compared to non-
transduced and rhodamine-labelled cells (A).  (B) Statistical analysis of transformed 
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3.4 Discussion  
3.4.1 Isolation of cell populations using DDX4-based FACS 
protocol 
The data detailed in this chapter demonstrate that, once the published protocol (White 
et al., 2012, Woods and Tilly, 2013) is optimised for use with the tissue of interest, a 
scarce number of cells can be isolated from bovine and human ovarian cortex using a 
DDX4-based FACS technique.  The finding of such cells has not been published in the 
cow previously and, at the time of the experiments, had only been reported by one 
group in humans (White et al., 2012).  The cells detected as being DDX4-positive 
comprised a rare population within the dissociated cortex, in keeping with previous 
studies (Pacchiarotti et al., 2010, White et al., 2012, Hernandez et al., 2015).  The 
prevalence of small DDX4-positive cells detected by immunohistochemistry was 
similarly low, although it is unclear whether these are the same cells as were detected 
by FACS.   
In the human experiments, there did not seem to be a correlation between the age of 
the patient and cell yield, despite previous observations of a decline in prevalence with 
age in mice (Pacchiarotti et al., 2010).  With regards pathology of the donating patient, 
all women undergoing elective Caesarean section, bar one, had lower yields than those 
patients who were undergoing ovarian cortex cryopreservation.  It may be that the 
hormonal milieu of pregnancy suppresses the proliferation of these cells; alternatively, 
it could be that the illnesses or treatment endured by the cryopreservation patients have 
stimulated their proliferation.  With regards the latter, it has recently been shown that 
women, such as Patient 2, who have been exposed to the ABVD regimen of 
chemotherapy (comprising adriamycin, bleomycin, vinblastine and dacarbazine) have 
significantly increased numbers of non-growing follicles (NGFs) when compared with 
age-related predicted values (McLaughlin et al., 2015, McLaughlin et al., 2016).  
Furthermore, follicle clusters similar to those seen in fetal and pre-pubertal ovaries are 
observed in these patients.  The underlying reason for this finding has not been 
elucidated, but one possible explanation is that the treatment has stimulated OSC 
proliferation and differentiation into new follicles.  With respect to the patients 
undergoing elective Caesarean section, Patient 8 was the clear exception: it may be 
that the dissociation of her tissue was much more effective due to its friable nature, for 
which the cause is unknown.  As the bovine experiments involved pooling of tissue 
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from several heifers of unknown age and health, a similar analysis was not possible 
for the cow.  Of note, it is clinically valuable that the cells can be isolated from 
cryopreserved ovarian cortex as it means that patients’ tissue could be stored until the 
cells were required. 
There was only one observable difference between the isolation experiments in the 
two species: bovine ovarian cortex required a higher concentration of enzymes for 
adequate disaggregation, possibly due to the stroma being more dense than human 
ovarian cortex.  All other aspects of the method yielded similar results, with two 
populations of DDX4-positive cells detected in both bovine and human tissue.  The 
identification of two populations has been reported in pigs (Bui et al., 2014), although 
a purified population was not examined in this study.  No studies analysing purified 
cell populations have reported more than one population to date.  The differences 
between these two populations, other than in cell size and prevalence, is yet to be 
ascertained.  It is possible Population B, which is larger in cell size, is at a different 
stage of the cell cycle than Population A: proliferating cells are largest at the end of 
interphase just prior to mitosis, when they have doubled the amount of their DNA in 
preparation for division (Cooper, 2000).  Unfortunately, poor cell yields meant that 
ploidy analysis of the isolated cells was not possible.  Another possible explanation is 
that Population B is a less pure population than Population A: if the cells are in 
aggregates, then they will appear larger in size during flow cytometry.  This may also 
explain why Population B established more often in culture than Population A, as the 
Population B may have contained “helper” cells that encouraged initiation of growth 
in vitro.  One hypothesis would be that these “helper” cells may be located next to 
putative OSCs within the ovarian cortex, possibly as part of a niche, and their presence 
contributes to the regulation of the normal function of the putative OSCs.  
With regards to cell size, the bovine cells were, on average, approximately 14-16 µm 
in diameter.  Although the size of the human cells was not calculated due to tissue 
availability, the FSC values for the two species were very similar, indicating that they 
are of similar size.  This finding is in keeping with that of previous groups: the mouse 
cells isolated by Wu’s group by MACS for either Ddx4 or Ifitm3 were 12-20 µm in 
diameter (Zou et al., 2009, Zou et al., 2011), whilst the putative OSCs reported by 
Pacchiarotti et al. were 10-15 µm in diameter (Pacchiarotti et al., 2010).  However, the 
cells are larger than those reported by White et al., who found that the human cells 
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they isolated were 5-8 µm (White et al., 2012).  It is difficult to ascertain whether these 
differences could be a result of different methods of measuring the cells, or whether 
different populations of cells are being isolated. 
An attempt was made to investigate whether IFITM3 could be used to isolate a similar 
population of bovine cells, as it had been validated for use by one previous group at 
the time of the experiment (Zou et al., 2011).  This was not successful and due to time 
limitations it was not repeated; however, optimisation of this technique may prove 
productive and would be a valid future study. 
Finally, in relation to the isolation data in this chapter, it is evident that the 
methodology hinges on adequate dissociation of the tissue and correct FACS gating 
strategies. There is a balance between disaggregating the tissue and causing cell death 
by exposure to dissociative enzymes.  An altered disaggregation protocol greatly 
increased the raw cell numbers obtained by decreasing the exposure to the enzymes 
but still allowing adequate disaggregation.  The prevalence of the cells also appeared 
to increase, however, which indicates either that the initial methodology wasn’t 
detecting all the DDX4-positive cells, or that the new protocol is selecting a less pure 
population.  Regarding the gating strategy, Population B was initially not detected but 
it was identified once the gating was adjusted.  It is therefore highly possible that the 
inability to recapitulate the sorting experiments (Zhang et al., 2015) could be a result 
of the gating strategy used. 
 
3.4.2 In vitro culture of isolated cells 
Isolated cells established in culture within 2 weeks and were ready for passage 1 week 
(bovine) or up to 4 weeks (human) later.  This is a shorter timeframe than that reported 
previously, where proliferating putative human OSCs were not detected until 4 - 8 
weeks after FACS (White et al., 2012).  This was also despite the fact that a feeder 
layer was not used, which had previously been reported as being required for the cells 
to initiate growth (Zou et al., 2009, Pacchiarotti et al., 2010, Hu et al., 2012, White et 
al., 2012, Bui et al., 2014, Zhou et al., 2014, Hernandez et al., 2015, Xiong et al., 
2015, Lu et al., 2016).  This indicates that the criticism that in vitro transformation is 
occurring in these cells (Oatley and Hunt, 2012) may be less likely.  In addition, the 
lack of a feeder layer (which is normally derived from mouse), means that there is no 
interspecies contamination which would be required if such cells were to be used 
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clinically.  One group has successfully used human umbilical cord mesenchymal stem 
cells as a feeder layer (Lu et al., 2016), but this would still result in the use of tissue 
from another human. 
The cell clusters, with blurred boundaries, that initially formed after isolation during 
these experiments were similar to those previously described (Zou et al., 2009), as was 
the morphology of the cells (Hu et al., 2012, Hernandez et al., 2015), being elongated 
and spindle-like.  However, this is in contrast to the morphology reported by others 
where the cells have been described as round with a large nuclear-to-cytoplasm ratio 
(Zou et al., 2009, Pacchiarotti et al., 2010, Bui et al., 2014, Zhou et al., 2014, Xiong 
et al., 2015, Lu et al., 2016).  However, it is often unclear from the literature whether 
the morphology that is described is the shape of the cell immediately after isolation, 
or whether it is what is observed in culture.  Furthermore, the morphology of these 
cells could perhaps be affected by the presence of a feeder layer: if feeder layers 
encourage colony growth rather than more even growth across the plate, then perhaps 
the morphology of the isolated cells is not as apparent. 
Bovine and human cells could be cultured in vitro long-term although there were both 
intra- and interspecies variations in growth rates.  Different patients exhibited different 
rates of growth, and although the youngest patient appeared to have the most rapidly 
proliferating cells, there did not seem to be any correlation between growth rate and 
either age or pathology of the patient.  The different bovine cell lines also demonstrated 
variable rates of growth, although the rates were not as significantly different as seen 
in the human cells: the bovine tissue was pooled, thus possibly masking any effect age 
or inter-individual variability may have had.  Bovine cells had higher growth rates than 
human cells.  It may be that it is an interspecies variation, however, as the culture 
medium for both species contained FBS, it is possible that this provided a more 
conducive environment for the proliferation of bovine cells.  It may be that substituting 
FBS for human serum albumin, human serum substitute or human adult serum (if 
available) would improve human cell growth rates.  Cells from both species could be 
successfully cryopreserved which is important for long-term maintenance of a cell line 
for ongoing experimentation.  Moreover, if these cells are be used clinically, it would 
be mean that cells could be stored for protracted periods of time, until the patient 
requires them.    
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As seen in previous studies, both bovine and human cultured cells spontaneously 
generated larger cells with an oocyte-like morphology (Pacchiarotti et al., 2010, White 
et al., 2012, Hu et al., 2012, Bui et al., 2014, Zhou et al., 2014, Hernandez et al., 2015).  
These OLCs were observed very infrequently.  The molecular nature of these cells will 
be explored further in Chapter 4. 
 
3.4.3 Fluorescent labelling of cultured isolated cells 
In contrast to previous OSC research (Zou et al., 2009, White et al., 2012), cells were 
fluorescently labelled using a lentivirus rather than a retrovirus.  Lentiviruses are a 
retrovirus subtype that have the advantage over retroviruses of being able to transduce 
non-dividing cells (Naldini et al., 1996).  In this research, lentivirus transduction was 
chosen as fluorescently labelled viruses that had been validated for use in stem cells 
were locally available.  Cultured cells could be labelled successfully by lentiviral 
transduction, with bovine cells being more readily transduced than human.  This may 
be because bovine cells were more susceptible to lentiviral cell membrane fusion, or 
perhaps because the lentivirus was more effective at transducing more rapidly 
proliferating cells.  In order for fluorescent cells to be used in future functional 
assessments, a pure population was preferable.  Unfortunately, FACS-based 
purification of the transduced cells appeared to be detrimental to cell health and 
therefore the observed long-term stability of the transduction was desirable as it 
avoided the need for repeated cell sorting for purification.  However, qualitatively 
(and, in the case of the human cells, quantitatively) it became evident that GFP-
transduced cells were not proliferating as quickly as non-transduced cells.  It was 
hypothesised that as the form of GFP used in the lentivirus (humanised recombinant 
GFP or hrGFP) can form dimers (Day and Davidson, 2009), it may be too 
metabolically demanding for the cells to translate the protein and thus they have less 
energy available for mitosis.  A mCherry-containing lentivirus was then evaluated as, 
being a monomer (Day and Davidson, 2009), it was thought that it might be less 
energy-depleting for the cells.  Unfortunately, mCherry transduction was equally 
damaging to human cell growth rates. 
Due to concerns about the health of lentiviral-transduced cells, an alternative method 
of labelling the cells was attempted which would not require the cell to perform any 
protein translation.  Fluorescently-tagged dextrans are inert hydrophilic 
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polysaccharides which are endocytosed by the cell and are contained within 
intracytoplasmic vesicles.  Their fluorescence does not rely on the cell to perform any 
biological processes and their use in tracing cells is well-established (Gimlich and 
Braun, 1985).  Labelling of the cultured cells from both species with rhodamine 
dextrans was straightforward and did not appear to have a detrimental effect on 
proliferation rates.  This appears to be a useful and novel approach to fluorescently 
labelling such cells, with no other reports of dextran use in putative OSCs in the 
literature. 
 
3.4.4 Summary  
In summary, two rare populations of cells were isolated from adult bovine and human 
ovarian cortex using a DDX4-based protocol, with one being smaller in size, but 
greater in prevalence than the other.  The cells established more rapidly in culture than 
previously reported, but have similar morphological features to some studies.  Bovine 
cells proliferated more quickly than human cells and there appeared to be variation in 
human cell growth that was not related to age or underlying pathology.  The cells could 
be fluorescently labelled in a stable manner, with fluorescent dextrans having no 
apparent effect on cell proliferation.  In order to determine whether these cells were 
putative OSCs are not, it was important to characterise them and evaluate their 
molecular signature, which is presented in the next Chapter. 
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4.1 Introduction 
 The Molecular Characteristics of an OSC 
As yet, no OSC-specific marker has been ascertained; instead, groups that have 
isolated putative OSCs have used a series of different markers to provide evidence of 
the cell’s dual germline and pluripotent nature.  Of note, a robust specific marker has 
not yet been elucidated even in the more widely studied SSC (Hermann et al., 2011) 
and investigators in this field have used a similar approach of utilising a combination 
of germline and pluripotent markers to characterise this population of stem cells 
(Kolasa et al., 2011).  Similar to OSCs, the scarcity of SSCs in adult testicular tissue 
has limited research, especially in humans, with the first stable human SSC line only 
derived very recently (Hou et al., 2015).  With regards OSCs, research has 
demonstrated that the cells both transcribe and translate germline and stem cell 
markers, with both mRNA and protein expression being reported. 
 
 mRNA expression 
A range of different genes have been analysed by the groups who have isolated pure 
populations of putative OSCs to date, with some groups publishing more 
comprehensive characterisation profiles than others (Table 4.1).  The most commonly 
used pluripotency markers have been POU5F1 and NANOG and the most frequently 
used germline markers have been DDX4, PRDM1, DPPA3 and IFITM3 (Zou et al., 
2009, Pacchiarotti et al., 2010, Zou et al., 2011, Hu et al., 2012, White et al., 2012, 
Wolff et al., 2013, Wolff et al., 2014, Bui et al., 2014, Zhou et al., 2014, Hernandez 
et al., 2015, Xiong et al., 2015, Lu et al., 2016).  The analysis of both freshly isolated 
and cultured cells is important: this allows both an assessment of whether the DDX4 
antibody is truly selecting DDX4-positive cells and some investigation of whether in 
vitro transformation in culture is occurring.  However, only three groups have reported 
the analysis of mRNA expression of freshly isolated putative OSCs (Pacchiarotti et 
al., 2010, White et al., 2012, Hernandez et al., 2015) and only two of these groups 
have examined both freshly isolated and cultured OSCs, with results indicating that a 
change in molecular signature does not occur in culture (White et al., 2012, Hernandez 








































































































































































































































































































































































































































































































Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
 
Characterisation of Putative OSCs 130 
Overall, there are many similarities between the gene expression of the putative OSCs 
as assessed by different groups, with consistent expression of Pou5f1/POU5F1 (Zou 
et al., 2009, Pacchiarotti et al., 2010, Zou et al., 2011, Hu et al., 2012, Bui et al., 2014, 
Zhou et al., 2014), Prdm1/PRDM1 (Zou et al., 2009, Pacchiarotti et al., 2010, Hu et 
al., 2012, White et al., 2012, Wolff et al., 2013, Bui et al., 2014, Wolff et al., 2014, 
Zhou et al., 2014, Xiong et al., 2015, Lu et al., 2016), Dppa3/DPPA3 (Zou et al., 2009, 
White et al., 2012, Wolff et al., 2013, Wolff et al., 2014, Hernandez et al., 2015) and 
Ifitm3/IFITM3 (Zou et al., 2009, Zou et al., 2011, White et al., 2012, Wolff et al., 
2013, Bui et al., 2014, Wolff et al., 2014, Zhou et al., 2014, Hernandez et al., 2015, 
Xiong et al., 2015, Lu et al., 2016).  The expression of Nanog/NANOG and 
Ddx4/DDX4 has shown variability, however. Wu’s group were unable to detect Nanog 
in cultured OSCs of either the mouse (Zou et al., 2009, Zou et al., 2011) or rat (Zhou 
et al., 2014), which is in contrast to findings by other groups (Hu et al., 2012, Wolff 
et al., 2013, Wolff et al., 2014, Bui et al., 2014).  Furthermore, as discussed in section 
1.2.5.2, one group did not detect Ddx4/DDX4 in either freshly isolated or cultured 
mouse or human cells, despite the DDX4 protein being utilised for cell isolation 
(Hernandez et al., 2015).    
 
 Protein expression 
Almost all reports of putative OSC isolation have demonstrated that the detected 
mRNA can be translated into protein (Zou et al., 2009, Pacchiarotti et al., 2010, Zou 
et al., 2011, Hu et al., 2012, White et al., 2012, Bui et al., 2014, Zhou et al., 2014, 
Xiong et al., 2015, Lu et al., 2016).  Again, some groups have performed more 
thorough characterisation than others, with the expression of between one (Zhou et al., 
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There have been no reports asserting any differences between mRNA expression of 
OSC markers and protein expression: once again, Pou5f1/POU5F1 (Zou et al., 2009, 
Pacchiarotti et al., 2010, Hu et al., 2012, Bui et al., 2014, Zhou et al., 2014), 
Prdm1/PRDM1 (Zou et al., 2009, White et al., 2012), Dppa3/DPPA3 (Zou et al., 2009, 
White et al., 2012, Bui et al., 2014) and Ifitm3/IFITM3 (Zou et al., 2009, Zou et al., 
2011, White et al., 2012, Bui et al., 2014, Xiong et al., 2015, Lu et al., 2016) are 
consistently detected, whereas Nanog/NANOG and Ddx4 expression is more variable.  
As seen with the mRNA data, Wu’s group could not detect Nanog protein in mouse 
OSCs (Zou et al., 2009), which is in disagreement with other groups (Pacchiarotti et 
al., 2010, Hu et al., 2012).  With regards to Ddx4, Hernandez et al. were also unable 
to demonstrate its expression at the protein level in the mouse, although no data for 
human OSCs were described (Hernandez et al., 2015).  
In terms of detection methodology, all groups bar one have demonstrated protein 
expression by immunocytochemical methods.  To date, only Hernandez et al. have 
utilised Western blotting to analyse protein expression in putative OSCs; however, its 
use was restricted to cultured mouse cells and only the presence of Ddx4 was examined 
(Hernandez et al., 2015). 
 
 Evidence for spontaneous in vitro neo-oogenesis 
A few groups have reported the spontaneous formation of OLCs in vitro (Pacchiarotti 
et al., 2010, White et al., 2012, Bui et al., 2014, Hernandez et al., 2015) as 
characterised by both morphology and oocyte-specific markers (Pacchiarotti et al., 
2010, White et al., 2012) and morphology alone (Bui et al., 2014, Hernandez et al., 
2015).  Pacchiarotti et al. and White et al. both demonstrated mRNA expression of 
several oocyte-specific genes including Gdf-9/GDF-9 (Pacchiarotti et al., 2010, White 
et al., 2012) and Nobox/NOBOX (White et al., 2012) at the mRNA levels and White 
et al. confirmed the expression of other oocyte markers (YBX2 and LHX8) at the 
protein level using immunofluorescence (White et al., 2012). 
Some groups have also examined the presence of oocyte-specific markers in putative 
OSCs, with varied results.  White et al. reported that markers such as Gdf-9/GFP-9, 
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Nobox/NOBOX and Zp3/ZP3 could not be detected in freshly isolated cells but could 
be demonstrated in cultured mouse and human cells, indicating that the isolated 
DDX4-positive cells were not oocytes and that in vitro neo-oogenesis in culture must 
be occurring (White et al., 2012).  Yet, other studies have failed to detect markers of 
oocytes in cultured rodent OSCs (Zou et al., 2009, Zhou et al., 2014, Xiong et al., 
2015, Lu et al., 2016). 
 
 Aims of this Chapter 
The primary aim of the experiments described in this Chapter was to identify the 
expression pattern of the cells isolated from bovine and human ovarian cortex, in order 
to assess if they showed the pattern expected of putative OSCs.  Prospective molecular 
markers for OSCs (detailed in section 1.2.2) were chosen based on previous studies on 
OSCs and the literature.  The objective was to investigate the expression of these 
markers in freshly isolated and cultured cells at both the mRNA and protein level by 
the use of RT-PCR, immunocytochemistry and Western blotting.  Lentiviral-
transduced cells were also analysed for protein expression of the fluorescent markers, 
GFP and mCherry, to confirm that the transduced cells were translating the integrated 
DNA.  The secondary aim was to analyse the cells and OLCs for the expression of 
oocyte-specific markers, thus allowing it to be determined whether spontaneous in 
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4.2 Materials and Methods 
 RT-PCR 
4.2.1.1 Cultured cells 
Cultured bovine and human cells were trypsinised, centrifuged for 5 mins at 800 x g 
and the cell pellet resuspended in 350µl RLT buffer containing 1% (v/v) β-ME.  Total 
RNA was extracted, cDNA was synthesised and RT-PCR was performed as per 
sections 2.9.1, 2.9.2 and 2.9.3.  Tables 2.4 and 2.5 detail the primers used for 
characterisation of bovine cells and Table 2.6 details the primers used in human 
experiments.  If possible, 500ng of RNA was used to synthesise cDNA.  For earlier 
passages, where cell numbers were lower, it was not possible to obtain 500ng of RNA, 
therefore the whole sample of RNA was utilised.   
 
4.2.1.2 Freshly isolated cells 
The characterisation of freshly isolated cells was technically more complicated due to 
low cell yields.  Two different disaggregation protocols, two different flow cytometry 
facilities and several different RNA extraction, cDNA synthesis and RT-PCR methods 
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Table 4.3.  Methodologies used to characterise freshly isolated cells.  The initial 
disaggregation protocol (section 2.3.1) and modified protocol (2.3.1.1) were used at 
two different flow cytometry facilities (QMRI and SBS).  The details and sources of 
the RNA extraction, cDNA synthesis and RT-PCR methods can be found in sections 
2.9.1, 2.9.2, 2.9.3, 4.2.1.2.1 and 4.2.1.2.2).  * This combination of methodologies 
yielded the cells used for characterisation as it provided the largest number of cells, 
collection directly into TRIzol was possible (this was not possible at QMRI due to 



























Bovine Modified QMRI TRIzol Maxima MyTaqTM 
Bovine 
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4.2.1.2.1 Initial disaggregation protocol 
The initial disaggregation protocol (see section 2.3.1) yielded extremely low numbers 
of cells and, with the methods described in section 2.9.1, RNA concentrations were 
very low.  Therefore, a different method of RNA extraction was used in an attempt to 
attain higher concentrations of RNA.  Bovine and human cells (n = 1 for each species) 
were collected in 1ml of PBS containing 10% (w/v) BSA and 0.5M EDTA and RNA 
was extracted immediately using the ARCTURUS® PicoPure® RNA Isolation kit 
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(Applied Biosystems, Life Technologies) as per the manufacturer’s instructions.  On-
column DNase I digestion was performed for 15 mins and total RNA was eluted in the 
kit’s Elution Buffer.  Total RNA concentrations were measured using a Nanodrop ND-
1000 spectrophotometer as per section 2.9.1.  RNA concentrations were low (< 
13µg/µl), therefore all of the RNA was utilised for cDNA synthesis.  First strand 
cDNA synthesis was performed using the Superscript® III First-Strand Synthesis 
System as per the manufacturer’s instructions and a PTC-100 Thermal Cycler was 
used with the cycling conditions described in Table 4.4. 
 
Table 4.4.  First strand cDNA synthesis Thermocycler programme for 
SuperScript® System. 











RNase H treatment was then performed to remove RNA, with an incubation of 37ºC 
for 20 mins.  RT-PCR was performed as per section 2.9.3.   
 
4.2.1.2.2 Modified disaggregation protocol 
The new disaggregation protocol (see section 2.3.1.1) yielded many more cells for 
analysis.  When cDNA synthesis and RT-PCR was performed as per sections 2.9.2 and 
2.9.3, mRNA expression could not be detected; however, utilisation of differing cDNA 
synthesis and RT-PCR methods was more successful.  These latter RT-PCR 
experiments were performed by Dr. Yvonne Clarkson from Prof. Telfer’s lab and were 
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carried out on bovine tissue only due to low human tissue availability.  DDX4-positive 
cells isolated by Dr. Marie McLaughlin and Dr. Yvonne Clarkson were pooled and 
analysed.  In brief, freshly isolated cells were lysed in TRIzol reagent (Thermo 
Scientific), cDNA was synthesised using the Omniscript® Reverse Transcription Kit 
(Qiagen) and RT-PCR was then performed using the Taq DNA Polymerase Kit 
(Qiagen).  Primer sequences are detailed in Table 2.4 and 2.5 and were purchased from 
IDT.  Gene fragment template DNA (designed by Dr. Yvonne Clarkson using 
MacVector7.2 and purchased from IDT) was used as a positive control.  RT- samples 
were used as a negative control to detect contamination.  
RT-PCR of freshly isolated cells derived by myself with the modified protocol and 
using the methods utilised by Dr. Yvonne Clarkson was unsuccessful, therefore the 
cells were analysed for RNA degradation (see section 4.2.2). 
 
4.2.1.3 Nested RT-PCR of OLCs 
Nested RT-PCR is a more sensitive technique than RT-PCR as it involves two rounds 
of PCR amplification.  A different set of primers for the gene of interest is used for 
each round, with the second set of primers internal to the sequence used in the first 
round.  This both amplifies the signal of the gene of interest and prevents amplification 
of non-specific products.  It was utilised to characterise human OLCs as the number 
of OLCs was extremely low, with the oocyte-specific gene, ZP3, being analysed.  The 
observation of bovine OLCs was so rare that analysis was not possible.    Culture 
medium containing OLCs was aspirated from 2 wells of a 12 well plate containing 
cultured human cells (Patient 4, Population B, P20), centrifuged at 800 x g for 5 mins 
and the cell pellet resuspended in RLT buffer containing 1% (v/v) β-ME.  Total RNA 
was extracted as per 2.9.1 and all of the extracted RNA was used for cDNA synthesis.  
First strand cDNA synthesis was performed using the SuperScript® III First-Strand 
Synthesis System as per the manufacturer’s instructions with subsequent RNase H 
treatment (see section 4.2.1.2.1).  RT-PCR was performed as per section 2.9.3, using 
the first set of ZP3 primers (Table 4.5) and RPL32 (Table 2.5) as a reference gene.  
Primers were designed using Primer Blast and purchased from IDT.  Ten microlitres 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
 
Characterisation of Putative OSCs 138 
of the samples were run on gels as per section 2.9.3 and the remainder of the first round 
product was then purified using the QIAquick PCR purification Kit (Qiagen) as per 
the manufacturer’s instructions.  The eluted, purified DNA was then used for RT-PCR 
with the second set of ZP3 primers (Table 4.5) and run on a gel as per section 2.9.3. 
 











TCCAGGCAGAAATCCACACT AACAGCAGTCAGAGTCAGGG 623 
Set 2 CTTCCATGGCTGTCTTGTCG GTGCCACAGTCACCTTTGTT 282 
 
 
4.2.2 Measurement of RNA integrity 
Due to problems with detecting mRNA despite the high numbers of cells isolated by 
myself using the modified dissociation protocol, samples were analysed to assess 
whether the RNA was being degraded during the sorting process.  Analysis of 
ribosomal RNA (rRNA) was performed as an assessment of the integrity of the less 
abundant mRNA.  Analysis was performed by Dr. Yvonne Clarkson (Prof. Telfer’s 
group) in collaboration with Dr. Jamie McQueen, post-doctoral scientist in Prof. Giles 
Hardingham’s laboratory (Centre of Integrative Physiology, University of Edinburgh).  
An Agilent 2100 bioanalyser (Agilent Technologies) and the Agilent RNA 6000 Nano 
Assay Kit (Agilent Technologies) was used to analyse samples on a Agilent RNA 6000 
Nano chip (Agilent Technologies) as per the manufacturer’s instructions.  In brief, the 
chip was primed with a gel-dye mix before loading dye, a RNA ladder and the sample 
were loaded onto it.  RNA in the samples was then separated by electrophoresis and 
fluorescence was measured, with the data represented on an electropherogram.  
Eukaryotic ribosomes are comprised of two rRNA subunits (18S and 28S), and the 
presence of these subunits was depicted on the graph.  The RNA Integrity Number 
(RIN) was also calculated, with samples of high rRNA integrity having higher RINs 
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than those of lower quality.  A positive control was run simultaneously for comparative 
purposes.  
   
4.2.3 Immunocytochemistry 
Cultured bovine and human cells were characterised for protein expression using ICC 
as per section 2.7.  Bovine cells were fixed in Bouin’s and human cells were fixed in 
50:50 methanol:ethanol.  Normal chicken serum or normal goat serum (both Thermo 
Scientific) were used depending on the secondary antibody used.  The primary and 
secondary antibodies used are detailed in Tables 4.6 and 4.7.  Green tyramide signal 
amplification and PI nuclear staining was used, with the exception of the mCherry 
experiments, when blue tyramide signal amplification and Sytox Green nuclear 
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Table 4.6.  Primary antibodies used for immunocytochemistry.  Antibodies marked 
by * were used in bovine experiments only; those marked by ** were used in human 
experiments only.  All other antibodies were used for both species.  The anti-RFP 





Species Raised Dilution Source 
LIN28 ab46020 Rabbit Polyclonal 1:1000 Abcam 
POU5F1* sc-8628 Goat Polyclonal 1:100 Santa Cruz 
IFITM3** ab74699 Rabbit Polyclonal 1:500 Abcam 
C-KIT A4502 Rabbit Polyclonal 1:100 Dako 
DDX4 ab13840 Rabbit Polyclonal 1:300 Abcam 
DAZL* MCA2336 Mouse monoclonal 1:400 AbD Serotec 
DAZL** ab34139 Rabbit polyclonal 1:800 Abcam 
RFP** 600-401-379 Rabbit Polyclonal 1:400 Rockland 




Table 4.7.  Secondary antibodies used for immunocytochemistry.  Antibody 
marked by * was used with the primary anti-RFP and anti-GFP antibodies only.    
Secondary Antibody Product Number Dilution Source 
Chicken anti-rabbit sc-2963 1:200 Santa Cruz 
Chicken anti-mouse sc-2962 1:100 Santa Cruz 
Chicken anti-goat sc-2953 1:200 Santa Cruz 
Goat anti-rabbit* P1-1000 1:200 Vector 
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4.2.4 Western blotting 
4.2.4.1 Cultured cells 
Cultured bovine and human cells were further analysed for protein expression by 
Western blotting as per section 2.10.  For cultured cells, 20-30µg of protein was loaded 
in each experiment, whilst 10µg of bovine or human fetal ovary protein was used as 
positive controls.  Tables 4.8 and 4.9 detail the primary and secondary antibodies used.  
Proteins of interest were detected using secondary antibodies visible in the 680nm 
channel (i.e. red) of the Li-cor Classic infrared imaging system.  ACTB was used as a 
loading control and was detected with a secondary antibody visible in the 800nm 
channel (i.e. green).  The primary antibody was omitted for negative controls. 
 
 





Species Raised Dilution Source 
LIN28 ab46020 Rabbit Polyclonal 1:1000 Abcam 
IFITM3 ab74699 Rabbit Polyclonal 1:500 Abcam 
C-KIT A4502 Rabbit Polyclonal 1:1500 Dako 
DDX4 ab13840 Rabbit Polyclonal 1:500 Abcam 
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925-32212 1:10000 Li-cor 
 
4.2.4.2 DDX4 detection in freshly isolated and cultured bovine cells 
Western blotting of freshly isolated and cultured bovine cells was performed to analyse 
DDX4 expression by a different methodology in an attempt to improve detection.  The 
experiments were carried out by Dr. Yvonne Clarkson using a standardised protocol 
utilised in Prof. Telfer’s laboratory.    Bovine fetal ovary was used as a positive control, 
while rat skeletal muscle was a negative control.  Rat skeletal muscle was selected as 
a negative control as it was readily available in Prof. Telfer’s laboratory and Dr. 
Clarkson had already validated that the DDX4 antibody could detect the protein in rat.  
HSP60 was used as a loading control. 
 
4.2.5 Sex chromosomes analysis 
To analyse the karyotype of cultured human cells, confluent cells were trypsinised, 
resuspended in 1ml of OSC culture medium and transported on fresh ice to the South 
East Scotland Genetics Service (Western General Hospital, Edinburgh).  
Approximately 30,000 Population B cells from Patient 2 (P7) and 30,000 Patient 8 
(P10) were sent to be analysed.  A member of staff (Charlotte Keith, Clinical Scientist) 
performed fluorescence in situ hybridisation (FISH) on interphase cells using a XY 
probe and their standardised protocol to analyse the sex chromosomes.   
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4.3 Results 
4.3.1 Characterisation of freshly isolated bovine cells 
4.3.1.1 mRNA expression 
During initial experiments using the modified method, cells sorted as being DDX4-
positive were pooled so only one population of cells was collected for mRNA analysis 
(n = 4).  These cells were confirmed to express DDX4 at the mRNA level and also 
expressed pluripotency markers (POU5F1 and LIN28) and a further marker of the 
germline (IFITM3) (Fig. 4.1).  Oocyte-specific markers (HDAC6, GDF9, SYCP3, ZP3 
and aromatase) were not expressed by the cells indicating that the DDX4-positive cells 
were not oocytes.  Cells detected as being DDX4-negative by FACS did not 
demonstrate DDX4 expression at the mRNA level.  These cells did not express 
POU5F1 either; however, LIN28 and IFITM3 expression was detected, at lower levels 
than the DDX4-positive cells.  
 
Figure 4.1.  RT-PCR results demonstrating the gene expression profile of bovine 
cells, freshly isolated using the DDX4 antibody.  DDX4-positive cells expressed 
both stem cell and germline markers and did not express oocyte-specific markers.  β-
actin (ACTB) was used as a reference gene.  Gene fragment template DNA was used 
as the positive control.  
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Subsequent experiments utilising the modified protocol did detect Populations A and 
B and yielded large numbers of cells, but no detection of any mRNA, including the 
reference gene, was demonstrated on RT-PCR because of RNA degradation (Fig. 4.2).  
Due to time limitations, further isolation using this method was not performed. 
 
 
Figure 4.2.  Electropherograms demonstrating RNA integrity of RNA from 
freshly isolated bovine cells.  The positive control demonstrates detected peaks 
corresponding to the 18S (black arrow) and 28S (white arrow) ribosomal subunits 
(RIN: 6.5).  These peaks were not detected in either Population A or B cells and the 
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4.3.1.2 Protein expression 
Freshly isolated cells derived by Dr. Marie McLaughlin and Dr. Yvonne Clarkson 
were also collected for protein analysis by Western blot (n = 1).  Cells isolated as 
DDX4-positive by FACS expressed DDX4 faintly at the protein level, whilst cells 
detected as being DDX4-negative by FACS did not demonstrate DDX4 protein 
expression (Fig. 4.3). 
 
 
Figure 4.3.  Western blot analysis of freshly isolated bovine cells demonstrating 
DDX4 expression (expected molecular weight of 76 kDa) in cells selected as 
DDX4-positive.  Bovine fetal ovary was used as a positive control and rat skeletal 
muscle was used as a negative control. HSP60 was used as a loading control (n=1).  
The low levels of HSP60 expression in the freshly isolated cells reflects the reduced 
protein concentrations in comparison to the positive and negative controls. 
 
4.3.2 Characterisation of cultured bovine cells 
4.3.2.1 mRNA expression 
The expression of both pluripotency (POU5F1 and LIN28) and germline (IFITM3, 
PRDM1) markers was demonstrated in cultured Population B bovine cells of all cell 
lines from the first passage onwards (Fig. 4.4 and Table 4.10).  Cultured bovine cells 
also consistently expressed the oocyte marker, NOBOX.  This molecular signature was 
consistent over long-term in vitro culture.  In contrast, C-KIT was not detected in initial 
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passages but was consistently detected after P14.  DDX4 expression was detected once 
during in vitro culture, whilst DPPA3 expression was never detected.  The single 
Population A cell line exhibited an identical gene expression pattern to early passage 
cells of Population B.  Bovine NANOG primers were designed but could not be 
validated for use as no band was detected in the positive control.  Of note, 
cryopreservation did not affect the pattern of gene expression. 
 
 
Figure 4.4.  RT-PCR results of cultured Cell Line 4, Population B, bovine cells 
demonstrating expression of stem cell, germline and oocyte markers across 
passages.  The results are representative of the other bovine cell lines.  POU5F1, 
LIN28, PRDM1, IFITM3 and NOBOX expression was consistent, whereas C-KIT and 
DDX4 expression was variable and cells did not express DPPA3.  β-actin (ACTB) was 
used as a reference gene.  Bovine fetal ovary was used as the positive control and 
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4.3.2.2 Protein expression 
Protein expression of cultured bovine cells was analysed by both ICC and Western 
blotting.  Immunocytochemical analysis demonstrated that the cells expressed both 
pluripotency (LIN28 and POU5F1) and germline (C-KIT, DDX4 and DAZL) markers, 
with POU5F1 expression being detected in the nucleus, as expected, and the other 
markers being located in the cytoplasm (Fig. 4.5).  Expression of each protein was 
detected in all analysed cells.  In addition, GFP expression could be detected in some 
cells exposed to GFP-containing lentivirus.  Optimal images were achieved using 
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Figure 4.5.  Immunocytochemistry of cultured bovine cells demonstrating 
expression of (A) pluripotency (LIN28 and POU5F1) and (B) germ cell (C-KIT, 
DDX4 and DAZL) markers.  GFP-lentiviral transduction resulted in a proportion of 
cells expressing the GFP protein.  Propidium iodide (PI) was used as a nuclear 
counterstain.  The images are of Cell Line 4, Population B, P13 cells. Negative controls 
(primary antibodies omitted) are shown for comparison.  Scale bars = 50µm. 
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Western blotting demonstrated IFITM3 protein expression in cultured bovine cells 
(Fig. 4.6).  LIN28 and C-KIT expression was not detected.  DDX4 expression could 
not be detected in the positive control (bovine fetal ovary) initially, although several 
other bands were seen, corresponding to different molecular weights (Fig. 4.7(a)).  
However, when an altered Western blot methodology was used, a band of the predicted 
size for DDX4 (76kDa) was detected consistently in the bovine fetal ovary.  
Expression in cultured bovine cells was more variable (Fig. 4.7(b)).   
 
 
Figure 4.6.  Western blot analysis of cultured bovine cells demonstrating IFITM3 
expression (expected molecular weight (mw) of 15 kDa), but no LIN28 (29 kDa) 
or C-KIT (145 kDa) expression.  Samples were also probed for β-actin (ACTB) as a 
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4.3.3 Characterisation of human cells 
4.3.3.1 mRNA expression 
Analysis of freshly isolated human cells was attempted once, with no mRNA 
expression of even the reference gene detected.  Due to scarcity of tissue, further 
experiments were not performed.   
Cultured Population B human cells expressed both pluripotency (POU5F1, LIN28 and 
NANOG) and germ cell (IFITM3, DPPA3, PRDM1 and C-KIT) markers consistently 
across passages (Fig. 4.8 and Table 4.11).  The oocyte-specific marker, GDF-9, was 
also consistently expressed.  DDX4 mRNA expression was again inconsistent, being 
detected in 3 out of the 5 patients and only after passage 10.  Population A cells from 
Patient 8 had an identical molecular signature to Population B cells; however, Patient 
4’s Population A cells demonstrated more inconsistent expression, with NANOG, 
IFITM3 and PRDM1 detected in passage 4 cells and NANOG, POU5F1, CKIT and 
DPPA3 detected in passage 7 cells.  Neither cryopreservation nor lentiviral 
transduction altered the gene expression pattern of the cells. 
 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
 
Characterisation of Putative OSCs 154 
 
Figure 4.8.  RT-PCR results of cultured Patient 4, Population B, human cells 
demonstrating expression of stem cell, germline and oocyte markers across 
passages.  The results are representative of the other human cell lines.  POU5F1, 
LIN28, NANOG, PRDM1, IFITM3, DPPA3, C-KIT and GDF-9 expression was 
consistent, whereas DDX4 expression was variable. Human fetal ovary was used as 
the positive control and mouse skeletal muscle was used as a negative control.  RPL32 
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4.3.3.2  Protein expression 
Cultured human cells demonstrated immunocytochemical protein expression of 
LIN28, IFITM3, C-KIT, DDX4 and DAZL (Fig. 4.9).  As seen in the bovine cells, 
expression appeared to be ubiquitous in the cell samples investigated.  Cells exposed 
to mCherry-containing lentivirus demonstrated mCherry protein expression.  Optimal 
images were achieved using 50:50 methanol:ethanol as a fixative.   
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Figure 4.9.  Immunocytochemistry of cultured human cells demonstrating 
expression of pluripotency (LIN28) and germ cell (IFITM3, C-KIT, DDX4 and 
DAZL) markers. Propidium iodide (PI) was used as a nuclear counterstain. The 
images are of Patient 1, Population B, P13 cells.  Transduction with mCherry-
lentiviruses resulted in some cells expressing the mCherry protein.  Sytox green was 
used as a nuclear counterstain for these cells. The images are of Patient 1, Population 
B, P15 cells.  Negative controls (primary antibodies omitted) are shown for 
comparison.  Scale bars = 50µm. 
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Western blotting for IFITM3, C-KIT and DDX4 confirmed that the cells express these 
germline markers at the protein level (Fig. 4.10), although C-KIT and DDX4 
expression was variable.  LIN28 expression was not demonstrated.  DDX4 detection 
was improved when an alternative protocol was used, but  variable expression was still 
demonstrated (Fig. 4.11).  Again, bands corresponding to other molecular weights 







Figure 4.10.  Western blot analysis of cultured human cells from different patients 
for pluripotency and germline markers.  (A) Cells demonstrated IFITM3 expression 
consistently (expected mw 15 kDa), whilst C-KIT (145 kDa) and DDX4 (76 kDa) 
expression was variable.  LIN28 (29 kDa) was not detected.  Samples were also probed 
for β-actin as a reference gene (expected mw 42 kDa).  Human fetal ovary was used 
as a positive control and the primary antibodies were omitted for the negative control.  
(B) When the cells were probed for DDX4, multiple bands corresponding to other 
molecular weights were observed in addition to the band at the expected mw of 76 kDa 
(black arrow).  Patient 1 cells = Population B, P11, Patient 2 cells = Population B, P14, 
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Figure 4.11.  Using a different Western blotting methodology, variable expression 
of DDX4 could be detected in cultured human cells.  Human fetal ovary was used 
as a positive control and rat skeletal muscle was a negative control.  HSP60 was a 
loading control.  Patient 1 cells = Population B, P11, Patient 2 cells = Population B, 
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4.3.3.3  Sex Chromosome Analysis 
A full karyotype of the cultured human cells was not possible as none were in 
metaphase.  FISH analysis of cells in interphase from two patients demonstrated that 
the cells contained two copies of the X chromosome (Fig. 4.12).  The total number of 
cells examined by FISH was not provided by the Clinical Scientist performing the 
analysis, however, all analysed cells were reported to be XX. 
 
 
Figure 4.12.  FISH analysis of cultured Population B human cells demonstrated 
that the cells were XX.  The green areas represent the X chromosomes, with each cell 
containing X chromosomes.  DAPI (blue) was used as the counterstain. 
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4.3.4 Characterisation of human OLCs 
Nested RT-PCR demonstrated that non-adherent human cells in in vitro culture (a 




Figure 4.13.  Nested RT-PCR demonstrating that non-adherent cells in in vitro 
culture (Patient 1, Population B, P20) did not express the oocyte-specific gene, 
ZP3.  Human fetal ovary was used as a positive control and demonstrated expression 
of both the reference gene (RPL32) and the two successive ZP3 primers.  Although the 
OLCs expressed RPL32, no ZP3 expression was detected.  bp = base pair. 
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4.4 Discussion 
4.4.1 The molecular signature of isolated cells 
The results of this Chapter indicate that the cells isolated from adult bovine and human 
ovarian cortex have the molecular characteristics expected of an OSC, with expression 
of both pluripotency and germline markers detected.  Furthermore, human cells 
contain two copies of the X chromosome, suggesting the cells are diploid.  This is the 
ploidy of all cells with the exception of oocytes just after fertilisation (following 
extrusion of the second polar body) and spermatozoa, which are haploid.  The gene 
expression pattern of freshly isolated bovine cells corroborates that of previous studies, 
with the detection of POU5F1 (Pacchiarotti et al., 2010), IFITM3 (White et al., 2012) 
and DDX4 (Pacchiarotti et al., 2010, White et al., 2012) as well as LIN28 (which, to 
date, has only been analysed at the protein level in cultured cells (Hu et al., 2012)).  
Moreover, the finding that freshly isolated cells express DDX4 at both the mRNA and 
protein level supports the use of anti-DDX4 antibodies in selecting for putative OSCs.   
Cultured bovine cells demonstrated consistent LIN28, POU5F1 and IFITM3 
expression at the mRNA and protein level, plus PRDM1 mRNA expression and DAZL 
protein expression.  Cultured human cells expressed both the mRNA and protein of 
LIN28, IFITM3 and C-KIT, the mRNA of POU5F1, NANOG, PRDM1 and DPPA3 
and the DAZL protein consistently.  This is the first time that protein expression of 
putative OSC markers (namely IFITM3, C-KIT, DDX4) has been demonstrated by the 
use of Western blotting, which confirms the expression seen on ICC.  This pattern of 
gene expression is in keeping with the previous findings in the literature (Zou et al., 
2009, Pacchiarotti et al., 2010, Zou et al., 2011, Hu et al., 2012, White et al., 2012, 
Wolff et al., 2013, Wolff et al., 2014, Bui et al., 2014, Zhou et al., 2014, Hernandez 
et al., 2015, Xiong et al., 2015, Lu et al., 2016).  The detection of NANOG supports 
the results reported by others (Pacchiarotti et al., 2010, Hu et al., 2012, Bui et al., 
2014, Hernandez et al., 2015) but contradicts the data reported by Wu’s group (Zou et 
al., 2009, Zou et al., 2011, Zhou et al., 2014). 
It is interesting to note, however, that DDX4 expression in cultured cells from both 
species is variable and infrequent, both at the mRNA and protein level, indicating that 
it may be both down- and up-regulated during in vitro culture.  This inconsistency in 
expression may explain why others have been unable to identify DDX4 in cultured 
cells (Hernandez et al., 2015).  Although the general pattern of mRNA expression over 
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time is otherwise very consistent, cultured bovine cells also have fluctuating C-KIT 
expression: it appears that the cells acquire the ability to express this germline marker 
over time.  Although the speed at which the cells established in culture was postulated 
to lower the chance of in vitro transformation, characterisation of the cells indicates 
that molecular changes are indeed occurring in vitro.  This phenomenon may be due 
to differentiation of some of the cells and may reflect the changes that occur during 
normal human germ cell development, where increased DDX4 expression occurs 
simultaneously with downregulation of pluripotency markers (e.g. POU5F1) (Stoop et 
al., 2005, Anderson et al., 2007).  Moreover, recent mouse research has led to the 
hypothesis that small POU5F1-expressing “germ stem cells” in adult ovaries can enter 
a developmental schedule such that cells lose their ability to express POU5F1 whilst 
sequentially acquiring the ability to express the germline markers DAZL and DDX4, 
before undergoing meiosis and folliculogenesis (Guo et al., 2016).  However, other 
explanations are also possible: firstly, differentiation of the cells in vitro could be a 
result of removal from their stem cell niche which may have been maintaining the 
putative OSCs in a less differentiated state (as seen in C. elegans and Drosophila; see 
section 1.2.3).  Secondly, the cells’ gene expression could be caused by prolonged in 
vitro culture and passaging.  Finally, as C-KIT was only faintly detected in cultured 
bovine cells when more cells (and thus RNA) were available for analysis, perhaps at 
the earlier passages there was inadequate RNA for C-KIT expression to be perceived. 
The gene expression pattern of Population A and B cells was identical, with the 
exception of Patient 4, where markers were more inconsistently expressed in 
Population A.  Interestingly, this was also the cell population that didn’t grow as 
readily as its Population B counterpart.  Therefore, although it appears, by 
morphology, growth and gene expression, that Population A is identical to Population 
B, Patient 4’s Population A is an exception, the reason for which has not yet been 
elucidated.    
With regards interspecies variation, although the molecular signature of cultured cells 
from both species was very similar, there was a notable difference in mRNA 
expression for one germline marker: DPPA3.  The reason for this unclear as it has been 
detected in mouse (Zou et al., 2009, White et al., 2012, Hernandez et al., 2015), pig 
(Bui et al., 2014), monkey (Wolff et al., 2013, Wolff et al., 2014) and human (White 
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et al., 2012, Hernandez et al., 2015) OSCs at the mRNA and/or protein level 
previously, therefore one would expect it to be present in bovine cells.     
Lastly with regards characterisation, lentiviral-transduced cells demonstrated protein 
expression of GFP (bovine cells) and mCherry (human cells), verifying that the 
fluorescence observed is due to the cells translating the fluorescent proteins.  
 
4.4.2 In vitro neo-oogenesis 
The analysis of oocyte-specific markers was performed in both freshly isolated and 
cultured bovine cells.  Several oocyte-specific markers were not detected in freshly 
isolated cells, indicating that this cell population was not contaminated with oocytes.  
Therefore, the isolated DDX4-positive cells must be a distinct population from 
oocytes.  In in vitro culture, however, NOBOX, a marker of oocytes in both primordial 
and growing follicles (Suzumori et al., 2002) with proven function in cows (Tripurani 
et al., 2011), was detected.  Correspondingly, cultured human cells expressed GDF-9, 
a member of the TGFβ family which has been found to be expressed in oocytes within 
the human fetal ovary prior to follicle formation (Bayne et al., 2015).  These results 
are in keeping with those of White et al., who reported that oocyte markers were absent 
in freshly isolated cells but became detectable during in vitro culture (White et al., 
2012).  This finding suggests that some cells may be differentiating into oocytes 
spontaneously and, indeed, OLCs were observed infrequently floating in the culture 
medium of both bovine and human cells, as seen previously in mice (Pacchiarotti et 
al., 2010, White et al., 2012), pigs (Bui et al., 2014) and humans (Hernandez et al., 
2015, White et al., 2012).  However, analysis of non-adherent cells for ZP3 (one of 
four glycoproteins which comprise the zona pellucida surrounding the human oocyte 
(Lefievre et al., 2004)), did not detect any expression.  Thus, although the adherent 
cells showed molecular evidence of undergoing spontaneous differentiation into 
oocytes, the non-adherent OLCs did not appear to be the product of this 
transformation.  It is possible that these OLCs were in fact degenerating cells which 
were detaching from the culture plate surface.  This finding is in contrast to the results 
of other groups, where the authors report that the non-adherent OLCs do express 
oocyte-specific markers and thus conclude that spontaneous neo-oogenesis is 
occurring (Pacchiarotti et al., 2010, White et al., 2012).   
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4.4.3 Summary 
In conclusion to this Chapter, the cells isolated on the basis of DDX4 from adult bovine 
and human ovarian cortex possess a molecular signature that indicates they are putative 
OSCs, with dual expression of pluripotency and germline markers demonstrating their 
early germline nature.  Moreover, the results detailed in this Chapter comprise one of 
the most comprehensive characterisation analysis in the OSC literature to date.  The 
DDX4-positive cells detected by flow cytometry are not oocytes, yet oocyte markers 
are expressed by the cells once they are cultured in vitro.  This fact, coupled with the 
variations in DDX4 and C-KIT expression indicates that the cells may be undergoing 
in vitro transformation or differentiation.  However, the OLCs observed in culture do 
not express a classic oocyte marker, therefore the cells’ potential to undergo 
spontaneous in vitro neo-oogenesis has not been confirmed.  If these cells are to be 
definitively regarded as OSCs, their functional capabilities must thus be tested, which 
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5.1 Introduction 
5.1.1 OSCs and Neo-oogenesis 
The definitive test of a putative OSC is to demonstrate that the cell has the capability 
to differentiate into a developmentally competent and fertilisable oocyte.  To date, both 
in vitro and in vivo approaches have been utilised by investigators to verify that they 
have isolated OSCs (Zou et al., 2009, Zou et al., 2011, White et al., 2012, Wolff et al., 
2013, Zhou et al., 2014, Wolff et al., 2014, Bui et al., 2014, Xiong et al., 2015, Lu et 
al., 2016, Wolff, 2016) (Fig. 5.1); however, in vivo systems have proven to be more 
effective, with live rodent offspring (Zou et al., 2009, Zhou et al., 2014, Xiong et al., 
2015, Lu et al., 2016), macaque monkey oocytes and embryos (Wolff et al., 2013, 
Wolff et al., 2014, Wolff, 2016) and immature human follicles (White et al., 2012) 
being created.  Two in vivo strategies have been described: (1) injection of species-
matched OSCs into the ovaries of live animals with subsequent natural mating (Zou et 
al., 2009, Zhou et al., 2014, Xiong et al., 2015, Lu et al., 2016) or ovarian hyper-
stimulation +/- IVF (White et al., 2012, Wolff et al., 2013, Wolff et al., 2014, Wolff, 
2016), and (2) injection of  human OSCs into adult human ovarian cortex, with 
xenografting of the cortex into immunodeficient mice (White et al., 2012). 
In vitro culture systems have resulted in spontaneous and induced differentiation of 
OSCs into OLCs, which expressed markers of oocytes (Pacchiarotti et al., 2010, Hu et 
al., 2012, White et al., 2012, Bui et al., 2014), and of the creation of primordial follicle-
like structures when OSCs and somatic cells were cultured together in a hanging drop 
(Pacchiarotti et al., 2010) or on a membrane (White et al., 2012).  However, the ability 
of these in vitro-derived structures to be matured and fertilised has not been 
investigated and therefore these studies have not reached the “ultimate gold standard” 
that has been laid down for in vitro-derived germ cells: the production of live, healthy 
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Figure 5.1.  Approaches used to investigate the neo-oogenesis potential of OSCs.  
In vivo strategies have been more effective at demonstrating the functional capacity of 
OSCs to date, with live rodent offspring, macaque monkey embryos and immature 
human follicles formed.  In vitro culture systems have resulted in OLCs and, when co-
cultured with somatic cells, primordial follicle-like structures (Zou et al., 2009, 
Pacchiarotti et al., 2010, Hu et al., 2012, White et al., 2012, Bui et al., 2014, Zhou et 
al., 2014, Xiong et al., 2015, Lu et al., 2016, Wolff, 2016). 
 
The development of an oocyte to maturity is a complex, multifaceted process under 
tight control by two-way communication with its surrounding somatic cells.  One 
critical aspect is the precise timing of both meiotic arrest and subsequent resumption 
(Li and Albertini, 2013): if oocytes derived in vitro are to be considered “true” oocytes, 
then they must undergo meiosis correctly and demonstrate developmental competence 
(Handel et al., 2014).  A second critical feature concerns genomic imprinting and 
epigenetics (Anckaert et al., 2013).  For viable offspring to be produced, imprinting of 
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certain genes by epigenetic mechanisms such as DNA methylation has to occur in 
order that only the maternal or paternal allele is expressed: incorrect imprinting can 
have phenotypic consequences, such as Prader-Willi and Angelman syndromes 
(Anckaert et al., 2013).  It has been demonstrated that the initial steps of gametogenesis 
(i.e. PGC specification and maturation) can be induced convincingly in vitro with 
ESCs and iPSCs (Hayashi et al., 2012), but to date in vivo conditions have been 
required for meiosis to occur and for the production of healthy offspring from in vitro-
derived germ cells of any source (Handel et al., 2014).   
Nevertheless, an in vitro culture system would currently be the preferred approach if 
OSCs are to be used clinically: a xenograft system is not clinically acceptable and there 
would have to be rigorous testing of OSCs to ensure that autologous injection into 
ovaries would not result in a malignancy.  Moreover, an in vitro culture strategy would 
also have the important basic science application of allowing investigation of the 
processes controlling oocyte development.  The focus of this chapter is the in vitro 
assessment of putative bovine and human OSCs within two distinct, previously 
validated culture systems which support follicular development: (1) in vitro culture of 
ovarian cortical fragments, and (2) artificial “ovary” experiments utilising aggregation 
with somatic cells. 
 
5.1.2 In vitro ovarian cortical culture 
The ability to mature oocytes from the primordial stage to MII oocytes capable of 
fertilisation, completely in vitro, has both basic science and clinical import.  It provides 
an experimental model for the enhancement of knowledge surrounding 
folliculogenesis and oocyte development and could also be beneficial in ovarian cortex 
cryopreservation fertility preservation strategies: for example, it may be useful for in 
vitro maturation of oocytes from ovarian tissue affected by malignancy that would not 
be safe for re-implantation.  The complete process has only been performed in rodents 
to date (Eppig and O'Brien, 1996, O'Brien et al., 2003).  The replication of these results 
in species with a more prolonged folliculogenesis process has not been reported; 
however, a serum-free two-step culture system has been developed which successfully 
supports folliculogenesis and oocyte development from the primordial stage in both 
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cows (McLaughlin and Telfer, 2010) and humans (Telfer et al., 2008) in a shorter 
timeframe than observed in vivo.  This system involves the culture of fragments of 
ovarian cortex containing only primordial and transitory follicles, with excessive 
stroma removed to enhance follicle activation.  After 6 days, preantral follicles are 
dissected from the fragments and cultured individually in culture medium 
supplemented with activin +/- FSH.  These steps have facilitated the growth of bovine 
oocytes contained within primordial follicles to greater than 100µm in diameter in 15 
days (McLaughlin and Telfer, 2010) and of human primordial follicles into antral 
follicles (Telfer et al., 2008).  In order to generate a MII oocyte, the next steps in this 
methodology would involve isolation and further in vitro growth of the cumulus-
oocyte complex and subsequent in vitro maturation (IVM) of the oocyte, in preparation 
for fertilisation.  It is evident that such a multi-step in vitro ovarian cortical culture 
system is required for provision of the changing requirements of a follicle during 
development.   
This system could be used to assess the functional capacity of the putative bovine and 
human OSCs by injecting the cells into the cortical fragments and culturing them as 
above.  This would require the ability to track the fate of the cells in order that they 
could be distinguished from native cells, including oocytes.  Fluorescent labelling of 
the cells would enable this to occur.  The incorporation of the cells into the established 
follicle culture system thus provides a theoretically straightforward methodology for 
the examination of neo-oogenesis.  
 
5.1.3 Creating an artificial “ovary” 
The creation of an artificial gonad by the aggregation of germ cells and somatic cells 
is well-established (O and Baker, 1978).  Chimaeric re-aggregated rodent ovaries have 
been utilised to investigate several aspects of germ cell development by examining the 
interactions between germ cells and somatic cells of different sexes, different species 
and different strains of the same species (O and Baker, 1978, Eppig and Wigglesworth, 
2000, Eppig et al., 2002, Gittens and Kidder, 2005, Qing et al., 2008).  Such 
experiments involve the disaggregation of ovaries, separation of the germ cells and 
somatic cells and subsequent re-aggregation of the required cell populations by 
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centrifugation.  The addition of phytohaemagglutinin, a lectin which agglutinates cells, 
has been found to aid the adhesion of the cells (Eppig and Wigglesworth, 2000).  The 
artificial ovaries have been cultured on both agar blocks (O and Baker, 1978) and 
tissue culture membrane inserts (Eppig and Wigglesworth, 2000, Eppig et al., 2002, 
Gittens and Kidder, 2005) overnight, before transplantation into ovariectomised mice.  
The approach supports follicular development and oocyte maturation, with live mouse 
offspring born after IVF (Eppig and Wigglesworth, 2000).  A similar model has also 
been used entirely in vitro: genital ridge re-aggregates derived from embryonic mice 
supported the entry of germ cells into meiotic prophase I during a 4 – 5 day culture 
period on agar blocks, although follicular assembly was not reported (McLaren and 
Southee, 1997).  
This culture system provides another opportunity to assess the ability of putative 
bovine and human OSCs to undergo neo-oogenesis.  By substituting the germ cells for 
putative OSCs, the putative OSCs can be provided with a physiologically relevant 
ovary-like structure which should support folliculogenesis if the putative OSCs have 
germ cell function. 
 
5.1.4 The role of somatic cells in neo-oogenesis 
It is reasonable to hypothesise that the correct somatic cell environment is a 
fundamental requirement of in vitro approaches aimed at providing the right 
environment for OSCs to form oocytes.  Not only are granulosa cells and theca cells 
required for the structural formation and endocrine function of follicles, but the 
surrounding stroma also has essential roles in structural support of, and bi-directional 
paracrine communication with, the follicle (Tagler et al., 2011).  All of these types of 
somatic cells thus contribute to the healthy growth and development of a follicle in 
vivo (Hummitzsch et al., 2015).  Research into the oogenesis potential of mouse ESCs 
has demonstrated the importance of somatic cells in the induction of ESCs to form 
OLCs.  Co-culture of ESCs with granulosa cells from newborn mice stimulated the 
expression of oocyte-specific markers (e.g. GDF-9 and ZP1-3) (Qing et al., 2007).  
This upregulation was not detected if ESCs were cultured in granulosa cell-
conditioned medium alone, providing evidence that cell-to-cell contact between ESCs 
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and somatic cells is essential for differentiation.  Furthermore, as discussed in section 
1.2.6, aggregation of mouse ESC- and iPSC-derived PGCLCs with developmentally-
appropriate fetal gonadal somatic cells supported the formation of developmentally 
competent oocytes which were fertilised to produce healthy pups (Hayashi et al., 
2012).  Thus, it is extremely unlikely that OSCs would differentiate into healthy, 
developmentally competent oocytes without the presence of supportive somatic cells.
  
 
5.1.5 Aims of this chapter 
Although OLCs, as classified by morphology, were spontaneously formed during in 
vitro culture of putative bovine and human OSCs, characterisation of the cells did not 
demonstrate expression of the definitive oocyte marker, ZP3.  As such, the ability of 
the cells to undergo neo-oogenesis was not proven and, thus, the overall aim of the 
experiments in this chapter was to assess this important aspect of the research.  We 
opted to use an exclusively in vitro approach to investigate the potential of the cells as, 
if the cells are to be used clinically, this is a more ethically acceptable strategy than 
current in vivo techniques and is thus more clinically relevant.  Due to the expertise of 
Prof. Telfer’s group in in vitro bovine and human follicle culture (Telfer et al., 2008, 
McLaughlin and Telfer, 2010), the initial aim was to incorporate the putative OSCs 
into this system.  However, a differing approach was subsequently required and a well-
established re-aggregation technique was modified for in vitro use, with the aim of 
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5.2 Materials and Methods 
Two different in vitro culture approaches were used to assess the capacity of putative 
bovine and human OSCs to undergo oogenesis: (1) injection of putative OSCs into 
adult ovarian cortex and (2) the creation of artificial ovaries using putative OSCs and 
fetal somatic cells.   
 
5.2.1 Injection experiments 
The first approach involved the injection of putative OSCs into adult ovarian cortical 
fragments and subsequent in vitro culture as previously described (Telfer et al., 2008, 
McLaughlin and Telfer, 2010; Fig. 5.2).  Fluorescently-labelled putative OSCs were 
utilised to allow the cells to be tracked within the tissue.  Injection experiments were 
performed with Dr. Marie McLaughlin (from Prof. Telfer’s group). 
 
 
Figure 5.2.  Schematic of the injection experiments intended to assess the ability 
of putative OSCs to undergo neo-oogenesis.  The aim was to inject OSCs transduced 
to express fluorescent markers into ovarian cortex fragments and culture the fragments 
in vitro for 1-2 weeks.  Developing preantral follicles would be dissected from the 
fragments and cultured individually, before the cumulus-oocyte complex (COC) was 
released and cultured on a membrane.  The final step would be in vitro maturation 
(IVM) of the oocyte.  Ultimately, Steps 4 and 5 were not performed. 
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5.2.1.1 Bovine experiments 
Cultured bovine putative OSCs (Cell Line 3, Population B, P10 and P15) were 
transduced with GFP-containing lentivirus and purified so that only GFP-positive cells 
were used in the experiments (see section 2.5.1).  Due to the detrimental effect of 
FACS on cell health, GFP-expressing cells were plated down after purification to 
ensure that only live cells were used in the experiments.  One week later, vitrified adult 
bovine ovarian cortex was thawed as per section 2.2 and the pieces were examined 
under the light microscope as previously described (Telfer et al., 2008, McLaughlin 
and Telfer, 2010), with excision of visible growing follicles.  The GFP-expressing cells 
were trypsinised, centrifuged at 800 x g for 5 mins and re-suspended in 1x PBS.  The 
cells were counted by haemocytometer (as per section 2.5.1) and a small amount of 
trypan blue solution (Sigma-Aldrich) was added so that the cell suspension could be 
visualised under a dissecting microscope during injections.  The cell suspension was 
drawn up into a Nanofil 10µl syringe (World Precision Instruments Ltd.) using a 26G 
Nanofil needle (World Precision Instruments Ltd.).  The needle was then replaced with 
a 35G bevelled Nanofil needle (World Precision Instruments Ltd.) and cells were 
injected into the thawed tissue pieces (n = 97).  Cells were either injected directly into 
small fragments of cortex (10mm x 1mm x 1mm) or into larger pieces of cortex (10mm 
x 10mm x 1mm) which were then cut with a sterile scalpel into smaller fragments.  
The amount of cell suspension injected into each fragment was recorded so that the 
number of cells injected could be calculated.  One to nine microlitres were injected per 
small fragment (mean: 5µl) and 11 – 14 µl (mean: 12µl) were injected per large 
fragment (which were each then cut into 10 smaller fragments).  The negative control 
comprised a vehicle control group where tissue fragments were injected with trypan 
blue-dyed PBS only (n = 32) and a non-injected group where tissue fragments were 
cultured without any injections (n = 2).  The tissue fragments were cultured in 24 well 
plates in 300µl of culture medium (comprising McCoy’s 5A (modified) medium 
(containing HEPES; Life Technologies) supplemented with 1mg/ml BSA, 100µg/ml 
penicillin G, 100µg/ml streptomycin sulphate, 3mM L-glutamine, 2.5µg/ml 
transferrin, 4ng/ml selenium, 10ng/ml insulin, 50µg/ml ascorbic acid and 50ng/ml 
recombinant human FSH (rhFSH; all Sigma-Aldrich) for 7 or 14 days, with half of the 
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culture medium replaced with fresh medium on alternate days.  Fragments were 
analysed for the presence of preantral follicles after 7 days: observed follicles were 
excised using 25G needles (BD Biosciences) attached to 1ml syringe barrels and 
cultured separately for a further 7 days.  Fragments and excised follicles were fixed 
for 24 hours in 4% NBF and subsequently processed for immunohistochemical 
analysis.  
5.2.1.2 Human experiments 
Lentiviruses containing mCherry were used to transduce cultured human putative 
OSCs (Patient 1, Population B, P9) and mCherry-expressing cells were purified as per 
section 2.5.1.  Cells were subsequently trypsinised, re-suspended in 1x PBS, counted 
using a haemocytometer and the cell suspension dyed with trypan blue as per section 
5.2.1.1.  Vitrified adult human ovarian cortex from a 33 year old women undergoing 
elective Caesarean section was thawed as per section 2.2 and cut into 10mm x 1mm x 
1mm fragments.  Injections were performed as per section 5.2.1.1, with two groups 
generated: putative OSC-injected tissue (n = 6) and vehicle control-injected tissue (n 
= 4).  Ten to fifteen microlitres (mean: 13µl) were injected into each fragment.  The 
tissue fragments were cultured in the culture medium described in section 5.2.1.1 for 
7 days, with half of the medium replaced with fresh medium on alternate days.  The 
fragments were then fixed for 24 hours in 4% NBF before being processed for IHC. 
5.2.1.3 Immunohistochemistry 
Tissue fragments were manually embedded, sectioned and mounted as per section 
2.6.1.  DAB IHC was performed to identify GFP or mCherry-expressing cells using 
avidin/biotin peroxidase detection (see section 2.6.4.1).  To detect GFP, either a rabbit 
polyclonal antibody against GFP (#2555, Cell Signaling Technology; used at 1:800) 
or a mouse monoclonal against GFP (MAB3580, Merck Millipore; used at 1:500) was 
utilised.  A rabbit polyclonal against RFP (600-401-379, Rockland; used at 1:100) was 
used to detect mCherry.  A goat anti-rabbit secondary antibody and normal goat serum 
or a horse anti-mouse secondary and normal horse serum (all Vectastain® ABC Kit) 
was used as appropriate.  The primary antibody was omitted for the purposes of a 
negative control.  The protocol was optimised, with many of the steps subsequently 
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being adjusted, including an increase in the length of time for serum blocking and a 
reduction in DAB incubation time.  The final attempt at achieving adequate analysis 
involved the addition of a further avidin/biotin blocking step prior to the primary 
antibody incubation step, with slides incubated at room temperature for 15 mins with 
avidin solution (Vector Laboratories), washed twice with TBST and incubated for a 
further 15 mins at room temperature with biotin solution (Vector Laboratories). 
 
5.2.2 Artificial ovary experiments 
The functional capacity of cultured putative OSCs from both species was subsequently 
investigated by aggregating fetal somatic cells and putative OSCs to create an artificial 
“ovary”, using a modified version of a previously published rodent ovary re-
aggregation protocol (Eppig and Wigglesworth, 2000, Eppig et al., 2002).  To ensure 
the culture model was effective, experiments were initially performed in mouse, using 
mouse somatic cells and mouse germ cells (rather than OSCs; Fig. 5.3).  
 
 
Figure 5.3.  Schematic representing the mouse artificial “ovary” experiment.  
Mouse germ cells and somatic cells were separated by dissociation of neonatal mouse 
ovaries and re-aggregated in the presence of phytohaemagglutinin (PHA).  The pellets 
were then cultured entirely on a membrane, or placed on a membrane or in a hanging 
drop for overnight culture, before longer term culture in collagen. 
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5.2.2.1 Murine experiments 
Mouse ovaries were obtained from post-natal CD1 mice (post-natal days 1 – 5; Charles 
River).  The mice were housed in the animal house at Chancellor’s Building, 
University of Edinburgh.  They were fed ad libitum and experienced a 12 hour light-
dark cycle at 19-21ºC, in accordance with UK Home Office and University of 
Edinburgh ethical standards.  Mice were culled by cervical dislocation prior to 
transportation to the laboratory.  Female mice were identified by examination of the 
anogenital distance.  Ovaries were then dissected out under a Leica MZ12.5 stereo-
microscope (Leica) in a laminar flow hood using sterile forceps.   
A previously published disaggregation and re-aggregation protocol (Eppig and 
Wigglesworth, 2000, Eppig et al., 2002) was used with some modifications.  All steps 
were performed under sterile conditions in a laminar flow hood.  Ovaries were placed 
in DPBS containing 1mg/ml BSA (DPBS/BSA) and extraneous tissue, including the 
ovarian bursae, was dissected from the ovary using sterile 25G needles attached to 1ml 
syringe barrels (BD Biosciences).  The ovaries were washed in DPBS/BSA and then 
dissociated in 0.05% trypsin-EDTA containing DNase I (1:100 DNase I:trypsin ratio) 
by incubating the ovaries at 37ºC / 5% CO2 for 15 mins.  The ovaries were then pipetted 
repeatedly for several minutes before being incubated for a further 5 mins.  This step 
was repeated once more before the cell suspension was filtered through a 100µm filter 
(Partec) into a 15ml centrifuge tube and the trypsin solution was neutralised with an 
equal volume of holding medium (M199 medium supplemented with 10% (v/v) FBS, 
1x penicillin-streptomycin (Life Technologies) and 0.22% (v/v) sodium DL-lactate 
syrup (60% (w/w) stock; Sigma-Aldrich)).  The suspension was centrifuged at 
2000rpm for 5 mins, the cell pellet was re-suspended in fresh holding medium and the 
cell suspension was then placed in a 35mm culture dish (Corning).  The dish was 
incubated overnight at 37ºC / 5% CO2 and the following day non-adherent cells (which 
include germ cells, blood cells and dead cells) were removed and placed in a separate 
culture dish with fresh holding medium.  The adherent monolayer of cells (i.e. somatic 
cells) were washed twice with DPBS/BSA and trypsinised.  After neutralisation with 
holding medium, the cell were centrifuged at 2000rpm for 5 mins and the pellet was 
re-suspended in fresh holding medium.  Both non-adherent and somatic cells were then 
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incubated at 37ºC / 5% CO2 for a further 5-6 hours.  To ensure complete separation of 
germ cells and somatic cells, the somatic cells were washed twice more and trypsinised 
again.  The cell suspension was neutralised with holding medium and following 
centrifugation at the above conditions and resuspension in fresh holding medium, the 
cells were counted using a haemocytometer (see section 2.5.1).  The germ cells were 
also centrifuged, re-suspended in holding medium and counted (distinguished from 
other cells by their morphology) and the desired ratio of somatic cells to germ cells 
was placed in a 0.5ml microfuge tube (Eppendorf).  Due to lack of information in the 
adapted protocols (Eppig and Wigglesworth, 2000, Eppig et al. 2002) regarding 
optimal ratios, a ratio of 10:1 somatic cells to germ cells was arbitrarily chosen to be 
used due to cell availability.  If, however, germ cell numbers were low, then ratios up 
to 50:1 were used.  Pellets contained between 55000 – 226000 cells in total.  PHA 
(Sigma-Aldrich) was added at final concentration of 35µg/ml to promote re-
aggregation of the cell populations.  The microfuge tube was centrifuged at 10000rpm 
for 30 secs, rotated 180º and re-centrifuged at the same conditions to aid compaction, 
and thus handling, of the pellet (termed positive pellet in this Chapter).  Somatic cell-
only pellets were also generated as negative controls.  The pellet was removed with a 
pipette and to encourage the pellet to develop a three-dimensional (3D) structure it was 
placed on either a membrane (initial experiments, as per Eppig & Wigglesworth 
(Eppig and Wigglesworth, 2000)) or in a hanging drop of culture medium (latter 
experiments) overnight.   
For membrane experiments, pellets were placed on Transwell®-COL collagen-coated 
3.0µm pore membrane inserts (Corning) which had been pre-equilibrated with culture 
medium (phenol red-containing Waymouth’s medium (Life Technologies) 
supplemented with 10% (v/v) FBS and 1 x penicillin-streptomycin) in a 12 well plate.  
Culture medium (1.5ml) was placed below the membrane and approximately 50µl of 
culture medium was placed on top of the pellet.  For hanging drop experiments, pellets 
were aspirated from the tube in 30µl of culture medium and placed in the drop of 
medium onto the inside of the lid of a 100mm culture dish.  The lid was then inverted 
onto the dish which was filled with sterile DPBS to maintain hydration of the tissue.  
Both culture plates and dishes were incubated overnight at 37ºC / 5% CO2.  
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The following day, the pellets were encapsulated in 3mg/ml collagen I (rat tail collagen 
I, Thermo Scientific) to confer an extracellular structural support.  The pellet was 
aspirated from the membrane or hanging drop in minimal medium and placing into a 
droplet of collagen.  The collagen encapsulated pellet was then incubated at 37ºC / 5% 
CO2 for 10 mins to allow the collagen to solidify before being transferred to fresh 
culture medium in a 24 well plate.  In one experiment, the pellets were kept on the 
membranes for the entire culture period, without collagen encapsulation.  Pellets were 
cultured for 7-14 days with 100µl fresh medium added on alternate days, before being 
fixed in either 4% NBF overnight (initial experiments) or Bouin’s for 3 hours (latter 
experiments).  
The number of replicates for each culture procedure is detailed in Table 5.1. 
 

















Membrane Membrane 7 3 1 
Membrane Collagen 7 8 4 
Hanging Drop Collagen 
10 2 1 
14 4 4 
 
Imaging of the pellets was performed during and at the end of experiments using an 
inverted microscope (Axiovert 200) and an attached Hamamatsu camera.  Scale bars 
were applied using the Zen software. 
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5.2.2.2 Bovine and human experiments 
For bovine and human experiments, fetal somatic cells had first to be isolated, before 
the aggregation experiments could be performed (Fig. 5.4). 
 
Figure 5.4.  Schematic representing the bovine and human artificial “ovary” 
experiments.  Putative OSCs and fetal somatic cells were re-aggregated in the 
presence of PHA.  The pellets were then cultured entirely on a membrane, or placed 
in a hanging drop for overnight culture, before longer term culture in collagen or on a 
membrane. 
5.2.2.2.1 Fetal somatic cell isolation and culture 
Bovine fetal ovarian somatic cells were derived from the ovaries of a 164 day old fetus 
(retrieved as per section 2.1.1).  Derivation was performed by Kelsey Grieve (PhD 
student in Prof. Anderson’s group).  The ovaries were placed on separate dimple slides 
and disaggregated enzymatically in 200µl of 10mg/ml collagenase (Type IV; Sigma-
Aldrich) in HBSS (minus Ca2+ and Mg2+) and mechanically with 19G needles (BD 
Biosciences).  The cell suspension was placed in a 1.5ml microfuge tube and incubated 
at 37ºC at 900rpm for 10 mins in a Thermomixer® (Eppendorf), with frequent 
pipetting to aid disaggregation.   Two hundred microlitres of 7mg/ml stock of DNase 
I was then added and a further 5 min incubation performed in identical conditions.  The 
cell suspension was centrifuged at 500 x g for 5 mins, the supernatant discarded and 
the pellet re-suspended in 1ml of HBSS.  This step was repeated once more before a 
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further centrifugation at 500 x g for 5 mins was performed.  The pellet was then washed 
in 1ml of somatic cell culture medium, comprising DMEM (phenol-red free, high 
glucose) supplemented with 10% (v/v) FBS, 2mM (v/v) L-glutamine, 1x NEAA and 
1x penicillin/streptomycin/amphotericin (all Life Technologies).  The suspension was 
filtered using a 70µm cell strainer (BD Biosciences) and centrifuged again at 500 x g 
for 5 mins.  The cell pellet was then re-suspended in somatic cell culture medium and 
placed in 8 wells of a 12 well culture plate (Corning).  The cells were incubated at 
37ºC / 5% CO2 overnight.  The following day, the cells were washed with fresh culture 
medium twice to remove dead and non-adherent cells.  Fresh culture medium was then 
added and the plate was placed back in the incubator.  Subsequently, the cells were 
passaged using 0.25% (v/v) trypsin-EDTA or cryopreserved as required.  For 
cryopreservation, cells were trypsinised, centrifuged at 800 x g for 5 mins and the 
pellet re-suspended in 1ml BambankerTM cell freezing medium (Lymphotec Inc.).  The 
cell suspension was placed in a cryovial and stored at -80ºC. 
Human fetal ovarian somatic cells were derived from the ovaries of three 
morphologically normal fetuses by Dr. Rosey Bayne (from Prof. Anderson’s group; 
see section 2.1.2 for further details).  The above methodology was utilised with the 
following modifications: due to the amount of tissue, only 50µl collagenase and DNase 
I were used per ovary and cells were placed in only 2 wells of a 12 well plate.  
Passaging and cryopreservation was performed as above. 
 
5.2.2.2.2 Bovine aggregation experiments 
Two bovine aggregation experiments were performed using fetal bovine somatic cells 
(P3) and rhodamine-expressing cultured putative bovine OSCs (Cell Line 4, P16 and 
P19).  Cultured putative OSCs were labelled with rhodamine as per section 2.5.2 and 
examined under an inverted microscope (Axiovert 200) to ensure fluorescence was 
detectable in the majority of cells prior to use in the experiments.  In the first 
experiment, the cells were aggregated as per section 5.2.2.1, cultured overnight in a 
hanging drop and in collagen for a further 7 days.  For the second experiment, the cells 
were aggregated as above, but in a 5:1 somatic cell to germ cell ratio and in OSC 
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culture medium (see section 2.4).  The pellets contained 73000 – 85000 cells.  The 
pellet was cultured on a membrane for 7 days with no encapsulation in collagen.  
Bouin’s was used as a fixative in both experiments.  The number of replicates for each 
experiment is shown in Table 5.2. 
Imaging of the pellets was performed using an inverted microscope (Axiovert 200) 
and an attached Hamamatsu camera.  Scale bars were applied using Zen software. 
 
5.2.2.2.3 Human aggregation experiments 
Four human aggregation experiments were performed using fetal human somatic cells 
(three different cell lines: Cell Line 1 from 16+1 week fetus, Cell Line 2 from 17+3 
week fetus and Cell Line 3 from 17+5 week fetus) and cultured putative human OSCs.  
The aggregations were performed as per section 5.2.2.1 and the details of each 
experiment are tabulated below (Table 5.3).  The pellets were comprised of between 
58,000 and 550,000 cells. 
Imaging of the pellets was performed during and at the end of experiments using a 
Leica MZ FLIII stereo-microscope (Leica), the PM Capture Pro 6.0 software 
(Photometrics) and an attached CoolSNAP camera (Photometrics).   
 
5.2.2.2.4 Chimaeric aggregation experiment 
One chimaeric aggregation experiment was performed to assess whether fetal bovine 
somatic cells could support folliculogenesis.  Fetal bovine somatic cells (P3) were 
aggregated with mouse germ cells (derived as per section 5.2.2.1) at a 30:1 ratio. The 
pellet was cultured in a hanging drop overnight before encapsulation in collagen and 
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5.2.2.3 Immunohistochemistry 
Due to their small size, pellets were embedded in 2.5% (w/v) agarose in 1x PBS prior 
to processing into paraffin wax blocks to ease transfer into blocks.  Embedded pellets 
were placed in 70% ethanol and mechanically processed, sectioned and mounted as 
per section 2.6.1.  Serial sectioning was performed with every 5th section placed on a 
separate slide for haematoxylin and eosin (H&E) staining (performed as per section 
2.6.3).  
Pellets from human aggregation experiment 1(a) were analysed by DAB detection for 
the presence of LIN28- and DAZL-expressing cells using avidin/biotin peroxidase 
detection as per section 2.6.4.1.  A rabbit polyclonal antibody against LIN28 (ab46020, 
Abcam; used at 1:500) and a mouse monoclonal against DAZL (MCA2336, AbD 
Serotec; used at 1:200) were used, with the appropriate goat anti-rabbit or horse anti-
mouse secondary antibody (Vectastain® ABC Kit). 
 
5.2.2.4 Immunofluorescence 
One mouse pellet (cultured in a hanging drop, then in collagen) and one human pellet 
(Expt 1(a)) was analysed for DDX4 expression using IF as per section 2.6.5.  Normal 
chicken serum, a rabbit polyclonal antibody against DDX4 (ab13840, Abcam; used at 
1:200), a chicken anti-rabbit peroxidase secondary antibody (sc-2963, Santa Cruz; 
used at 1:200), a red tyramide signal identification kit and DAPI nuclear counterstain 
were utilised.  The primary antibody was omitted for a negative control.   
One bovine pellet was also analysed for rhodamine expression using a simplified IF 
protocol.  Slides were dewaxed and rehydrated as per section 2.6.2, before a DAPI 
nuclear counterstain (1:1000, diluted in PBS) was applied for 10 mins at room 
temperature.  After two washes in PBS, slides were mounted with PermaFluorTM and 
stored at 4°C in the dark. 
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5.2.3 Histological Analysis 
IHC analysis was performed using a light microscope as per section 2.8.1 and IF 




5.3.1 Injection experiments 
Between 500 and 600 putative OSCs were injected into each tissue fragment in both 
bovine and human experiments; however, it was a technically difficult procedure so 
this may be an overestimate as some of the cell suspension unintentionally extruded 
into the surrounding medium instead of into the tissue.  This remained the case even if 
cells were injected into larger pieces of cortex, which were then cut into smaller 
fragments.  In the GFP-labelled experiments, there was an infrequent occurrence of 
DAB-positive cells closely associated with somatic cells and adjacent to native 
follicles (Fig. 5.5).  In mCherry-labelled experiments, collections of DAB-positive 
cells were observed around the sites of injection, with no association with any other 
cells or structures (Fig. 5.5).  However, it was not possible to analyse the tissue by IHC 
reliably as in both GFP and mCherry experiments, at least one oocyte per section of 
tissue was observed to be DAB-positive in vehicle-injected tissue and non-injected 
tissue (Fig. 5.5).  When the primary antibody was omitted, no DAB staining was 
observed, indicating that the cause of the oocyte staining in vehicle-injected tissue was 
non-specific binding of the primary antibody.  This non-specific antibody binding 
occurred despite numerous methodological alterations, including increased blocking 
steps.  Moreover, the structural integrity of the human tissue was poor, likely due to 
the necessary handling of the tissue during injections (Fig. 5.5).  These findings, 
coupled with the observation that transduction appeared detrimental to the health of 
the putative OSCs (see Chapter 3), resulted in a different functional testing approach 
being undertaken.                           
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Figure 5.5.  Immunohistochemical analysis of bovine (A – F) and human (G – L) 
injection experiments using an antibody against GFP and mCherry respectively.  
(A, B) Small DAB-positive cells (white arrows) in association with somatic cells and 
adjoining native follicles (black arrows) were observed rarely. (C) Other DAB-
positive cells were detected throughout the cortex with no obvious association with 
other structures.  (D, E)  Vehicle-injected tissue acted as a negative control; however, 
non-specific binding to some oocytes was observed despite methodological 
alterations.  Black arrows denote native immature bovine follicles.  (F) The primary 
antibody was omitted as an additional negative control.  No DAB staining was 
observed in oocytes (black arrow), indicating that the cause of the DAB staining in 
vehicle-injected tissue was non-specific binding of the primary antibody.  (G, H) 
Collections of DAB-positive cells (white arrows) were detected around the injection 
sites, which demonstrated no association with any other structures. (I) Manipulation 
of the tissue was detrimental to the structural integrity of the cortex.  A track mark 
from the insertion of the needle is denoted by the black arrow.  (J) Vehicle-injected 
and (K) non-injected tissue was used as negative controls; however, non-specific 
binding to oocytes was again observed despite methodological alterations.  Black 
arrows denote native immature human follicles.  (L) The primary antibody was 
omitted as an additional negative control.  Again, no DAB staining was detected (black 
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5.3.2 Artificial ovary experiments 
5.3.2.1 Murine experiments 
Murine re-aggregation experiments were utilised to ensure that the in vitro artificial 
ovary culture system could support neo-folliculogenesis prior to utilising bovine and 
human cells.  Different techniques were utilised in an attempt to optimise the system.  
Cell pellets were flat and disc-shaped immediately after re-aggregation, therefore in 
order to form a more physiological relevant spherical pellet, overnight culture on either 
membranes or in hanging drops was performed, with the latter proving the more 
straightforward and effective method (Fig. 5.6).  When pellets were cultured on a 
membrane for the entire culture period, the pellets grew out over the membrane and 
did not maintain a coherent structure, therefore histological analysis of these pellets 
was not possible.   
When pellets were encapsulated in collagen, they kept their spherical structure.  
Moreover, the pellets used the surrounding collagen as an extracellular matrix (ECM), 
with protrusions of cells observed growing into the collagen (Fig. 5.6).  Growing 
follicles could be seen macroscopically (Fig. 5.7(a)) and when the fixative was 
changed to Bouin’s, morphologically healthy follicles were observed, in primordial, 
transitory and primary follicle stages (Fig. 5.7(b)).  Germ cells were located 
peripherally within the pellet whilst the centre of the pellet appeared less healthy on 
H&E staining, with pyknotic nuclei observed.  Furthermore, although healthy follicles 
were formed with maintenance of DDX4 expression (Fig. 5.8), there were evidently 
high germ cells losses in the culture system: only 0.3% ± 0.2% (mean ± S.E.M.) of 
germ cells included in the initial pellets were observed on histological analysis at the 
end of the culture period.   
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Figure 5.6.  Bright field images of re-aggregated mouse pellets and negative 
controls (i.e. somatic cells only).  (A, B) After 24 hours in hanging drop culture, the 
flat pellets became spherical in structure.  (C, D) Subsequent culture in collagen 
droplets resulted in the somatic cells of the pellets projecting into the collagen.  Scale 
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Figure 5.7.  The in vitro culture system supported follicular development.  (A) 
Bright field images of a re-aggregated pellet and corresponding negative control, 
demonstrating translucent areas within the positive pellet indicative of follicles (black 
arrows).  Scale bars = 200µm.  (B)  H&E analysis of re-aggregated mouse pellets.  (i) 
4% NBF was found to be a poor fixative, with oocytes observed to be in poor 
association with surrounding somatic cells.  Scale bar = 50µm.  (ii) Bouin’s fixative 
demonstrated morphologically healthy immature murine follicles, located peripherally 
within the pellet.  The centre of the pellet was less dense and contained cells with 
pyknotic nuclei.  Scale bar = 50µm. (iii) An enlarged area of the section in (ii) 
demonstrating a healthy primary follicle (black arrow) and transitory follicle (white 
arrow).  Scale bar = 20µm.  (iv) A negative control pellet demonstrating the presence 
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Figure 5.8.  Immunofluorescence images demonstrating that mouse oocytes 
expressed DDX4 (red) within re-aggregated positive pellets.  DAPI (blue) was used 
as a nuclear counterstain.  The primary antibody was omitted for the purposes of a 
negative control: two unstained oocytes are visible (white arrows).  Scale bars = 20µm. 
 
 
5.3.2.2 Bovine experiments 
As a result of the murine experiments, the overnight hanging drop culture method was 
used in the bovine experiments in order to encourage formation of a spherical pellet.  
Culture in collagen was attempted in the first experiment, however, in contrast to the 
murine pellets, the bovine pellets did not protrude into the collagen.  A membrane 
culture was also attempted; yet, pellets cultured in collagen or on a membrane for the 
remainder of the culture period were extremely unhealthy, as demonstrated on H&E 
analysis (Fig 5.9). 
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Figure 5.9.  Images of a bovine re-aggregated “ovary” and its corresponding 
negative control.  (A, B) Phase contrast images of pellets cultured on membranes 
demonstrating a rounded structure.  Scale bars = 200µm.  (C, D) H&E analysis 
revealed very unhealthy structures, with shrunken, pyknotic nuclei and no clear 
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A change in culture medium to the more complex and growth factor-enriched OSC 
culture medium did not improve the health of the pellet. It was difficult to distinguish 
between the two cell populations on H&E staining alone, but rhodamine labelling of 
putative OSCs demonstrated that they were evenly dispersed throughout the pellet 
(Fig. 5.10).  However, no morphological changes to the cells (e.g. expansion in size) 
or follicle formation was observed.  The experiment could only be performed twice 
due to cell availability and time constraints. 
 
 
Figure 5.10.  Rhodamine-labelled putative OSCs (red) were evenly dispersed 
throughout the pellet.  DAPI (blue) was used as a nuclear counterstain.  A somatic 
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5.3.2.3 Human experiments 
One human experiment was performed prior to testing the culture system with murine 
tissue, whereby the pellets were cultured on a membrane for the entire culture period.  
H&E analysis of these positive pellets revealed larger cells, with expanded cytoplasm, 
one of which was associated with somatic cells in a primordial follicle-like structure 
(Fig. 5.11).  Such cells were not observed in the negative control.   
 
 
Figure 5.11.  H&E analysis of a human re-aggregated “ovary” and its 
corresponding negative control. (A) Larger cells (white arrow) were seen within the 
aggregate, with one cell associated with somatic cells in a primordial follicle-like 
structure (black arrow).  A higher power image is shown in the box. (B) Negative 
control aggregate containing human fetal somatic cells only.  Scale bars = 20µm. 
 
Further analysis of the tissue to ascertain whether these larger cells expressed the germ 
cell markers, LIN28 or DAZL, was not possible due to widespread non-specific DAB 
staining (Fig. 5.12).  The reason for this is unclear, but may be due to non-specific 
binding of the DAB to the PHA used to aggregate the cells.  The small number of 
tissue sections meant that further optimisation of the method was not possible.  IF 
demonstrated a small number of DDX4-positive cells within the pellet but no follicular 
structures were observed (Fig. 5.13). 
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Figure 5.12. Immunohistochemical analysis was uninterpretable for either the 
presence of LIN28 (A, B) or DAZL (C, D).  The primary antibodies were omitted for 
negative controls (B, D).  Scale bars for (A, B) = 20µm.  Scale bars for (C, D) = 100µm.  
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Figure 5.13.  A rare population of DDX4-positive cells (red) were detected within 
a re-aggregated pellet from the first human experiment (white arrows).  DAPI 
(blue) was used as a nuclear counterstain.  A somatic cell only pellet and a positive 
pellet with the primary antibody omitted were used as negative controls.  Scale bars = 
20µm.     
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The remaining human experiments were performed following the murine experiments, 
the results of which informed the decisions regarding the methodologies used.  
Therefore, hanging drops were used for initial overnight culture to promote a spherical 
structure and Bouin’s was used as a fixative.  As seen in the bovine experiments, the 
human pellets did not protrude into the surrounding collagen and pellets grown on 
either collagen (Fig. 5.14) or membranes (Fig. 5.15) for the remainder of the culture 
period were extremely unhealthy, as demonstrated by H&E staining.  
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Figure 5.14.  Re-aggregated human “ovary” and its corresponding negative 
control cultured in collagen.  (A, B) Bright field images of pellets after 24 hours in 
hanging drop culture, with a spherical structure seen.  Scale bars = 200µm.  (C, D) 
Bright field images after 1 week of culture in collagen droplets demonstrating no 
projection of cells into the collagen.  Scale bars = 200µm.  (E, F)  H&E analysis of the 
pellets demonstrating poor cell viability, especially in the positive pellet.  Scale bars = 
50µm. 
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Figure 5.15.  Re-aggregated human “ovary” and its corresponding negative 
control cultured on a membrane.  (A, B) Images of pellets immediately after re-
aggregation and transfer into hanging drops, with a flat morphology.  Scale bars = 
500µm.  (C, D) Images after 24 hours in the hanging drops, demonstrating compaction 
of the pellet and a spherical structure.  Scale bars = 500µm.  (E, F)  H&E analysis of 
the pellets at the end of the culture period, demonstrating poor cell viability.  Scale 
bars = 100µm. 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
 
The In Vitro Neo-oogenesis Potential of Putative OSCs
 205 
5.3.2.4 Chimaeric experiment 
Given the bovine and human aggregation results, a chimaeric experiment was 
performed in order to assess whether fetal bovine somatic cells could support neo-
folliculogenesis with mouse germ cells.  No follicles, or recognisable germ cells, were 
observed in the pellet (Fig. 5.16).  
 
 
Figure 5.16.  Fetal bovine somatic cells did not support folliculogenesis with 
mouse germ cells. (A) No follicles were observed in the chimaeric pellet.  Healthy 
cells were located around the periphery, whilst the central area was unhealthy and 
comparatively acellular.  Scale bar = 100µm.  (B) An enlarged image demonstrating 
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5.4 Discussion 
The experiments detailed in this Chapter have demonstrated that, rarely, putative 
human OSCs can form a close association with somatic cells, with some apparently 
located in primordial follicle-like structures.  It was not possible to prove that the OSCs 
had differentiated into oocytes, with methodological issues contributing to difficulties 
in data interpretation.  Yet, it should be stated that the recapitulation of germ cell 
development from before the primordial follicle stage to a mature oocyte, entirely in 
vitro, has not been reported in any species and therefore the optimum environment for 
the support of this pathway remains unknown.  As such, selecting the culture 
conditions for the experiments in this Chapter was a complex and difficult task with 
many possible variables, including the surrounding supportive cells, the structure of 
any extracellular support and the composition of the culture medium with regards 
growth factors etc.  The findings described herein therefore represent significant 
preliminary work towards investigation of the most favourable in vitro environment 
for OSC differentiation. 
 
5.4.1 Injection experiment issues 
Several groups have successfully utilised injection techniques to deliver OSCs into 
whole ovaries (Zou et al., 2009, White et al., 2012, Wolff et al., 2013, Wolff et al., 
2014, Zhou et al., 2014, Xiong et al., 2015, Lu et al., 2016) or ovarian cortical pieces 
(White et al., 2012), and have demonstrated the ability of the cells to undergo 
oogenesis.  However, all of the investigators used the technique in in vivo approaches.  
The decision to focus on in vitro culture systems and the proficiency of Prof. Telfer’s 
group in in vitro follicle culture (Telfer et al., 2008, McLaughlin and Telfer, 2010) led 
to the novel approach of injecting putative OSCs into ovarian cortical pieces and 
subsequent in vitro tissue culture.  Despite being theoretically straightforward, several 
methodological difficulties were experienced which resulted in inconclusive results. 
Firstly, the injections were technically challenging: the use of small cortical fragments 
is crucial to the success of the culture system (Telfer and McLaughlin, 2011) and the 
delivery of OSCs into these small fragments was difficult.  Cell losses occurred via 
unintended extrusion of the cell suspension into the surrounding medium and, 
additionally, areas of dense stroma in the tissue impeded the injection of the cells.  In 
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an attempt to improve cell delivery, blue dye was used to aid visualisation of the cell 
suspension and the protocol was altered so that cells were injected into larger tissue 
pieces, which were then cut into smaller fragments; however, neither of these 
modifications was effective.  As a result, the number of cells estimated to be injected 
was much less than that reported by White et al., who injected approximately 5 - 6 
times more cells into the same volume of tissue (White et al., 2012).   Moreover, the 
manipulation of the tissue for injection and the insertion of the needle often resulted in 
visible damage to the structural integrity of the tissue, especially in the human 
experiments.  Thus a combination of low putative OSC numbers and inadequate 
somatic cell environment may have prevented the process of neo-oogenesis. 
A crucial technical issue concerned the IHC analysis of the injected tissue.  Despite 
many alterations to the IHC protocol, with a focus on increased blocking processes, 
non-specific binding of the GFP and RFP antibody to some oocytes was observed in 
all treatment groups.  Small GFP-positive cells in association with somatic cells and 
follicular structures were only observed in putative OSC-injected tissues; nevertheless, 
due to the non-specific staining, robust interpretation of the results in relation to 
assessing the developmental potential of injected OSCs was not possible.   
Finally, it was observed that transduced cells did not appear to proliferate as quickly 
during in vitro culture as non-transduced cells (see Chapter 3); as such, lentiviral 
transduction was considered to be detrimental to the health of the cells.  It is therefore 
possible that, even if the cells were delivered efficiently into the tissue, they were less 
likely to have the capacity to undergo neo-oogenesis.  As a result of these difficulties, 
a second method was undertaken: the creation of artificial ovaries. 
 
5.4.2 Artificial “ovary” experiment issues        
The creation of an artificial ovary was postulated to have two main benefits over the 
injection experiment: (1) it would allow the combination of putative OSC and somatic 
cells to occur in a more controlled manner, and (2) fluorescent labelling of the putative 
OSCs was not essential as any oocytes observed in the “ovary” must have been OSC-
derived.  Re-aggregated “ovaries” are a well-recognised technique for analysing 
differing aspects of oocyte and follicle development; for example, such experiments 
have revealed that XY germ cells can mature in an XX somatic cell environment, but 
not vice versa (O and Baker, 1978); that oocyte-somatic cell interactions are 
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evolutionarily conserved as rat ovarian somatic cells can support the normal 
development of mouse germ cells, and vice versa (Eppig and Wigglesworth, 2000); 
that the oocyte controls the rate of follicular growth in mice (Eppig et al., 2002); and 
that the gap junction protein, connexin37, is essential for oocytes to communicate with 
granulosa cells (Gittens and Kidder, 2005).  Similar techniques have been used in OSC 
research by two groups: Pacchiarotti et al. demonstrated that aggregates of neonatal 
granulosa cells and mouse OSCs generated primordial follicle-like structures when 
cultured in hanging drops overnight (Pacchiarotti et al., 2010), whilst White et al. 
reported comparable results, with 24 hour cultures of aggregates containing 
dissociated adult human ovarian cortex and human OSCs on membranes also 
generating follicle-like structures (White et al., 2012).  The in vitro culture was not 
extended past 24 (Pacchiarotti et al., 2010) or 72 (White et al., 2012) hours and the 
developmental competency of OLCs within the follicle-like structures was not tested.  
A further advantage of the technique was, therefore, that it had already been validated 
for use with OSCs in vitro. 
An initial attempt at creating human artificial “ovaries” and culturing them entirely on 
membranes revealed some technical difficulties: handling of the pellet immediately 
after centrifugation often led to its disintegration, and an inadequately spherical 
structure was formed.  It was therefore decided to use mouse artificial “ovaries” as a 
model for the technique in order to optimise it prior to further experimentation with 
the less freely available putative OSCs.  The optimal technique, which supported the 
formation of healthy immature murine follicles that maintained their expression of 
DDX4, comprised an overnight hanging drop culture and subsequent encapsulation in 
collagen for the remainder of the culture period.  Hanging drop culture (or inverted 
drop culture) has previously been reported to be a valuable in vitro culture system for 
both follicles (Wycherley et al., 2004, Nation and Selwood, 2009) and fetal ovaries 
(Jorgensen et al., 2015).  Both mouse (Wycherley et al., 2004) and marsupial (Nation 
and Selwood, 2009) follicles demonstrated improved growth and viability using this 
approach compared to upright cultures and short term culture of human fetal ovaries 
supported germ cell proliferation (Jorgensen et al., 2015).  In our experiments, the 
hanging drop was found to be very effective at promoting the formation of a spherical 
“ovary” from the initial flat, disc-shaped pellet; this, coupled with encapsulation in 
collagen, allowed the pellet to maintain a 3D structure throughout the culture period.  
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This is in contrast to the pellets cultured on membranes, which did not form a spherical 
structure.  This is an important aspect of the culture system as a 3D structure is more 
comparable to the normal structure of an ovary and, compared to a two-dimensional 
(2D) approach, allows increased cell-to-cell interaction between somatic cells and 
putative OSCs for possible folliculogenesis (Fig. 5.17).  It is well-established that 3D 
culture systems are superior at mimicking the in vivo environment than 2D approaches 
(Cukierman et al., 2001) and, although 2D systems can support oocyte maturation 
from primordial follicles in mice (Eppig and O'Brien, 1996, Cortvrindt et al., 1996, 
O'Brien et al., 2003), mouse follicles lose their spherical follicular structure during the 
culture period, with the growth of granulosa cells out through the basement membrane 
of the follicle (Cortvrindt et al., 1996).  It is possible that this loss of 3D structure has 
contributed to the inability to recapitulate such experiments in larger animals with 
more prolonged follicle development.   
 
Figure 5.17. Three-dimensional (3D) culture systems, such as encapsulation in 
collagen, mimic in vivo circumstances better than two-dimensional (2D) systems, 
with increased cell-to-cell contact. 
Collagen is only one possible option as an ECM: other materials such as alginate, 
hyaluronic hydrogels and synthetic matrices have all been used in 3D in vitro culture 
(West et al., 2007, Belli et al., 2012).  However, collagen was selected as it is an 
important component of both the basement membrane of the follicle and the 
surrounding stroma (Rodgers et al., 2003) and is therefore a physiologically relevant, 
biocompatible material.  Moreover, its use as an ECM for successful support of in vitro 
follicle development has been validated previously in several species, including mice 
(Torrance et al., 1989), pigs (Hirao et al., 1994), buffalo (Sharma et al., 2009) and 
humans (Abir et al., 1999).  Not only did collagen provide mechanical support to the 
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mouse pellets, but it also appeared to support cell proliferation, with visible protrusion 
of cells growing into it.  This system supported healthy follicular development for up 
to two weeks, although cell death was detectable, with pyknotic nuclei concentrated in 
the centre of the pellet.  Furthermore, germ cells were restricted to the periphery of the 
pellet, suggesting that cells in closer proximity to the surrounding culture medium had 
improved survival. 
Yet, despite optimisation of the culture system in mice, the application of the technique 
to bovine and human putative OSCs was not successful.  One issue may have been the 
ratios of somatic cells to putative OSCs used in the experiments: the methodologies of 
previously published literature did not state the successfully utilised ratios of germ 
cells to somatic cells (O and Baker, 1978, Eppig and Wigglesworth, 2000, Eppig et al. 
2002, Gittens and Kidder, 2005), resulting in ratios being chosen principally on cell 
availability.  Although ratios of 10 – 50 somatic cells to 1 germ cell were effective in 
the mouse experiments, it may be that much higher ratios of somatic cells to putative 
OSCs are required for successful folliculogenesis to occur.  Furthermore, in contrast 
to previous OSC studies using neonatal (Pacchiarotti et al., 2010) and adult (White et 
al., 2012) somatic cells, our approach utilised fetal somatic cells.  This strategy was 
chosen in the anticipation that it might provide a more developmental stage-
appropriate somatic cell environment for the earliest steps of follicular assembly, with 
the cells possessing more plasticity than those derived from post-natal ovaries.  The 
importance of the use of somatic cells at the correct developmental stage has been 
demonstrated by Hayashi et al., who successfully induced the development of mature, 
fertilisable oocytes by incorporating fetal gonadal somatic cells mouse into aggregates 
with ESC- and iPSC-derived PGCLCs (Hayashi et al., 2012). 
The observation of possible primordial follicle-like structures was observed in only 
one experiment, where human aggregates were cultured on membrane for the entire 
culture period.  Only morphological assessment of the structures was possible, with 
IHC providing uninterpretable results.  IF did demonstrate that a small population of 
DDX4-positive cells could be detected in the same human pellet, which was not 
present in the negative controls, although they were not larger than the surrounding 
cells and no follicular structures were identified.  The sparsity of these cells indicates 
that either high numbers of OSCs are lost during the technique (for example, during 
the pellet formation or through cell death) or that not all OSCs are expressing DDX4.  
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The former hypothesis is supported by the finding of high levels of mouse germ cell 
loss in the murine experiments: it may be that the re-aggregation process reduces germ 
cell viability or that the somatic cells can only support a certain number of germ cells.  
The latter hypothesis is supported by the finding of inconsistent DDX4 protein 
expression in cultured putative OSCs (as described in Chapter 4).    
However, none of the other experiments, which utilised modifications tested in the 
mouse model, generated such structures, with extremely poor cell health observed.  
Cell viability was not improved by exposure to more growth factors within the OSC 
culture medium.  Moreover, bovine and human pellets did not appear to utilise 
collagen as a ECM in the same manner as observed in the murine experiments, with 
few, or no, cellular projections seen protruding from the pellets.  A chimaeric 
experiment, performed to test whether fetal bovine somatic cells could support 
folliculogenesis with mouse germ cells, resulted in no follicle formation.  It is therefore 
possible that neo-oogenesis could not be confirmed because: (a) cells did not thrive 
within the culture systems, (b) the fetal somatic cells may not have been able to support 
differentiation of OSCs and/or (c) the putative OSCs may not be genuine OSCs.   
Unfortunately, there were a great deal of variables in these experiments, thus it is 
difficult to determine which aspect(s) required alteration.  Furthermore, the number of 
bovine and human experiments performed was restricted by cell availability, thereby 
constraining the ability to optimise the culture system.  Due to time and tissue 




5.4.3 Summary of this chapter 
In vitro culture systems are extremely useful basic science tools in ovarian biology, 
providing a controllable environment for the examination of folliculogenesis and 
oocyte development.  Two novel in vitro culture systems for the support of OSC 
differentiation, adapted from previously validated in vivo approaches, were utilised; 
however, the approaches provided inconclusive results regarding the ability of the 
putative bovine and human OSCs to generate new oocytes.  There are two principal 
reasons that may account for this finding: (1) the putative OSCs are not capable of 
undergoing neo-oogenesis and (2) the culture systems cannot support OSC 
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differentiation.  Further optimisation of the culture systems may allow a more 
definitive assertion regarding the oogenesis potential of the putative OSCs. 
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6.1.1 Stem cells as models for germ cell development 
As discussed in Chapter 5, OSCs have the potential to be an invaluable tool in basic 
science, as their in vitro culture would allow investigation of germ cell development, 
interaction with somatic cells, and differentiation into oocytes.  To date, much of our 
knowledge of human female germ cell development has been inferred from rodent 
models; however, variations in the process between species mean that a human-
specific model, or at least a large animal model that may be more translational to 
humans, is necessary for a more accurate understanding (Jung and Kee, 2015).  Recent 
developments have demonstrated that ESCs and iPSCs are a promising novel way of 
exploring germ cell development: the induction of such cells to form female mouse 
PGCLCs in vitro, which were shown to form viable offspring (Hayashi et al., 2012), 
will allow closer examination of the earliest stages of germ cell development.  
Furthermore, the ability to perform these experiments in vitro provides a more 
convenient, and controllable, system than in vivo strategies.  Yet, once again, this 
research utilises the mouse model and does not address human germ cell development 
directly.   
Human ESCs and iPSCs can be induced in vitro to form EBs (Aflatoonian et al., 2009) 
and PGCLCs (Kee et al., 2009, Irie et al., 2015, Sugawa et al., 2015).  Resultant 
oocyte-like and primordial follicle-like structures have been observed by morphology; 
however, zona pellucida was never detected in these structures, thus uncertainties 
remain regarding whether mature oocytes were produced (Aflatoonian et al., 2009).  
Nevertheless, hESC studies have elucidated a critical aspect of early PGC 
development: the transcription factor, SOX17, has been shown to be the earliest 
marker of human PGCLCs and is essential for PGCLC specification (Irie et al., 2015).   
It is possible it determines germ cell fate via its downstream stimulatory effects on 
PRDM1, which is known to be essential for PGC development (Vincent et al., 2005, 
Ohinata et al., 2009).  A SOX17 knock-out hESC line did not form PGCLCs and lacked 
expression of PRDM1, in contrast to the wild-type cells (Irie et al., 2015).  This is an 
example of species dimorphism, as Sox17 has no role in mouse PGC specification 
(Hara et al., 2009), thus emphasising the need for a human-specific model of germ cell 
development.       
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In both humans and mice, ESCs and iPSCs have been directed to differentiate into 
PGCLCs by altering the culture medium to contain key regulators of PGC 
development.  A “pre-induction” of naïve ESCs to primed epiblast-like cells (EpiLCs) 
has been performed using activin A and bFGF (Hayashi et al., 2012, Irie et al., 2015), 
whilst subsequent formation of PGCLCs has been induced by the presence of BMPs, 
including BMP4 (Aflatoonian et al., 2009, Kee et al., 2009, Hayashi et al., 2012, Irie 
et al., 2015, Sugawa et al., 2015).  RA has also been utilised as an induction agent in 
hESCs (Aflatoonian et al., 2009).   
As OSCs are presumed to be located further along the differentiation pathway than 
totipotent ESCs, they may provide an alternative germ cell model that would require 
less manipulation to create in vitro PGCLCs.  If OSCs are to be used in this regard, 
they must demonstrate similar responses to key regulators of PGC development as that 
seen in vivo.  A key aspect to explore would be the expression of meiosis-related genes 
as (a) meiosis is an essential aspect of oocyte formation, and (b) germ cells are the 
only cell known to be capable of this process; thus, the detection of meiotic genes 
could provide preliminary evidence that the OSCs may be undergoing differentiation.  
To date, only one study has been performed on OSCs investigating this possible 
application (Park et al., 2013).  Park et al. demonstrated that mouse OSCs express 
BMP receptors and respond to BMP4 in the same manner as PGCs, with upregulation 
of genes involved in meiotic initiation, namely Stra8, Msx1 and Msx2 (Park et al., 
2013).  In addition, BMP4 treatment resulted in an increase in the appearance of OLCs, 
in a dose-dependent manner.  Given their critical roles in PGC development, meiotic 
entry and in the stimulation of pluripotent stem cell and OSC differentiation, this 
Chapter will focus on the effects of two major regulators, BMP4 and RA, on putative 
bovine and human OSCs in order to assess their potential as a germ cell model.   
 
6.1.2 Bone morphogenetic protein-4 (BMP4) 
BMP4 is a member of the TGFβ1 family of growth factors, which has many essential 
roles in organogenesis.  The first known function of the BMP family of cytokines was 
in the induction of formation of new bone, hence their name; however, they are now 
known to be involved in proliferation, differentiation and apoptosis within many 
divergent biological systems, including skeletal muscle development, the formation of 
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adipose tissue, eye development and the regulation of iron homeostasis (Hogan, 1996, 
Katagiri and Watabe, 2016).  Most pertinent to this research are their roles in germ cell 
development: Bmp2, 4 and 8b have all been demonstrated to be critical in murine PGC 
specification and proliferation (Lawson et al., 1999, Ying et al., 2000, Ying and Zhao, 
2001), with Bmp4 homozygous null mutants being the most severely affected with 
regards to PGC numbers (Lawson et al., 1999).  In humans, data are more limited, 
however, BMP receptors are expressed by germ cells and BMP4 has been found to 
stimulate PGC apoptosis in the human fetal ovary (Childs et al., 2010). 
BMP4 is activated by cleavage of its inactive precursor by furin (a proprotein 
convertase enzyme (Nelsen and Christian, 2009)) to form mature, monomeric 
carboxy-terminal proteins which can dimerise to produce a biologically active ligand 
(Katagiri and Watabe, 2016).  The active protein acts through serine-threonine kinase 
transmembrane receptors, binding initially to a type II receptor, which then complexes 
with a type I receptor and results in phosphorylation of intracellular signaling proteins, 
called SMAD proteins (Hogan, 1996, Katagiri and Watabe, 2016; Fig. 6.1).  SMADs 
are transcription factors, with SMAD1, SMAD5 and SMAD8 being receptor-regulated 
SMADs that, once phosphorylated, form a complex with SMAD4 (Katagiri and 
Watabe, 2016).  SMAD4 enables translocation of the complex to the nucleus to elicit 
downstream effects on BMP4-response genes.   
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Figure 6.1.  Schematic of the BMP signalling pathway.  BMP4 binds to Type II 
BMP receptors (green), which form a complex with Type I receptors (blue).  This 
stimulates phosphorylation (P) of intracellular SMAD proteins, which move into the 
nucleus and stimulate transcription of BMP4-response genes, including ID1, MSX1, 
MSX2 and SYCP3.  Adapted from Katagiri and Watabe, 2016. 
 
Four examples of BMP4-response genes are Muscle segment homeobox 1 (MSX1), 
MSX2, SYCP3 and ID1.  MSX1 and 2 have been demonstrated to have a role in meiosis 
initiation in the mouse, with reduced numbers of meiotic cells seen in double Msx1/2 
homozygous null mice (Le Bouffant et al., 2011).  This deficit is apparently “rescued”, 
however, if either Msx1 or 2 are present, with single Msx1 or Msx2 null mice exhibiting 
no change in meiotic cell numbers (Le Bouffant et al., 2011).  The same study reported 
that Bmp4 treatment of mouse fetal ovaries upregulates Msx1 and 2 expression (Le 
Bouffant et al., 2011).  In humans, MSX2 appears to mediate BMP4’s pro-apoptotic 
effects, both in the human fetal ovary (Childs et al., 2010) and in other cell types, 
including an embryonal carcinoma cell line (Marazzi et al., 1997).  SYCP3 is a 
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component of the synaptonemal complex which is required for the correct pairing of 
homologous chromosomes by chiasmata during zygotene (Yuan et al., 2002): as such, 
it can be considered a marker of meiotic entry.  It is also upregulated in response to 
BMP4, with BMP4 treatment of hESCs resulting in EB formation and concurrent 
upregulation of SYCP3 expression (Kee et al., 2006).  Lastly, unpublished work from 
Prof. Anderson’s group has demonstrated that ID1 expression is stimulated by BMP4 
treatment in human fetal ovaries: this has been supported by similar findings in mouse 
embryonic gonads (Dudley et al., 2007) and other cell types, including mouse ESCs 
(Hollnagel et al., 1999) and human pulmonary arterial smooth muscle cells (Yang et 
al., 2013).  
 
6.1.3 Retinoic acid (RA) 
RA, an active derivative of Vitamin A, is an important morphogen within the 
developing embryo, with crucial roles in the correct development and differentiation 
of various tissues, including the brain, limbs and neural tube (Rhinn and Dolle, 2012).  
Its role in germ cell development is also well-established: murine studies have revealed 
that RA is essential for meiotic entry of PGCs as antagonism of RA receptors (RARs) 
results in female PGCs failing to initiate meiosis (Bowles et al., 2006, Koubova et al., 
2006).  Human data have revealed by IHC that germ cells are the principal target of 
RA signaling in the fetal ovary, with two RARs (RARα and RARβ) and one retinoid 
receptor (RXRα) predominantly localised to the germ cells (Childs et al., 2011).  In 
addition, two separate in vitro culture systems have demonstrated that RA treatment 
of human fetal ovaries significantly increases the number of meiotic germ cells 
present, as identified by the protein expression of doublesex and mab-3 related 
transcription factor 1 (DMRT1; a regulator of meiosis) (Jorgensen et al., 2015) and 
H2A histone family, member X (ɣH2AX; a marker of the double-strand breaks (DSBs) 
in DNA which allow recombination during meiosis) (Kuo and Yang, 2008, Le 
Bouffant et al., 2010, Jorgensen et al., 2015).     
RA is produced by two successive oxidation steps: firstly, retinol is oxidised to 
retinaldehyde by retinol dehydrogenases, then retinaldehyde is converted to RA by 
retinaldehyde dehydrogenases (Rhinn and Dolle, 2012).  Levels of RA are controlled 
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by the presence of RA-inactivating cytochrome p450, 26 (CYP26) enzymes (Rhinn 
and Dolle, 2012).  In mice, Cyp26b1 is widely expressed by the somatic cell 
compartment of the fetal testes, in particular the Sertoli cells, and thus prevents 
premature entry of male germ cells into meiosis (Bowles et al., 2006), although this 
phenomenon does not appear to be conserved in humans (Childs et al., 2011).  RA 
stimulates the nuclear receptors, RARα, RARβ and RARɣ, which form heterodimers 
with nuclear retinoid X receptors (RXRα, RXRβ and RXRɣ) (Bowles and Koopman, 
2007, Rhinn and Dolle, 2012; Fig. 6.2).  These heterodimers can bind with the RA-
response element (RARE) of RA-responsive genes (Bowles and Koopman, 2007).  
RA-response genes of interest in the ovary are related to meiosis, with murine studies 
demonstrating upregulation of Msx1, Sycp3 and Stra8 in fetal ovaries or isolated PGCs 
in response to RA (Bowles et al., 2006, Koubova et al., 2006, Le Bouffant et al., 2011, 
Tedesco et al., 2013).  One study demonstrated this was accompanied by 
downregulation of the pluripotency gene, Pou5f1 (Bowles et al., 2006).  RA treatment 
of human fetal testis and ovary stimulates expression of STRA8 (Le Bouffant et al., 
2010, Childs et al., 2011), but is not associated with a significant change in SYCP1 in 
the ovary (Le Bouffant et al., 2010) or SYCP3 expression in the testis (Childs et al., 
2011).     
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Figure 6.2.  Schematic of retinoic acid signalling.  Oxidation by retinol 
dehydrogenases (RDHs) and retinaldehyde dehydrogenases (RALDHs) converts 
retinol to retinoic acid (RA).  RA then binds to nuclear receptors (RAR) which 
heterodimerise with retinoid X receptors (RXR).  These receptors then bind with the 
RA-response element (RARE) of RA-responsive genes, eliciting their upregulation.  
RA-response genes include MSX1, SYCP3 and STRA8.  Adapted from Rhinn and 
Dolle, 2012. 
 
6.1.4 The role of DAZL in meiosis 
An alternative method for the enhanced induction of hESCs and iPSCs has been 
reported, utilising plasmids to generate overexpression of DAZL within the stem cells 
(Medrano et al., 2012).  Increased DAZL expression resulted in augmented 
differentiation to PGCLCs and expression of meiotic markers compared with non-
transfected cells.  DAZL, along with DAZ and BOLL, is a member of the DAZ family 
of RNA binding proteins.  Knock-out mouse studies have demonstrated its essential 
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role in gametogenesis, with female homozygous null mutants completely lacking in 
germ cells (Ruggiu et al., 1997).  In humans, analysis of single nucleotide 
polymorphisms (SNPs) of the DAZL gene has revealed a correlation between some 
SNPs and an earlier age of POI (Tung et al., 2006).  Specifically, DAZL appears to be 
a critical requirement for PGC entry into meiosis: following Dazl knock-out studies in 
mice, it has been postulated that intrinsic Dazl expression converts mouse PGCs into 
meiosis-competent germ cells that are able to respond to extrinsic RA and enter 
meiosis (Lin et al., 2008).  In human fetal ovaries, DAZL is located in central “nests” 
and expression markedly increases in the second trimester, during the time of meiotic 
initiation (Anderson et al., 2007, He et al., 2013).  This is accompanied by a switch in 
intracellular location, from the nucleus to the cytoplasm (Anderson et al., 2007).  
Research has demonstrated that this meiotic role may be linked to Sycp3 expression: 
in male Dazl null mutant mice, Sycp3 expression is decreased at the protein level and 
complete synaptonemal complexes are not detected, indicating that Dazl is required 
for effective translation of Sycp3 mRNA (Saunders et al., 2003, Reynolds et al., 2007).  
In humans, overexpression of the DAZL gene in ESCs using plasmids has resulted in 
increased SYCP3 expression (Kee et al., 2009); however, female PGCs have not been 
investigated. 
 
6.1.5 Aims of this chapter 
The overarching aim of the research detailed in this Chapter was to ascertain whether 
putative bovine and human OSCs had potential for use as a model for germ cell 
development.  Although mouse OSC research has shown promise in this regard, 
studies using human OSCs, or OSCs from larger animal models, are currently lacking 
and there has been no research examining the response of the cells to RA.  Therefore, 
the primary aim was to examine the response of the bovine and human cells to BMP4 
and/or RA, by analysing the expression of BMP4- and RA-response genes, including 
ID1, MSX1, MSX2 and SYCP3.  The secondary aim was to overexpress DAZL in the 
putative OSCs to explore the effect this may have on cell differentiation and the 
expression of meiosis-related genes. 
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6.2 Materials and Methods 
6.2.1 BMP4 and/or RA treatment experiments 
6.2.1.1 Cell culture and treatments 
Putative bovine OSCs (Cell Line 4, Population B, varying passages), putative human 
OSCs (Patient 1, Population B, varying passages) and fetal bovine somatic cells (P3) 
were cultured in 12 well plates in OSC culture medium, which included FBS, until 
approximately 80% confluent.  Serum contains a variety of proteins, including BMP4 
(Kodaira et al., 2006, Herrera and Inman, 2009), therefore, the cells were serum-
starved for 24 hours prior to treatment in order to remove this confounding factor from 
the experiment.  As LIF prevents differentiation of stem cells (Hirai et al., 2011) and 
the aim of the experiment was to analyse the effect of pharmacological agents on cell 
differentiation, LIF was also omitted from the culture medium.  This was performed 
by simply replacing the culture medium with OSC culture medium containing no FBS 
and LIF.  The following day, individual wells were allocated to one of four treatment 
groups (Table 6.1).  BMP4 (recombinant human BMP4; Life Technologies), all-trans 
RA (Sigma-Aldrich) and their diluents (4mM HCl containing 0.1% (w/v) BSA and 
DMSO respectively) were utilised.  The concentrations of BMP4 and RA were chosen 
as they had previously been used by Prof. Anderson’s group in human fetal gonad 
research (Childs et al., 2010, Childs et al., 2011) and have been successfully utilised 
in ESC (Kee et al., 2006, Sugawa et al., 2015) and OSC (Park et al., 2013) induction. 
All treatments were added to 1ml of OSC culture medium with FBS and LIF omitted.  
The cells were washed twice with DPBS and the treated culture medium was added to 
the appropriate wells.  After 24 hours of treatment, cells were trypsinised with 0.25% 
(v/v) trypsin-EDTA, centrifuged at 800 x g for 5 mins at room temperature and 
resuspended in 350µl RLT buffer containing 1% (v/v) β-ME.  Samples were then 
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Table 6.1.  Details of the treatments groups used in the germ cell model 
experiments.  The diluent for BMP4 was 4mM HCl + 0.1% BSA and the diluent for 
RA was DMSO. 
Treatment Group Treatment Final Concentration 
BMP4 only 
BMP4 100ng/ml 
DMSO 0.0001% (v/v) 
RA only 
RA 1.0µM 
4mM HCl + 0.1% BSA 1% (v/v) 




DMSO 0.0001% (v/v) 
4mM HCl + 0.1% BSA 1% (v/v) 
 
6.2.1.2 qRT-PCR 
Total RNA was extracted and first strand cDNA synthesised as per sections 2.9.1 and 
2.9.2. qRT-PCR was then performed as per section 2.9.4.   The primers detailed in 
Table 2.11 and 2.12 were utilised depending on the species of cells.  Primers for 
POU5F1, LIN28, PRDM1, IFITM3 and C-KIT were also used in putative bovine OSC 
experiments (detailed in Table 2.4).  In putative bovine OSC experiments, 150ng of 
total RNA was used for cDNA synthesis, in putative human OSC experiments, 150 – 
300ng was used and in fetal bovine somatic cell experiments, 200ng was utilised.  
 
6.2.1.3 Immunocytochemistry 
To analyse the protein expression of genes of interest, ICC experiments were 
performed, as detailed in section 2.7.  Cells were serum- and LIF-starved overnight as 
per section 6.2.1.1.  The following day, cells were allocated to one of two treatment 
groups: (1) BMP4 and RA or (2) vehicles only (concentrations as per Table 6.1).  After 
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24 hours, cells were washed and fixed in 4% NBF for 10 mins.  NBF was used as it 
was the required fixative for the antibody against SYCP3.  Normal chicken serum was 
used as a blocking agent.  The primary and secondary antibodies utilised are detailed 
in Table 6.2. 
 
Table 6.2.  Antibodies used for immunocytochemical analysis of BMP4 plus RA 





Species Raised Dilution Source 
ID1 sc-488 Rabbit Polyclonal 1:100 Santa Cruz 
MSX2 sc-15396 Rabbit Polyclonal 1:100 Santa Cruz 
SYCP3 ab15093 Rabbit Polyclonal 1:10000 Abcam 
Secondary Antibody Product Number Dilution Source 
Chicken anti-rabbit sc-2963 1:200 Santa Cruz 
      
Green tyramide signal amplification and either PI (putative bovine OSC experiments) 
or DAPI (putative human OSC and fetal bovine somatic cell experiments) was used as 
a nuclear counterstain.  The primary antibody was omitted for the purposes of negative 
controls.  Slides were analysed and images were acquired as per section 2.8.2.   
 
6.2.2 DAZL transfection experiments 
To investigate whether an increase in endogenous DAZL would enhance the expression 
of meiotic genes, putative bovine and human OSCs were transfected with a DAZL-
containing plasmid.  These experiments were performed in collaboration with Dr. 
Roseanne Rosario (post-doctoral scientist in Prof. Anderson’s group). 
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6.2.2.1 Liposomal-mediated transfection 
Putative OSCs were cultured in 24-, 12- or 6-well plates in antibiotic-free OSC culture 
medium for at least 24 hours prior to transfection and were not transfected until they 
were approximately 70% confluent.  On the day of transfection, lipid/DNA complexes 
were prepared in a laminar flow hood as per the manufacturer’s instructions, with a 
final plasmid concentration of 1µg/ml (Table 6.3).  The lipid transfection reagent 
encapsulates the DNA to form a liposome, enabling uptake through the hydrophobic 
cell membrane (Fig. 6.3).  
 
Table 6.3.  Lipid/DNA complex constituents used for DAZL transfection of 




Source Culture plate 
24 well 12 well 6 well 
Opti-MEM® (1X) + 
GlutaMAXTM (serum-free 
medium) 
50 100 250 Life Technologies 
TransIT®-LT1 lipid 
transfection reagent 
1.5 3 7.5 Mirus 
DNA plasmid (500ng/µl) 
OR 
Control plasmid (500ng/µl) 
1 2 5 OriGene 
GFP plasmid (500ng/µl)* 1 N/A 5 
Clontech 
Laboratories, Inc. 
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Figure 6.3.  Schematic of liposomal-mediated transfection.  Lipid/DNA complexes 
are formed during incubation of the DNA plasmid and lipid transfection reagent.  
These liposomes can enter the cell via the hydrophobic membrane.  The DNA is 
transcribed to mRNA in the nucleus and translated by cytoplasmic ribosomes to 
produce the desired protein.  
 
Cells were transfected with either a DAZL plasmid (TrueORF cDNA clone pCMV6-
entry plasmid containing human DAZL transcript variant 2, Myc-DDK-tagged; 
accession number: NM_001351) or an empty plasmid (pCMV6-entry plasmid, Myc-
DDK-tagged with no coding sequence downstream of the CMV promoter), which 
acted as a control to assess whether transfection itself affected the cells’ viability.   
The lipid/DNA complexes were incubated at room temperature for 20 mins before 
being added to fresh antibiotic-free OSC medium (0.5ml for 24 well plates, 1ml for 12 
well plates and 5ml for 6 well plates).  The medium of the cells was then replaced with 
this plasmid-containing medium.  Cells were cultured at 37ºC / 5% CO2 for 24, 48 or 
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72 hours before being collected for either qRT-PCR (bovine cells) or Western blotting 
(bovine and human cells). 
Subsequent experiments involving enrichment for transfected cells by flow cytometry 
required cells to be co-transfected with a GFP-containing plasmid (pEGFP-C1 plasmid 
with CMV promoter; Clontech Laboratories, Inc.).  As with the DAZL and control 
plasmids, a final concentration of 1µg/ml was used.   
 
6.2.2.2 Treatment of transfected cells 
To determine if treatment with a combination of DAZL transfection and BMP4 plus 
RA treatment would affect downstream expression of genes of interest, a 5 day 
experiment was devised (Fig. 6.4).  Putative human OSCs (Patient 1, Population B, 
P10) were passaged on Day 1 so that they would be approximately 70% confluent the 
following day.  Transfection with DAZL or control plasmid was performed on Day 2.  
On Day 3, the antibiotic-free OSC culture medium was changed to OSC culture 
medium without antibiotics, serum or LIF.  On Day 4, cells were allocated to one of 
two treatment groups: (1) BMP4 and RA or (2) vehicles only (concentrations as per 
Table 6.1).  On Day 5, cells were collected for analysis by trypsinisation, 
centrifugation at 800 x g for 5 mins and resuspension in 350µl RLT buffer containing 
1% (v/v) β-ME.   
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Figure 6.4.  Methodology for combined transfection and BMP4 plus RA 
treatment experiments.  After passaging on the first day to achieve the correct 
confluence, cells were transfected the following day with either DAZL plasmids or 
empty (control) plasmids.  Forty-eight hours later, and following serum- and LIF-
starvation, cells were treated with BMP4 and RA for 24 hours.  Cells were then 
collected for gene expression analysis. 
In subsequent experiments (Fig. 6.5), enrichment for transfected cells was performed 
by co-transfecting the cells with a GFP plasmid.  The protocol above was repeated 
with both bovine cells (Cell Line 4, Population B, P17 and P19) and human cells 
(Patient 1, Population B, P12 and P15), but GFP plasmid was added on the day of 
transfection and cells were collected in 0.5ml DPBS.  They were then subjected to 
FACS (using the BD FACSAriaTM II cytometer at QMRI, University of Edinburgh), 
with GFP expression being used to enrich for DAZL or control transfected cells.  Staff 
at the Facility (Shonna Johnston and Will Ramsay) performed the analysis and cell 
sorting in discussion with myself.  Transfected cell samples were compared to cells 
which had not been exposed to GFP plasmids and gates were set up using a 
fluorescence wavelength of 525nm in order to select GFP-positive cells.  The cells 
were collected into 1ml of PBS containing 10% (w/v) BSA and 0.5M EDTA in 1.5ml 
microfuge tubes and transported back to the laboratory for analysis. 
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Figure 6.5.  Modified methodology for combined transfection and BMP4 plus RA 
treatment experiments, allowing enrichment of transfected cells.  On Day 2, cells 
were transfected with DAZL plasmids or control plasmids plus GFP plasmids.  
Following BMP4 and RA treatment, cells were subjected to FACS and transfected 
cells were selected on the basis of GFP expression.  This enriched cell population was 
then analysed for gene expression. 
 
6.2.2.3 qRT-PCR 
For experiments where FACS enrichment was not performed, total RNA was extracted 
and first strand cDNA was synthesised as per sections 2.9.1 and 2.9.2.  If possible, 
500ng of RNA was used for cDNA synthesis.  For experiments where enrichment was 
performed, total RNA was extracted using the ARCTURUS® PicoPure® RNA 
Isolation kit and cDNA was synthesised using the Superscript® III First-Strand 
Synthesis System as per section 4.2.1.2.1.  Total RNA concentrations were extremely 
low in these experiments, therefore all RNA was used for cDNA synthesis.  qRT-PCR 
was subsequently performed in all experiments as per section 2.9.4.   The primers 
detailed in Table 2.11 and 2.12 were utilised.   
 
6.2.2.4 Western blotting 
DAZL-transfected, non-enriched putative bovine and human cells were analysed for 
protein expression after 24, 48 and 72 hours of transfection by Western blotting as per 
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section 2.10.  Bovine Cell Line 4, Population B, P19 cells and human Patient 8 
Population A, P13 cells were analysed.  Thirty micrograms of protein was loaded in 
each experiment.  Cells were compared to either control plasmid-transfected cells 
(bovine) or non-transfected cells (human) of the same cell lines and passages.  Tables 
6.4 and 6.5 detail the primary and secondary antibodies used.   
 






Species Raised Dilution Source 
DAZL #8042 Rabbit Polyclonal 1:1000 
Cell Signaling 
Technology 
α-tubulin T-6074 Mouse Monoclonal 1:1000 Sigma-Aldrich 
 


















925-32212 1:10000 Li-cor 
 
Proteins of interest were detected using secondary antibodies visible in the 680nm 
channel (i.e. red) of the Li-cor Classic infrared imaging system.  Alpha-tubulin (α-
tubulin) was used as a loading control and was detected with a secondary antibody 
visible in the 800nm channel (i.e. green).  In the bovine experiment, human embryonic 
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kidney 293 (HEK-293) cells transfected with the same DAZL plasmid (kindly donated 
by Dr. Roseanne Rosario) were used as a positive control. 
 
6.2.3 Statistical Analyses 
Gene expression in the qRT-PCR experiments was calculated and analysed as per 
section 2.9.4.1.  In brief, normalised gene expression was calculated using the ΔΔCq 
method (Livak and Schmittgen, 2001), with comparison to the expression of the 
references genes β-actin (bovine samples) and RPL32 (human samples).  Calculated 
2^-ΔΔCq values were logarithmically transformed and checked for normalcy.  
Normally distributed data was analysed with the parametric one-way analysis of 
variance (ANOVA) with a post-hoc Tukey test.  Data that was not normally distributed 
was analysed with the non-parametric Kruskal-Wallis test with post-hoc Dunn’s test.  
A p level of < 0.05 was considered significant. 
To analyse the ICC experiments, ImageJ software (National Institutes of Health) was 
used to perform staining intensity comparisons.  The software was used to select areas 
of cytoplasmic or nuclear staining (Fig. 6.6).  The red, green or blue colour was then 
converted by the software to grayscale using the following formula: gray = 0.299red 
+ 0.587green + 0.114blue.  The mean gray value was subsequently calculated by 
dividing the sum of the grayscale values of the pixels in the selected areas by the 
number of pixels.  As the same laser settings were used for every image, the nuclear 
staining intensity should be similar, therefore in order to account for differing number 
of cells in each image, the cytoplasmic (i.e. green) staining was compared to the 
nuclear (i.e. red or blue) staining of the same image by dividing the cytoplasmic mean 
gray value by the nuclear mean gray value.  The resultant non-treated cell values were 
compared to treated cell values for each protein: by standardising the values to 1 (i.e. 
by dividing both values by the non-treated cell value), an estimate of fold change in 
staining intensity was obtained. 
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Figure 6.6.  Quantification of staining of proteins of interest was performed using 
ImageJ software.  Following acquisition of images of the cells using a confocal 
microscope, ImageJ software was utilised to select and quantify areas of (A) 
cytoplasmic and (B) nuclear staining.  Further details on the quantification methods 
are described in the text.  The images are representative of putative bovine OSCs 
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6.3.1 BMP4 and/or RA treatment experiments 
6.3.1.1 Putative bovine OSC experiments 
Twenty-four hour treatment of putative bovine OSCs with BMP4 alone or combined 
with RA resulted in significant upregulation of gene expression of all the analysed 
genes:  ID1, MSX1, MSX2 and SYCP3 (Fig. 6.7; n = 6 or 7 per treatment).  ID1 and 
MSX2 mRNA expression was significantly upregulated with BMP4 treatment alone (p 
< 0.0001 and p < 0.01 respectively), but dual treatment with both BMP4 and RA 
augmented this effect, with a significant increase in expression above that of BMP4 
treatment only observed (p < 0.05 for ID1 and < 0.001 for MSX2).  MSX1 expression 
was not increased with BMP4 alone, but did increase significantly with combined 
BMP4 and RA treatment (p < 0.01).  Furthermore, combined treatment resulted in 
significantly increased expression above that of BMP4 only treated cells (p < 0.0001), 
but not RA only treated cells.  Both BMP4 alone and combined treatment with BMP4 
and RA significantly increased the expression of SYCP3 (both p < 0.0001).  STRA8 
was not reliably detected.  Bovine primers for RARβ were designed, however, the 
mRNA sequence on the NCBI Nucleotide database is a predicted sequence only and 
the primers were unable to detect expression in a positive control (bovine fetal ovary).  
The primers were therefore not validated for use.  No OLCs were observed during the 
culture period.  
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Figure 6.7.  Expression of BMP4- and RA-response genes in putative bovine 
OSCs that had been treated with BMP4 and/or RA for 24 hours was analysed by 
qRT-PCR.  (A), (C) and (D) ID1, MSX2 and SYCP3 expression increased 
significantly with BMP4 only treatment and a synergistic effect was seen when 
combined treatment of BMP4 and RA was used in the case of ID1 and MSX2. (B) In 
contrast, MSX1 expression was significantly upregulated only in the presence of RA, 
with expression in response to combined treatment significantly higher than both 
control and BMP4 treated cells.  (*p < 0.05, **p < 0.01, *** p < 0.001, ****p < 0.0001; 
mean ± S.E.M.; n = 6 or 7 replicates per treatment group performed during 2 separate 
experiments). 
 
The expression of stem cell (LIN28, POU5F1) and germ cell (IFITM3, C-KIT) markers 
did not significantly change with any treatment, with the exception of PRDM1, where 
a non-significant trend in increased expression was observed with BMP4 treatment 
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only but combined treatment with both BMP4 and RA significantly upregulated its 
expression (p < 0.01); Fig. 6.8). 
 
Figure 6.8.  Expression of pluripotency and germline markers putative in bovine 
OSCs that had been treated with BMP4 and/or RA for 24 hours.  (A), (B), (D) and 
(E) POU5F1, LIN28, IFITM3 and C-KIT expression was not affected significantly by 
treatment.  (C) In contrast, PRDM1 expression was significantly upregulated by 
exposure to combined BMP4 plus RA treatment.  (**p < 0.01; mean ± S.E.M.; n = 6 
or 7 replicates per treatment group performed during 2 separate experiments). 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
 
 
The Potential of Putative OSCs as a Germ Cell Model
 236
  
Protein expression of BMP4- and RA-response genes was also affected by treatment, 
as demonstrated by ICC.  Due to cell availability only two treatment groups could be 
allocated: given that combined BMP4 and RA treatment led to the greatest increase in 
mRNA expression, cells were exposed to either vehicle controls or BMP4 with RA.  
ID1 and MSX2 were located in both the cytoplasm and the nucleus whereas SYCP3 
was located exclusively in the nucleus.  Although the ID proteins inhibit DNA binding 
of basic helix-loop-helix proteins, ID1 can be located in the cytoplasm as well as the 
nucleus (Coppe et al., 2003, Nishiyama et al., 2007).  MSX2 can similarly be found in 
both cellular compartments (Lanigan et al., 2010, Gremel et al., 2011).    
Qualitative analysis of cultured cells treated with combined BMP4 plus RA treatment 
suggested an increase in protein expression of ID1, MSX2 and SYCP3 compared to 
vehicle-treated cells (Fig. 6.9). This also allowed an estimate of the fold change in 
expression: the staining intensity of ID1 in BMP4 and RA-treated cells was 7 times 
that of vehicle-treated cells, whilst the intensity of MSX2 was 4 times higher in BMP4 
and RA-treated cells.  Quantitative analysis of SYCP3 staining established that 50% 






Figure 6.9.  Immunocytochemistry of putative bovine OSCs treated with either 
vehicle or BMP4 plus RA.  BMP4 plus RA-treated cells demonstrated increased 
expression of ID1, MSX2 and SYCP3 compared with vehicle controls.  Propidium 
iodide (PI) was used as a nuclear counterstain.  An enlarged image of a SYCP3-
positive cell is shown.  The primary antibody was omitted for the purposes of a 
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6.3.1.2 Putative human OSC experiments 
ID1 was the only gene analysed in the bovine experiments that was significantly 
affected by treatment in the human experiments (Fig. 6.10; n = 6 - 8 per treatment).  
Gene expression of ID1 was again significantly upregulated by BMP4 treatment alone 
or combined treatment with RA, although the addition of RA did not result in any 
further significant upregulation, in contrast to the bovine studies.  The cells were also 
shown to be RA-responsive, with RARβ expression significantly upregulated in 
response to RA treatment alone or in combined treatment with BMP4.  BMP4 only 
treatment did not increase the gene’s expression.  MSX1 expression was only detected 
in three experiments: although there was a trend for increased expression with RA 
treatment, it was not significant.  MSX2 expression was undetectable in all 
experiments.  SYCP3 expression showed a trend for upregulation with BMP4 and RA 
treatment, however, this did not reach significance.  As in the bovine experiments, no 
OLCs were observed during the culture period. 
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Figure 6.10.  Expression of BMP4- and RA-response genes in putative human 
OSCs that had been treated with BMP4 and/or RA for 24 hours.  (A) ID1 
expression increased significantly with BMP4 only treatment and combined BMP4 
plus RA treatment. (B) MSX1 was only detectable in three experiments and showed no 
significant changes in expression. (C) The cells demonstrated RA-responsiveness, 
with significant upregulation of RARβ if RA was included in treatment.  (D) SYCP3 
expression exhibited a non-significant trend for increased expression with RA only 
and BMP4 plus RA treatment (*** p < 0.001, ****p < 0.0001; mean ± S.E.M.; n = 6 
- 8 replicates per treatment group, performed during 4 separate experiments, with 
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Contrary to the bovine ICC results, increased protein expression of ID1 or MSX2 was 
not suggested in BMP4 and RA-treated cells compared to vehicle-treated cells, either 
qualitatively or quantitatively (Fig. 6.11).  ID1 staining intensity was calculated to be 
1.1 times higher in the BMP4 and RA-treated cells, while MSX2 intensity was 1.2 
times higher, indicating no differences.  No cells in either treatment group 








Figure 6.11.  Immunocytochemistry of putative human OSCs treated with either 
vehicle or BMP4 plus RA.  No change in ID1 or MSX2 protein expression was 
observed with treatment.  SYCP3 expression was not detected in any cells.  DAPI was 
used as a nuclear counterstain.  The primary antibody was omitted for the purposes of 
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6.3.1.3 Fetal bovine somatic cell experiments 
To investigate whether other types of ovarian cells were similarly BMP4 and/or RA 
responsive, fetal bovine somatic cells were treated and analysed for mRNA and protein 
expression.  Although the cells appeared to be BMP4-responsive, with trends for 
upregulation of ID1, MSX1 and MSX2 with BMP4 or combined BMP4 and RA 
treatment, these trends did not reach significance (Fig. 6.12; n = 3).  Neither SYCP3 
nor STRA8 demonstrated any significant change in expression with treatment. 
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Figure 6.12.  Expression of BMP4- and RA-response genes in fetal bovine somatic 
cells that had been treated with BMP4 and/or RA for 24 hours.  (A), (B) and (C) 
The cells demonstrated BMP4-responsiveness, with non-significant upregulation of 
ID1, MSX1 and MSX2 with BMP4 only treatment or and/or combined BMP4 plus RA 
treatment.  (D) and (E) Expression of the meiotic entry genes, SYCP3 and STRA8, was 
not significantly altered with treatment.  (Mean ± S.E.M.; n = 3 replicates per treatment 
group performed during 1 experiment).   
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Immunocytochemical analysis demonstrated similar results to the human experiments, 
with no qualitative or quantitative difference in protein expression of ID1 or MSX2 
between BMP4 and RA-treated cells and vehicle-treated cells (Fig. 6.13).  ID1 staining 
intensity was calculated to be the same in both treatment groups, while MSX2 intensity 
was actually 1.7 times higher in the vehicle-treated cells.  SYCP3 expression was not 








Figure 6.13.  Immunocytochemistry of fetal bovine somatic cells treated with 
either vehicle or BMP4 plus RA.  No increased expression of ID1 or MSX2 protein 
was observed with treatment.  SYCP3 expression was not detected in any cells.  DAPI 
was used as a nuclear counterstain.  The primary antibody was omitted for the purposes 
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6.3.2 DAZL transfection experiments 
Given the key role of DAZL in meiosis (Lin et al., 2008) and its ability to induce 
hESCs and iPSCs to form PGCLCs (Medrano et al., 2012), an experiment was 
designed to investigate whether overexpression of DAZL in putative OSCs would 
result in increased expression of meiosis-related genes.  A liposomal-mediated 
transfection technique was utilised to introduce the DAZL plasmid into the cells.  
 
6.3.2.1 Non-enriched experiments 
A preliminary experiment was performed using putative bovine OSCs (Cell Line 4, 
P19; n = 1 per treatment group) to determine whether (a) the cells could be transfected 
to upregulate the expression of DAZL and (b) if the transfection was effective, how 
long it took for increased DAZL expression to be detected.  A time course experiment 
demonstrated that the transfection was successful after 24 hours of transfection, but 
that there was a further increase in DAZL expression after 48 hours (Fig. 6.14).  There 
was little difference between 48 and 72 hours.  Statistical analysis for significance was 
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Figure 6.14.  Preliminary transfection experiments utilising putative bovine OSCs 
demonstrated that transfection with a DAZL overexpression plasmid resulted in 
upregulation of DAZL expression, with a plateau of expression at 48 – 72 hours.  
(Mean; n = 1 replicate per treatment group performed during 1 experiment).   
 
The same cells were then analysed for ID1, MSX1, MSX2 and SYCP3 expression (Fig. 
6.15).  Again, statistical analysis for significant changes in gene expression was not 
possible, although, there appeared to be a slight trend for upregulation of expression 
with time for ID1, MSX1 and MSX2 in DAZL transfected cells.  However, DAZL 
transfection was not associated with clear effects on the expression of these genes 
compared with the control plasmid-transfected cells. 
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Figure 6.15.  Analysis of downstream genes demonstrated that DAZL 
transfection alone did not significantly affect gene expression at any of the chosen 
time points.  (Mean; n = 1 replicate per treatment group performed during 1 
experiment) 
 
A DAZL transfection and BMP4 plus RA treatment experiment was subsequently 
performed to analyse whether a combination of upregulation of DAZL expression and 
treatment would affect downstream gene expression.  A period of 48 hours between 
transfection and treatment was chosen as the time course experiment above indicated 
that transcription levels were high at this time point.  This experiment, utilising 
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putative human OSCs, demonstrated that human cells could also be transfected to 
upregulate expression of DAZL, although this did not reach significance, possibly due 
to the low n numbers (Fig. 6.16; n = 3 per treatment).    
 
Figure 6.16.  DAZL transfection of putative human OSCs resulted in 
upregulation of DAZL expression at non-significant levels. (Mean ± S.E.M.; n = 3 
replicates per treatment group performed during 3 separate experiments). 
Analysis of the downstream genes revealed that, as expected, ID1 and RARβ showed 
evidence for upregulation with combined BMP4 and RA treatment; however, DAZL 
transfection did not augment this effect (Fig. 6.17).  MSX1 was only detectable in one 
experiment, therefore, although it appears DAZL overexpression caused increased 
MSX1 expression in vehicle-treated cells compared to control transfected and vehicle-
treated cells, it is not possible to interpret the results reliably.  As seen in the human 
BMP4 and/or RA treatment experiments described above, MSX2 was not detectable.  
The combination of DAZL transfection and treatment did appear to result in an increase 
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in SYCP3 expression compared to control transfected and either BMP4 plus RA-
treated or vehicle-treated cells; however, this did not reach significance. 
 
Figure 6.17.  Expression of BMP4- and RA-response genes in putative human 
OSCs that had been transfected with DAZL or control vectors and treated with 
vehicle or BMP4 plus RA.  (A) and (C) ID1 and RARβ expression exhibited a trend 
for increased expression with BMP4 plus RA treatment, which was not augmented by 
DAZL overexpression. (B) MSX1 data was difficult to interpret due to only being 
detectable in 1 experiment.  (D) SYCP3 expression was increased in DAZL transfected 
and BMP4 plus RA treated cells, but the change was not significant.  (Mean ± S.E.M.; 
n = 3 replicates per treatment group performed during 3 separate experiments, with 
exception of MSX1, where n = 1 replicate). 
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As a result of these experiments, it was postulated that the transfection of the cells may 
not be efficient and thus any effect on gene expression may be masked by the presence 
of a majority of non-transfected cells.  It was therefore decided to use an enrichment 
method, in order to select only transfected cells for further gene expression analysis.  
6.3.2.2 Enriched experiments 
Co-transfection with DAZL or control plasmids and a GFP plasmid was performed in 
order that transfected cells could be sorted for the presence of GFP by flow cytometry 
(Fig. 6.18).  This utilised the principle that if a cell allowed one plasmid to enter, it 
would likely take up the other; nevertheless, not all cells containing the DAZL or 
control plasmid would be GFP-positive and vice versa, therefore this experiment was 
used for enrichment, not purification, of DAZL or control transfected cells.   
 
Figure 6.18.  Cells could be enriched for presence of the DAZL or control 
plasmids by co-transfecting the (A) bovine and (B) human cells with a GFP 
plasmid.  GFP-positive cells were collected using FACS.  Control transfected and 
DAZL transfected cells exhibited similar transfection rates.  Non-transfected cells 
were used to gate for GFP fluorescence. 
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Putative bovine OSCs demonstrated a wide range of transfection rates from 5.2% to 
24.7%, with similar intra-experiment, but variable inter-experiment rates observed 
(Table 6.6).  Transfection rates were similar regardless of whether the DAZL plasmid 
or the control plasmid had been utilised.   
 




(Mean ± S.E.M) 
17 21.1% ± 0.6% 
19 5.3% ± 0.3% 
 
The enrichment of putative bovine OSCs was effective, with DAZL transfected cells 
demonstrating a significantly increased expression of DAZL mRNA compared with 
control transfected cells (p < 0.01 or < 0.001; Fig. 6.19; n = 5 or 6 per treatment group).  
DAZL expression was not affected by treatment with BMP4 and RA.    
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Figure 6.19.  Enrichment for transfected putative bovine OSCs was effective, with 
DAZL transfected cells demonstrating significant upregulation of the mRNA. (a 
vs. b: p < 0.001, c vs. d: p < 0.01; mean ± S.E.M.; n = 5 or 6 replicates per treatment 
group performed during 2 separate experiments). 
Analysis of the downstream genes demonstrated a pattern of increased expression with 
BMP4 and RA treatment of ID1, MSX1 and SYCP3 compared with vehicle-treated 
cells for both transfected groups, and in MSX2 for the DAZL transfected cells only 
(Fig. 6.20).  There was also a trend for DAZL transfected and BMP4 plus RA treated 
cells to have upregulated expression of ID1, MSX2 and SYCP3 compared with control 
transfected and BMP4 plus RA treated cells.  However, none of these results were 
statistically significant and despite similar n numbers to the BMP4 and/or RA 
treatment experiments, the standard errors of the mean were larger, indicating less 
consistent results. 
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Figure 6.20.  Expression of BMP4- and RA-response genes in enriched putative 
bovine OSCs that had been transfected with DAZL or control vectors and treated 
with vehicle or BMP4 plus RA.  (A), (B), and (D) ID1, MSX1 and SYCP3 expression 
exhibited a trend for increased expression with BMP4 plus RA treatment, which was 
only seen in DAZL transfected cells for MSX2 (C).  ID1 and SYCP3 appeared to be 
augmented by DAZL overexpression if the cells had been treated with BMP4 and RA, 
but this was not significant. (Mean ± S.E.M.; n = 5 or 6 replicates per treatment group 
performed during 2 separate experiments). 
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The experiment was repeated with putative human OSCs, which also demonstrated 
variable inter-experimental transfection rates, ranging from 1.5% to 16.4% (Table 6.7).   
 




(Mean ± S.E.M) 
12 13.2% ± 1.3% 
15 3.0% ± 0.2% 
 
The enrichment for DAZL-expressing cells was again successful, with significant 
upregulation of the gene in DAZL plasmid-exposed cells (p < 0.0001; Fig. 6.21(a); n 
= 5 or 6 per treatment group).  ID1 was significantly upregulated with BMP4 and RA 
treatment in both transfected groups, however, DAZL transfected cells exhibited this 
increase in expression to a lesser degree than control transfected cells (p < 0.05 
compared with p < 0.001; Fig. 6.21(b)).  RARβ expression was also increased by BMP4 
plus RA treatment, reaching significant levels when DAZL transfected, BMP4 and RA 
treated cells were compared with DAZL transfected, vehicle-treated cells (p < 0.01; 
Fig. 6.21(c)).  Cells that had been both transfected with DAZL and treated with BMP4 
plus RA also exhibited significantly upregulated levels of RARβ compared with control 
transfected, vehicle-treated cells (p < 0.01).  MSX1, MSX2 and SYCP3 were 
undetectable. 
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Figure 6.21.  Enrichment for transfected putative human OSCs was also effective 
(A), with DAZL transfected cells demonstrating significant upregulation of DAZL 
mRNA. (a vs. b: p < 0.0001; mean ± S.E.M.; n = 5 or 6 replicates per treatment 
group performed during 2 separate experiments). (B) and (C) Analysis of BMP4- 
and RA-response genes in enriched human OSCs that had been transfected with DAZL 
or control vectors and treated with vehicle or BMP4 plus RA revealed significant 
upregulation of ID1 with BMP4 and RA treatment, which was greater in control 
transfected cells compared with DAZL transfected cells.  RARβ expression was 
significantly upregulated only in DAZL transfected and BMP4 plus RA treated cells. 
(*p < 0.05, **p < 0.01, *** p < 0.001; mean ± S.E.M.; n = 5 or 6 replicates per 
treatment group performed during 2 separate experiments). 
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6.3.2.3 DAZL protein expression 
As the results of the enrichment experiments did not demonstrate significant 
downstream effects with increased DAZL transcription, Western blotting was 
performed to investigate whether the cells were capable of translating the DAZL 
mRNA to protein.  A time course experiment for putative OSCs of both species was 
performed to investigate when protein expression was highest.  DAZL expression was 
not confirmed in the bovine cells at any time point (Fig. 6.22; n = 1 replicate per 
treatment group); however, the human cells did demonstrate protein expression, which 
appeared to be highest 24 – 48 hours after transfection, before declining (Fig. 6.23; n 
= 1 replicate).    
 
 
Figure 6.22.  Western blot time course analysis for DAZL expression in putative 
bovine OSCs that had been exposed to DAZL plasmids or control plasmids.  
Probing of the cells failed to detect the protein, which was detected in the positive 
control (HEK-293 cells; black arrow).  The expected molecular weight (mw) of DAZL 
is 38 kDa, however the Myc-DDK tag on the plasmid results in the band being located 
at a slightly higher mw.  α-tubulin was used as a loading control (white arrow; expected 
mw 50 kDa).  
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
 
 






Figure 6.23.  Western blot time course analysis for DAZL expression in putative 
human OSCs that had either been exposed to DAZL plasmids or not transfected.  
Non-transfected cells demonstrated low levels of endogenous DAZL, that was 
increased with DAZL transfection (black arrows; expected molecular weight (mw) 
38 kDa, however a band of greater mw is seen due to the Myc-DDK tag on the 
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6.4.1 The effect of BMP4 and/or RA treatment on putative OSCs 
The findings detailed in this Chapter demonstrate that bovine putative OSCs show 
promise as a germ cell model as their molecular response to two key regulators of the 
PGC development pathway, BMP4 and RA, was similar to that of germ cells, i.e. 
BMP4- and RA-response genes related to germ cell differentiation and meiosis 
initiation were upregulated.  Firstly, putative bovine OSCs significantly upregulated 
their expression of ID1 in response to BMP4.  This is in keeping with both unpublished 
work from Prof. Anderson’s group in human fetal ovaries and studies in mouse fetal 
gonads (Dudley et al., 2007).  A further enhancement of this response was observed 
with combined BMP4 plus RA treatment.  Although the effect of RA on germ cell ID1 
expression has not been previously reported, the gene has been demonstrated to be 
RA-responsive in other cell types, including keratinocytes (Villano and White, 2006) 
and acute promyelocytic leukaemia cells (Nigten et al., 2005).     
MSX2 expression followed the same pattern as ID1.  In contrast, MSX1 was not 
upregulated by BMP4 alone: combined BMP4 and RA exposure was required for a 
significant increase in gene expression to be detected.  Again, this is a similar response 
to that found in previous work using human fetal ovary, where BMP4 treatment 
selectively upregulated MSX2, but had no effect on MSX1 (Childs et al., 2010).  It also 
supports mouse fetal ovary studies which demonstrated upregulation of Msx2 in 
response to Bmp4 and increased Msx1 expression in response to RA (Le Bouffant et 
al., 2011).  In contrast to the human fetal ovary study and the putative bovine OSC 
results, Msx1 has been found to be BMP4-responsive in mouse fetal ovaries (Le 
Bouffant et al., 2011): it is possible that inter-species differences may account for this 
incongruity.  This further highlights the need for species-specific germ cell models, as 
findings from other species are not necessarily applicable to the species of interest. 
Research on hESCs has demonstrated a link between BMP4 and SYCP3, with BMP4 
treatment leading to an increased expression of SYCP3 during the differentiation of 
hESCs into EBs (Kee et al., 2006).  RA has also been found to stimulate SYCP3 
expression in isolated mouse PGCs (Tedesco et al., 2013).  Similarly, our cultured 
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bovine cells demonstrated a significant upregulation of SYCP3 following BMP4 
treatment, with the addition of RA apparently augmenting this effect.   
These mRNA effects were confirmed when the protein expression of ID1, MSX2 and 
SYCP3 was analysed immunocytochemically, with BMP4 plus RA-treated cells 
exhibiting increased expression, both qualitatively and quantitatively, of each of the 
three proteins when compared with vehicle-treated cells.  SYCP3 expression was only 
seen in BMP4 plus RA-treated cells and exhibited an elongated staining, postulated by 
others to correspond to synaptonemal complexes at the zygotene, pachytene or 
diplotene stages of meiotic prophase I (Kee et al., 2009, Medrano et al., 2012). 
If the putative OSCs were undergoing differentiation and meiotic entry, loss of 
pluripotency markers and increased expression of markers of meiotic germ cells may 
be expected.  Indeed, analysis of hESC-derived EBs revealed downregulation of the 
pluripotency genes, POU5F1 and NANOG, and successive upregulation of the germ 
cell markers, DAZL and DDX4, during the two week culture period (Aflatoonian et al., 
2009).  This was accompanied by an increase in expression of the oocyte marker GDF-
9 and the marker of meiotic entry, SYCP3.  The putative bovine OSCs demonstrated 
no significant changes in mRNA expression of POU5F1, LIN28, IFITM3 or C-KIT, 
although a shorter culture period was used.  However, this is in keeping with 
unpublished work from Prof. Anderson’s group which has demonstrated that BMP4-
treated human fetal ovaries do not exhibit changes in pluripotency (POU5F1) and 
germline (DAZL and DDX4) markers.  In contrast, our experiments demonstrated that 
PRDM1 expression was upregulated by combined BMP and RA treatment.  This 
finding is of note, as in mice Bmp4 has been shown to stimulate epiblast cells to 
express Prdm1 and cause germ cell specification (Ohinata et al., 2009).  The 
upregulation of the gene in the bovine cells may therefore reflect differentiation of the 
cells into PGCs. 
The human data were not as robust as the bovine experiments, with the ID1 response 
to BMP4 and/or RA treatment being the only finding conserved between the two 
species.  MSX1 again appeared to be RA-responsive and SYCP3 demonstrated a trend 
for increased expression, but these results were not significant.  Higher n numbers may 
help to elucidate the gene expression effects.  The cells did, however, upregulate the 
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expression of the RA receptor, RARβ, when treated with RA alone or combined BMP4 
and RA treatment, demonstrating their RA-responsiveness.  The gene was not 
responsive to BMP4 treatment alone, indicating the increased levels in response to 
combined treatment were only due to the presence of RA.  Unlike the bovine cells, 
analysis of the proteins of interest did not reveal differences in ID1 and MSX2 
expression between vehicle-treated and BMP4 plus RA-treated cells.  It was 
noteworthy that MSX2 protein was detectable, yet MSX2 mRNA was not.  This may 
have been a technical issue with the MSX2 primers, although they had been previously 
validated for use on human fetal ovary (Childs et al., 2010).  No SYCP3 expression 
was seen in any cells.  It would appear, therefore, that mRNA changes were not 
translated to protein expression changes in the human cells.  This may, once again, be 
due to inter-species differences, or it may be that the human cells required a longer 
period of treatment than the bovine cells for translation to occur and an effect to be 
observed, or that they require additional factors not present in these experiments. 
PGCs are not the only cell type that demonstrate BMP4 and RA-responsiveness, with 
multiple roles established in many different tissues (Hogan, 1996, Rhinn and Dolle, 
2012, Katagiri and Watabe, 2016); however, germ cells are the only cell type with the 
ability to undergo meiosis.  BMP4 and/or RA treatment experiments were therefore 
performed on fetal bovine somatic cells to assess whether the putative OSCs 
demonstrated a distinct molecular response compared to ovarian somatic cells.  The 
somatic cells appeared to be BMP4-responsive, with increased expression of ID1, 
MSX1 and MSX2.  Although none of the changes in expression reached significance, 
this may be due to an insufficient sample size.  Importantly, the cells did not 
demonstrate an increase in gene expression with treatment of classic markers of 
meiotic entry, with no significant changes in expression of SYCP3 and STRA8 
detected.  Again, no changes in ID1 and MSX2 protein expression with BMP4 plus 
RA treatment were observed and no cells expressed SYCP3.  
 
Overall, these results demonstrate that the bovine putative OSCs robustly mimic the 
molecular response of PGCs to two key regulators of germ cell development, including 
upregulation of the expression of the meiotic entry gene, SYCP3, at both the mRNA 
and protein level.  This is not observed in fetal bovine ovarian somatic cells.  Thus, the 
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putative bovine OSCs demonstrate promise as a model for germ cell development.  As 
a large animal, this could prove valuable in providing a more translatable model to 
explore the intricacies of human female germ cell development, as well as providing a 
bovine-specific germ cell model.  Currently, derivation of bovine ESCs is proving 
problematic: derived ESC-like cells fail to maintain an undifferentiated state and have 
not been shown to proliferate long term (Maruotti et al., 2012, Hall et al., 2013).  
Therefore, putative bovine OSCs may provide an alternative option for examining 
bovine germ cell development.  It should be emphasised, however, that while SYCP3 
is a hallmark of entry into meiosis, relevant chromosomal changes were not explored 
thus it remains unclear whether these cells can in fact enter meiosis.  Nevertheless, 
these findings corroborate those of Park et al., who are the only group to publish data 
on OSCs and BMP4 treatment (Park et al., 2013).  Their research utilising mouse 
OSCs also demonstrated upregulation of Msx1, Msx2 and another classis marker of 
meiotic entry, Stra8.  However, in contrast to the murine experiments (Park et al., 
2013), no OLCs were observed during the bovine and human investigations.   
 
6.4.2 The effect of overexpression of DAZL on putative OSCs 
Following the BMP4 and/or RA treatment experiments, we postulated that an increase 
in DAZL expression may further augment the expression of meiotic markers in putative 
bovine OSCs and elucidate the SYCP3 treatment response in the human cells.  DAZL 
was selected as (a) it is essential for germ cells to enter meiosis, with Dazl deficient 
mice exhibiting significantly reduced levels of several genes related to meiosis (Lin et 
al., 2008), (b) overexpression of the gene has been shown to induce differentiation of 
hESCs and iPSCs into PGCLCs (Medrano et al., 2012) and (c) Sycp3 has been 
demonstrated to be a Dazl target in mice (Saunders et al., 2003, Reynolds et al., 2007).  
In order to generate DAZL overexpression in putative bovine and human OSCs, a 
liposomal-mediated transfection technique was utilised.  This method of transfection 
has previously been performed in rodent OSCs, to both silence (Zhang et al., 2011) 
and cause overexpression (Zhou et al., 2014) of specific genes, generating transgenic 
offspring.  To our knowledge, it has never been utilised in the setting of investigating 
OSCs regarding germ cell model potential.   
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
 
 
The Potential of Putative OSCs as a Germ Cell Model
 263
  
DAZL transfection of the bovine and human cells was rapidly effective with a 
significant increase in DAZL mRNA expression in DAZL transfected cells compared 
to the very low levels of endogenous DAZL detected in control transfected cells.  This 
low level of endogenous DAZL expression was also demonstrated at the protein level 
in non-transfected human cells, with transfection successfully resulting in increased 
protein levels.   Preliminary experiments on bovine and human cells demonstrated that 
DAZL transfection alone did not affect the expression of the downstream genes, ID1, 
MSX1, MSX2 (detected in bovine experiments only) and SYCP3.  When human cells 
were both transfected and then treated with BMP4 plus RA, the expected ID1 and 
RARβ response to BMP4 plus RA was observed in both control and DAZL transfected 
cells, although this did not reach significance, possibly due to low n numbers.  No 
significant augmentation of expression of any of the analysed genes was seen in the 
DAZL transfected, BMP4 plus RA treated human cells compared with control 
transfected cells, although SYCP3 expression in DAZL transfected, BMP4 plus RA 
treated cells was higher than the other treatment groups.    
Co-transfection of the cells with DAZL/control plasmid and GFP plasmid allowed 
transfection rates to be estimated by flow cytometry, with low and variable rates 
detected.  Given the standardised transfection methodology and the use of the same 
bovine and human cell lines in the experiments, it is possible that the cause of the 
variations in transfection rates was due to heterogeneity of the cells at differing 
passages.  Indeed, there was an observed association between lower transfection rates 
and later passages in both species.  This phenomenon has been observed in other cell 
lines: HEK-293 cells exhibit differing transfection rates between lower and higher 
passages depending on the serum content of the culture medium, with serum-free 
medium demonstrating lower transfection rates at greater passages (de Los Milagros 
Bassani Molinas et al., 2014).  In our protocol, cells were initially transfected in serum-
containing medium, before being changed to serum-free medium for BMP4 plus RA 
treatment, therefore the changing serum content may have had an effect on transfection 
efficiency.  Human cells appeared to be less readily transfected than bovine cells, as 
human cells at passage 15 exhibited lower transfection rates than bovine cells at P17.  
This is in keeping with the lentiviral transduction rates detailed in Chapter 3 and may 
be due to interspecies differences in susceptibility to plasmid uptake.  
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Enrichment for transfected cells by flow cytometry was successful, allowing analysis 
of a purer population of DAZL (or control) transfected cells, thus removing the 
“dilution” effect of large numbers of non-transfected cells that were present in the 
initial experiments.  The BMP4 plus RA treatment response appeared conserved in 
enriched DAZL and control transfected cells of both species, although only ID1 and 
RARβ expression in the human cells reached significant levels.  This observed blunting 
of the treatment effect seen in non-transfected cells may be due to less consistent 
results in the transfection experiments (indicated by larger S.E.Ms).  One possible 
reason for this is that poor transfection rates resulted in low numbers of enriched cells 
and thus low total RNA concentrations for qRT-PCR analysis, making robust analysis 
of the genes, especially lowly expressed genes, difficult.  This is supported by the 
finding that MSX1 was lowly detected in the non-transfected and non-enriched human 
experiments, but was never detectable in the enriched experiments.  Furthermore, 
transfection may have been detrimental to the cells’ ability to respond to BMP4 plus 
RA treatment: GFP transduction of the cells has already been demonstrated to be 
detrimental to cell health in Chapter 3 and perhaps translation of GFP was too energy-
demanding for transcription of other genes to occur. 
Yet, cells that were both DAZL transfected and BMP4 plus RA treated did demonstrate 
increased expression of ID1, MSX2 and SYCP3 compared with control transfected and 
BMP4 plus RA treated cells in the bovine experiments, although significant changes 
were not detected.  In contrast, DAZL transfected human cells actually demonstrated 
lower levels of ID1 upregulation than control transfected cells after BMP4 plus RA 
treatment.  Similar to the GFP hypothesis, perhaps the high levels of DAZL 
transcription generated by the overexpression plasmid was injurious to the ability of 
the human cells to respond to treatment.  The only gene where DAZL transfection 
appeared to have a significant effect on expression was RARβ in the human 
experiments.  This is in keeping with mouse studies which demonstrated that Dazl 
enables PGCs to respond to RA for meiosis to be initiated (Lin et al., 2008).  Yet, both 
DAZL transfection and BMP4 plus RA treatment had to be performed for the cells to 
significantly upregulate their expression: although there was a trend for increased 
expression in DAZL transfected cells compared with control transfected cells when 
the two BMP4 plus RA treatment groups were compared, this was not significant.  Our 
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sample sizes were limited by cell availability, however; a greater sample size would 
improve the power of the experiment. 
Lastly, it is of note that, in contrast to human cells, DAZL protein expression was not 
detectable in bovine cells.  As the same plasmid and Western blotting antibody were 
used in both species and non-enriched cells were utilised, it is possible that the levels 
of DAZL protein were simply too low in the bovine cells to be detectable by Western 
blotting.  The hypothetical stimulatory effect of downstream genes in the presence of 
elevated levels of DAZL may therefore not have been observed due to inadequate 
DAZL expression.  Yet, this does not explain why human cells, which did exhibit 
increased DAZL expression after DAZL transfection, did not demonstrate significant 
downstream effects due to DAZL transfection alone.   
Overall, the findings did not prove the hypothesis that DAZL overexpression results in 
increased expression of downstream meiosis-related genes, although limitations with 
regards inefficient transfection rates and low numbers of transfected cells may have 
contributed to the inconclusive results. 
 
6.4.3 Summary 
In vitro approaches do not address the fundamental question of the physiological 
relevance of OSCs, but do provide an opportunity to explore germ cell development 
in ways that are not possible in vivo in large animals and humans.  Experiments aimed 
at exploring the potential of putative bovine and human OSCs as a model of germ cell 
development demonstrated that the bovine cells showed changes in downstream genes, 
including meiosis-related genes, in response to key regulators of the development 
pathway, in keeping with the findings reported in fetal ovary and PGC research in the 
literature.  Putative human OSCs showed similar trends in gene response patterns; 
however, the results were not as conclusive.  Overexpression of a critical gene related 
to meiotic entry, DAZL, did not have significant stimulatory effects on downstream 
genes.  The effects of either RA exposure or DAZL overexpression on OSCs have not 
been investigated previously and are therefore novel approaches in the investigation 
of the potential of such cells as germ cell models.  Clearly, mRNA expression of genes 
critical to meiosis initiation does not equate to the cells truly entering meiosis and 
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therefore future work should focus on examining the chromosomal changes that occur 
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7.1 Introduction 
7.1.1 The delivery of OSCs to the ovary for clinical applications 
As discussed in section 1.1.3, an exciting possible role of OSCs in clinical Medicine 
could be in the area of fertility preservation.  One proposed technique by which OSCs 
could be utilised is the isolation of the cells from an ovarian biopsy prior to POI-
inducing treatment, proliferation of the cells in vitro and then injection of the cells 
back into the woman’s ovaries following disease remission (Dunlop et al., 2013).  
Once in situ, the OSCs could potentially produce new oocytes in vivo and restore a 
woman’s reproductive and ovarian endocrine function, at least temporarily.  However, 
as detailed in Chapter 5, injections of cells into ovarian tissue can be technically 
difficult, with the risk of cell extrusion into the surrounding environment.  This may 
be especially true if injections are performed laparoscopically, when adequately 
immobilising the ovary for efficient injection could prove problematic.  An acellular 
scaffold could provide an alternative method of cell delivery: insertion of the scaffold, 
seeded with OSCs, into the ovarian medulla via an incision could be performed 
laparoscopically, in a similar manner to the orthotopic reimplantation of cryopreserved 
ovarian cortex during fertility preservation techniques (Sanchez-Serrano et al., 2010, 
Donnez et al., 2013).  Scaffolds have been proposed to allow greater retention of 
transplanted cells within the desired location than injection techniques (Damous et al., 
2015). 
The use of artificial, or engineered, ovaries utilising scaffolds to both mature oocytes 
in vitro and transplant isolated follicles and ovarian somatic cells for in vivo oocyte 
maturation is currently an emergent area of research.  This approach would be 
especially valuable in women with haematological malignancies as reimplanting 
cryopreserved ovarian cortex in these patients carries the risk of reintroducing 
malignant cells (Dolmans et al., 2010, Rosendahl et al., 2010).  Materials used to create 
3D artificial ovaries include agarose honeycomb-shaped moulds (Krotz et al., 2010), 
alginate and alginate-matrigel matrices (Vanacker et al., 2012, Laronda et al., 2014, 
Vanacker et al., 2014), fibrin clots (Luyckx et al., 2013, Luyckx et al., 2014, Kniazeva 
et al., 2015, Soares et al., 2015, Chiti et al., 2016, Paulini et al., 2016), decellularised 
ovaries (Laronda et al., 2015) and a gelatin scaffold created by a 3D printer (Laronda 
et al., 2016).  The majority of studies have been performed in mice by Amorim and 
colleagues in Belgium, utilising an in vivo technique that comprises seeding of a fibrin 
or alginate-containing scaffold with isolated immature murine follicles and additional 
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supportive ovarian cells before subsequent autografting of these structures into 
recipient mice (Vanacker et al., 2012, Luyckx et al., 2014, Vanacker et al., 2014, Chiti 
et al., 2016).  This has resulted in healthy follicle growth after 1 week of grafting, as 
assessed by TUNEL staining for apoptosis and staining for the proliferative marker, 
Ki67.  The group extended this research into humans, with fibrin-encapsulated isolated 
human preantral follicles demonstrating growth and viability after being xenografted 
into nude mice for 1 week (Paulini et al., 2016).  However, although growth to the 
antral stage in mice (Vanacker et al., 2014) and to secondary follicles in humans 
(Paulini et al., 2016) has been reported, the complete maturation and fertilisation 
competence of the oocyte was not demonstrated in these studies.   
Using an agarose mould as a scaffold, in vitro maturation of human oocytes from early 
antral follicles has been reported, following seeding of the moulds with theca cells and 
COCs (Krotz et al., 2010).  After 3 days, the COCs were surrounded by theca cells and 
one (of three) oocytes had undergone polar body extrusion.  However, the sample size 
was clearly very small and, again, developmental competence of the oocyte was not 
tested.  Furthermore, if such a technique was to be used clinically, then efficient 
maturation from the primordial stage would be necessary to maximize the number of 
competent oocytes obtained.  Another group at the forefront of this research, Woodruff 
and colleagues in the USA, have reported both resumption of endocrine function and 
livebirths in mice using a variety of scaffolds and isolated follicles, including those at 
the primordial stage (Kniazeva et al., 2015, Laronda et al., 2015, Laronda et al., 2016).  
Decellularised bovine ovary scaffolds, seeded with ovarian cells from mice and grafted 
under the kidney capsule, supported the development of large antral follicles and the 
initiation of puberty in ovariectomised mice (Laronda et al., 2015) and autografted 
fibrin-embedded immature murine follicles also resulted in the resumption of ovarian 
function (Kniazeva et al., 2015).  Furthermore, if the fibrin contained vascular 
endothelial growth factor (VEGF), the recipient mice produced live pups (Kniazeva et 
al., 2015), likely due to improved vascularisation, and thus survival, of the graft.  Most 
recently, a 3D printed gelatin scaffold devised by the group was reported to similarly 
support the production of live pups when seeded with isolated follicles and supportive 
ovarian cells (Laronda et al., 2016).  Similar principles could be applied to deliver 
OSCs directly into the ovary, or to transplant heterotopically both OSCs and 
supportive ovarian somatic cells for in vivo neo-oogenesis in women who have 
undergone bilateral oophorectomies.  The biomaterial utilised in the experiments 
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detailed in this Chapter was gelatin, in the form of a clinically available product called 
Gelfoam®. 
   
7.1.2 Gelfoam® as a cell delivery system 
Gelfoam® is a gelatin sponge, derived from porcine skin, with a well-established 
clinical use in haemostasis (Jenkins et al., 1946, Smith, 1947).  It is a biocompatible, 
porous, flexible matrix, which can take up fifty times its weight in water and is 
absorbed by soft tissues within four to six weeks (Jenkins et al., 1946, Smith, 1947).  
When placed on bleeding surfaces, it liquefies in one to four days (Jenkins et al., 1946).  
These are valuable properties for a cell scaffold as (a) the sponge can absorb a large 
volume of cell suspension and (b) the cells can be gradually delivered to the desired 
area during liquefaction or absorption of the sponge.  Several studies have now used 
Gelfoam® for this purpose: it has shown promise as a scaffold for bone marrow 
mesenchymal stem cells (MSCs) to enable cartilage regeneration (Ponticiello et al., 
2000) and enhance bone allograft healing (Lee et al., 2011), and has been used to 
regenerate the right ventricular outflow tract in rats using fetal cardiomyocytes (Sakai 
et al., 2001).  Most relevantly, it has been used as a scaffold to deliver adipose tissue-
derived stem cells (ASCs) to ovaries in rats (Damous et al., 2015).  Intra-ovarian 
injections of ASCs have previously been reported to improve ovarian function in mice 
after chemotherapy treatment, as assessed by follicle numbers and ovulated oocytes 
(Sun et al., 2013).  When ASC-seeded Gelfoam® was applied to frozen-thawed rat 
ovaries which were reimplanted into the retroperitoneum of oophorectomised rats in 
an attempt to restore ovarian function, the animals recommenced estrous cycles sooner 
than non-ASC controls, although no effect on follicle numbers or health was detected 
(Damous et al., 2015) thus the mechanism of this apparent beneficial effect remains 
unknown at present.   
 
7.1.3 Aims of this chapter 
The aim of the experiments described in this Chapter was to perform a preliminary 
investigation of the potential of Gelfoam® as a cell delivery scaffold for OSCs.  
Although it has been utilised for the delivery of other types of stem cell, this would be 
a novel cell delivery approach for OSCs.  The objectives of the experiments were to 
(a) assess whether Gelfoam® could be seeded successfully with putative bovine OSCs 
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and (b) explore whether cell-seeded Gelfoam® could effectively deliver the cells into 
bovine ovarian cortex. 
 
7.2 Materials & Methods 
7.2.1 Fluorescent labelling of putative bovine OSCs 
Putative bovine OSCs (Cell Line 4, varying passages) were labelled with rhodamine-
conjugated dextrans as per section 2.5.2.  Cells were analysed using an inverted 
microscope (Axiovert 200) prior to use in experiments to ensure fluorescence was 
detectable (detailed in section 2.5.2). 
 
7.2.2 Cell seeding of Gelfoam® 
Gelfoam® sheets (Pharmacia and Upjohn Company) were cut into 1cm x 1cm x 0.3cm 
squares under sterile conditions and hydrated in OSC culture medium (see section 2.4) 
in 24 well culture plates for 1 hour prior to cell seeding.  Rhodamine-labelled putative 
bovine OSCs were trypsinised, centrifuged at 800 x g for 5 mins and resuspended in 
100µl of fresh OSC culture medium.  The culture medium was then adjusted so the 
top of the Gelfoam® was just above the surface of the medium and the bovine cells 
were pipetted onto the top of the Gelfoam®.  Cells from one confluent well of a 12 
well plate was seeded onto each square (i.e. approximately 60000 cells).  The seeded 
Gelfoam® squares were then incubated at 37ºC / 5% CO2.  Two sponges were cultured 
for 7 days, with fresh OSC medium added on alternate days so that the surface level 
of the medium was maintained just below the top surface of the Gelfoam®.  These 
pieces were then fixed in 4% NBF for 24 hours.  Three sponges were utilised in cell 
delivery experiments after only 24 hours of culture. 
 
7.2.3 Cell delivery experiment 
Cryopreserved bovine ovarian cortical pieces were removed from liquid nitrogen 
storage and thawed as per section 2.2.2.  The pieces were cultured in McCoy’s 5A 
medium with supplements (see section 5.2.1.1) in 24 well plates at 37ºC / 5% CO2 for 
24 hours prior to use.  The following day, the pieces were removed from culture and 
placed in a glass Petri dish in a laminar flow hood.  One piece was placed on a sterilised 
stainless steel acupuncture needle with fine forceps.  A seeded Gelfoam® square was 
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then placed on the needle, before a second ovarian cortical piece was threaded onto 
the needle, thus “sandwiching” the Gelfoam® square (Fig. 7.1).  The cortical pieces 
were placed on the needle so that the OSE was on the outside of the “sandwich”, thus 
ensuring the Gelfoam® was in contact with the cut edges of the innermost cortex.  The 
needle was trimmed with sterile scissors and the “sandwich” was placed with the 
needle orientated vertically in one well of a 24 well plate containing fresh OSC culture 
medium, then incubated at 37ºC / 5% CO2 for 7 days before being fixed in 4% NBF 
for 24 hours. 
 
 
Figure 7.1.  Schematic of the ovarian cortex/Gelfoam® “sandwich” utilised in the 
cell delivery experiments. 
 
7.2.4 Haematoxylin and eosin staining 
Fixed cell-seeded Gelfoam® and cortex/Gelfoam® “sandwiches” were embedded at 
SuRF and serial sectioned as per section 2.6.1.  Haematoxylin and eosin staining was 
then performed as per sections 2.6.2 and 2.6.3.  Slides were analysed and images were 
acquired as detailed in section 2.8.1. 
 
7.2.5 Immunofluorescence 
Every 3rd slide of cell-seeded Gelfoam® and cortex/Gelfoam® “sandwiches” was 
analysed by IF for the presence of rhodamine-labelled cells.  Slides were dewaxed and 
rehydrated as per section 2.6.2, counterstained with DAPI (1:1000, diluted in PBS) 
and mounted with PermaFluorTM as per section 5.2.2.4.  Slides were analysed and 
images were acquired as per section 2.8.2.  For negative controls, non-seeded 
Gelfoam® or a “sandwich” containing Gelfoam® seeded with non-rhodamine labelled 
cells was utilised. 
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7.3 Results 
7.3.1 Cell seeding of Gelfoam® 
Putative bovine OSCs were labelled with rhodamine-conjugated dextrans (Fig. 7.2) 
and seeded into Gelfoam® squares (Fig. 7.3(a)).  Cells could not be detected by 
haematoxylin and eosin staining alone (Fig. 7.3(b)), but were detectable by IF, with 




Figure 7.2.  Putative bovine cells were fluorescently labelled with rhodamine-
conjugated dextrans prior to seeding on Gelfoam®.  (A) Rhodamine-labelled cells, 
adherent to the plate, were clearly visible after dextrans exposure. The white circular 
cells visible were non-adherent and non-viable.  (B) Non-labelled cells were used as a 
negative control.  Scale bar = 50µm. 
 
 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 





Figure 7.3.  Putative OSC-seeded Gelfoam®. (A) Appearance of cell-seeded 
Gelfoam® within OSC culture medium after 7 days of culture in a 24 well plate.  Prior 
to being placed in the medium, the Gelfoam® was sponge-like with a porous structure; 
once equilibrated in medium, it became more gelatinous in nature.  (B) Haematoxylin 
and eosin staining demonstrates the structure of Gelfoam® but putative OSCs were 
not detectable.  Scale bar = 100µm. 
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Figure 7.4.  IF images of putative OSC-seeded Gelfoam®.  (A) Cells were visible 
within the matrix, either by the presence of nuclei stained with DAPI, or rhodamine 
fluorescence.  Not all cells were rhodamine-positive.  Scale bar = 50µm.  (B) An 
enlarged image of a rhodamine-positive cell demonstrating typical punctate 
cytoplasmic expression.  Scale bar = 20µm.  (C) Non-seeded Gelfoam® was used as 
a negative control.  Scale bar = 50µm.    
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7.3.2 Gelfoam® as a cell delivery system 
Ovarian cortex/Gelfoam® “sandwiches” were constructed (Fig. 7.5), which allowed 
close contact between the raw surface of the cortex and the seeded Gelfoam®.    
 
 
Figure 7.5.  Images of the bovine ovarian cortex/Gelfoam® “sandwich”.  (A) The 
pieces of cortex and cell-seeded Gelfoam® were threaded onto an acupuncture needle.  
(B) The acupuncture needle was then trimmed and the “sandwich” orientated so that 
the needle was vertical.  Black arrows = ovarian cortex, white arrow = Gelfoam®.  (C)  
The orientation of the “sandwich” within a well of a 24 well plate. 
 
Haematoxylin and eosin staining allowed the histological structure of the “sandwich” 
to be visualised (Fig. 7.6).  Unhealthy, immature follicles were visible in the cortex, 
as assessed by morphology, with oocytes demonstrating poor association with 
surrounding pyknotic granulosa cells.  IF revealed that rhodamine-labelled cells were 
detectable in the Gelfoam®, including at the cortex/Gelfoam® interface, but none 
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Figure 7.7.  IF images of ovarian cortex/Gelfoam® “sandwiches”.  (A – C) 
Rhodamine-positive cells (white arrows) were observed within the Gelfoam®, 
including at the cortical/Gelfoam® interface; however, no rhodamine-positive cells 
were seen within the cortex.  (D) A “sandwich” with non-rhodamine cells was used as 
a negative control.  Cells are visible in the Gelfoam®, as detected by their nuclei (black 
arrows).  Scale bars = 100µm (A), 20µm (B) and 50µm (C, D). 
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7.4 Discussion 
7.4.1 The use of Gelfoam® as a cell scaffold 
The results of these preliminary investigations into the use of Gelfoam® as an OSC 
delivery strategy demonstrate that putative bovine OSCs can be retained within the 
sponge for at least 7 days, being easily detectable by DAPI staining and rhodamine 
fluorescence.  A study utilising ASCs demonstrated that the cells remained viable 
throughout a similar in vitro culture period of 5 days (Damous et al., 2015).  For the 
cell delivery experiments, the Gelfoam® was only seeded overnight, in an attempt to 
ensure adequate cell attachment to the matrix but avoid excessive cell loss through the 
porous structure that was hypothesised may happen during a longer seeding time 
period.  This is in keeping with the short time frames of other studies: Damous et al. 
only seeded the Gelfoam® with ASCs for 10 mins prior to grafting (Damous et al., 
2015), whilst Lee et al. seeded and grafted the Gelfoam® on the same day (Lee et al., 
2011).  In contrast, cardiomyocytes were seeded onto the scaffold for 1 to 3 weeks to 
allow intra-matrix in vitro expansion prior to engraftment (Sakai et al., 2001).  Given 
the paucity of published research on the use of Gelfoam® for cell delivery, it is perhaps 
unsurprising that a standardised protocol for its use is not available.   
Our experiments focused on in vitro assessment of cell delivery as neither 
allotransplantation or xenografting of the putative OSC-seeded Gelfoam® was 
feasible due to lack of access to the required animals.  Due to its structure, it would be 
technically challenging to make the Gelfoam® pieces small enough to place into 
mouse ovaries, whilst still being large enough to allow cell seeding.  Therefore, a larger 
animal, such as the cow or, perhaps more accessible, sheep, would be necessary.  To 
our knowledge, all studies reporting the use of Gelfoam® as a cell delivery strategy 
have used in vivo approaches to date: bone marrow MSC/Gelfoam® constructs did 
produce cartilage-like ECM in vitro, however, cell delivery to tissue was only 
performed in vivo (Ponticiello et al., 2000).  The “sandwich” structure used in our 
experiments was devised in an attempt to (a) expose as much of the surface area of the 
Gelfoam® to ovarian cortex as possible and (b) apply light pressure on the Gelfoam® 
to encourage absorption, or liquefaction.  The cut edge of the ovarian cortex was 
chosen to be located next to the Gelfoam®, as it was hypothesised that this would more 
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likely enable invasion of the putative OSCs than the intact OSE.  Furthermore, the 
innermost cortex/medullary region would be the intended location of the scaffold in 
vivo if it was to be used clinically.  The “sandwich” was orientated so that the 
acupuncture needle was vertical, so that any effect of gravity on the putative bovine 
OSCs led to the cells coming into contact with cortex and not the culture medium.   
It was only possible to culture the structures for 1 week: for ease of handling, the 
cortical pieces were larger than would normally be cultured in vitro (Telfer et al., 2008, 
McLaughlin and Telfer, 2010) and follicular health was noted to be poor after this time 
period, indicating that in vitro culture was not fully maintaining the viability of the 
tissue.  However, the freeze-thaw process may have contributed to this detrimental 
effect on follicle viability.  It may be that this short culture period, and the lack of a 
vascular surface, was the reason why the Gelfoam® did not liquefy or was not 
absorbed by the tissue.   
With regards the biomaterial used in these experiments, several different materials 
have been used as scaffolds to create artificial ovaries to date, as discussed in section 
7.1.  Gelatin, the principal constituent of Gelfoam®, has already been utilised 
successfully in the form of a 3D printed, porous, cross-linked structure, with livebirths 
produced when the structure, seeded with isolated murine follicles and ovarian cells, 
was autografted into recipient mice (Laronda et al., 2016).  The authors postulate that 
this structure, which is similar in characteristics to that of Gelfoam®, is important to 
optimise handling and allow follicle growth, ovulation and vascularisation of the 
scaffold (Laronda et al., 2016).  Indeed, no angiogenic factors were required in 
Laronda et al.’s study for live pups to be produced, in contrast to fibrin, which has 
been reported to require the addition of VEGF in order to achieve livebirths (Kniazeva 
et al., 2015, Laronda et al., 2016).  This recent study therefore supports the use of 
gelatin-based scaffolds, such as Gelfoam®, for the purpose of cell delivery and 
folliculogenesis. 
In contrast to the in vitro approach used in experiments detailed in this Chapter, the 
artificial ovary research reporting follicular growth and livebirths has thus far involved 
in vivo approaches (Luyckx et al., 2014, Vanacker et al., 2014, Kniazeva et al., 2015, 
Laronda et al., 2015, Chiti et al., 2016, Laronda et al., 2016).  Furthermore, the 
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scaffolds were seeded with both follicles and additional somatic cells, thus providing 
the theca and stromal cells required for structural and endocrine support of the 
developing follicle.  Thus, important further investigations would involve 1) auto- or 
xenografting of putative OSC-seeded Gelfoam® into sterilised or oophorectomised 
cows or sheep, with subsequent analysis for evidence of neo-folliculogenesis, and 2) 
seeding of Gelfoam® with both putative OSCs and ovarian somatic cells of the same 
species, to assess whether this allows new follicles to form within the scaffold itself.  
 
7.4.2 Summary 
Overall, Gelfoam® has shown promise as a scaffold for the retention of putative 
bovine OSCs; however, while rhodamine-labelled putative bovine OSCs could be 
identified within the Gelfoam®, including at the interface between the cortex and 
scaffold, no labelled cells were detected in the cortex. It has thus not been shown that 
Gelfoam® can efficiently deliver putative OSCs into tissue.  Yet, these are preliminary 
results: further optimisation of the cell delivery strategy is required to assess whether 
it can efficiently deliver cells into the ovarian cortex.  Future experiments should focus 
on in vivo strategies, as exposure to the physiological ovarian environment and 
vascular surfaces may be critical to improving cell delivery, and on co-seeding with 
ovarian somatic cells to ascertain whether the scaffold can support neo-
folliculogenesis.  Lastly, trialing of other types of cell scaffolds may also be of value, 
given the success of biomaterials such as fibrin, alginate and decellularised ovaries in 
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8.1  Introduction 
The overall aim of the research detailed in this thesis was to investigate the existence 
of OSCs within adult bovine and human ovarian cortex.  This was, and indeed remains, 
a very novel and controversial field as little research into these cells existed at the time 
of commencing this body of work: indeed, only four groups had reportedly isolated 
the cells in only two species, mice and humans (Zou et al., 2009, Pacchiarotti et al., 
2010, Zou et al., 2011, Hu et al., 2012, White et al., 2012).  Since then, OSCs have 
been reported in rats, pigs and rhesus macaque monkeys (Wolff et al., 2013, Bui et al., 
2014, Wolff et al., 2014, Zhou et al., 2014, Hernandez et al., 2015, Wolff, 2016); 
however, this thesis is the first to describe putative OSCs in the cow and substantiates 
only two previous reports of human OSCs (White et al., 2012, Hernandez et al., 2015).  
The experiments undertaken thus add to the growing body of evidence that has 
demonstrated a population of cells exists within adult mammalian ovaries which 
exhibit features of both stem cells and germ cells (Zou et al., 2009, Zou et al., 2011, 
Pacchiarotti et al., 2010, Hu et al., 2012, White et al., 2012, Wolff et al., 2013, Bui et 
al., 2014, Wolff et al., 2014, Zhou et al., 2014, Hernandez et al., 2015, Xiong et al., 
2015, Lu et al., 2016, Wolff, 2016).   
 
8.1.1 Putative OSC isolation 
The investigations described in Chapter 3 demonstrated that a small number of DDX4-
positive cells could be isolated from both species by a previously reported 
methodological approach (White et al., 2012, Woods and Tilly, 2013).  These cells, 
which were demonstrated by molecular characterisation to be distinct from oocytes, 
could be classified into two groups by cell size, with the smaller cells (Population A) 
being greater in number than the larger cells (Population B).  The existence of two 
populations has not been described in the literature previously, except in pigs, where 
unsorted ovarian cells were analysed.  However, given that other groups have reported 
ranges in cell size (Zou et al., 2009, Pacchiarotti et al., 2010, Zou et al., 2011, White 
et al., 2012), it may be that more than one cell population was present in these studies, 
but not detected.  Examination of all the literature published to date on OSCs derived 
from adult ovarian cortex reveals differences, as well as similarities, between cell 
prevalence and non-molecular characteristics (Table 8.1).  This supports the 
hypothesis that heterogeneous populations of cells are being isolated, both between 
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different groups of investigators as well as probably within different experimental 
approaches. 
Heterogeneity of the cell type, coupled with methodological variations, may explain 
why some investigators (Zhang et al., 2015, Zarate-Garcia et al., 2016) have been 
unable to isolate or culture these cells, despite using the same isolation methodology 
as White et al. (White et al., 2012): perhaps they are not isolating the same population 
as those who have reported cells with neo-oogenesis capabilities.  A report on a 
collaboration between two groups utilising FACS to study human breast cells 
describes how, after meticulous investigation into the inability of one group to 
reproduce the other’s data, it was discovered that the critical methodological variation 
accounting for the lack of reproducibility was the speed and length of agitation for 
tissue dissociation (Hines et al., 2014).  Similarly, it took our group several months to 
optimise White et al.’s isolation technique with small changes in tissue dissociation 
and gating strategies essential for successful detection of the desired cell population.  
Therefore, even seemingly small alterations in technique may have a great impact on 
the findings.  Furthermore, recent unpublished work from Prof. Telfer’s group suggests 
that careful examination of human DDX4-positive cells, isolated with the modified 
disaggregation protocol, reveals three discrete populations, of differing cell sizes and 
levels of DDX4 expression.  Work is ongoing to elucidate the differences between the 
populations; however, it appears that one of the ways in which the populations can be 
differentiated is by their expression of different splice variants of DDX4.  Analysis in 
several species including buffalo (Bubalus bubalis; Kaushik et al., 2015), cattle (Bos 
taurus; Luo et al., 2013), the tammar wallaby (a marsupial) and the platypus (Hickford 
et al., 2011) has previously revealed that several splice variants of DDX4 mRNA exist, 
some of which appear to be conserved in the mouse, at least in silico (Hickford et al., 
2011).  If OSCs express such splice variants, it may account for the lack of DDX4 
expression reported by some groups (Hernandez et al., 2015, Zhang et al., 2015, 
Zarate-Garcia et al., 2016), as the primers utilised by the authors may not be specific 
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Another methodological aspect that could account for differences in results is the use 
of a polyclonal anti-DDX4 antibody.  The controversy surrounding the use of DDX4 
for OSC isolation has already been discussed in Chapter 1, with the specificity of the 
antibody used by our group being questioned subsequent to its apparently successful 
use in the experiments in this thesis (Hernandez et al., 2015, Zhang et al., 2015, Zarate-
Garcia et al., 2016).  Perhaps less contentiously, isolation has also been performed 
using a more specific monoclonal anti-DDX4 antibody (Fakih et al., 2015) and an 
alternate marker, IFITM3, which is known to contain an external epitope (Zou et al., 
2011, Zhou et al., 2014, Xiong et al., 2015, Lu et al., 2016).  However, recently, there 
have been calls to abandon the use of polyclonal and even current monoclonal 
antibodies in favour of standardised, sequenced recombinant antibodies due to the 
inherit variabilities of the former, resulting in difficulties with experimental 
reproducibility (Bradbury and Pluckthun, 2015).  Furthermore, questions have been 
raised very recently regarding the use of IFITM3, as it has been reported to be more 
widely expressed within the mouse ovary than previously thought, indicating it is may 
be not be germ cell-specific (Zarate-Garcia et al., 2016).  An alternative, less 
controversial, marker for cell sorting is now necessary if one of the criticisms regarding 
the existence of OSCs is to be answered.  C-KIT is a cell-surface receptor and thus a 
potential candidate (Saiti and Lacham-Kaplan, 2007) as it is expressed by human 
primordial germ cells both during migration to the gonadal ridge and during 
proliferation thereafter (Robinson et al., 2001, Hoyer et al., 2005).  However its lack 
of germ cell specificity (Besmer et al., 1993) means it is not an ideal choice.  Moreover, 
the putative bovine OSCs only acquired detectable levels of C-KIT during in vitro 
culture.  Detailed molecular characterisation of OSCs may provide an alternative 
option. 
 
8.1.2 Putative OSC characterisation      
Chapter 4 described the molecular signature of the isolated cells.  Bovine and human 
cells exhibited molecular features of both stem cells and germ cells at the mRNA and 
protein level, indicating that they were putative OSCs.  The characterisation described 
is one of the most comprehensive in the published literature and, in the case of the 
bovine experiments, included analysis of both freshly isolated and cultured cells, 
which has rarely been reported (White et al., 2012, Hernandez et al., 2015).  This 
analysis provided confirmation that DDX4 was present in the freshly isolated cells at 
Isolation, Characterisation and In Vitro Potential of Oogonial Stem Cells 
General Discussion 289 
both the mRNA and protein level.  The overall molecular signature generally 
corroborated the findings of previous OSC research (Tables 8.2 and 8.3), with the 
exception of NANOG, C-KIT (both not detected by Wu’s group in rodents (Zou et al., 
2009, Zhou et al., 2014)), DPPA3 (not detected in this research in bovine cells) and 
DDX4 (not detected by Hernandez et al. (Hernandez et al., 2015) and inconsistently 
detected in our experiments).  Although lack of expression of these markers may be 
genuine findings, it has been suggested that failure to detect mRNA expression may 
be due to technical issues (Woods and Tilly, 2013).  Certainly, Chapter 4 describes 
difficulties in detecting DDX4/DDX4, with alterations in isolation and molecular 
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Differences in OSC marker detection between studies may also be a result of in vitro 
transformation.  Characterisation of putative bovine and human OSCs demonstrated 
that this phenomenon might be occurring, with acquisition of C-KIT expression 
(bovine cells) and variable expression of DDX4 (both species).  Therefore, the time 
points at which cells were analysed by other groups may have contributed to failure in 
the detection of some markers.  Moreover, murine research that recently provided 
evidence of a physiological role for OSCs, has reported the in vivo transformation that 
the cells undergo: a small number of Pou5f1-positive, mitotic “germ stem cells” 
exhibited successive loss of Pou5F1, acquisition of Dazl and finally acquisition of 
Ddx4, and apparently entered meiosis, with Stra8 and Sycp3 expression detected (Guo 




Figure 8.1.  Schematic of the results reported by Guo et al. (Guo et al., 2016).  A 
population of Pou5f1-positive “germ stem cells” was discovered at the ovarian surface 
epithelium (OSE) of juvenile mouse ovaries, which appeared to proliferate.  Some of 
the daughter cells were reported to enter a developmental pathway, with successive 
acquisition of Dazl and Ddx4 and loss of Pou5f1, during which time the cells increased 
in size.  These cells were purported to initiate meiosis and subsequently undergo 
follicle formation, with replenishment of the ovarian reserve. Adapted from Anderson 
and Telfer, 2016. 
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This developmental pathway has similarities to that seen in PGCs within the 
mammalian fetal ovary.  For example, in mice, Pou5f1 expression in PGCs precedes 
and overlaps with Dazl and Ddx4 expression, with pre-migratory and migratory PGCs 
expressing Pou5f1 but lacking Dazl and Ddx4 (Saiti and Lacham-Kaplan, 2007).  It is 
only after migration to the genital ridges has been completed that PGCs begin to 
express Dazl and Ddx4 and Pou5f1 expression starts to decline (Saiti and Lacham-
Kaplan, 2007).   
This research not only provides new evidence that OSCs may have a physiological 
role in replenishing the ovarian reserve, at least in mice, it also offers a possible 
explanation for the heterogeneity of the reported OSCs, both in terms of cell size and 
molecular characterisation.  For example, OSCs isolated by Pou5f1 expression 
(Pacchiarotti et al., 2010) were slightly smaller than some cells isolated by 
Ddx4/DDX4 (Zou et al., 2009, Zou et al., 2011, and results from this thesis), which 
would fit with Guo et al.’s findings (Guo et al., 2016). Furthermore, it may be that 
isolation of putative OSCs by DDX4 is targeting a population of cells further along 
the developmental programme and thus they may have lost, or gained, expression of 
markers compared with cells earlier in the pathway, and their characteristics may 
change further in culture.  They also may have lost some of their stem cell features, 
such as immortal self-renewal. 
In addition to in vitro transformation, there was evidence in our research that 
spontaneous in vitro differentiation into oocytes may be occurring, with acquisition of 
mRNA of oocyte-specific markers (NOBOX in bovine cells and GDF-9 in human 
cells) and detection, rarely, of OLCs as assessed by morphology.  Yet, characterisation 
did not verify that they were genuine oocytes and therefore expression of oocyte-
specific markers was likely occurring in the adherent cells, rather than the non-
adherent OLCs.  However, acquisition of oocyte markers is not proof that oogenesis 
is occurring, therefore the functional capabilities of the cells necessitated investigation.    
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8.1.3 The functional capabilities of putative OSCs 
The in vitro potential of putative bovine and human OSCs was examined in Chapters 
5 and 6.  In Chapter 5, the incorporation of the cells into two distinct in vitro culture 
systems was explored with the aim of observing neo-oogenesis.  Injection of putative 
bovine and human OSCs into adult ovarian cortex and re-aggregation of the cells with 
fetal ovarian somatic cells was performed, with subsequent histological analysis.  
Although human cells were observed, rarely, in close association with somatic cells, 
with some in primordial follicle-like structures, no definite proof of neo-oogenesis was 
evident.  The published literature on OSCs has described differing functional endpoints 
with regards oocyte formation.  Table 8.4 places the experimental findings of this 
research in the context of the wider OSC literature.  In vitro approaches have evidently 
not been as successful as in vivo strategies, with no development past the formation of 
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Table 8.4.  Summary table comparing the oogenesis potential of putative OSCs in 
this thesis with that of the findings of all other published reports of adult OSCs. 
 
Given that many aspects of PGC development remain unexplored, it is reasonable to 
assume that the in vivo milieu better provides for the requirements of OSCs than the 
Group Species Culture Strategy Functional endpoint 
Zou et al., 2009 Mouse In vivo Live offspring 
Pacchiarotti et al., 
2010 
Mouse In vitro 
OLCS and follicle-
like structures 
Zou et al.,  2011 Mouse In vivo Not stated 
Hu et al., 2012 Mouse In vitro OLCs 
White et al., 2012 
Mouse In vivo Hatching blastocysts 
Human In vivo Immature follicles 








In vivo Embryos 
Zhou et al., 2014 Rat In vivo Live offspring 
Bui et al., 2014 Pig In vitro OLCs 
Hernandez et al., 
2015 
Mouse In vitro 





OLCs by morphology 
only 
Human In vitro 
OLCs by morphology 
only 
Xiong et al., 2015 Mouse In vivo Live offspring 
Lu et al., 2016 Mouse In vivo Live offspring 
This Thesis 
Cow In vitro 
OLCs by morphology 
only 
Human In vitro 
OLCs and follicle-like 
structures by 
morphology only 
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in vitro environment.  As such, in vivo approaches for putative bovine OSC culture are 
currently being undertaken by a fellow PhD student in Prof. Anderson’s and Prof. 
Telfer’s groups in order to examine their oogenesis potential further.  The use of 
Gelfoam® as a cell scaffold, as described in Chapter 7, may provide a novel in vivo 
strategy for the investigation of OSC potential.   
In Chapter 6, the potential of putative bovine and human OSCs as a germ cell model 
was investigated, by analysing their response to two key regulators of PGC 
development, BMP4 and RA.  Despite the lack of conclusive evidence that neo-
oogenesis was occurring in vitro, the investigations indicated that bovine and human 
cells were behaving as bona fide OSCs would be expected to in response to these 
regulators.  The molecular responses mimicked those of PGCs, with evidence of 
upregulation of a critical meiotic entry gene, SYCP3, in response to BMP4 and RA.  
This was similar to the findings of the only other published report on OSCs and BMP4 
treatment, which utilised mouse OSCs (Park et al., 2013).  These were preliminary 
experiments to explore the potential of the cells to act as germ cell models; however, 
the findings suggested that the bovine cells at least, may be a promising in vitro 
approach to exploring the intricate complexities of the PGC developmental 
programme.   
 
8.2 Novel aspects of the research 
The principle novel finding of the research detailed in this thesis was the discovery of 
putative OSCs in the cow.  Although OSCs have now been reported in pigs (Bui et al., 
2014) and rhesus macaque monkeys (Wolff et al., 2013, Wolff et al., 2014, Wolff, 
2016), at the time of the isolation and initial characterisation of the bovine cells, OSCs 
had not been reported in any large animal model.  As already discussed in Chapter 3, 
the similarities between bovine and human follicular development have led to a large 
body of work exploring the cow as an important model for human ovarian 
development, and as such, with the exception of monkey OSCs, bovine OSCs are 
probably the most valuable type of OSCs yet reported, with respect to translation to 
humans.  An additional novel aspect, with regards cell isolation, was the isolation of 
two different DDX4-positive populations from adult ovarian cortex.  Two discrete 
populations of OSCs have been described previously in pigs; however, a purified, 
sorted population was not analysed in this study (Bui et al., 2014).  Although not novel, 
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the isolation of putative human OSCs had only been reported once when the research 
contained within this thesis began (White et al., 2012) and was not confirmed by others 
until recently (Hernandez et al., 2015).  Even then, Hernandez et al.’s findings 
(Hernandez et al., 2015) were not entirely consistent with White et al.’s results (White 
et al., 2012), with the former group unable to demonstrate DDX4 expression at either 
the mRNA or protein level.  The research in this thesis provides data in the middle 
ground of these two papers: DDX4/DDX4 expression could be detected in the cells 
isolated in this thesis, however, its expression was not consistent.  As discussed in 
section 1.2.5.3, reproducibility of data is critical in science and, therefore, although 
our human findings were not novel, they still demonstrate an important development 
in the OSC field.    
With respect to another aspect of cell characterisation, Western blotting was utilised 
for the first time to our knowledge to demonstrate expression of germline markers, 
providing additional confirmation of the ICC findings that the cells express these 
proteins.  DDX4 analysis of OSCs by immunoblotting has been reported once before; 
however, no protein was detected in that study (Hernandez et al., 2015).  A feature of 
the research that was novel at the time of the experiments was the use of lentiviruses 
for transduction.  Lentiviral transduction of OSCs for the purposes of fluorescent 
labelling has since been published by other groups (Wolff et al., 2013, Wolff et al., 
2014, Xiong et al., 2015, Lu et al., 2016), although none of these studies reported a 
detrimental effect on cell viability. 
During the investigation of the in vitro potential of the putative bovine and human 
OSCs, two novel approaches to in vitro OSC culture were devised, by adapting cortical 
injection and re-aggregated ovary strategies that had been shown to be successful in 
vivo (Eppig and Wigglesworth, 2000, White et al., 2012).  Moreover, for the first time, 
RA-responsiveness and the effect of overexpression of a gene related to meiosis (i.e. 
DAZL) on putative OSCs was investigated.  Finally, a novel OSC delivery system, 
using a Gelfoam® cell scaffold, was explored: future studies regarding this 
preliminary study will be discussed in section 8.5.  
 
8.3 Limitations of the research 
Clearly, the fact that our investigations have not been able to prove definitively the 
ability of the isolated cells to generate new oocytes is the principal limitation of the 
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research presented within this thesis, and means that the cells can only be termed 
putative OSCs.  The cells could perhaps be another type of ovarian stem cell that is 
permissive and can be reprogrammed to behave like an OSC under the right in vitro 
conditions, although freshly isolated putative bovine OSCs also expressed stem cell 
and germline markers, supporting the hypothesis that the isolated cells were OSCs.  
However, evidence suggestive of in vitro transformation is a limitation to the use of 
the cells in clinical and basic science applications as it indicates that the long-term 
expansion of the cells may not be possible without an effect on germline function.  
This could have an impact on their clinical use, as freshly isolated cells may have to 
be utilised for the generation of new oocytes, which will greatly restrict the number of 
cells available to a patient.  It also affects their use as a germ cell model as in vitro 
transformation may result in a heterogeneous population with differing responses to 
signals which do not mimic that of germ cells.  Additionally, with regards clinical use, 
the retrieval of cells may not be possible in all women as our studies showed that the 
isolated cells of three of the eight women did not establish in culture. Although that 
may reflect the limitations of the current isolation and culture methods, as low numbers 
of cells were isolated in these experiments due to high levels of cell death, it may be 
that OSCs are not a viable fertility preservation option for all women.   
In terms of the germ cell model experiments described in Chapter 6, the induction of 
genes involved in meiotic initiation by BMP4 and RA treatment was detected; 
however, the studies met none of the standards proposed by Handel et al. for the 
evaluation of meiosis in in vitro-derived germ cells (Handel et al., 2014).  The authors 
recommended that in order to confirm in vitro oogenesis, the following benchmarks 
had to be met:  
1) Verification of DNA content from the pre-meiotic stage until after the second 
meiotic division, with the correct content observed at each critical stage. 
2) Evaluation of chromosome counts and correct organisation on the spindle, 
particularly in MII oocytes and early embryos. 
3) Evidence of chromosomal recombination. 
4) Ultimately, generation of live, euploid offspring (Handel et al., 2014). 
Although ICC demonstrated the expression of SYCP3 protein within the nuclei of the 
treated cells, chromosomal spreads were not performed to assess chromosomal 
recombination.  Therefore, the results presented in this thesis appear to indicate 
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induction of meiosis, or at least some aspects of it, but have not provided gold standard 
proof. 
Many of the experiments described would have benefitted from a greater number of 
replicates to increase reliability; however, tissue and cell availability and time 
constraints were limiting factors in this regard.  Bovine tissue is more freely available 
than human tissue, yet, it is still limited in supply, preventing more large-scale 
investigations.  This was especially true in the studies characterising freshly isolated 
cells: this could not be performed in humans due to lack of tissue and was limited in 
bovine due to the amount of tissue required per experiment.  Due to time limitations, 
several investigations could not be pursued further, including isolation of cells using 
IFITM3 as an alternative marker, optimisation of the in vitro culture system for 
aggregated “ovaries”, further exploration of meiotic entry in BMP4 and RA treated 
cells and development of the Gelfoam® cell scaffold studies.   With regards the 
aggregated “ovary” experiments, it may be that longer in vitro culture periods are 
required for confirmed neo-oogenesis to occur; however, given the extent of cell death 
detected within 1 – 2 weeks of culture, improvements in the culture system are 
imperative to support cell viability for more extended time periods.  Future work, 
discussed in section 8.5, will hopefully address many of the issues discussed in this 
section. 
   
8.4 Applications of OSCs  
Despite the controversies, the discovery of putative OSCs has elicited much discussion 
and interest amongst reproductive biologists, as not only has it led to the questioning 
of a longstanding dogma, but the applications of the cells, in basic science, agricultural 
and clinical fields are potentially cutting-edge.  
8.4.1 Basic science applications 
In addition to their putative role as an in vitro model for germ cell development, 
discussed in Chapter 6, OSCs are already being utilised to create transgenic rodents 
(Zhang et al., 2011, Zhou et al., 2014).  The use of transgenic animal models is a well-
established, valuable tool in basic science to allow investigation of gene function.  
Several different techniques for generating transgenic animals, with varying degrees 
of efficiency and cost, have been developed over the last few decades, including, but 
not restricted to, microinjection of DNA fragments into the pronucleus of a one-cell 
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embryo, use of viral vectors to introduce desired DNA into a nucleus and sophisticated, 
inducible Cre-LoxP systems which integrate DNA into a cell’s genome and can cause 
conditional gene knock-outs (Houdebine, 2007).  OSCs provide an effective, novel 
technique of generating transgenic animals with putative murine OSCs already 
reported to produce transgenic mice and rats, via a rapid and inexpensive approach 
(Zhang et al., 2011, Zhou et al., 2014).  Three methods have been utilised thus far: 
retrovirus transduction, lentivirus transduction and liposome-mediated transfection 
(Zhang et al., 2011, Zhou et al., 2014).   
Recombinant retroviruses and lentiviruses have been utilised to create transgenic GFP-
expressing OSCs by several groups and, in some cases, when transplanted into sterile 
mice which were mated with wild-type males, these OSCs have generated 
heterozygous GFP-expressing offspring which can pass their transgene onto the next 
generation (Zou et al., 2009, Zhang et al., 2011, White et al., 2012, Wolff et al., 2013, 
Wolff et al., 2014, Wolff, 2016).  However, retrovirus-mediated transduction of OSCs 
has also generated transgenic mice which can overexpress the Oocyte-G1 and dynein 
axonemal intermediate chain 2 (Dnaic2) genes with high efficiency (Zhang et al., 
2011).  The function of these genes is poorly understood, therefore analysis of the 
transgenic mice allowed possible roles to be hypothesised, with mice overexpressing 
Dnaic2 demonstrating a subfertile (female) or sterile (male) phenotype.  In the same 
study, liposomal transfection was performed to create knockdown mice by introducing 
a short hairpin RNA (shRNA) into the OSC genome to “silence” the expression of 
Oocyte-G1.  Again, analysis of the transgenic offspring allowed theories regarding the 
function of the gene to be postulated, with mice demonstrating gonadal and brain 
abnormalities (Zhang et al., 2011).  
Rats OSCs have also been genetically manipulated to produce transgenic offspring in 
an efficient manner.  Liposome-mediated transfection resulted in expression of both 
GFP and the fat-1 gene and in the case of fat-1, after transplantation into infertile rats 
and mating with wild-type males, 28% of the offspring were heterozygous for the gene 
(Zhou et al., 2014).  These offspring were generated in 2 months, were healthy and 
demonstrated the phenotype expected of a fat-1 overexpressing animal (i.e. higher 
levels of n-3 fatty acids compared to wild-type mice).  Thus, OSCs have already been 
demonstrated to be an efficient approach to producing transgenic animals which could 
prove extremely useful in basic science research. 
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Finally, Wu’s group have demonstrated that pre-pubertal mouse OSCs can be 
dedifferentiated into embryonic stem-like cells (ESLCs) under certain in vitro culture 
conditions (Wang et al., 2014).  ESLCs were shown to be pluripotent during in vitro 
characterisation and they formed teratomas in vivo, unlike OSCs.  When GFP-
expressing ESLCs were injected into wild-type blastocysts, the resultant fetuses 
contained GFP-positive cells in organs derived from all three germ layers, including 
heart, muscle and testes.  Such findings will be important in elucidating further the 
processes involved in in vitro stem cell reprogramming and, indeed, may have 
potential in regenerative medicine applications (Wang et al., 2014). 
8.4.2 Agricultural applications 
Cattle are an extremely valuable species in agriculture for meat and dairy production: 
the Department for Environment, Food and Rural Affairs (Defra) reported that the 
cattle population in the UK in 2015 rose to 9.9 million, with an economic value of 
£2,739 million (Defra, 2016).  Globally, bovine embryos are produced in vitro in large 
quantities in order to enhance breeding for desired characteristics (Hall et al., 2013).  
Bovine IVF allows the embryos of genetically valuable heifers and bulls to be 
implanted into several less valuable surrogate heifers and can result in a prized heifer 
producing many offspring in one year.  Cloning is also a well-established technique 
by which genetically modified cattle can be produced in order that preferred genetic 
characteristics are propagated (Cibelli et al., 1998).  OSCs may have a valuable role 
in agricultural applications as cells from a genetically superior heifer could be used as 
a source of oocytes for bovine IVF.  Secondly, transgenic bovine OSCs could be used 
to generate genetically modified cattle that may have both agricultural and basic 
science (see section 8.4.1) applications. 
Another theoretical role for OSCs in both agriculture and the wider animal kingdom, 
could be in species conservation.  Cloning has already been used to save an endangered 
species of cow (the Enderby Island cow; Wells et al., 1998)) and a species of wild 
sheep (Ovis orientalis musimon; Loi et al., 2001)) from extinction, and it is hoped it 
could even be used to resurrect extinct species, such as the mammoth (Stone, 1999).  
Again, OSCs from the ovaries of endangered (or indeed, preserved extinct) animals 
may be theoretically utilised to create oocytes or provide the genetic material required 
for nuclear transfer into the enucleated oocyte of a genetically similar animal. 
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8.4.3 Clinical applications  
Currently, there are three possible fertility preservation options for post-pubertal girls 
and women who know they are at risk of POI: 1) oocyte cryopreservation after ovarian 
stimulation, 2) embryo cryopreservation after ovarian stimulation and in vitro 
fertilisation (IVF) with their partner’s sperm, and 3) ovarian cortex cryopreservation 
with re-implantation of the thawed tissue after the patient is disease-free.  The last 
approach is the only available strategy for pre-pubertal girls (Wallace et al., 2005, 
Anderson and Wallace, 2011) and women who cannot afford the delay in life-saving 
treatment that ovarian stimulation would inevitably cause.  Unfortunately, none of the 
current approaches result in a large number of oocytes being obtained for future use.  
In addition, although girls and women with recognised genetic causes of POI, such as 
Turner’s syndrome, may present in time for fertility preservation strategies to be 
possible, these options are often not feasible for women who experience idiopathic 
POI as they present too late.  In such cases, where there is approximately only a 5% 
chance of a spontaneous conception (Goswami and Conway, 2007), oocyte donation 
and IVF currently offer the best opportunity to conceive.  Other drawbacks include 
delays in potentially life-saving treatment (if ovarian stimulation is required) and, in 
the case of ovarian cortex cryopreservation in cancer patients, the risk of reintroducing 
malignant cells during the re-implantation of the tissue, particularly in those with 
haematological malignancies (Dolmans et al., 2010, Rosendahl et al., 2010).  OSCs 
may be able to circumvent these disadvantages and also be an additional option for 
pre-pubertal girls.   
The theoretical technique would involve removing a sample of ovarian cortex prior to 
commencing infertility-inducing treatment, isolating the OSCs and then either 
culturing and maturing the cells in vitro to generate potentially large numbers of 
oocytes which could be used in IVF, or injecting the cells back into a woman’s ovaries 
following disease remission.  As discussed in Chapter 7, intra-ovarian OSC injection 
could potentially replenish the woman’s ovarian reserve and restore endocrine 
function, at least on a temporary basis.  The success of this approach might be 
constrained by the health of the stromal cells within the ovary: these cells, which would 
be critical for neo-folliculogenesis to occur, may have been negatively affected by the 
cancer treatment and therefore may not be able to support the differentiation and 
development of OSCs.  However, if this approach worked, there would be no delay in 
commencing treatment, no risk of introducing malignant cells and the generation of 
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much larger numbers of oocytes than is currently possible.  Additionally, as 
demonstrated in this thesis and by others (White et al., 2012), the cells can be isolated 
from cryopreserved, as well as fresh tissue, meaning that cortex can be stored for a 
long time prior to OSC isolation, thus allowing advances in technologies to be occur.  
The finding that OSCs can be isolated from chemotherapy-exposed ovaries in mice, 
and used therapeutically to rescue infertility, also provides promise for those 
individuals who have already received cancer treatment (Xiong et al., 2015).  As such, 
there is no doubt that the potential of OSCs is deserving of further investigation. 
A more speculative clinical use of OSCs would be in women suffering from age-
related ovarian insufficiency, i.e. the menopause.  The current secular trend for 
delaying childbearing in the developed world is resulting in some women having to 
resort to oocyte donation or undergoing pre-emptive “social” oocyte storage in order 
to have a child.  Infertility is not the only aspect of concern, however, with the 
menopause associated with troublesome climacteric symptoms such as vasomotor 
effects (hot flushes, night sweats) and mood changes (Nelson, 2008).  As discussed in 
section 1.2.4.1., OSCs have been reportedly detected in aged mouse ovaries (Niikura 
et al., 2009), therefore, menopausal women hypothetically may possess a scarce 
population of OSCs that could be isolated from ovarian cortex biopsies.  These cells 
could then be cultured in vitro to generate oocytes for use in IVF.  The reversal of 
detrimental menopausal symptoms is perhaps more aspirational as it appears that the 
age of the surrounding stromal milieu is essential for OSCs to undergo oogenesis 
(Niikura et al., 2009); therefore merely injecting OSCs back into an aged ovarian 
environment may not reinitiate ovarian function. 
OSCs have already been used clinically in a slightly different way to aid women with 
age-related subfertility, using a procedure termed AUtologous Germline-derived 
Mitochondrial ENergy Transfer (AUGMENT) (Tilly and Sinclair, 2013).  In this 
procedure, OSCs are isolated from a woman’s ovarian biopsy and the mitochondria 
from these cells are purified before being transferred into the women’s own oocytes.  
As it is believed that oocytes from older women may be of poorer quality due to 
decreased energy availability in the form of mitochondrial-derived adenosine 
triphosphate (ATP) (Bentov et al., 2011), it is thought that transferring the purified 
OSC mitochondria into oocytes will “boost” their energy and enhance their ability to 
be fertilised and undergo healthy embryogenesis (Tilly and Sinclair, 2013).  Indeed, it 
has been demonstrated that pig oocytes with reduced levels of mitochondrial DNA 
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(mtDNA) are less developmentally competent and mitochondrial supplementation 
(isolated from MII oocytes) of such oocytes significantly improves the number of 
oocytes reaching the blastocyst stage following fertilisation (Cagnone et al., 2016).  It 
is postulated that the OSCs will have accumulated less damage to their mitochondria 
with age as they are slowly dividing cells and is reported that the mitochondria of these 
cells have greater ATP production than ESCs and other adult somatic stem cells, 
therefore justifying their use (Tilly and Sinclair, 2013).  Furthermore, it is an 
autologous treatment, therefore no DNA from other humans is required (thus avoiding 
the ethical difficulties of so-called “three parent babies”) and as mtDNA is maternally 
inherited, this means all the offspring’s mitochondria contain their mother’s DNA.  
Babies have been reportedly born following this treatment (Couzin-Frankel, 2015), 
although evidence thus far is anecdotal, and robust randomised trials will be necessary 
to prove that this is as the direct result of the OSC mitochondria transfer. 
In summary, the applied use of OSCs for oogeneic clinical purposes remains 
speculative, but the potential beneficial impact they could have in the field of 
oncofertility, and beyond, means that there is great value in investigating their 
capabilities further. 
 
8.5 Future directions  
Future work will be essential to analyse the cells’ characteristics further and assess 
their oogenesis potential.  Colleagues in Prof. Telfer’s group have already modified 
the dissociation protocol to improve cell yields, as discussed in Chapters 3 and 4, 
which is allowing further elucidation of the DDX4 expression of the freshly isolated 
cells.  It may also enable the discovery of a novel, specific OSC marker which would 
be a significant breakthrough in the field, circumventing the controversies around 
DDX4 and possibly now IFITM3.  Prof. Telfer’s group is also now beginning to 
optimise the in vitro aggregated “ovary” experiments further with putative human 
OSCs.  The in vivo potential of the cells from both species will be important to 
investigate and, as seen in the published work on OSCs (Table 8.4), may yield results 
more quickly than the in vitro approach.  Work is already ongoing using the bovine 
cells within Prof. Anderson’s laboratory, involving the xenografting of aggregated 
“ovaries” into nude mice.  Hopefully, this will help determine whether the cells are 
genuine OSCs or not. 
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In order to determine whether the upregulation of meiosis entry-related genes reflects 
true initiation of meiosis, future investigations will have to assess at least three of the 
four standards set by Handel et al. (detailed in section 8.3; Handel et al., 2014).  DNA 
content of BMP4 and RA treated cells could be assessed by flow cytometry, whilst 
chromosomal counts and organisational changes could be assessed by FISH and 
chromosomal spreads with immunological detection of recombination-related 
proteins, e.g. DMC1.  With regards the generation of viable offspring, fertilisation of 
bovine OSC-derived oocytes and intrauterine transfer of resultant embryos into a 
surrogate heifer would be feasible; however, legal and ethical barriers would currently 
prevent the investigation of the fertilisation capacity of human OSC-derived oocytes, 
with Human Fertilisation and Embryology Authority (HFEA) approval required for 
such experiments.  Moreover, the production of healthy offspring is reliant on the 
correct imprinting of OSC-derived oocytes.   Mouse in vitro follicle culture research 
has demonstrated evidence of correct imprinting in oocytes by DNA methylation 
(Anckaert et al., 2009, Trapphoff et al., 2010, El Hajj et al., 2011), whilst one bovine 
oocyte IVM study (Heinzmann et al., 2011) has also provided reassuring results.  
However, these studies look at oocytes that are already formed: differentiation of an 
OSC into an oocyte and subsequent IVM is likely a more complex process, perhaps 
with the potential for more epigenetic errors to occur.  Combined bisulfite restriction 
analysis (COBRA) enables detection of DNA methylation of specific loci (Eads and 
Laird, 2002) and has been utilised by Wu’s group to demonstrate that rodent OSCs 
were maternally imprinted, with partial methylation of maternally imprinted regions 
of DNA and demethylation of paternally imprinted regions detected (Zou et al., 2009, 
Zhou et al., 2014).  These OSCs were then reported to produce viable offspring.  Such 
a technique could also be utilised in bovine and human OSCs and OSC-derived 
oocytes. 
Finally, the pilot studies utilising Gelfoam® as a cell scaffold could be modified for 
use in vivo: due to the structure of the material and the size of the ovaries, grafting of 
OSC-seeded Gelfoam® into rodent ovaries would be technically challenging, although 
grafting of the bovine “sandwiches” into nude mice may be productive.  A larger 
animal model, such as the cow or sheep, would be preferable, however.  This strategy 
would allow practice of the insertion technique of Gelfoam® into ovaries and be more 
translatable to clinical use in humans.   
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8.6 Concluding remarks 
The research presented in this thesis demonstrates that, in support of previous research, 
putative OSCs can be isolated from adult human ovarian cortex and, for the first time, 
they have been extracted from adult bovine ovaries.  A variety of approaches, 
including many novel strategies, were utilised to investigate the nature and potential 
of these cells and the findings have provided a strong foundation on which future work 
can be based.  The investigations have revealed that the isolated cells bear the 
molecular signature of OSCs and mimic the response of PGCs to key regulators of the 
germ cell development pathway.  Their oocyte-forming capabilities have not been 
proven; however, the optimal in vitro environment within which the putative OSCs 
may develop into germ cells is unknown.  The work described within this thesis 
represents some of the first attempts at establishing favourable conditions for putative 
OSC differentiation, including investigation of support cells, matrices and 
differentiation-inducing factors.  The concept of the OSC remains controversial in the 
field of reproductive biology; however, the data presented here show clearly that a 
population of cells exists within adult ovaries that have both stem cell and germline 
characteristics, although the quality and quantity of the isolated cells is dependent on 
the isolation methodology.  Whether these cells have a physiological role within the 
ovary remains unclear.  OSCs have great potential in basic science, agricultural and 
clinical applications, yet their use in these areas remains mostly aspirational at present.  
Much more research is required before such cells can be translated to the clinical 
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a  b  s  t  r  a  c  t
One  of  the  principal  beliefs  in reproductive  biology  is that  women  have  a  finite  ovarian  reserve,  which  is
fixed  from  the  time  they  are  born.  This  theory  has  been  questioned  recently  by  the  discovery  of ovarian
stem  cells  which  are purported  to  have  the  ability  to form  new  oocytes  under  specific  conditions  post-
natally.  Almost  a decade  after  their  discovery,  ovarian,  or oogonial,  stem  cells  (OSCs)  have  been  isolated
in mice  and  humans  but remain  the  subject  of much  debate.  Studies  in  mice  have shown  that  these  cells
can  be  cultured  to  a mature  oocyte  stage  in  vitro,  and  when  injected  into  germ-cell  depleted  ovary  they
can form  follicles  and  have  resulted  in  the  birth  of healthy  offspring.  There  are  few  data  from  human
OSCs  but  this  finding  would  open  the  door  to novel  fertility  preservation  strategies  for  women  with  bothertility preservation
VF
remature ovarian insufficiency
age-related  and premature  ovarian  insufficiency  (POI).  As  the  number  of  girls  and  young  women  sur-
viving  cancer  increases  worldwide,  POI  secondary  to  gonadotoxic  treatments,  such as  chemotherapy,  is
becoming  more  common.  The  ideal  fertility  preservation  approach  would  prevent  delays  in  commencing
life-saving  treatment  and  avoid  transplanting  malignant  cells back  into  a woman  after  treatment:  OSCs
may  offer  one  route  to  achieving  this. This  review  summarises  our current  understanding  of OSCs  and
discusses  their potential  clinical  application  in  infertility  treatment  and  fertility  preservation.© 2013 Elsevier Ireland Ltd. All rights reserved.
ontents
1. Introduction  . .  . . . .  . .  .  . . .  .  . . .  .  . . .  .  . .  .  . . .  . . . . . . .  .  . . . .  . . . .  . . . .  . . . . . . . . . .  . .  .  .  . .  .  . . .  . . .  . . . . . .  . . . . . . .  . . . . . . .  .  . . . . . . .  .  . . .  .  . . .  .  . . . . .  . . .  . .  . . . . . . . . . .  . .  .  . . .  . .  .  .  . 00
1.1. Identification  and  isolation  of OSCs  . . .  .  . . .  .  .  . . .  .  . . .  . . . . . . .  . . . . .  .  . .  .  . . . . .  .  . . . . . .  . .  .  . . .  .  .  . .  . . . . .  . . . . .  .  . . .  . . . .  . . .  .  . . . . .  .  .  . .  .  . . . . . .  .  . . .  . .  .  . . .  . .  .  . 00
1.2.  Controversy  surrounding  OSCs  . . . .  . . .  .  .  . .  .  . . .  .  . . .  . . . .  . . . . . . .  . . . . . . .  .  .  .  . . .  . . .  . . . .  . .  .  . . .  . . . . .  . . . . . . .  .  . . . . . .  .  . . . . . . . .  .  .  . . .  .  .  .  . . .  . . . . . . .  . . .  .  . .  .  . . 00
1.3.  Clinical  applications  of OSCs  in  infertility  . .  .  . . . .  . . . .  . . .  . .  .  . . . .  . . . . . . .  . . .  . . . . . . .  . . .  . . .  . . . .  . . . . . . .  .  . . . . . .  .  .  .  . .  .  . . . .  .  .  . . . .  .  . . . . . . . . .  .  . . .  . .  .  .  . .  . . 00
1.3.1.  Age-related  infertility  . . .  . . . .  .  . . .  .  . . .  . . .  .  . . . . . . .  . . . . . . .  . . . .  . . . . . .  . . . . . . .  . . .  . . .  . .  . . . . . .  .  . . . . . .  .  . . . .  .  . .  .  .  .  . . . .  . . . . .  .  . .  .  . .  . . .  .  . .  . . . .  . . . 00
1.3.2.  Iatrogenic  premature  ovarian  insufficiency  .  . . . .  .  .  . . .  .  .  .  . . . . . .  .  . . . . . . . .  . . . .  .  . . . . .  . . .  . . .  . . . . . . .  . . . . .  . .  . . . . .  . . . . .  . .  .  .  .  .  . . .  . .  .  .  .  . .  . . .  . 00
1.3.3.  Non-iatrogenic  premature  ovarian  insufficiency  . .  . . . . . .  .  . .  . . . . .  .  . . . .  . . .  .  . . . .  . . .  . . .  . . .  .  . . .  . . . . . .  . . . . .  . .  . . . .  .  .  .  . .  .  . . . . . . . . .  .  .  .  .  . .  .  . 00
2.  Conclusion.  . .  . . . .  . . .  . . . .  .  . . .  .  . . .  . . .  . . .  .  . . .  .  . . . .  . . . .  . . . . . . .  .  . . . . . .  .  . . . . . .  .  . . . .  . . .  . . . . .  .  . . . . .  . . .  .  . . .  . . . . . .  . . . . .  . .  .  .  . . .  .  . . . . . . . .  .  . . . . .  .  . .  .  . .  . . .  .  . . . .  . . .  . . 00
Contributors  .  . . .  . .  .  . . . .  .  . . . .  . . .  . . . .  .  . .  .  . . .  . . . . . .  .  .  . .  .  .  . . .  . . . . . . .  . . . . . . . .  . . . .  . .  . . . . . . .  .  . . . . . . .  .  .  . . .  .  .  . . . . . .  .  . . . . . . .  . . .  .  . . . . .  .  . .  . . .  .  . . . . . .  . . . . . .  .  .  .  .  . . .  . .  . 00
Competing  interest .  . .  . . .  . . .  .  . . .  .  . .  . . . .  . . .  .  . . . .  . . .  .  . . .  .  . . . .  . . .  . . . . . .  .  . . . .  . .  .  . . . .  . . .  . . . .  .  . . . . . .  . . . . .  . .  .  . . . .  . . .  . .  . . .  . .  . . . .  . . .  .  .  . .  .  .  .  . .  .  . . . . . .  .  . .  .  . .  .  . .  .  . . . 00
Provenance  and  peer  review  .  . . .  . . . .  . . .  .  . . .  .  . . .  .  . . . .  . . . . . .  .  . . . . . .  .  . . . . . .  .  .  . . .  . . .  . . . . . . .  . . .  .  . . . . . .  . . . . . . .  .  . . . .  . . .  . . . . .  . . .  .  . . . . .  . . . . .  .  .  . .  . .  .  . . .  . . . . . .  . .  . . 00
Acknowledgements  . . . .  . . .  . . . .  . . .  . . .  .  . . .  .  . . .  .  . . .  .  . . .  . . .  .  . . . . . . .  . . . . . . .  .  . . .  . .  . . . .  .  . . . . . .  . .  .  . . . .  . . .  . . . .  .  . . . .  . .  .  . . . . . .  .  .  . . .  .  . . . .  . .  .  . . . .  . .  .  .  .  .  .  . . . .  . . . . . . 00
References  . . . .  . . . .  .  . . .  .  .  . . .  . . .  .  . . .  . .  . .  . . . .  . . . . . . .  .  . . .  .  . . .  . . . .  . . . . . .  . . . . . . .  .  .  .  . . . . . . . .  . . .  . .  .  .  . . .  . . .  . . . . . . .  .  . . .  . . .  .  . . .  .  . . . .  . . . . .  .  .  .  . .  .  . . . .  .  .  . . .  .  . . .  . .  .  . 00
. IntroductionPlease cite this article in press as: Dunlop CE, et al. Ovarian stem cells—Pote
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The dogma that female mammals are born with all of the oocytes
hey will ever possess has its foundations in a paper from Sir
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ttp://dx.doi.org/10.1016/j.maturitas.2013.04.017Solomon Zuckerman published in 1951 [1]. Simply put, Zuckerman
failed to find any experimental evidence available at that time that
he felt was  inconsistent with an earlier hypothesis [2] that germ
cell production in female mammals ceases prior to birth (reviewed
by Zuckerman) [3]. This paper and its main conclusion profoundlyntial roles in infertility treatment and fertility preservation. Maturitas
affected the subsequent interpretation of experimental and clinical
observations relating to ovarian development, function and failure
for the next 50 years. A paper published by Jonathan Tilly’s labo-
ratory in 2004 reignited this debate by reporting the presence of a
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Fig. 1. White et al.’s method of isolating, purifying and culturing human OSCs usingARTICLEAT-5967; No. of Pages 5
C.E. Dunlop et al. / Ma
opulation of mitotically active germline stem cells (GSCs) in the
ouse ovary which, the authors postulated, maintain oocyte and
ollicle production in the ovary after birth [4]. The finding of GSCs, or
ogonial stem cells (OSCs) as they are now more commonly known,
as generated a lively debate in the field over the last decade as it
s in direct opposition to the dogma that female mammals have
 non-renewable oocyte reserve from birth. This debate has been
erceived as representing two clearly opposing viewpoints with no
ommon ground (reviewed by Powell) [5], but there is the possibil-
ty that both views can co-exist, with the formation of a population
f oocytes at birth that is the main contributor to ovarian function
nd fertility and subject to little, if any, renewal and the existence
f OSCs in adult ovaries that can only be activated under specific
ircumstances. It is impossible to prove the absence of any given
ell in a tissue but the debate cannot be resolved until the pres-
nce and function of OSCs within adult ovaries can be unequivocally
emonstrated.
Regardless of the physiological significance of these cells what
s undeniable are the possible clinical applications of OSCs in infer-
ility and fertility preservation if their potential can be harnessed;
his review will address the background to current understanding
f OSCs, and provide a speculative discussion of their potential clin-
cal applications. If human OSCs can be grown into fully functional
ocytes, can this be harnessed to address the age-related decline
n oocyte quality? Could girls and young women about to undergo
onadotoxic therapy, e.g. for cancer, be able to cryopreserve some
SCs within their ovarian cortex prior to commencing treatment?
nstead of concentrating on the finite number of primordial folli-
les within that ovarian tissue, it is conceivable that OSCs could
ubsequently be retrieved from this tissue and either cultured to
orm mature oocytes for use in in vitro fertilisation (IVF), or injected
ack into the woman’s ovarian cortex for in vivo development. The
umber of new follicles that could be generated from OSCs could be
uch larger than the number of follicles in the stored ovarian tissue,
nd certainly much larger than the number of mature oocytes that
 woman could store using the conventional approach of ovarian
timulation and aspiration of mature oocytes.
.1. Identification and isolation of OSCs
Johnson et al. identified cells they considered OSCs whilst inves-
igating follicular atresia in the mouse ovary [4]. They discovered
hat follicles were dying at a rate such that the ovary would
e deplete of oocytes far earlier than is found in vivo. Analy-
is of the ovary revealed ovoid cells that both immunostained
or a germ-cell specific marker (mouse vasa homologue or MVH,
 germ-cell specific RNA helicase) and demonstrated incorpora-
ion of 5-bromodeoxyuridine (BrdU), indicative of proliferating
ells. Furthermore, these cells expressed a meiosis-specific pro-
ein (synaptonemal complex protein 3, SCP3) required to initiate
eiosis for the production of oocytes. In their final set of experi-
ents, ovarian tissue from wild-type mice was transplanted onto
he ovaries of mice which ubiquitously expressed green fluores-
ent protein (GFP). After 3–4 weeks, the wild-type ovary contained
FP-positive oocytes surrounded by wild-type granulosa cells, per-
uading the authors that OSCs from the GFP mouse had initiated
olliculogenesis in the wild-type mouse and that they had discov-
red mitotically active OSCs that had the ability to form new oocytes
fter birth [4].
However, scepticism surrounded the idea of OSCs amongst
eproductive biologists [6,7]. A key finding supporting claims that
dult mouse ovaries retain the capacity for oogenesis came in aPlease cite this article in press as: Dunlop CE, et al. Ovarian stem cells—Pote
(2013), http://dx.doi.org/10.1016/j.maturitas.2013.04.017
aper that reported that OSCs had been isolated and cultured from
eonatal and adult mouse ovaries [8]. These cells, termed female
ermline stem cells (FGSC), were initially identified using the same
riteria used by Johnson et al. [4] i.e., expression of MVH  and BrdUa  xenograft. FACS: fluorescent-activated cell sorting.
From Telfer and Albertini [43].
incorporation. By employing a cell-sorting approach using an anti-
body against Ddx4 (DEAD box polypeptide 4, another name for
MVH), the authors reported the ability to isolate and purify OSCs
in mice. Furthermore, by transplanting GFP-positive OSCs into the
ovaries of infertile mice, they were able to produce live GFP-positive
offspring.
The main findings of this key study were developed further
by White et al. [9] who  not only managed to isolate human
OSCs using DDX4 (the human orthologue of MVH, or VASA),
but they were able to isolate, culture and form early follicle-
like structures after injection of both mouse and human OSCs
into ovarian tissue which was xenotransplanted into NOD-SCID
(non-obese diabetic – severe combined immunodeficiency) mice
to provide a suitable environment for early folliculogenesis (Fig. 1)
[9].ntial roles in infertility treatment and fertility preservation. Maturitas
Interestingly, and from an entirely separate line of evidence,
the case for post-natal neo-oogenesis has been bolstered by a
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n the germline in female mice. There was a positive correla-
ion between thus-determined oocyte ‘depth’ and mouse age, i.e.
ocytes in older mice were found to have undergone more mitotic
ivisions than those in younger mice [10]. Although this may be
n part explained by the “production-line” hypothesis, whereby
ocytes are ovulated in the order in which they were formed
11], that explanation does not appear adequate for the degree
f ‘depth’ identified, and the alternative explanation of post-natal
e novo oogenesis could not be ruled out experimentally by the
uthors [12].
Of note, OSCs are not the only stem cells to have been shown
o produce oocyte-like cells under the right conditions. Hayashi
t al. recently published evidence that both embryonic stem cells
ESCs) and induced pluripotent stem cells (iPSCs) can be induced
nto primordial germ cell-like cells (PGCLCs) which, upon combi-
ation with gonadal somatic cells and transplantation into mice,
an generate germinal vesicle-stage oocytes [13]. These oocytes
an then be matured in vitro and, after IVF, can produce offspring
hich are themselves fertile. This study highlights the need to con-
ider the appropriate stage of somatic cell support and so far has
nly been carried out in mice, but it offers an alternative model of
erm cell development.
.2. Controversy surrounding OSCs
The isolation of OSCs has been independently performed by only
 small number of other groups to date [14–16] although full cor-
oboration is as yet lacking. Many criticisms have been levelled at
he experimental techniques utilised and the interpretation of the
ndings in these OSC experiments [7,17]. For example, mathemat-
cal modelling has been used to challenge Johnson et al.’s follicular
tresia rate finding [18], although mathematical data supporting
he theory of post-natal folliculogenesis in the mouse has also been
roduced [19]. Critics have been sceptical of the use of Ddx4/DDX4
s a cell surface marker in cell sorting as it has an intracytoplas-
ic  localisation in oocytes [20]. However, it has been proposed
hat Ddx4/DDX4 has a transmembrane-spanning domain in OSCs,
efore becoming intracellular in more mature oocytes [9], although
xperimental evidence for this is still lacking. The argument for the
xistence of OSCs has been further strengthened by subsequent
ork reporting the isolation of OSCs in mice using alternative mark-
rs for cell sorting [14,21]. Wu’s lab showed improved purification
fficiency by employing interferon-inducible transmembrane pro-
ein 3 (Ifitm3, or fragilis), a widely accepted early germ cell-specific
urface marker [21], whilst Pacchiarotti et al. used transgenic mice
hat expressed GFP under the control of another germline-specific
arker, Oct-4 [14,22].
It has been questioned why these cells have gone undiscovered
or so long [6]; however, it seems that OSCs are exceedingly rare,
ith White et al., reporting that they constitute a mere 0.014%
f all cells in mouse ovaries [9]. They also seem to become rarer
ith increasing age, declining from 1 to 2% of cells in the neonatal
ouse ovary to 0.05% in the adult [13]. The variation between val-
es reported by different groups is likely to reflect the very different
solation methods used. This also perhaps explains the timespan
etween the initial purported discovery of these cells and their iso-
ation from ovarian cortex. Furthermore, there are concerns about
n vitro transformation given that the length of time it takes for
hese cells to establish in culture (10–12 weeks in the mouse and
–8 weeks in humans) [9] is much greater than for the equivalentPlease cite this article in press as: Dunlop CE, et al. Ovarian stem cells—Pote
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ells in the male [23]. Still, live offspring have been produced from
uch OSC cultures in mice [8] and early follicle-like structures have
een generated in human tissue [9]. Despite these on-going dis-
utes, the discovery of OSCs offers exciting new potential strategies
or clinical application. PRESS
s xxx (2013) xxx– xxx 3
1.3. Clinical applications of OSCs in infertility
1.3.1. Age-related infertility
The age-related decline in female fertility is a central feature of
human reproduction [24]. Whilst not the only aspect of concern,
it is within the ovary and oocyte that most of this decline resides
and will be of greater significance as pregnancy at advanced age
becomes more prevalent. Currently the main strategy reproductive
medicine has to offer is the use of oocyte donation: whilst undoubt-
edly successful, it is of huge consequence both for individual
couples and for society [25]. ‘Social’ oocyte storage is increasingly
prevalent, but even with multiple ovarian stimulation cycles the
number of oocytes will be limited, and the financial costs high.
Might OSCs have a role here? The isolation of OSCs from older
women indicates the possibility, and the fact that they are capable
of proliferation (i.e. they are pre-meiotic) means that the age-
related aneuploidy risk might not exist, or at least be much less
of an issue. OSCs also provide an unparalleled opportunity for the
improved understanding of the basis of such clinically relevant
aspects of human oocyte biology. Options for both the treatment
and prevention of age-related fertility loss therefore exist at least in
theory, but are critically dependant on understanding of whether,
and why, neo-oogenesis ceases at the menopause.
1.3.2. Iatrogenic premature ovarian insufficiency
The survival rates from childhood cancer have increased sig-
nificantly over the last 15–20 years [26], resulting in many young
women suffering from premature ovarian insufficiency (POI) after
being exposed to gonadotoxic treatment. At present, approaches
available to women  who  want to attempt to preserve their fertility
prior to gonadotoxic therapy include having oocytes or embryos
cryopreserved after undergoing ovarian stimulation (and subse-
quent IVF with their partner’s or donor’s sperm in the case of
embryo cryopreservation). Unfortunately, both of these approaches
involve hormonal medication and lead to delays in commencing
treatment for the patient’s disease. The alternative option, which is
the only approach appropriate for pre-pubertal girls [27,28], is cry-
opreservation of ovarian tissue with subsequent re-transplantation
into the woman after cessation of her treatment. The first livebirth
from this method was  in 2004 when a woman  with successfully
treated Hodgkin’s lymphoma underwent orthotopic autotrans-
plantation of cryopreserved ovarian tissue [29] and there have been
a number of livebirths reported since [30]. There have, however,
been concerns surrounding this approach with certain diagnoses as
there is a risk of reintroducing malignant cells within the transplant
into the patient, particularly with haematological malignancies
[27,31,32]. Consequently, an approach that avoids a delay in com-
mencing life-saving treatment and employs a method to prevent
transplanting cancer cells back into a patient would be preferable.
OSCs may  offer the potential to provide this approach.
To date, human OSCs have only been grown to early follicle-like
structures in a xenotransplantation model [9], which is unaccept-
able in clinical use. However, the development of a multi-step
culture system in cows and humans that supports folliculogen-
esis and oocyte growth from the primordial follicle stage means
that there is the potential to produce mature oocytes from OSCs
completely in vitro, if the correct somatic cell support is avail-
able [33,34] (Fig. 2). This serum-free culture model supports
oocyte development in a shorter time frame compared with that
seen in vivo, by culturing primordial follicles in small ovarian
cortical strips to the pre-antral stage, before these pre-antral
follicles are dissected out and cultured individually in activin-ntial roles in infertility treatment and fertility preservation. Maturitas
supplemented media [33,34]. Once the follicles reach the antral
stage, the oocyte–granulosa cell complexes (OGCs) can be removed
and placed on membranes for a final period of development prior
to undergoing in vitro maturation (IVM) [35,36].
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ig. 2. A multi-step, serum-free culture system for in vitro human follicle developm
GC:  oocyte–granulosa cell complex.
rom Telfer and McLaughlin [44].
Oocyte development and maturation is a multifaceted process
nd, as such, livebirths have only been achieved with folli-
les/oocytes grown from the primordial stage in mice [37,38]. In
articular, there are concerns that in vitro oocyte culture and IVM
ay  interfere with the complex genome imprinting stages and epi-
enetic mechanisms that are required for the development of a fully
ompetent oocyte and subsequent embryo [39]. Animal studies
ave so far been reassuring; human studies will be a very consid-
rable challenge.
With regard to human OSCs, if they can be transplanted into
uman ovarian cortex and the ensuing primordial follicles cultured
n vitro in a serum-free multi-step system, any resultant mature,
ompetent oocytes could be used in IVF. This opens the door to a
ovel fertility preservation approach that would be of use in those
emale patients who, for reasons of age or urgency for treatment,
annot have mature oocytes removed prior to gonadotoxic treat-
ents that may  render them infertile. Additionally, the expansion
f OSC number in culture may  allow for a considerably greater
umber of oocytes to be available to the women.
Another possible strategy is the injection of isolated OSCs
nto a patient’s ovaries, where they, theoretically, could undergo
eo-oogenesis in vivo and generate an entire population of
ormone-secreting follicles as well as allowing a more physio-
ogical oocyte maturation. This may  have the additional benefit
f reversing the climateric symptoms and general health conse-
uences associated with the menopause, at least temporarily. As
ith in vitro folliculogenesis, this remains a distant prospect at
resent.
.3.3. Non-iatrogenic premature ovarian insufficiency
Although an increasing number of women with POI have an
nderlying iatrogenic cause [40], the aetiology of POI is hetero-
eneous, with the majority of cases being idiopathic [41]. Unless
 family is aware of a hereditary genetic cause, women  with
on-iatrogenic POI often present too late for current fertility preser-
ation methods to be feasible. At present, these women can either
ope to spontaneously conceive (with an approximately 5% chance
f spontaneously conceiving following diagnosis [41]), or opt to
se donor oocytes and IVF. Hypothetically, OSCs could also be
mployed in the management of these women as it may  be pos-
ible to isolate OSCs from these women’s ovaries, despite theirPlease cite this article in press as: Dunlop CE, et al. Ovarian stem cells—Pote
(2013), http://dx.doi.org/10.1016/j.maturitas.2013.04.017
enopausal state. Indeed, OSCs have already been isolated in aged
ouse ovaries and have been shown to undergo oogenesis when
ransplanted into a young mouse [42]. Again, these OSCs could be
ultured as above and used in IVF.m the primordial follicle stage to isolation of oocytes for in vitro maturation (IVM).
Of note, White et al. have shown that OSCs can be isolated from
cryopreserved, as well as fresh, human ovarian tissue [9]. This is
encouraging from a fertility preservation point-of-view as it means
that ovarian cortical tissue removed from girls or women can be
safely stored until OSCs are required, thus allowing for technical
advances in their isolation.
2. Conclusion
Few topics in the field of reproductive biology have led to as
much animated discussion as the existence, or lack thereof, of
oogonial stem cells. There is, however, increasing evidence that
a rare population of cells with germline characteristics and pro-
liferative capabilities can be retrieved from the ovaries of some
species, including humans. What the purpose of these cells is under
“normal” circumstances and what potential uses they have is still
unclear; recent progress has been promising but their potential
therapeutic use remains distant. Their existence also challenges
current concepts as to the basis of the menopause: if there remains
a potential oocyte source in the ovaries of postmenopausal women,
what causes their development into follicles to stop? Although
there is a very long way to go before the findings discussed here
may  have a clinical application in human infertility and fertility
preservation, it seems likely that novel treatments may  result from
oogonial stem cell research in the future.
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It has long been established that germline stem cells
(GSCs) are responsible for lifelong gametogenesis in
males, and some female invertebrates (for example,
Drosophila) and lower vertebrates (for example, teleost
fish and some prosimians) also appear to rely on GSCs
to replenish their oocyte reserve in adulthood.
However, the presence of such cells in the majority of
female mammals is controversial, and the idea of a
fixed ovarian reserve determined at birth is the
prevailing belief among reproductive biologists.
However, accumulating evidence demonstrates the
isolation and culture of putative GSCs from the ovaries
of adult mice and humans. Live offspring have been
reportedly produced from the culture of adult mouse
GSCs, and human GSCs formed primordial follicles
using a mouse xenograft model. If GSCs were present
in adult female ovaries, it could be postulated that the
occurrence of menopause is not due to the
exhaustion of a fixed supply of oocytes but instead is
a result of GSC and somatic cell aging. Alternatively,
they may be benign under normal physiological
conditions. If their existence were confirmed, female
GSCs could have many potential applications in both
basic science and clinical therapies. GSCs not only may
provide a valuable model for germ cell development
and maturation but may have a role in the field of
fertility preservation, with women potentially being
able to store GSCs or GSC-derived oocytes from their
own ovaries prior to infertility-inducing treatments.
Essential future work in this field will include further
independent corroboration of the existence of GSCs
in female mammals and the demonstration of the
production of mature competent oocytes from GSCs
cultured entirely in vitro.Critically, the physiological role of these cells in vivo* Correspondence: richard.anderson@ed.ac.uk
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2014Introduction
Germline stem cells (GSCs) are a unique cell population
committed to producing gametes for the propagation of
the species. The concept of a GSC most likely originates
from Regaud [1,2], whose work on spermatogenesis was
published over a century ago. He postulated that, in
order for sperm production to occur, a population of
self-renewing cells must be present in the testis which
could produce differentiated progeny. It is now well
established that these cells, now known as spermatogon-
ial stem cells, contribute to spermatogenesis in adult-
hood in the males of all species studied [3]. Research on
the existence of a female counterpart, an ovarian GSC
that is able to undergo postnatal neo-oogenesis and thus
contribute to oocyte production in adulthood, has re-
vealed a more complicated picture. Although female
GSCs (fGSCs) appear to have a role in oogenesis
throughout reproductive life in some non-mammalian
species, these examples appear to be relatively rare
across the phyla of the animal kingdom [4], and the
presence of fGSCs in mammals has been greatly de-
bated. Indeed, the prevailing view is that female mam-
mals are born with a finite stock of mature oocytes that
become exhausted with aging, a hypothesis first sug-
gested by the 19th century embryologist Waldeyer [5].
General opinion changed at the beginning of the 20th
century when the prevailing belief was in favor of neo-
oogenesis in adulthood [6] until an influential article by
Zuckerman [7] in 1951 reported no evidence that new
oocytes are formed once a female is born, and the idea
of a fixed ovarian reserve in mammals has been a central
dogma in the field since. However, since 2004, a growing
number of researchers have found cause to question this
doctrine. The debate was reignited with the proposition
[8], and subsequent isolation [9-13], of purported fGSCs
(also known as oogonial stem cells, or OSCs).
in the adult mammalian ovary has yet to be determined.
Development and maturation of an oocyte entail a com-
plex and multifaceted process which has to be tightly
regulated in order for the oocyte to be competent for
fertilization. This includes bidirectional communicationLtd. The licensee has exclusive rights to distribute this article, in any medium,
this time, the article is available under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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precise timing of cessation and resumption of meiosis,
and correct genomic imprinting (reviewed last year by Li
and Albertini [14] and Anckaert and colleagues [15]).
Imprinting involves epigenetic alterations of the parental
alleles by DNA methylation and determines whether the
maternal or paternal gene will be expressed in the em-
bryo. Incorrect imprinting can lead to conditions such
as Angelman and Prader-Willi syndromes. Therefore, fu-
ture research involving the culture of oocytes derived
from purported adult mammalian fGSCs will have to en-
sure that these processes are intact for these cells to be
useful in clinical practice. This review will examine the
existence of OSCs in various species, consider where re-
search in the field is heading, and assess the therapeutic
potential of such cells.
Ovarian germline stem cells in non-mammalian species
and prosimian primates
There are several animals in which fGSCs actively re-
plenish the ovarian reserve postnatally. fGSCs in ‘lower’
invertebrates have been extensively studied in the fruit
fly, Drosophila [4]. In this species, a few primordial germ
cells (PGCs) are effectively ‘segregated’ in a special germ
cell niche at the tip of each ovariole (16 to 18 tubes that
make up the ovary) prenatally [16]. The environment
within this niche, in contrast to environments elsewhere
in the ovary, prevents the PGCs from differentiating,
and these undifferentiated cells subsequently become
fGSCs [17]. Postnatally, this niche controls the division
of fGSCs and the production of new oocytes, therefore
providing a continuous supply of germ cells throughout
reproductive life.
fGSCs have also been reported in teleost fish, includ-
ing the medaka (Oryzias latipes) [18] and zebrafish (Da-
nio rerio) [19]. As in Drosophila, medaka have a germ
cell niche, called the germinal cradle, situated in the
ovarian cords [18]. Within this area reside mitotic cells
that have the characteristics of fGSCs and that continu-
ously supply the ovary with new oocytes. Furthermore,
zebrafish possess a distinct zone on the ovarian surface
to which germ cells are confined, and this may also be
analogous to the Drosophila germ cell niche [19], sug-
gesting evolutionary conservation across animal phyla.
Oogenesis throughout reproductive life may be neces-
sary for the huge numbers of eggs produced during the
fish and fly life span and appears more similar to sperm-
atogenesis than the restrictive processes of oogenesis
and associated follicle development in higher mammals.
Although prior to 2004 it was widely believed that the
vast majority of adult mammals lack fGSCs, a few excep-
tions had been described. The adult ovaries of two mem-
bers of the loris family, which are prosimians related to
the lemur, have been reported to possess mitoticallyactive germ cells located within ‘nests’ in the ovarian
cortex [20-22]. It has not been proven, however, that
these cells, found in a slow loris (Nycticebus coucang)
and a slender loris (Loris tardigradus lydekkerianus), are
actually capable of undergoing folliculogenesis and pro-
ducing mature oocytes.
If fGSCs can be identified in such animals, why would
they not be present in the ovaries of the vast majority of
adult female mammals? Zuckerman himself was actually
an advocate for neo-oogenesis until his convictions were
changed by his extensive review of the literature [23], in
which he stated: ‘None of the experimental and quantita-
tive evidence which we have considered thus supports
the view that oogenesis occurs in the adult ovary, and
much of it bears very clearly against the proposition’ [7].
Lack of evidence is not definitive, and proving that a
cell does not exist is difficult, especially if they are a
scarce population. So what is the evidence for the exist-
ence of fGSCs in adult mammals?
Ovarian germline stem cells in mammals
The discovery of purported fGSCs in adult mice oc-
curred during an investigation of oocyte atresia and its
role in follicular dynamics, when an apparent mathemat-
ical anomaly was observed. Johnson and colleagues [8]
reported that follicular atresia was occurring at a rate
such that the adult mouse should exhaust her ovarian
reserve well before the age that it in fact occurs. This
implied that the follicle pool must be replenished in
adulthood by neo-oogenesis in order to sustain the re-
productive life of the mouse, and considering the germ
cell dynamics model of Faddy and colleagues [24], the
authors suggested that the adult mouse has to make 77
new primordial follicles a day. On further investigation,
a rare population of mitotically active ovoid cells in the
ovarian surface epithelium (OSE), which expressed the
germ cell-specific protein mouse vasa homolog (MVH),
was identified. Furthermore, when small pieces of wild-
type ovarian cortex were transplanted onto the ovaries
of transgenic mice that ubiquitously expressed green
fluorescent protein (GFP) for 3 to 4 weeks, GFP-positive
oocytes surrounded by wild-type somatic cells were
found within the wild-type graft. These results per-
suaded the authors that new oocytes must continue to
be produced throughout reproductive life in mice and
that the proliferating cells in the OSE may be putative
fGSCs and therefore the source of the ongoing
oogenesis.
The article by Johnson and colleagues was met with
widespread criticism, and subsequent work from the
Tilly group, who suggested that the source of these
fGSCs was the bone marrow and peripheral blood [25],
was even more controversial [26,27]. However, Zou and
colleagues [9] took a step forward when they reported
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ically activated cell sorting technique, the authors iso-
lated putative fGSCs measuring 12 to 20 μm in diameter
by using an antibody against either DDX4 (DEAD box
polypeptide 4; also known as vasa or MVH) or IFITM3
(interferon-induced transmembrane protein 3; also
known as fragilis) [9,11]. These cells expressed both
pluripotency and germ cell markers, had a normal
karyotype, and were maternally imprinted. Evidence of
their capacity to undergo oogenesis was provided when
GFP-expressing fGSCs were transplanted into sterilized
mice, with GFP-positive offspring being produced. These
findings in adult mice were supported by subsequent ar-
ticles by Pacchiarotti and colleagues [10] and Hu and
colleagues [12], who reported isolation of putative fGSCs
by using different techniques, though with limited dem-
onstration of oocyte-like competence. The first, and
only, published evidence of the existence of these cells
in humans was provided by the Tilly group in 2012 [13].
White and colleagues [13] developed a fluorescence-
activated cell sorting protocol that consistently isolated
fGSCs, which the authors named OSCs, from both adult
mice and humans. Measuring 5 to 8 μm, the cells were
smaller than those isolated by Zou and colleagues [9]
but expressed similar germ cell markers. The reason
these cells have not been detected in the past may be ex-
plained by the fact that White and colleagues [13] esti-
mated that the OSC population makes up only 0.014 %
± 0.002 % of the mouse ovary. The authors noted spon-
taneous production of oocyte-like cells from fGSCs in
in vitro culture (also observed by Pacchiarotti and col-
leagues [10]); these cells showed expression of oocyte-
specific and meiotic markers. Finally, by injecting GFP-
expressing fGSCs into non-GFP ovarian cortex and
xenotransplanting the tissue into mice, the authors re-
ported that primordial follicles comprising a GFP-
positive oocyte and wild-type granulosa cells could be
seen on removal of the graft.
In addition to these putative fGSCs, another popula-
tion of ovarian stem cells that reportedly differentiate
into oocytes has been isolated from the OSE [28-30].
These cells, named very small embryonic-like (VSEL)
stem cells, are cultured from OSE scrapings, are smaller
than the fGSCs discussed above, and differ in morph-
ology from those reported by White and colleagues [13].
The cells express a number of stem cell markers, includ-
ing SSEA-4, and spontaneously generate large, oocyte-
like cells in culture. Interestingly, Parte and colleagues
[29] also isolated a second putative ovarian stem cell
population, slightly larger in size than the VSEL stem
cells and perhaps more analogous to fGSCs. They postu-
lated that the VSEL stem cells are, in fact, the precursors
of these larger cells, which may be tissue-committed
ovarian stem cells [29]. To date, VSEL stem cells havebeen reported in adult mice, rabbits, sheep, marmoset
monkeys, and humans [28,29], including postmeno-
pausal women and women with premature ovarian in-
sufficiency [31]. VSEL stem cells from the OSE would
appear to be distinct from fGSCs; however, the existence
of VSEL stem cells, much like that of fGSCs, has also
been controversial [32].
More recent evidence for the existence of mammalian
fGSCs has been published by a Mexican group working
with three species of phyllostomid bats [33]. The use of
these species of bats is especially pertinent because they
share some reproductive similarities with primates, both
anatomically and with respect to ovulation patterns. For
example, Glossophaga soricina are polyoestrous mono-
ovulates with menstrual cycles of 22 to 26 days, includ-
ing a luteal phase and periodic endometrial shedding
[34]. Antonio-Rubio and colleagues [33] demonstrated
that the ovaries of Artibeus jamaicensis, Glossophaga sori-
cine, and Sturnira lilium are polarized, with a medullary
region containing developing follicles and a cortical region
containing both primordial follicles and a population of
cells which looked similar to germ cells histologically.
These cells, when analyzed with immunofluorescence,
expressed proliferation, pluripotency, and early germline
markers, including phosphorylated histone H3, POU5F1,
DDX4, and IFITM3, and were termed adult cortical germ
cells (ACGCs). The authors thus postulated that ACGCs
may be involved in adult neo-oogenesis in these species,
although, as with the loris species mentioned previously,
this was not demonstrated in this study.
In addition to this emergent body of proof, there is in-
direct evidence to support neo-oogenesis in adult female
mammals. Work on rhesus monkey ovaries in the 1950s
demonstrated findings similar to those of Johnson and
colleagues [8] in the mouse, with the observed rates of
follicular atresia predicting that monkey ovarian reserve
should be depleted within 2 years [35]. The author cal-
culated that the maximum life span of an oocyte was
2 years, and therefore the data suggested that the new
oocytes must be continually produced throughout repro-
ductive life. Mathematical modeling has provided con-
flicting data, and both Bristol-Gould and colleagues [36]
and Wallace and Kelsey [37] found that the ‘germline
stem cell model’ did not fit follicular kinetics data in ei-
ther mice [36] or humans [37]. Conversely, Kerr and col-
leagues [38] have published data in support of postnatal
oogenesis. Although they did not find evidence of GSCs,
the authors demonstrated that the mean number of
primordial follicles in mice did not decline between days
7 and 100 of age, leading them to surmise that there is a
mechanism by which postnatal neo-folliculogenesis sus-
tains the follicular pool.
Further indirect evidence has come from lineage tracing,
although this has also provided conflicting evidence; some
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been unable to disprove that postnatal neo-oogenesis ex-
ists [39,40]. Lei and Spradling [39] have reported that
primordial follicles are very stable, with no evidence of
high rates of turnover, therefore suggesting that the pool
is sufficient to sustain fertility without the requirement of
fGSCs. In contrast, by examining the accumulation of
microsatellite mutations in mice, Reizel and colleagues
[40] found that oocyte ‘depth’ increased with age; in other
words, the older the mouse, the more mitotic divisions
the oocyte has undergone. If neo-oogenesis were not oc-
curring postnatally, then depth should be stable through-
out life and independent of any interventions; however,
depth was also shown to increase after ovariectomy and
this would indicate neo-oogenesis [41]. The ‘production-
line hypothesis’ of Henderson and Edwards [42] may go
some way to explaining this observation; however, the for-
mation of new oocytes after birth is a possible alternative
explanation. The findings of Lei and Spradling have also
been refuted by Bhartiya and colleagues [43], who ob-
served germ cell ‘cysts’ in adult mice and sheep which, the
authors believe, reflect clonal expansion of stem cells
within the ovary.
Germline stem cell aging
If ovaries are capable of producing new oocytes during
adulthood, then the obvious question is: why do women
go through menopause? It has traditionally been be-
lieved that women enter menopause when their finite
supply of oocytes has been exhausted; however, if neo-
oogenesis does indeed exist, then the rate of new oocyte
production must lessen with age in order for menopause
to occur. There may be two potential underlying mecha-
nisms: failure of the fGSCs to form oocytes or failure of
the somatic environment to support oocyte development
(or both). It is possible that fGSCs, like many other cells,
undergo an aging process and thus lose their capacity to
regenerate and differentiate. In Drosophila, there is a re-
duction in oocyte production with age, associated with
declining rates of fGSC division and increased apoptosis
of developing oocytes [44]. Furthermore, an age-
dependent deterioration in germ cell niche signaling
may affect the ability of fGSCs to regenerate [44]. Sev-
eral putative causative mechanisms for these age-related
changes have been proposed, including a decrease in
bone morphogenetic protein (BMP) production by the
germ cell niche, a reduction in GSC-niche cell adhesion
via E-cadherin, and an increase in harmful reactive oxy-
gen species [45]. Manipulation of all of these factors has
been shown to increase fGSC life span [45].
It is likely that mammalian aging can also be attrib-
uted, at least partly, to age-related stem cell senescence,
and hematopoietic, neural, and muscle stem cell func-
tion all demonstrate a decline in function (reviewed in[46]). With regard to ovarian GSCs, Pacchiarotti and
colleagues [10] found that the number of fGSCs they
were able to isolate from mouse ovaries diminished with
increasing age of the mouse. Furthermore, a study has
reported the presence of putative fGSCs in aged mice
that appear to undergo folliculogenesis only when trans-
planted back into a young mouse ovary, thus implying
that the surrounding ovarian environment may have a
role to play in the ability of fGSCs to sustain a woman’s
reproductive function [47]. Therefore, the idea that the
existence of menopause renders neo-oogenesis impos-
sible is not necessarily correct: the two phenomena may
co-exist. However, the key demonstration that fGSCs
contribute to the postnatal follicle pool and potentially
to fertility in a physiological context has not been made.
Although fGSCs may be isolatable from ovarian tissue
and potentially able to form oocytes within follicles after
various manipulations, this may occur only under ex-
perimental conditions and they may not have any rele-
vance to the normal processes of ovarian function.
Basic science uses for germline stem cells
The potential uses for fGSCs are numerous, particularly
in basic science but potentially even in clinical applica-
tions. With regard to the former, fGSCs provide an ex-
citing prospect as a germ cell model in order to study
the development and maturation of the oocyte. Park and
colleagues [48] have used adult mouse-derived fGSCs to
investigate the effect of BMP4. BMPs are a member of
the transforming growth factor-beta family of growth
factors with a critical role in PGC specification [49,50]
and have been shown to act on germ cells within the de-
veloping human ovary [51]. Treatment of fGSCs with
BMP4 increased both the rate of in vitro differentiation
into oocyte-like structures and the expression of genes
associated with the initiation of meiosis: muscle-segment
homeobox 1 (Msx1), Msx2, and stimulated by retinoic
acid gene 8 (Stra8) [48].
fGSCs have also been genetically manipulated to pro-
duce transgenic mice. Zhang and colleagues [52] trans-
fected female adult mouse GSCs with recombinant
viruses containing vectors for different genes, including
GFP. When transplanted into sterilized mice and mated
with wild-type male mice, offspring heterozygous for the
transfected genes were produced. Using a liposome-
mediated transfection, the same group was also able to
create a knockout mouse to investigate the role of the
gene Oocyte-G1 [52]. The ability to produce transgenic
animals in this way could be an excellent tool for repro-
ductive biologists in the future.
Therapeutic uses for germline stem cells
There is no doubt that if fGSCs can be shown to develop
into mature, competent, correctly imprinted oocytes
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owing to technical and regulatory issues, it may be a
long time before this potential can be fulfilled. For ex-
ample, in the UK, research into whether fGSC-derived
oocytes would be capable of fertilization and develop-
ment into a blastocyst would be possible only with the
approval of the Human Fertilization and Embryology
Authority. Nevertheless, fGSCs may have a role in both
fertility preservation and the reversal of reproductive
senescence. With regard the former, it is conceivable
that fGSCs could be used as a fertility preservation
strategy for women who require gonadotoxic treatment
for cancer that may render them infertile. A sample of
ovarian cortex could be taken prior to commencing
treatment, and fGSCs could be isolated and cryopre-
served for future use. The fGSCs, when required, could
subsequently be injected back into a woman’s ovaries
where they could undergo neo-folliculogenesis, or they
could be cultured in vitro in ovarian cortex to a mature
oocyte stage and resultant oocytes used in in vitro
fertilization (IVF). The benefits of this approach are
twofold: firstly, taking ovarian cortex samples would not
require life-saving treatment to be delayed in contrast
to the ovarian superovulation regimens required for
oocyte and embryo cryopreservation; secondly, many
more new follicles and oocytes could be achieved from
fGSCs than would be present in cryopreserved tissue or
from ovarian stimulation.
Women with age-related infertility or premature ovar-
ian insufficiency may also benefit from fGSCs. ‘Social’
oocyte storage is becoming increasingly sought by
women who are anxious about how much longer their
ovarian reserve will last. However, this is an expensive
endeavor, is not without health risks, and may result in
only a small number of oocytes being cryopreserved. As
mentioned previously, putative fGSCs have been re-
ported in aged mice [47]; therefore, it is not impossible
that women who are perimenopausal, prematurely or
not, may have a very small number of these cells resid-
ing in their ovaries. The prospect of these cells growing
into oocytes in the aged stromal environment is less cer-
tain; however, they may be able to be used in IVF. The
idea of ‘reversing’ the reproductive clock and thereby
avoiding the detrimental health effects and climacteric
symptoms of menopause is appealing to some; however,
the aging ovarian milieu may also restrict the use of
fGSCs to this end. In summary, such clinical applica-
tions are currently aspirational but worthy of further
investigation.
Germline stem cells – the future
The field of reproductive biology remains very skeptical
of the idea that female mammalian GSCs exist and par-
ticularly that they have any physiological role in normalovarian function. Further demonstration of their isola-
tion and in vitro characteristics from a range of species
is needed as a first step. The potential for fGSCs to
differentiate into daughter cells that become mature oo-
cytes in an in vivo environment remains to be demon-
strated. Given the apparent scarcity of fGSCs in the
female mouse ovary, this may prove difficult to demon-
strate. For those groups who have already isolated puta-
tive fGSCs, the essential next steps are investigating the
conditions under which these cells will develop into oo-
cytes that are capable of fertilization and thus exploring
their potential as gametes. For fGSCs to be used in a
clinical context, a complete in vitro culture system will
need to be developed. In this regard, we are currently
investigating whether fGSCs can be grown into a ma-
ture oocyte by using a multi-step serum-free culture
system that we have already shown promotes healthy
follicular growth in bovine and human ovarian cortex
[53-55].
Conclusions
The reported existence of female mammalian GSCs has
stimulated much interest among reproductive biologists,
many of whom are yet to be convinced that these cells
are a real entity. However, there are now a growing
number of reports of their isolation and culture, and
strides are being taken to investigate their neo-oogenesis
capabilities. Whether these cells have a physiological role
has yet to be determined, and concerns remain that iso-
lated putative fGSCs have undergone in vitro transform-
ation in order to form oocytes; yet if their potential can
be harnessed, they may contribute greatly to our under-
standing of oocyte development and may be of import-
ant clinical relevance.
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 Abstract 
 Folliculogenesis is the process by which waves of small primordial follicles possessing immature oocytes are recruited to 
undergo development into large antral follicles, with one then being selected for ovulation of a fully competent oocyte. 
Folliculogenesis can be divided into three stages: follicle recruitment, selection and ovulation, and has two phases: the 
initial gonadotrophin-independent phase and the later gonadotrophin-dependent phase. It involves an elaborate array of 
biochemical signalling factors, both stimulatory and inhibitory, and the regulation of follicle growth relies on these being 
tightly controlled. Their increasing understanding allows reproductive biologists to attempt manipulation of folliculogen-
esis, which can be useful in clinical areas such as assisted reproduction and contraception. The rising average age of 
childbearing in many developed countries is bringing an additional focus on the importance of assessing a woman ’ s non-
growing follicular pool; i.e. her ovarian reserve. This review examines the important regulatory players in the different 
stages of folliculogenesis and describes some of the currently available measures of ovarian reserve. 
 Key Words:  Anti-M ü llerian hormone ,  folliculogenesis ,  non-growing follicular pool ,  ovarian reserve 
 Introduction 
 The follicle, consisting of an oocyte surrounded by 
supporting somatic cells, is fundamental to the ova-
ry ’ s role as a reproductive organ. Oocytes are formed 
in the developing fetus when proliferating primor-
dial germ cells enter meiosis from the 11th week of 
gestation. The earliest follicular structures, the 
primordial follicles, consist of an oocyte halted in 
prophase I of meiosis surrounded by one layer of 
squamous granulosa cells. They arise once oocytes 
recruit pre-granulosa cells after around 18 weeks of 
gestation. Despite there being approximately 7    10 6 
oogonia in fetal life, newborn girls have only 1 mil-
lion primordial follicles; a fi gure that continues to 
fall during early life such that females enter their 
reproductive years with a pool of around 300,000 
primordial follicles. The vast majority of these fol-
licles are destined to become atretic. At the start of 
every menstrual cycle, a cohort, or  ‘ wave ’ , of pri-
mordial follicles is recruited to grow, with only one 
(in monovular species, such as humans and rumi-
nants) or several (in polyovular species, such as 
mice) follicles achieving dominance by mid-cycle 
with subsequent release of their now mature and 
fertilizable, oocyte during ovulation. A myriad of 
factors, acting at the autocrine, paracrine and endo-
crine level, are involved in the complex process of 
folliculogenesis, which comprises follicle recruit-
ment from the primordial pool, dominant follicle 
selection and, fi nally, ovulation. This review will 
examine these three stages, outlining the important 
biochemical players involved. The methods of 
assessing follicle growth will also be described. 
 Initiation of follicular growth 
 The activation of primordial follicle growth is 
regulated by a fi ne balance between stimulatory 
and inhibitory factors. It is this balance that helps 
determine the length of a woman ’ s reproductive 
lifespan and understanding of its regulation is thus 
a key goal in reproductive biology. Once activated, 
primordial follicles become primary follicles (an 
oocyte surrounded by one layer of cuboidal granu-
losa cells) and then secondary follicles (with mul-
tiple layers of granulosa cells and an outermost 
theca cell layer) which subsequently develop a fl uid 
fi lled antral cavity. Selection for ovulation occurs 
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following further growth and with increasing 
gonadotropin dependence, rather than the gonado-
tropin sensitivity of earlier stages (Figure 1). 
 A critical pathway identifi ed to be involved in the 
regulation of the initiation of primordial follicle 
growth is the phosphatidylinositide 3-kinase (PI3K) 
pathway, located within the oocyte. When this intra-
cellular signalling pathway is activated by growth 
factors such as stem cell factor (SCF; also known as 
Kit ligand), a cytokine produced by the granulosa 
cells of the primordial follicle, an increase in PI3K 
results in increased phosphorylation of Akt, a serine/
threonine-specifi c protein kinase, with the end result 
being increased cell survival and proliferation and 
inhibition of apoptosis. Follicular activation can also 
be stimulated via this pathway by the mammalian 
target of rapamycin complex (mTORC). The role of 
mTORC in human follicular activation has been 
shown by demonstrating that treatment of immature 
follicles with rapamycin, an inhibitor of mTORC, 
can lead to oocyte death [1]. 
 The PI3K pathway is kept in control by inhibi-
tory factors, including phosphatase and tensin 
homolog (PTEN) and the transcription factor fork-
head box O3a (FOXO3a). PTEN inhibits the stim-
ulation of Akt and therefore suppresses cell 
proliferation. Consequently, PTEN null mice dem-
onstrate premature activation of the primordial fol-
licle pool, thus shortening the reproductive lifespan 
considerably [2]. This is oocyte specifi c, as PTEN 
defi ciency in granulosa cells does not induce this 
phenotype. FOXO3a, a member of the forkhead 
family of transcription factors, is another important 
downstream component to the PI3K pathway. Like 
PTEN, FOXO3a inhibits follicular activation and 
thus knock-out mice also demonstrate premature 
ovarian insuffi ciency [3]. 
 Recently, another intracellular signalling path-
way, the Hippo signalling pathway, has been sug-
gested as potentially having a role in follicle 
activation [4]. The Hippo pathway is a highly con-
served kinase cascade, activated by cell membrane-
bound regulators in areas of high cell density. 
Activation leads to phosphorylation and inactiva-
tion of a cell proliferation transcription factor called 
yes-associated protein (YAP). Therefore, in cell 
dense tissue, cell growth and proliferation is 
impeded, whilst in areas of low cell density, the 
pathway remains inactivated and YAP promotes cell 
growth: this mechanism has been implicated in 
 Figure 1. A summary of folliculogenesis. The primordial follicle pool develops into primary then secondary follicles independently of 
gonadotrophins, but the process is closely regulated by activating (green box) and inhibitory (red box) factors. Growth from a secondary 
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determining organ size, and may explain why frag-
mentation of ovarian cortex, and hence disruption 
of the Hippo pathway, leads to increased initiation 
of follicle growth [4]. 
 Several other factors have been shown to activate 
primordial follicles to form primary follicles [5]. Bone 
morphogenetic proteins 4 and 7 (BMP4 and BMP7) 
are members of the transforming growth factor  β 
(TGF β ) family, with proven roles in early follicular 
development. Furthermore, BMP4 is necessary for 
the survival of oocytes. Leukaemia inhibitory factor 
(LIF), a granulosa cell-secreted cytokine, and fi bro-
blastic growth factor (bFGF), produced by the oocyte, 
also appear to stimulate the transition of primordial 
follicles to primary follicles in various species [5]. 
 Conversely there are important inhibitory factors 
present in the ovary to control the rate of primordial 
follicle activation, one of which is anti-M ü llerian hor-
mone (AMH). Like the BMPs, AMH is a member 
of the TGF β superfamily; however, a key role appears 
to be suppression of primordial follicle recruitment 
[6]. AMH is produced by the granulosa cells of pre-
antral and small antral follicles, with a sharp decline 
in larger antral follicles [7]. It is possible that AMH 
produced by the cohort of growing preantral and 
early antral follicles inhibit the growth of their neigh-
bouring primordial follicles, thereby restraining the 
number of follicles activated at any one time. In addi-
tion to its direct inhibitory role in early follicle devel-
opment, AMH can also suppress activation indirectly, 
by reducing the expression of SCF and bFGF [5]. 
 After activation from primordial follicles to 
primary follicles, the next step is development into 
secondary, or pre-antral, follicle stages. This pro-
cess requires further oocyte growth and prolifera-
tion of the granulosa cells. Once again, members 
of the TGF β superfamily play a role, with the 
dimeric protein activin enhancing granulosa cell 
proliferation [8]. At this point, follicular growth is 
gonadotrophin-sensitive rather than dependent; 
activin also promotes the responsiveness of granu-
losa cells to follicle-stimulating hormone (FSH) 
[8], and, consequently, further follicular growth 
relies on gonadotrophins. Growth differentiation 
factor 9 (GDF9) and BMP15 are both expressed 
by the oocyte and are essential in the development 
of follicles past the primary stage [9]. They work 
synergistically to regulate cell proliferation within 
the follicle and regulate SCF expression. AMH has 
a further inhibitory role at this stage of folliculo-
genesis, by reducing FSH-sensitivity. The down-
regulation of AMH expression as follicles grow 
coincides with an equally sharp upregulation of 
aromatase expression, and thus the capacity of the 
follicle to make estradiol [7]. AMH is thus not only 
involved in controlling the rate at which follicles 
leave the primordial pool, but it may play a role in 
the selection of the dominant follicle. While these 
growth factors have increasingly defi ned roles, 
there are likely to be other, as yet, unrecognized 
pathways of key importance. 
 A crucial aspect to the whole process is the abil-
ity for the oocyte and its surrounding somatic cells 
to communicate with each other. It is now clear 
that this communication is bi-directional, via gap 
junctions and transzonal projections, which allow 
essential molecules to pass between the oocyte and 
granulosa cells (reviewed in [10]). 
 Follicle selection and ovulation 
 As follicles grow, they become progressively more 
dependent on gonadotrophins for continued devel-
opment and survival. FSH promotes granulosa cell 
proliferation and differentiation, allowing the folli-
cle to increase in size. By the time the follicle forms 
an antrum, from follicular fl uid produced by the 
granulosa cells, it is entirely FSH-dependent for 
further development. Both the granulosa cells and 
theca cells express gonadotrophin receptors and 
become responsible for sex steroidogenesis, with 
theca cells becoming LH responsive (thus produc-
ing androgen) and granulosa cells responding to 
FSH (and converting theca cell-derived androgen 
to oestradiol by aromatization: the two-cell, two-
gonadotrophin hypothesis). By now, granulosa cells 
can be compartmentalized into two groups: cumu-
lus cells surrounding the oocyte and promoting its 
maturation, and mural granulosa cells around the 
inner aspect of the follicle, producing sex steroids. 
The follicle destined for when ovulation occurs is 
now  ∼ 10 – 12 mm in diameter and can be accurately 
monitored by ultrasound. 
 Subsequent ovulation is triggered by a surge of 
LH and an antral follicle will only become preovu-
latory if both its granulosa cells and theca cells 
express LH receptors at the time of this surge. It 
has become clear that the effect of the LH surge is 
mediated through EGF family members including 
epiregulin and amphiregulin produced by mural 
granulosa cells and acting on the cumulus [11]. 
Most mammals control their ovulation rate in order 
to regulate the number of offspring they can con-
ceive at one time. In humans, this requires that only 
one growing follicle attains  ‘ dominance ’ , whilst the 
rest become  ‘ subordinate ’ and, eventually, atretric. 
The importance of the oocyte in regulating this pro-
cess is demonstrated by the effect of heterozygosity 
for mutations in BMP15 and GDF9 in sheep which 
can result in higher ovulation rates, whereas 
homozygosity leads to sterility [12]. 
 The basis for the model for the regulation of ovu-
lation rate was fi rst proposed almost 30 years ago [13]. 
It is thought that, during a follicular wave, there is a 
fi gurative  ‘ gate ’ or  ‘ window ’ of time during which FSH 
concentrations are above the threshold necessary for 
large, gonadotrophin-dependent follicles to escape 
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tates how many follicles become ovulatory: one would 
hypothesize that monovular species have a short win-
dow, thus allowing only one follicle to undergo ovula-
tion following the necessary LH surge. 
 Clearly, folliculogenesis is complicated and not 
yet fully understood. However, could some of the 
major players involved be useful clinically in assess-
ing the follicular pool? 
 Assessment of the follicular pool 
 It is widely believed that women are born with a fi nite 
supply of oocytes (although this has been challenged 
in the last decade (reviewed in [14]). As such, the size 
of the non-growing follicular (NGF) pool determines 
the length of a woman ’ s reproductive lifespan. For 
clinical purposes, it is useful to know the size of a 
woman ’ s available follicular pool to aid assessment and 
management of infertility. Furthermore, the increasing 
trend of delaying having children in women in western 
societies indicates that accurate prediction of ovarian 
reserve is important, not only medically, but socio-
logically, as women seek to fi nd out how long they have 
left on their  ‘ biological clock ’ . These two pools should 
be distinguished: the term  ‘ ovarian reserve ’ is often 
used in this context although more correctly should be 
reserved for the primordial follicle pool. What is often 
meant is the potential ovarian response to exogenous 
gonadotrophins (most commonly in superovulation 
for IVF), which consists of follicles already at the antral 
stage of development. At present there are no known 
biomarkers of the primordial follicle pool, and the 
available markers have, at best, indirect relationships 
with the number of primordial follicles in the ovary 
based on the assumption that the size of the pool of 
follicles that are potentially recruitable is related to the 
primordial follicle number, allowing prediction of 
reproductive lifespan. Histological analysis of primor-
dial follicle number has been correlated with ultra-
sound and serum assessment of ovarian reserve 
markers [15] showing that there are indeed useful rela-
tionships, but the indirectness of these relationships 
must always be borne in mind in interpretation. This 
has been recently demonstrated in an analysis of AMH 
in children with newly diagnosed cancer, which showed 
that AMH was generally low compared to age-matched 
controls, and correlated negatively with markers of ill 
health such as C reactive protein [16]. 
 One physical method of evaluating the ovarian 
reserve is measurement of the antral follicle count 
(AFC) by transvaginal ultrasonography (TVUSS). 
The AFC is the number of follicles less than 10 mm 
in diameter in the early follicular phase of the men-
strual cycle and has a close inverse correlation with 
age. However, AFC shows some variation from one 
menstrual cycle to the next and there is inter-observer 
variability by the sonographer. Additionally improve-
ments in ultrasound technology have had an impact 
on image quality and thus follicle recognition: this is 
of importance where the AFC is used for diagnostic 
purposes, e.g. in polycystic ovary syndrome [17]. 
 Various serum biomarkers have also been pro-
posed for the prediction of the size of the remaining 
follicular pool. Three hormones that have been 
assessed as biomarkers are FSH, inhibin B and AMH; 
however, the  ‘ perfect ’ biomarker is yet to be found. 
Early follicular phase FSH has been the most exten-
sively used biomarker to date as it has long been 
measurable and indicates ovarian feedback on the 
hypothalamic-pituitary axis. As women age and their 
ovarian reserve declines, FSH concentrations rise. 
The major drawback is the marked cycle-to-cycle 
variation in FSH, as well as the need for the sample 
to be taken in the early follicular phase. 
 Inhibin B is produced by the granulosa cells of small 
antral follicles and is a key physiological inhibitor of 
FSH secretion, limiting the inter-cycle FSH rise. There 
was considerable interest in inhibin B as a predictor of 
ovarian response in assisted reproduction but it has 
now largely been replaced by measurement of AMH. 
 AMH has now been used in clinical practice for 
some years for the assessment of response to supero-
vulation regimens used in  in vitro fertilization (IVF), 
and its role and potential value is increasingly recog-
nized [18]. It is useful as a predictor of those likely 
to respond poorly, but unlike FSH can also identify 
women at high risk of ovarian hyperstimulation. AMH 
has the advantage of low inter- and intra-cycle vari-
ability so can be measured at any time of the men-
strual cycle. It is also being explored as a predictor of 
time to menopause, provided a woman ’ s age is 
accounted for when interpreting the measurement 
[19]. It is, however, affected by suppressed gonado-
trophin levels, with lower AMH concentrations seen 
during pregnancy and long-term gonadotrophin-re-
leasing hormone (GnRH) analogue treatment. In 
addition, there is a pressing need for standardization 
of AMH quantifi cation between the available com-
mercial assays [18]. 
 While AMH shows much promise as a serum 
biomarker, in general it is of very similar predictive 
value as AFC and the clinical situation will therefore 
at present determine which test is preferred. There 
remains a need for more biomarkers for the earliest 
stages of follicle number, and ultimately of primor-
dial follicle number. Increasing molecular analysis of 
follicle populations using human samples may well 
provide insights of value in this quest [20]. 
 Conclusion 
 It is evident that a multitude of signalling factors are 
required, at the right concentrations and at the right 
time, in order for a competent, mature oocyte to be 
produced on a monthly basis. Furthermore, a fi ne 
balance of activating and inhibitory factors is essen-
tial to regulate the rate at which follicles are recruited 
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is important if we wish to understand the regulation 
that allows follicles formed before birth to suffi ce for 
50 years of ovarian activity. Additionally, it is neces-
sary for manipulation of folliculogenesis for use in 
assisted reproductive techniques and new contracep-
tives. Although AMH is showing promise in the 
assessment of ovarian reserve, there is still much to 
learn about the process of folliculogenesis and fur-
ther research may yet uncover a new, more accurate 
biomarker of ovarian reserve. 
 Questions and answers 
 Q (Villa): Does the relationship between AMH (anti-
M ü llerian hormone) and follicular growth vary in 
different pathological conditions? 
 A (Anderson): There is a little data on this but not 
much. Recently a group from Rotterdam published a 
paper in the journal  Human Reproduction , which showed 
that at the point of diagnosis, AMH concentrations 
were lower than they ought to be in children with can-
cer. Also the concentrations were inversely correlated 
to CRP concentrations and to hemoglobin concentra-
tions, so the more ill the child, the lower the AMH. 
 Comment (Carmina): There are also data in 
patients with Klinefelter ’ s disease and in patients 
with delayed puberty. AMH is used by pediatric 
oncologists to differentiate patients who will go on 
to regular puberty from those who will not. 
 Comment (Anderson): Related to this is the gonad-
otropin dependence of AMH. Long-term gonadotro-
pin suppression treatment will lead to decreased 
AMH. 
 Comment (Burney): There are other situations in 
which AMH is decreased such as endometriosis, 
infl ammatory bowel disease and pelvic infl ammatory 
disease. 
 Q (Burney): Is there any progress towards a refer-
ence standard for AMH? 
 A (Anderson and Beastall): There has been talk 
about this and moves towards it. There is growing 
recognition that AMH is a biomarker which is of use 
and for which there is a future. If it is to be used for 
clinical purposes, it is essential that assays are good 
and standardization is a prerequisite for this. There 
are other possible markers but the data on them is 
not robust and the evidence is sometimes indirect. 
 Q (Ballieux): My professor in Obstetrics and 
Gynaecology says that ultrasound is better than 
AMH which is thus unnecessary. Is AMH useful for 
patient care or for research? 
 A (Anderson): Ultrasound examinations are expen-
sive and in primary care a blood test is much more 
useful. AMH concentration measurements are likely 
to become of much more clinical use in the future. 
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